entity_type,gtopdb_id,name,abbreviation,systematic_name,url,class,families,uniprot_accessions,gene_symbols,gene_ids,ligand_pubchem_cid,ligand_pubchem_sid,smiles,inchi,inchikey
Target,380,K<sub>Ca</sub>1.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=380,VGIC,"Calcium- and sodium-activated potassium channels (K<sub>Ca</sub>, K<sub>Na</sub>)",Human:Q12791|Mouse:Q08460|Rat:Q62976,Human:KCNMA1|Mouse:Kcnma1|Rat:Kcnma1,Human:6284|Mouse:MGI:99923|Rat:620715,,,,,,
Target,262,H<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=262,GPCR,Histamine receptors,Human:P35367|Mouse:P70174|Rat:P31390,Human:HRH1|Mouse:Hrh1|Rat:Hrh1,Human:5182|Mouse:MGI:107619|Rat:2830,,,,,,
Target,3139,CoV RNA-dependent RNA polymerase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3139,OtherProtein,Coronavirus (CoV) proteins,SARS-CoV-2:P0DTD1|SARS-CoV:P0C6X7,,,,,,,,
Target,3125,CoV Replicase polyprotein 1ab,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3125,OtherProtein,Coronavirus (CoV) proteins,SARS-CoV-2:P0DTD1|SARS-CoV:P0C6X7,,,,,,,,
Target,3124,CoV Replicase polyprotein 1a,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3124,OtherProtein,Coronavirus (CoV) proteins,SARS-CoV-2:P0DTC1|SARS-CoV:P0C6U8,,,,,,,,
Target,8,5-HT<sub>2C</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=8,GPCR,5-Hydroxytryptamine receptors,Human:P28335|Mouse:P34968|Rat:P08909,Human:HTR2C|Mouse:Htr2c|Rat:Htr2c,Human:5295|Mouse:MGI:96281|Rat:2848,,,,,,
Target,2285,zeta chain of T cell receptor associated protein kinase 70,ZAP70,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2285,Enzyme,Syk family,Human:P43403|Mouse:P43404,Human:ZAP70|Mouse:Zap70|Rat:Zap70,Human:12858|Mouse:MGI:99613|Rat:3983,,,,,,
Target,2289,ZAK sterile alpha motif and leucine zipper containing kinase AZK,ZAK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2289,Enzyme,MLK subfamily,Human:Q9NYL2|Mouse:Q9ESL4,Human:MAP3K20|Mouse:Map3k20|Rat:Map3k20,Human:17797|Mouse:MGI:2443258|Rat:1561394,,,,,,
Target,307,Y<sub>4</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=307,GPCR,Neuropeptide Y receptors,Human:P50391|Mouse:Q61041|Rat:Q63447,Human:NPY4R|Mouse:Npy4r|Rat:Npy4r,Human:9329|Mouse:MGI:105374|Rat:61864,,,,,,
Target,306,Y<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=306,GPCR,Neuropeptide Y receptors,Human:P49146|Mouse:P97295|Rat:Q9ERC0,Human:NPY2R|Mouse:Npy2r|Rat:Npy2r,Human:7957|Mouse:MGI:108418|Rat:620475,,,,,,
Target,898,y+L amino acid transporter 1,y+LAT1,SLC7A7,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=898,Transporter,SLC7 family,Human:Q9UM01|Mouse:Q9Z1K8|Rat:Q9R0S5,Human:SLC7A7|Mouse:Slc7a7|Rat:Slc7a7,Human:11065|Mouse:MGI:1337120|Rat:619902,,,,,,
Target,2284,"YES proto-oncogene 1, Src family tyrosine kinase",Yes,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2284,Enzyme,Src family,Human:P07947|Mouse:Q04736|Rat:F1LM93,Human:YES1|Mouse:Yes1|Rat:Yes1,Human:12841|Mouse:MGI:99147|Rat:3977,,,,,,
Target,2790,X-linked inhibitor of apoptosis,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2790,OtherProtein,Inhibitors of apoptosis (IAP) protein family,Human:P98170|Mouse:Q60989|Rat:Q9R0I6,Human:XIAP|Mouse:Xiap|Rat:Xiap,Human:592|Mouse:MGI:107572|Rat:620692,,,,,,
Target,2646,xanthine dehydrogenase,XDH,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2646,Enzyme,1.-.-.- Oxidoreductases|Nucleoside synthesis and metabolism,Human:P47989|Mouse:Q00519|Rat:P22985,Human:XDH|Mouse:Xdh|Rat:Xdh,Human:12805|Mouse:MGI:98973|Rat:62043,,,,,,
Target,2278,WEE1 G2 checkpoint kinase,Wee1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2278,Enzyme,WEE family,Human:P30291|Mouse:P47810|Rat:Q63802,Human:WEE1|Mouse:Wee1|Rat:Wee1,Human:12761|Mouse:MGI:103075|Rat:1307895,,,,,,
Target,822,V-type ATPase V<sub>1</sub> motor H subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=822,Transporter,V-type ATPase,Human:Q9UI12|Mouse:Q8BVE3,Human:ATP6V1H|Mouse:Atp6v1h|Rat:Atp6v1h,Human:18303|Mouse:MGI:1914864|Rat:1562450,,,,,,
Target,821,V-type ATPase V<sub>1</sub> motor G3 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=821,Transporter,V-type ATPase,Human:Q96LB4|Mouse:Q8BMC1,Human:ATP6V1G3|Mouse:Atp6v1g3|Rat:Atp6v1g3,Human:18265|Mouse:MGI:2450548|Rat:1304635,,,,,,
Target,820,V-type ATPase V<sub>1</sub> motor G2 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=820,Transporter,V-type ATPase,Human:O95670|Mouse:Q9WTT4,Human:ATP6V1G2|Mouse:Atp6v1g2|Rat:Atp6v1g2,Human:862|Mouse:MGI:1913487|Rat:1303186,,,,,,
Target,819,V-type ATPase V<sub>1</sub> motor G1 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=819,Transporter,V-type ATPase,Human:O75348|Mouse:Q9CR51,Human:ATP6V1G1|Mouse:Atp6v1g1|Rat:Atp6v1g1,Human:864|Mouse:MGI:1913540|Rat:1310088,,,,,,
Target,818,V-type ATPase V<sub>1</sub> motor F subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=818,Transporter,V-type ATPase,Human:Q16864|Mouse:Q9D1K2|Rat:P50408,Human:ATP6V1F|Mouse:Atp6v1f|Rat:Atp6v1f,Human:16832|Mouse:MGI:1913394|Rat:621552,,,,,,
Target,817,V-type ATPase V<sub>1</sub> motor E2 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=817,Transporter,V-type ATPase,Human:Q96A05|Mouse:Q9D593,Human:ATP6V1E2|Mouse:Atp6v1e2|Rat:Atp6v1e2,Human:18125|Mouse:MGI:1922165|Rat:1311680,,,,,,
Target,816,V-type ATPase V<sub>1</sub> motor E1 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=816,Transporter,V-type ATPase,Human:P36543|Mouse:P50518|Rat:Q6PCU2,Human:ATP6V1E1|Mouse:Atp6v1e1|Rat:Atp6v1e1,Human:857|Mouse:MGI:894326|Rat:735157,,,,,,
Target,815,V-type ATPase V<sub>1</sub> motor D subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=815,Transporter,V-type ATPase,Human:Q9Y5K8|Mouse:P57746,Human:ATP6V1D|Mouse:Atp6v1d|Rat:Atp6v1d,Human:13527|Mouse:MGI:1921084|Rat:735119,,,,,,
Target,814,V-type ATPase V<sub>1</sub> motor C2 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=814,Transporter,V-type ATPase,Human:Q8NEY4|Mouse:Q99L60|Rat:Q6AYE4,Human:ATP6V1C2|Mouse:Atp6v1c2|Rat:Atp6v1c2,Human:18264|Mouse:MGI:1916025|Rat:1359430,,,,,,
Target,813,V-type ATPase V<sub>1</sub> motor C1 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=813,Transporter,V-type ATPase,Human:P21283|Mouse:Q9Z1G3|Rat:Q5FVI6,Human:ATP6V1C1|Mouse:Atp6v1c1|Rat:Atp6v1c1,Human:856|Mouse:MGI:1913585|Rat:1311082,,,,,,
Target,812,V-type ATPase V<sub>1</sub> motor B2 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=812,Transporter,V-type ATPase,Human:P21281|Mouse:P62814|Rat:P62815,Human:ATP6V1B2|Mouse:Atp6v1b2|Rat:Atp6v1b2,Human:854|Mouse:MGI:109618|Rat:620284,,,,,,
Target,811,V-type ATPase V<sub>1</sub> motor B1 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=811,Transporter,V-type ATPase,Human:P15313,Human:ATP6V1B1|Mouse:Atp6v1b1|Rat:Atp6v1b1,Human:853|Mouse:MGI:103285|Rat:1310619,,,,,,
Target,810,V-type ATPase V<sub>1</sub> motor A subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=810,Transporter,V-type ATPase,Human:P38606|Mouse:P50516,Human:ATP6V1A|Mouse:Atp6v1a|Rat:Atp6v1a,Human:851|Mouse:MGI:1201780|Rat:1596464,,,,,,
Target,832,V-type ATPase V<sub>0</sub> motor e2 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=832,Transporter,V-type ATPase,Human:Q8NHE4|Mouse:Q91XE7|Rat:Q5EB76,Human:ATP6V0E2|Mouse:Atp6v0e2|Rat:Atp6v0e2,Human:21723|Mouse:MGI:1923502|Rat:1303238,,,,,,
Target,831,V-type ATPase V<sub>0</sub> motor e1 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=831,Transporter,V-type ATPase,Human:O15342|Mouse:Q9CQD8|Rat:Q794C0,Human:ATP6V0E1|Mouse:Atp6v0e|Rat:Atp6v0e1,Human:863|Mouse:MGI:1328318|Rat:621393,,,,,,
Target,830,V-type ATPase V<sub>0</sub> motor d2 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=830,Transporter,V-type ATPase,Human:Q8N8Y2|Mouse:Q80SY3|Rat:Q5FVL0,Human:ATP6V0D2|Mouse:Atp6v0d2|Rat:Atp6v0d2,Human:18266|Mouse:MGI:1924415|Rat:1306900,,,,,,
Target,829,V-type ATPase V<sub>0</sub> motor d1 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=829,Transporter,V-type ATPase,Human:P61421|Mouse:P51863,Human:ATP6V0D1|Mouse:Atp6v0d1|Rat:Atp6v0d1,Human:13724|Mouse:MGI:1201778|Rat:1306159,,,,,,
Target,828,V-type ATPase V<sub>0</sub> motor c subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=828,Transporter,V-type ATPase,Human:P27449|Mouse:P63082|Rat:P63081,Human:ATP6V0C|Mouse:Atp6v0c|Rat:Atp6v0c,Human:855|Mouse:MGI:88116|Rat:621394,,,,,,
Target,827,V-type ATPase V<sub>0</sub> motor b subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=827,Transporter,V-type ATPase,Human:Q99437|Mouse:Q91V37,Human:ATP6V0B|Mouse:Atp6v0b|Rat:Atp6v0b,Human:861|Mouse:MGI:1890510|Rat:1308303,,,,,,
Target,826,V-type ATPase V<sub>0</sub> motor a4 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=826,Transporter,V-type ATPase,Human:Q9HBG4|Mouse:Q920R6,Human:ATP6V0A4|Mouse:Atp6v0a4|Rat:Atp6v0a4,Human:866|Mouse:MGI:2153480|Rat:1305055,,,,,,
Target,825,V-type ATPase V<sub>0</sub> motor a3 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=825,Transporter,V-type ATPase,Human:Q13488,Human:TCIRG1|Mouse:Tcirg1|Rat:Tcirg1,Human:11647|Mouse:MGI:1350931|Rat:735136,,,,,,
Target,824,V-type ATPase V<sub>0</sub> motor a2 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=824,Transporter,V-type ATPase,Human:Q9Y487|Mouse:P15920,Human:ATP6V0A2|Mouse:Atp6v0a2|Rat:Atp6v0a2,Human:18481|Mouse:MGI:104855|Rat:621006,,,,,,
Target,823,V-type ATPase V<sub>0</sub> motor a1 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=823,Transporter,V-type ATPase,Human:Q93050|Mouse:Q9Z1G4|Rat:P25286,Human:ATP6V0A1|Mouse:Atp6v0a1|Rat:Atp6v0a1,Human:865|Mouse:MGI:103286|Rat:68405,,,,,,
Target,368,V<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=368,GPCR,Vasopressin and oxytocin receptors,Human:P30518|Mouse:O88721|Rat:Q00788,Human:AVPR2|Mouse:Avpr2|Rat:Avpr2,Human:897|Mouse:MGI:88123|Rat:2186,,,,,,
Target,367,V<sub>1B</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=367,GPCR,Vasopressin and oxytocin receptors,Human:P47901|Mouse:Q9WU02|Rat:P48974,Human:AVPR1B|Mouse:Avpr1b|Rat:Avpr1b,Human:896|Mouse:MGI:1347010|Rat:61886,,,,,,
Target,366,V<sub>1A</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=366,GPCR,Vasopressin and oxytocin receptors,Human:P37288|Mouse:Q62463|Rat:P30560,Human:AVPR1A|Mouse:Avpr1a|Rat:Avpr1a,Human:895|Mouse:MGI:1859216|Rat:2185,,,,,,
Target,2645,vitamin K epoxide reductase complex subunit 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2645,Enzyme,1.-.-.- Oxidoreductases,Human:Q9BQB6|Mouse:Q9CRC0|Rat:Q6TEK4,Human:VKORC1|Mouse:Vkorc1|Rat:Vkorc1,Human:23663|Mouse:MGI:106442|Rat:1303107,,,,,,
Target,605,Vitamin D receptor,,NR1I1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=605,NHR,1I. Vitamin D receptor-like receptors,Human:P11473|Mouse:Q922X0|Rat:P13053,Human:VDR|Mouse:Vdr|Rat:Vdr,Human:12679|Mouse:MGI:103076|Rat:3959,,,,,,
Target,1012,Vesicular monoamine transporter 2,VMAT2,SLC18A2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1012,Transporter,SLC18 family of vesicular amine transporters,Human:Q05940|Mouse:Q8BRU6|Rat:Q01827,Human:SLC18A2|Mouse:Slc18a2|Rat:Slc18a2,Human:10935|Mouse:MGI:106677|Rat:3694,,,,,,
Target,1011,Vesicular monoamine transporter 1,VMAT1,SLC18A1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1011,Transporter,SLC18 family of vesicular amine transporters,Human:P54219|Mouse:Q8R090|Rat:Q01818,Human:SLC18A1|Mouse:Slc18a1|Rat:Slc18a1,Human:10934|Mouse:MGI:106684|Rat:3693,,,,,,
Target,1031,Urate anion exchanger 1,URAT1,SLC22A12,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1031,Transporter,Urate transporter,Human:Q96S37|Mouse:Q8CFZ5|Rat:Q3ZAV1,Human:SLC22A12|Mouse:Slc22a12|Rat:Slc22a12,Human:17989|Mouse:MGI:1195269|Rat:621628,,,,,,
Target,2273,unc-51 like kinase 3,ULK3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2273,Enzyme,Unc-51-like kinase (ULK) family,Human:Q6PHR2|Mouse:Q3U3Q1|Rat:D3ZHP7,Human:ULK3|Mouse:Ulk3|Rat:Ulk3,Human:19703|Mouse:MGI:1918992|Rat:1587417,,,,,,
Target,2272,unc-51 like autophagy activating kinase 2,ULK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2272,Enzyme,Unc-51-like kinase (ULK) family,Human:Q8IYT8|Mouse:Q9QY01,Human:ULK2|Mouse:Ulk2|Rat:Ulk2,Human:13480|Mouse:MGI:1352758|Rat:1310181,,,,,,
Target,2271,unc-51 like autophagy activating kinase 1,ULK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2271,Enzyme,Unc-51-like kinase (ULK) family,Human:O75385|Mouse:O70405,Human:ULK1|Mouse:Ulk1|Rat:Ulk1,Human:12558|Mouse:MGI:1270126|Rat:1589743,,,,,,
Target,2990,UDP glucuronosyltransferase family 1 member A1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2990,Enzyme,UDP glucuronosyltransferases (UGT),Human:P22309|Mouse:Q63886|Rat:Q64550,Human:UGT1A1|Mouse:Ugt1a1|Rat:Ugt1a1,Human:12530|Mouse:MGI:98898|Rat:3935,,,,,,
Target,2528,UDP-glucose ceramide glucosyltransferase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2528,Enzyme,Ceramide glucosyltransferase,Human:Q16739|Mouse:O88693|Rat:Q9R0E0,Human:UGCG|Mouse:Ugcg|Rat:Ugcg,Human:12524|Mouse:MGI:1332243|Rat:621870,,,,,,
Target,2429,ubiquitin specific peptidase 14,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2429,Enzyme,C19: Ubiquitin-specific protease,Human:P54578|Mouse:Q9JMA1,Human:USP14|Mouse:Usp14|Rat:Usp14,Human:12612|Mouse:MGI:1928898|Rat:1311825,,,,,,
Target,2426,ubiquitin C-terminal hydrolase L1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2426,Enzyme,C12: Ubiquitin C-terminal hydrolase,Human:P09936|Mouse:Q9R0P9|Rat:Q00981,Human:UCHL1|Mouse:Uchl1|Rat:Uchl1,Human:12513|Mouse:MGI:103149|Rat:3928,,,,,,
Target,1841,tyrosine kinase with immunoglobulin like and EGF like domains 1,TIE1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1841,CatalyticReceptor,Type XII RTKs: TIE family of angiopoietin receptors,Human:P35590|Mouse:Q06806,Human:TIE1|Mouse:Tie1|Rat:Tie1,Human:11809|Mouse:MGI:99906|Rat:621642,,,,,,
Target,2246,tyrosine kinase non receptor 2,Ack,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2246,Enzyme,Ack family,Human:Q07912|Mouse:O54967|Rat:Q5U2X5,Human:TNK2|Mouse:Tnk2|Rat:Tnk2,Human:19297|Mouse:MGI:1858308|Rat:1305957,,,,,,
Target,2245,tyrosine kinase non receptor 1,Tnk1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2245,Enzyme,Ack family,Human:Q13470|Mouse:Q99ML2,Human:TNK1|Mouse:Tnk1|Rat:Tnk1,Human:11940|Mouse:MGI:1930958|Rat:1310113,,,,,,
Target,2269,tyrosine kinase 2,Tyk2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2269,Enzyme,Janus kinase (JakA) family,Human:P29597|Mouse:Q9R117,Human:TYK2|Mouse:Tyk2|Rat:Tyk2,Human:12440|Mouse:MGI:1929470|Rat:2320469,,,,,,
Target,2527,Tyrosine aminotransferase,TAT,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2527,Enzyme,Catecholamine turnover,Human:P17735|Mouse:Q8QZR1|Rat:P04694,Human:TAT|Mouse:Tat|Rat:Tat,Human:11573|Mouse:MGI:98487|Rat:3820,,,,,,
Target,2643,tyrosinase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2643,Enzyme,1.-.-.- Oxidoreductases,Human:P14679|Mouse:P11344,Human:TYR|Mouse:Tyr|Rat:Tyr,Human:12442|Mouse:MGI:98880|Rat:1589755,,,,,,
Target,1836,TYRO3 protein tyrosine kinase,Tyro3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1836,CatalyticReceptor,"Type XI RTKs: TAM (TYRO3-, AXL- and MER-TK) receptor family",Human:Q06418|Mouse:P55144|Rat:P55146,Human:TYRO3|Mouse:Tyro3|Rat:Tyro3,Human:12446|Mouse:MGI:104294|Rat:3923,,,,,,
Target,2268,TXK tyrosine kinase,TXK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2268,Enzyme,Tec family,Human:P42681|Mouse:P42682,Human:TXK|Mouse:Txk|Rat:Txk,Human:12434|Mouse:MGI:102960|Rat:1306481,,,,,,
Target,1870,tumor necrosis factor receptor 1,TNFR1,TNFRSF1A,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1870,CatalyticReceptor,Tumour necrosis factor (TNF) receptor family,Human:P19438|Mouse:P25118|Rat:P22934,Human:TNFRSF1A|Mouse:Tnfrsf1a|Rat:Tnfrsf1a,Human:11916|Mouse:MGI:1314884|Rat:621237,,,,,,
Target,2640,tubulin beta class I,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2640,OtherProtein,Tubulins,Human:P07437|Mouse:P99024|Rat:P69897,Human:TUBB|Mouse:Tubb5|Rat:Tubb5,Human:20778|Mouse:MGI:107812|Rat:628596,,,,,,
Target,2641,tubulin beta 4B class IVb,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2641,OtherProtein,Tubulins,Human:P68371|Mouse:P68372|Rat:Q6P9T8,Human:TUBB4B|Mouse:Tubb4b|Rat:Tubb4b,Human:20771|Mouse:MGI:1915472|Rat:735101,,,,,,
Target,2752,tubulin beta 3 class III,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2752,OtherProtein,Tubulins,Human:Q13509|Mouse:Q9ERD7|Rat:Q4QRB4,Human:TUBB3|Mouse:Tubb3|Rat:Tubb3,Human:20772|Mouse:MGI:107813|Rat:628595,,,,,,
Target,2639,tubulin alpha 4a,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2639,OtherProtein,Tubulins,Human:P68366|Mouse:P68368|Rat:Q5XIF6,Human:TUBA4A|Mouse:Tuba4a|Rat:Tuba4a,Human:12407|Mouse:MGI:1095410|Rat:1359623,,,,,,
Target,2638,tubulin alpha 1a,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2638,OtherProtein,Tubulins,Human:Q71U36|Mouse:P68369|Rat:P68370,Human:TUBA1A|Mouse:Tuba1a|Rat:Tuba1a,Human:20766|Mouse:MGI:98869|Rat:619717,,,,,,
Target,2264,TTK protein kinase,TTK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2264,Enzyme,TTK family,Human:P33981|Mouse:P35761,Human:TTK|Mouse:Ttk|Rat:Ttk,Human:12401|Mouse:MGI:1194921|Rat:1305558,,,,,,
Target,2424,tryptase alpha/beta 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2424,Enzyme,S1: Chymotrypsin,Human:Q15661,Human:TPSAB1,Human:12019,,,,,,
Target,510,TRPV4,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=510,VGIC,Transient Receptor Potential channels (TRP),Human:Q9HBA0|Mouse:Q9EPK8|Rat:Q9ERZ8,Human:TRPV4|Mouse:Trpv4|Rat:Trpv4,Human:18083|Mouse:MGI:1926945|Rat:69337,,,,,,
Target,509,TRPV3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=509,VGIC,Transient Receptor Potential channels (TRP),Human:Q8NET8|Mouse:Q8K424,Human:TRPV3|Mouse:Trpv3|Rat:Trpv3,Human:18084|Mouse:MGI:2181407|Rat:1564531,,,,,,
Target,508,TRPV2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=508,VGIC,Transient Receptor Potential channels (TRP),Human:Q9Y5S1|Mouse:Q9WTR1|Rat:Q9WUD2,Human:TRPV2|Mouse:Trpv2|Rat:Trpv2,Human:18082|Mouse:MGI:1341836|Rat:3965,,,,,,
Target,507,TRPV1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=507,VGIC,Transient Receptor Potential channels (TRP),Human:Q8NER1|Mouse:Q704Y3|Rat:O35433,Human:TRPV1|Mouse:Trpv1|Rat:Trpv1,Human:12716|Mouse:MGI:1341787|Rat:628841,,,,,,
Target,500,TRPM8,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=500,VGIC,Transient Receptor Potential channels (TRP),Human:Q7Z2W7|Mouse:Q8R4D5|Rat:Q8R455,Human:TRPM8|Mouse:Trpm8|Rat:Trpm8,Human:17961|Mouse:MGI:2181435|Rat:620762,,,,,,
Target,499,TRPM7,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=499,VGIC,Transient Receptor Potential channels (TRP)|ChaK subfamily,Human:Q96QT4|Mouse:Q923J1|Rat:Q925B3,Human:TRPM7|Mouse:Trpm7|Rat:Trpm7,Human:17994|Mouse:MGI:1929996|Rat:620053,,,,,,
Target,496,TRPM4,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=496,VGIC,Transient Receptor Potential channels (TRP),Human:Q8TD43|Mouse:Q7TN37|Rat:Q9ESQ5,Human:TRPM4|Mouse:Trpm4|Rat:Trpm4,Human:17993|Mouse:MGI:1915917|Rat:620244,,,,,,
Target,485,TRPA1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=485,VGIC,Transient Receptor Potential channels (TRP),Human:O75762|Mouse:Q8BLA8|Rat:Q6RI86,Human:TRPA1|Mouse:Trpa1|Rat:Trpa1,Human:497|Mouse:MGI:3522699|Rat:1303284,,,,,,
Target,363,TRH<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=363,GPCR,Thyrotropin-releasing hormone receptors,Human:P34981|Mouse:P21761|Rat:Q01717,Human:TRHR|Mouse:Trhr|Rat:Trhr,Human:12299|Mouse:MGI:98824|Rat:3904,,,,,,
Target,2851,transthyretin,TTR,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2851,OtherProtein,Transthyretin,Human:P02766|Mouse:P07309|Rat:P02767,Human:TTR|Mouse:Ttr|Rat:Ttr,Human:12405|Mouse:MGI:98865|Rat:3916,,,,,,
Target,2421,transmembrane serine protease 2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2421,Enzyme,S1: Chymotrypsin,Human:O15393|Mouse:Q9JIQ8,Human:TMPRSS2|Mouse:Tmprss2|Rat:Tmprss2,Human:11876|Mouse:MGI:1354381|Rat:620766,,,,,,
Target,2879,Translocator protein,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2879,OtherProtein,Mitochondrial-associated proteins,Human:P30536|Mouse:P50637|Rat:P16257,Human:TSPO|Mouse:Tspo|Rat:Tspo,Human:1158|Mouse:MGI:88222|Rat:2228,,,,,,
Target,3015,transglutaminase 2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3015,Enzyme,2.3.2.13 Transglutaminases,Human:P21980|Mouse:P21981,Human:TGM2|Mouse:Tgm2|Rat:Tgm2,Human:11778|Mouse:MGI:98731|Rat:621081,,,,,,
Target,1795,transforming growth factor beta receptor 2,TGFBR2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1795,CatalyticReceptor,Type II receptor serine/threonine kinases,Human:P37173|Mouse:Q62312|Rat:P38438,Human:TGFBR2|Mouse:Tgfbr2|Rat:Tgfbr2,Human:11773|Mouse:MGI:98729|Rat:69651,,,,,,
Target,1788,transforming growth factor beta receptor 1,TGFBR1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1788,CatalyticReceptor,Type I receptor serine/threonine kinases,Human:P36897|Mouse:Q64729|Rat:P80204,Human:TGFBR1|Mouse:Tgfbr1|Rat:Tgfbr1,Human:11772|Mouse:MGI:98728|Rat:3852,,,,,,
Target,2244,TRAF2 and NCK interacting kinase,TNIK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2244,Enzyme,MSN subfamily,Human:Q9UKE5|Mouse:P83510,Human:TNIK|Mouse:Tnik|Rat:Tnik,Human:30765|Mouse:MGI:1916264|Rat:1561817,,,,,,
Target,346,TP receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=346,GPCR,Prostanoid receptors,Human:P21731|Mouse:P30987|Rat:P34978,Human:TBXA2R|Mouse:Tbxa2r|Rat:Tbxa2r,Human:11608|Mouse:MGI:98496|Rat:3825,,,,,,
Target,2243,tousled like kinase 2,TLK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2243,Enzyme,Tousled-like kinase (TLK) family,Human:Q86UE8|Mouse:O55047,Human:TLK2|Mouse:Tlk2|Rat:Tlk2,Human:11842|Mouse:MGI:1346023|Rat:1310907,,,,,,
Target,2242,tousled like kinase 1,TLK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2242,Enzyme,Tousled-like kinase (TLK) family,Human:Q9UKI8|Mouse:Q8C0V0,Human:TLK1|Mouse:Tlk1|Rat:Tlk1,Human:11841|Mouse:MGI:2441683|Rat:1310370,,,,,,
Target,2759,topoisomerase (DNA) I mitochondrial,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2759,Enzyme,DNA topoisomerases,Human:Q969P6|Mouse:Q8R4U6|Rat:Q6IM78,Human:TOP1MT|Mouse:Top1mt|Rat:Top1mt,Human:29787|Mouse:MGI:1920210|Rat:1303177,,,,,,
Target,2247,TNNI3 interacting kinase,HH498,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2247,Enzyme,HH498 subfamily,Human:Q59H18|Mouse:Q5GIG6|Rat:Q7TQP6,Human:TNNI3K|Mouse:Tnni3k|Rat:Tnni3k,Human:19661|Mouse:MGI:2443276|Rat:727908,,,,,,
Target,1759,TLR9,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1759,CatalyticReceptor,Toll-like receptor family,Human:Q9NR96|Mouse:Q9EQU3,Human:TLR9|Mouse:Tlr9|Rat:Tlr9,Human:15633|Mouse:MGI:1932389|Rat:631352,,,,,,
Target,1758,TLR8,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1758,CatalyticReceptor,Toll-like receptor family,Human:Q9NR97|Mouse:P58682,Human:TLR8|Mouse:Tlr8|Rat:Tlr8,Human:15632|Mouse:MGI:2176887|Rat:1590327,,,,,,
Target,1757,TLR7,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1757,CatalyticReceptor,Toll-like receptor family,Human:Q9NYK1|Mouse:P58681,Human:TLR7|Mouse:Tlr7|Rat:Tlr7,Human:15631|Mouse:MGI:2176882|Rat:1563357,,,,,,
Target,1754,TLR4,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1754,CatalyticReceptor,Toll-like receptor family,Human:O00206|Mouse:Q9QUK6|Rat:Q9QX05,Human:TLR4|Mouse:Tlr4|Rat:Tlr4,Human:11850|Mouse:MGI:96824|Rat:3870,,,,,,
Target,1752,TLR2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1752,CatalyticReceptor,Toll-like receptor family,Human:O60603|Mouse:Q9QUN7,Human:TLR2|Mouse:Tlr2|Rat:Tlr2,Human:11848|Mouse:MGI:1346060|Rat:735138,,,,,,
Target,2526,thyroid peroxidase,TPO,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2526,Enzyme,Thyroid hormone turnover,Human:P07202|Mouse:P35419|Rat:P14650,Human:TPO|Mouse:Tpo|Rat:Tpo,Human:12015|Mouse:MGI:98813|Rat:3900,,,,,,
Target,589,Thyroid hormone receptor-&beta;,,NR1A2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=589,NHR,1A. Thyroid hormone receptors,Human:P10828|Mouse:P37242|Rat:P18113,Human:THRB|Mouse:Thrb|Rat:Thrb,Human:11799|Mouse:MGI:98743|Rat:3858,,,,,,
Target,588,Thyroid hormone receptor-&alpha;,,NR1A1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=588,NHR,1A. Thyroid hormone receptors,Human:P10827|Mouse:P63058|Rat:P63059,Human:THRA|Mouse:Thra|Rat:Thra,Human:11796|Mouse:MGI:98742|Rat:3857,,,,,,
Target,2642,thymidylate synthetase,TYMS,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2642,Enzyme,2.1.1.- Methyltransferases|Nucleoside synthesis and metabolism,Human:P04818|Mouse:P07607|Rat:P45352,Human:TYMS|Mouse:Tyms|Rat:Tyms,Human:12441|Mouse:MGI:98878|Rat:3921,,,,,,
Target,1722,Thrombopoietin receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1722,CatalyticReceptor,Prolactin receptor family,Human:P40238|Mouse:Q08351,Human:MPL|Mouse:Mpl|Rat:Mpl,Human:7217|Mouse:MGI:97076|Rat:1311069,,,,,,
Target,2257,testis specific serine kinase 1B,TSSK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2257,Enzyme,Testis specific kinase (TSSK) family,Human:Q9BXA7|Mouse:Q61241,Human:TSSK1B|Mouse:Tssk1|Rat:Tssk1b,Human:14968|Mouse:MGI:1347557|Rat:1307352,,,,,,
Target,2239,testis associated actin remodelling kinase 1,TESK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2239,Enzyme,TESK subfamily,Human:Q15569|Mouse:O70146|Rat:Q63572,Human:TESK1|Mouse:Tesk1|Rat:Tesk1,Human:11731|Mouse:MGI:1201675|Rat:62059,,,,,,
Target,1842,TEK receptor tyrosine kinase,TIE2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1842,CatalyticReceptor,Type XII RTKs: TIE family of angiopoietin receptors,Human:Q02763|Mouse:Q02858,Human:TEK|Mouse:Tek|Rat:Tek,Human:11724|Mouse:MGI:98664|Rat:620980,,,,,,
Target,2238,tec protein tyrosine kinase,TEC,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2238,Enzyme,Tec family,Human:P42680|Mouse:P24604,Human:TEC|Mouse:Tec|Rat:Tec,Human:11719|Mouse:MGI:98662|Rat:620973,,,,,,
Target,364,TA<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=364,GPCR,Trace amine receptor,Human:Q96RJ0|Mouse:Q923Y8|Rat:Q923Y9,Human:TAAR1|Mouse:Taar1|Rat:Taar1,Human:17734|Mouse:MGI:2148258|Rat:621621,,,,,,
Target,2235,TAO kinase 3,TAO3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2235,Enzyme,TAO subfamily,Human:Q9H2K8|Mouse:Q8BYC6|Rat:Q53UA7,Human:TAOK3|Mouse:Taok3|Rat:Taok3,Human:18133|Mouse:MGI:3041177|Rat:1562861,,,,,,
Target,2234,TAO kinase 2,TAO2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2234,Enzyme,TAO subfamily,Human:Q9UL54|Mouse:Q6ZQ29|Rat:Q9JLS3,Human:TAOK2|Mouse:Taok2|Rat:Taok2,Human:16835|Mouse:MGI:1915919|Rat:621590,,,,,,
Target,2233,TAO kinase 1,TAO1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2233,Enzyme,TAO subfamily,Human:Q7L7X3|Mouse:Q5F2E8|Rat:O88664,Human:TAOK1|Mouse:Taok1|Rat:Taok1,Human:29259|Mouse:MGI:1914490|Rat:708455,,,,,,
Target,2237,TANK binding kinase 1,TBK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2237,Enzyme,IKK family,Human:Q9UHD2|Mouse:Q9WUN2,Human:TBK1|Mouse:Tbk1|Rat:Tbk1,Human:11584|Mouse:MGI:1929658|Rat:1588588,,,,,,
Target,2634,synaptic vesicle glycoprotein 2A,,SLC22B1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2634,Transporter,Atypical SLC22B subfamily|P2B P-type ATPases: Ca<sup>2+</sup>-ATPases,Human:Q7L0J3|Mouse:Q9JIS5|Rat:Q02563,Human:SV2A|Mouse:Sv2a|Rat:Sv2a,Human:20566|Mouse:MGI:1927139|Rat:619715,,,,,,
Target,2290,sugen kinase 110,SGK110,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2290,Enzyme,NKF1 family,Human:P0C264|Mouse:P0C5K0,Human:SBK3|Mouse:Sbk3,Human:44121|Mouse:MGI:2685924,,,,,,
Target,166,succinate receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=166,GPCR,Succinate receptor,Human:Q9BXA5|Mouse:Q99MT6|Rat:Q6IYF9,Human:SUCNR1|Mouse:Sucnr1|Rat:Sucnr1,Human:4542|Mouse:MGI:1934135|Rat:1303193,,,,,,
Target,632,Steroidogenic factor 1,,NR5A1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=632,NHR,5A. Fushi tarazu F1-like receptors,Human:Q13285|Mouse:P33242|Rat:P50569,Human:NR5A1|Mouse:Nr5a1|Rat:Nr5a1,Human:7983|Mouse:MGI:1346833|Rat:68350,,,,,,
Target,2633,steroid 5 alpha-reductase 2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2633,Enzyme,1.-.-.- Oxidoreductases,Human:P31213|Mouse:Q99N99|Rat:P31214,Human:SRD5A2|Mouse:Srd5a2|Rat:Srd5a2,Human:11285|Mouse:MGI:2150380|Rat:621480,,,,,,
Target,2200,STE20 like kinase,SLK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2200,Enzyme,SLK subfamily,Human:Q9H2G2|Mouse:O54988|Rat:O08815,Human:SLK|Mouse:Slk|Rat:Slk,Human:11088|Mouse:MGI:103241|Rat:3780,,,,,,
Target,2418,ST14 transmembrane serine protease matriptase ,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2418,Enzyme,S1: Chymotrypsin,Human:Q9Y5Y6|Mouse:P56677,Human:ST14|Mouse:St14|Rat:St14,Human:11344|Mouse:MGI:1338881|Rat:69288,,,,,,
Target,359,SST<sub>5</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=359,GPCR,Somatostatin receptors,Human:P35346|Mouse:O08858|Rat:P30938,Human:SSTR5|Mouse:Sstr5|Rat:Sstr5,Human:11334|Mouse:MGI:894282|Rat:3765,,,,,,
Target,358,SST<sub>4</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=358,GPCR,Somatostatin receptors,Human:P31391|Mouse:P49660|Rat:P30937,Human:SSTR4|Mouse:Sstr4|Rat:Sstr4,Human:11333|Mouse:MGI:105372|Rat:3764,,,,,,
Target,357,SST<sub>3</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=357,GPCR,Somatostatin receptors,Human:P32745|Mouse:P30935|Rat:P30936,Human:SSTR3|Mouse:Sstr3|Rat:Sstr3,Human:11332|Mouse:MGI:98329|Rat:620308,,,,,,
Target,356,SST<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=356,GPCR,Somatostatin receptors,Human:P30874|Mouse:P30875|Rat:P30680,Human:SSTR2|Mouse:Sstr2|Rat:Sstr2,Human:11331|Mouse:MGI:98328|Rat:3763,,,,,,
Target,355,SST<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=355,GPCR,Somatostatin receptors,Human:P30872|Mouse:P30873|Rat:P28646,Human:SSTR1|Mouse:Sstr1|Rat:Sstr1,Human:11330|Mouse:MGI:98327|Rat:3762,,,,,,
Target,2209,SRSF protein kinase 2,SRPK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2209,Enzyme,SRPK family,Human:P78362|Mouse:O54781,Human:SRPK2|Mouse:Srpk2|Rat:Srpk2,Human:11306|Mouse:MGI:1201408|Rat:1305107,,,,,,
Target,2207,src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites,Srm,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2207,Enzyme,Src family,Human:Q9H3Y6|Mouse:Q62270,Human:SRMS|Mouse:Srms|Rat:Srms,Human:11298|Mouse:MGI:101865|Rat:1306602,,,,,,
Target,2206,"SRC proto-oncogene, non-receptor tyrosine kinase",Src,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2206,Enzyme,Src family,Human:P12931|Mouse:P05480|Rat:Q9WUD9,Human:SRC|Mouse:Src|Rat:Src,Human:11283|Mouse:MGI:98397|Rat:620795,,,,,,
Target,2433,squalene monooxygenase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2433,Enzyme,Lanosterol biosynthesis pathway,Human:Q14534|Mouse:P52019|Rat:P52020,Human:SQLE|Mouse:Sqle|Rat:Sqle,Human:11279|Mouse:MGI:109296|Rat:3755,,,,,,
Target,2230,spleen associated tyrosine kinase,Syk,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2230,Enzyme,Syk family,Human:P43405|Mouse:P48025|Rat:Q64725,Human:SYK|Mouse:Syk|Rat:Syk,Human:11491|Mouse:MGI:99515|Rat:3796,,,,,,
Target,1419,sPLA<sub>2</sub>-2E,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1419,Enzyme,Phospholipase A<sub>2</sub>,Human:Q9NZK7|Mouse:Q9QUL3,Human:PLA2G2E|Mouse:Pla2g2e|Rat:Pla2g2e,Human:13414|Mouse:MGI:1349660|Rat:1309611,,,,,,
Target,1418,sPLA<sub>2</sub>-2D,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1418,Enzyme,Phospholipase A<sub>2</sub>,Human:Q9UNK4|Mouse:Q9WVF6,Human:PLA2G2D|Mouse:Pla2g2d|Rat:Pla2g2d,Human:9033|Mouse:MGI:1341796|Rat:1309862,,,,,,
Target,1417,sPLA<sub>2</sub>-2A,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1417,Enzyme,Hydrolases|Phospholipase A<sub>2</sub>,Human:P14555|Mouse:P31482|Rat:P14423,Human:PLA2G2A|Mouse:Pla2g2a|Rat:Pla2g2a,Human:9031|Mouse:MGI:104642|Rat:620857,,,,,,
Target,1416,sPLA<sub>2</sub>-1B,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1416,Enzyme,Phospholipase A<sub>2</sub>,Human:P04054|Mouse:Q9Z0Y2|Rat:P04055,Human:PLA2G1B|Mouse:Pla2g1b|Rat:Pla2g1b,Human:9030|Mouse:MGI:101842|Rat:61949,,,,,,
Target,1422,sPLA<sub>2</sub>-10,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1422,Enzyme,Phospholipase A<sub>2</sub>,Human:O15496|Mouse:Q9QXX3|Rat:Q9QZT3,Human:PLA2G10|Mouse:Pla2g10|Rat:Pla2g10,Human:9029|Mouse:MGI:1347522|Rat:61935,,,,,,
Target,2205,sphingosine kinase 2,SPHK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2205,Enzyme,Sphingosine kinase,Human:Q9NRA0|Mouse:Q9JIA7|Rat:Q6AYB2,Human:SPHK2|Mouse:Sphk2|Rat:Sphk2,Human:18859|Mouse:MGI:1861380|Rat:1307757,,,,,,
Target,2522,sphingosine-1-phosphate lyase 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2522,Enzyme,Sphingosine 1-phosphate lyase,Human:O95470|Mouse:Q8R0X7|Rat:Q8CHN6,Human:SGPL1|Mouse:Sgpl1|Rat:Sgpl1,Human:10817|Mouse:MGI:1261415|Rat:628599,,,,,,
Target,2517,sphingomyelin phosphodiesterase 4,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2517,Enzyme,Sphingomyelin phosphodiesterase,Human:Q9NXE4|Mouse:Q6ZPR5,Human:SMPD4|Mouse:Smpd4|Rat:Smpd4,Human:32949|Mouse:MGI:1924876|Rat:1310674,,,,,,
Target,2516,sphingomyelin phosphodiesterase 3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2516,Enzyme,Sphingomyelin phosphodiesterase,Human:Q9NY59|Mouse:Q9JJY3|Rat:O35049,Human:SMPD3|Mouse:Smpd3|Rat:Smpd3,Human:14240|Mouse:MGI:1927578|Rat:619754,,,,,,
Target,2514,sphingomyelin phosphodiesterase 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2514,Enzyme,Sphingomyelin phosphodiesterase,Human:P17405|Mouse:Q04519|Rat:Q5XIA6,Human:SMPD1|Mouse:Smpd1|Rat:Smpd1,Human:11120|Mouse:MGI:98325|Rat:1549719,,,,,,
Target,848,SPCA2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=848,Transporter,P2B P-type ATPases: Ca<sup>2+</sup>-ATPases,Human:O75185|Mouse:A7L9Z8|Rat:Q8R4C1,Human:ATP2C2|Mouse:Atp2c2|Rat:Atp2c2,Human:29103|Mouse:MGI:1916297|Rat:620647,,,,,,
Target,847,SPCA1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=847,Transporter,P2B P-type ATPases: Ca<sup>2+</sup>-ATPases,Human:P98194|Mouse:Q80XR2|Rat:Q64566,Human:ATP2C1|Mouse:Atp2c1|Rat:Atp2c1,Human:13211|Mouse:MGI:1889008|Rat:621311,,,,,,
Target,2572,solute carrier family 52 member 2,RFVT2,SLC52A2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2572,Transporter,SLC52 family of riboflavin transporters,Human:Q9HAB3|Mouse:Q9D8F3|Rat:B5MEV3,Human:SLC52A2|Mouse:Slc52a2|Rat:Slc52a2,Human:30224|Mouse:MGI:1289288|Rat:1560410,,,,,,
Target,2610,sodium/potassium-transporting ATPase subunit &gamma;,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2610,Transporter,Na<sup>+</sup>/K<sup>+</sup>-ATPases,Human:P54710|Mouse:Q04646|Rat:Q04679,Human:FXYD2|Mouse:Fxyd2|Rat:Fxyd2,Human:4026|Mouse:MGI:1195260|Rat:2173,,,,,,
Target,835,sodium/potassium-transporting ATPase subunit &alpha;-3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=835,Transporter,Na<sup>+</sup>/K<sup>+</sup>-ATPases,Human:P13637|Mouse:Q6PIC6|Rat:P06687,Human:ATP1A3|Mouse:Atp1a3|Rat:Atp1a3,Human:801|Mouse:MGI:88107|Rat:2169,,,,,,
Target,834,sodium/potassium-transporting ATPase subunit &alpha;-2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=834,Transporter,Na<sup>+</sup>/K<sup>+</sup>-ATPases,Human:P50993|Mouse:Q6PIE5|Rat:P06686,Human:ATP1A2|Mouse:Atp1a2|Rat:Atp1a2,Human:800|Mouse:MGI:88106|Rat:2168,,,,,,
Target,833,sodium/potassium-transporting ATPase subunit &alpha;-1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=833,Transporter,Na<sup>+</sup>/K<sup>+</sup>-ATPases,Human:P05023|Mouse:Q8VDN2|Rat:P06685,Human:ATP1A1|Mouse:Atp1a1|Rat:Atp1a1,Human:799|Mouse:MGI:88105|Rat:2167,,,,,,
Target,950,Sodium/hydrogen exchanger 3,NHE3,SLC9A3,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=950,Transporter,SLC9 family of sodium/hydrogen exchangers,Human:P48764|Rat:P26433,Human:SLC9A3|Mouse:Slc9a3|Rat:Slc9a3,Human:11073|Mouse:MGI:105064|Rat:3720,,,,,,
Target,948,Sodium/hydrogen exchanger 1,NHE1,SLC9A1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=948,Transporter,SLC9 family of sodium/hydrogen exchangers,Human:P19634|Mouse:Q61165|Rat:P26431,Human:SLC9A1|Mouse:Slc9a1|Rat:Slc9a1,Human:11071|Mouse:MGI:102462|Rat:3718,,,,,,
Target,916,Sodium/glucose cotransporter 2,SGLT2,SLC5A2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=916,Transporter,Hexose transporter family,Human:P31639|Mouse:Q923I7|Rat:P53792,Human:SLC5A2|Mouse:Slc5a2|Rat:Slc5a2,Human:11037|Mouse:MGI:2181411|Rat:620217,,,,,,
Target,1171,sodium-coupled neutral amino acid transporter 4,SNAT4,SLC38A4,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1171,Transporter,System A-like transporters,Human:Q969I6|Mouse:Q8R1S9|Rat:Q9EQ25,Human:SLC38A4|Mouse:Slc38a4|Rat:Slc38a4,Human:14679|Mouse:MGI:1916604|Rat:621836,,,,,,
Target,1172,Sodium-coupled neutral amino acid transporter 3,SNAT3,SLC38A3,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1172,Transporter,System N-like transporters,Human:Q99624|Mouse:Q9DCP2|Rat:Q9JHZ9,Human:SLC38A3|Mouse:Slc38a3|Rat:Slc38a3,Human:18044|Mouse:MGI:1923507|Rat:628620,,,,,,
Target,1170,sodium-coupled neutral amino acid transporter 2,SNAT2,SLC38A2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1170,Transporter,System A-like transporters,Human:Q96QD8|Mouse:Q8CFE6|Rat:Q9JHE5,Human:SLC38A2|Mouse:Slc38a2|Rat:Slc38a2,Human:13448|Mouse:MGI:1915010|Rat:69420,,,,,,
Target,1169,sodium-coupled neutral amino acid transporter 1,SNAT1,SLC38A1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1169,Transporter,System A-like transporters,Human:Q9H2H9|Mouse:Q8K2P7|Rat:Q9JM15,Human:SLC38A1|Mouse:Slc38a1|Rat:Slc38a1,Human:13447|Mouse:MGI:2145895|Rat:69645,,,,,,
Target,945,Sodium/calcium exchanger 1,NCX1,SLC8A1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=945,Transporter,SLC8 family of sodium/calcium exchangers,Human:P32418|Mouse:P70414|Rat:Q01728,Human:SLC8A1|Mouse:Slc8a1|Rat:Slc8a1,Human:11068|Mouse:MGI:107956|Rat:3717,,,,,,
Target,960,Sodium/bile acid and sulphated solute cotransporter 2,ASBT,SLC10A2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=960,Transporter,SLC10 family of sodium-bile acid co-transporters,Human:Q12908|Mouse:P70172|Rat:Q62633,Human:SLC10A2|Mouse:Slc10a2|Rat:Slc10a2,Human:10906|Mouse:MGI:1201406|Rat:3682,,,,,,
Target,2202,SNF related kinase,SNRK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2202,Enzyme,SNRK subfamily,Human:Q9NRH2|Mouse:Q8VDU5|Rat:Q63553,Human:SNRK|Mouse:Snrk|Rat:Snrk,Human:30598|Mouse:MGI:108104|Rat:69653,,,,,,
Target,921,SMVT,,SLC5A6,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=921,Transporter,"Sodium iodide symporter, sodium-dependent multivitamin transporter and sodium-coupled monocarboxylate transporters",Human:Q9Y289|Mouse:Q5U4D8|Rat:O70247,Human:SLC5A6|Mouse:Slc5a6|Rat:Slc5a6,Human:11041|Mouse:MGI:2660847|Rat:69648,,,,,,
Target,239,SMO,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=239,GPCR,Class Frizzled GPCRs,Human:Q99835|Mouse:P56726|Rat:P97698,Human:SMO|Mouse:Smo|Rat:Smo,Human:11119|Mouse:MGI:108075|Rat:3726,,,,,,
Target,2711,sirtuin 5,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2711,Enzyme,3.5.1.- Histone deacetylases (HDACs),Human:Q9NXA8|Mouse:Q8K2C6|Rat:Q68FX9,Human:SIRT5|Mouse:Sirt5|Rat:Sirt5,Human:14933|Mouse:MGI:1915596|Rat:1303285,,,,,,
Target,2709,sirtuin 3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2709,Enzyme,3.5.1.- Histone deacetylases (HDACs),Human:Q9NTG7|Mouse:Q8R104,Human:SIRT3|Mouse:Sirt3|Rat:Sirt3,Human:14931|Mouse:MGI:1927665|Rat:1308374,,,,,,
Target,2708,sirtuin 2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2708,Enzyme,3.5.1.- Histone deacetylases (HDACs),Human:Q8IXJ6|Mouse:Q8VDQ8|Rat:Q5RJQ4,Human:SIRT2|Mouse:Sirt2|Rat:Sirt2,Human:10886|Mouse:MGI:1927664|Rat:621481,,,,,,
Target,2707,sirtuin 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2707,Enzyme,3.5.1.- Histone deacetylases (HDACs),Human:Q96EB6|Mouse:Q923E4,Human:SIRT1|Mouse:Sirt1|Rat:Sirt1,Human:14929|Mouse:MGI:2135607|Rat:1308542,,,,,,
Target,2199,SIK family kinase 3,QSK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2199,Enzyme,QIK subfamily,Human:Q9Y2K2|Mouse:Q6P4S6,Human:SIK3|Mouse:Sik3,Human:29165|Mouse:MGI:2446296,,,,,,
Target,2994,signal transducer and activator of transcription 3,STAT3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2994,OtherProtein,STAT transcription factors,Human:P40763|Mouse:P42227|Rat:P52631,Human:STAT3|Mouse:Stat3|Rat:Stat3,Human:11364|Mouse:MGI:103038|Rat:3772,,,,,,
Target,2552,sigma non-opioid intracellular receptor 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2552,OtherProtein,Sigma receptors,Human:Q99720|Mouse:O55242|Rat:Q9R0C9,Human:SIGMAR1|Mouse:Sigmar1|Rat:Sigmar1,Human:8157|Mouse:MGI:1195268|Rat:68364,,,,,,
Target,2193,SH3 domain binding kinase 1,SBK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2193,Enzyme,NKF1 family,Human:Q52WX2|Mouse:Q8QZX0|Rat:Q9Z335,Human:SBK1|Mouse:Sbk1|Rat:Sbk1,Human:17699|Mouse:MGI:2135937|Rat:628713,,,,,,
Target,2703,"SET domain containing 7, histone lysine methyltransferase",,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2703,Enzyme,2.1.1.43 Histone methyltransferases (HMTs),Human:Q8WTS6|Mouse:Q8VHL1,Human:SETD7|Mouse:Setd7|Rat:Setd7,Human:30412|Mouse:MGI:1920501|Rat:1586346,,,,,,
Target,1536,serum/glucocorticoid regulated kinase family member 3,SGK3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1536,Enzyme,SGK family,Human:Q96BR1|Mouse:Q9ERE3|Rat:Q8R4V0,Human:SGK3|Mouse:Sgk3|Rat:Sgk3,Human:10812|Mouse:MGI:2182368|Rat:620242,,,,,,
Target,1534,serum/glucocorticoid regulated kinase 1,SGK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1534,Enzyme,SGK family,Human:O00141|Mouse:Q9WVC6|Rat:Q06226,Human:SGK1|Mouse:Sgk1|Rat:Sgk1,Human:10810|Mouse:MGI:1340062|Rat:3668,,,,,,
Target,928,SERT,,SLC6A4,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=928,Transporter,Monoamine transporter subfamily,Human:P31645|Mouse:Q60857|Rat:P31652,Human:SLC6A4|Mouse:Slc6a4|Rat:Slc6a4,Human:11050|Mouse:MGI:96285|Rat:3714,,,,,,
Target,2632,serpin family C member 1,"antithrombin, antithrombin III",,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2632,Enzyme,Blood coagulation components,Human:P01008|Mouse:P32261,Human:SERPINC1|Mouse:Serpinc1|Rat:Serpinc1,Human:775|Mouse:MGI:88095|Rat:1307404,,,,,,
Target,2291,serine/threonine-protein kinase NIM1,NIM1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2291,Enzyme,NIM1 subfamily,Human:Q8IY84|Mouse:Q8BHI9,Human:NIM1K|Mouse:Nim1k|Rat:Nim1k,Human:28646|Mouse:MGI:2442399|Rat:1308116,,,,,,
Target,2287,serine/threonine-protein kinase MST4,MST4,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2287,Enzyme,YSK subfamily,Human:Q9P289|Mouse:Q99JT2,Human:STK26|Mouse:Stk26|Rat:Stk26,Human:18174|Mouse:MGI:1917665|Rat:1563568,,,,,,
Target,2224,serine/threonine kinase 39,STLK3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2224,Enzyme,FRAY subfamily,Human:Q9UEW8|Mouse:Q9Z1W9|Rat:O88506,Human:STK39|Mouse:Stk39|Rat:Stk39,Human:17717|Mouse:MGI:1858416|Rat:621643,,,,,,
Target,1518,Serine/threonine kinase 38 like,NDR2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1518,Enzyme,NDR family,Human:Q9Y2H1|Mouse:Q7TSE6,Human:STK38L|Mouse:Stk38l|Rat:Stk38l,Human:17848|Mouse:MGI:1922250|Rat:1564793,,,,,,
Target,1517,Serine/threonine kinase 38,NDR1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1517,Enzyme,NDR family,Human:Q15208|Mouse:Q91VJ4,Human:STK38|Mouse:Stk38|Rat:Stk38,Human:17847|Mouse:MGI:2442572|Rat:1309455,,,,,,
Target,2223,serine/threonine kinase 36,Fused,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2223,Enzyme,Unc-51-like kinase (ULK) family,Human:Q9NRP7|Mouse:Q69ZM6,Human:STK36|Mouse:Stk36|Rat:Stk36,Human:17209|Mouse:MGI:1920831|Rat:1307318,,,,,,
Target,2222,serine/threonine kinase 35,CLIK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2222,Enzyme,NKF4 family,Human:Q8TDR2|Mouse:Q80ZW0,Human:STK35|Mouse:Stk35|Rat:Stk35,Human:16254|Mouse:MGI:1914583|Rat:1310247,,,,,,
Target,2221,serine/threonine kinase 33,STK33,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2221,Enzyme,CAMK-unique family,Human:Q9BYT3|Mouse:Q924X7,Human:STK33|Mouse:Stk33|Rat:Stk33,Human:14568|Mouse:MGI:2152419|Rat:1590972,,,,,,
Target,1537,serine/threonine kinase 32A,YANK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1537,Enzyme,YANK family,Human:Q8WU08|Mouse:Q8BGW6,Human:STK32A|Mouse:Stk32a|Rat:Stk32a,Human:28317|Mouse:MGI:2442403|Rat:1308338,,,,,,
Target,2219,serine/threonine kinase 3,MST2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2219,Enzyme,MST subfamily,Human:Q13188|Mouse:Q9JI10|Rat:O54748,Human:STK3|Mouse:Stk3|Rat:Stk3,Human:11406|Mouse:MGI:1928487|Rat:68412,,,,,,
Target,2217,serine/threonine kinase 24,MST3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2217,Enzyme,YSK subfamily,Human:Q9Y6E0|Mouse:Q99KH8|Rat:B0LT89,Human:STK24|Mouse:Stk24|Rat:Stk24,Human:11403|Mouse:MGI:2385007|Rat:1561742,,,,,,
Target,2215,serine/threonine kinase 17b,DRAK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2215,Enzyme,Death-associated kinase (DAPK) family,Human:O94768|Mouse:Q8BG48|Rat:Q91XS8,Human:STK17B|Mouse:Stk17b|Rat:Stk17b,Human:11396|Mouse:MGI:2138162|Rat:620457,,,,,,
Target,2214,serine/threonine kinase 17a,DRAK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2214,Enzyme,Death-associated kinase (DAPK) family,Human:Q9UEE5,Human:STK17A,Human:11395,,,,,,
Target,2213,serine/threonine kinase 16,MPSK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2213,Enzyme,NAK family,Human:O75716|Mouse:O88697|Rat:P57760,Human:STK16|Mouse:Stk16|Rat:Stk16,Human:11394|Mouse:MGI:1313271|Rat:629474,,,,,,
Target,2211,serine/threonine kinase 10,LOK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2211,Enzyme,SLK subfamily,Human:O94804|Mouse:O55098|Rat:E9PTG8,Human:STK10|Mouse:Stk10|Rat:Stk10,Human:11388|Mouse:MGI:1099439|Rat:3779,,,,,,
Target,2400,serine protease 8,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2400,Enzyme,S1: Chymotrypsin,Human:Q16651|Mouse:Q9ESD1|Rat:Q9ES87,Human:PRSS8|Mouse:Prss8|Rat:Prss8,Human:9491|Mouse:MGI:1923810|Rat:619973,,,,,,
Target,2399,serine protease 3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2399,Enzyme,S1: Chymotrypsin,Human:P35030,Human:PRSS3|Mouse:Prss3|Rat:LOC679835,Human:9486|Mouse:MGI:102758|Rat:1583654,,,,,,
Target,2398,serine protease 2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2398,Enzyme,S1: Chymotrypsin,Human:P07478|Mouse:P07146,Human:PRSS2|Mouse:Prss2,Human:9483|Mouse:MGI:102759,,,,,,
Target,2397,serine protease 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2397,Enzyme,S1: Chymotrypsin,Human:P07477|Rat:P08426,Human:PRSS1|Mouse:Prss1|Rat:Prss3b,Human:9475|Mouse:MGI:98839|Rat:708437,,,,,,
Target,2511,serine palmitoyltransferase long chain base subunit 3,SPT3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2511,Enzyme,Serine palmitoyltransferase,Human:Q9NUV7|Mouse:Q8BG54|Rat:D4A9V0,Human:SPTLC3|Mouse:Sptlc3|Rat:Sptlc3,Human:16253|Mouse:MGI:2444678|Rat:1310030,,,,,,
Target,2510,serine palmitoyltransferase long chain base subunit 2,SPT2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2510,Enzyme,Serine palmitoyltransferase,Human:O15270|Mouse:P97363|Rat:Q3B7D2,Human:SPTLC2|Mouse:Sptlc2|Rat:Sptlc2,Human:11278|Mouse:MGI:108074|Rat:1305447,,,,,,
Target,2509,serine palmitoyltransferase long chain base subunit 1,SPT1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2509,Enzyme,Serine palmitoyltransferase,Human:O15269|Mouse:O35704|Rat:D4A2H2,Human:SPTLC1|Mouse:Sptlc1|Rat:Sptlc1,Human:11277|Mouse:MGI:1099431|Rat:1307140,,,,,,
Target,1585,Serine carboxypeptidase 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1585,Enzyme,S10: Carboxypeptidase Y,Human:Q9HB40|Mouse:Q920A5|Rat:Q920A6,Human:SCPEP1|Mouse:Scpep1|Rat:Scpep1,Human:29507|Mouse:MGI:1921867|Rat:620067,,,,,,
Target,841,SERCA2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=841,Transporter,P2A P-type ATPases: Ca<sup>2+</sup>-ATPases,Human:P16615|Mouse:O55143|Rat:P11507,Human:ATP2A2|Mouse:Atp2a2|Rat:Atp2a2,Human:812|Mouse:MGI:88110|Rat:2174,,,,,,
Target,840,SERCA1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=840,Transporter,P2A P-type ATPases: Ca<sup>2+</sup>-ATPases,Human:O14983|Mouse:Q8R429|Rat:Q64578,Human:ATP2A1|Mouse:Atp2a1|Rat:Atp2a1,Human:811|Mouse:MGI:105058|Rat:621293,,,,,,
Target,3020,sepiapterin reductase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3020,Enzyme,1.-.-.- Oxidoreductases,Human:P35270|Rat:P18297,Human:SPR|Mouse:Spr|Rat:Spr,Human:11257|Mouse:MGI:103078|Rat:3753,,,,,,
Target,2198,salt inducible kinase 2,QIK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2198,Enzyme,QIK subfamily,Human:Q9H0K1|Mouse:Q8CFH6,Human:SIK2|Mouse:Sik2|Rat:Sik2,Human:21680|Mouse:MGI:2445031|Rat:1559698,,,,,,
Target,2197,salt inducible kinase 1,SIK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2197,Enzyme,QIK subfamily,Human:P57059|Mouse:Q60670|Rat:Q9R1U5,Human:SIK1|Mouse:Sik1|Rat:Sik1,Human:11142|Mouse:MGI:104754|Rat:69407,,,,,,
Target,1269,S-Adenosylmethionine decarboxylase ,SAMDC,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1269,Enzyme,Decarboxylases,Human:P17707|Mouse:P31154|Rat:P17708,Human:AMD1|Mouse:Amd1|Rat:Amd1,Human:457|Mouse:MGI:88004|Rat:2104,,,,,,
Target,1233,S-Adenosylhomocysteine hydrolase,SAHH,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1233,Enzyme,Adenosine turnover,Human:P23526|Mouse:P50247|Rat:P10760,Human:AHCY|Mouse:Ahcy|Rat:Ahcy,Human:343|Mouse:MGI:87968|Rat:69260,,,,,,
Target,279,S1P<sub>5</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=279,GPCR,Lysophospholipid (S1P) receptors,Human:Q9H228|Mouse:Q91X56|Rat:Q9JKM5,Human:S1PR5|Mouse:S1pr5|Rat:S1pr5,Human:14299|Mouse:MGI:2150641|Rat:620566,,,,,,
Target,278,S1P<sub>4</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=278,GPCR,Lysophospholipid (S1P) receptors,Human:O95977|Mouse:Q9Z0L1,Human:S1PR4|Mouse:S1pr4|Rat:S1pr4,Human:3170|Mouse:MGI:1333809|Rat:1304801,,,,,,
Target,277,S1P<sub>3</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=277,GPCR,Lysophospholipid (S1P) receptors,Human:Q99500|Mouse:Q9Z0U9,Human:S1PR3|Mouse:S1pr3|Rat:S1pr3,Human:3167|Mouse:MGI:1339365|Rat:1583843,,,,,,
Target,275,S1P<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=275,GPCR,Lysophospholipid (S1P) receptors,Human:P21453|Mouse:O08530|Rat:P48303,Human:S1PR1|Mouse:S1pr1|Rat:S1pr1,Human:3165|Mouse:MGI:1096355|Rat:61958,,,,,,
Target,3083,S100 calcium binding protein A11,,S100A11,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3083,OtherProtein,EF-hand domain containing proteins,Human:P31949|Mouse:P50543|Rat:Q6B345,Human:S100A11|Mouse:S100a11|Rat:S100a11,Human:10488|Mouse:MGI:1338798|Rat:1303295,,,,,,
Target,748,RyR2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=748,VGIC,Ryanodine receptors (RyR),Human:Q92736|Mouse:Q9ERN6|Rat:B0LPN4,Human:RYR2|Mouse:Ryr2|Rat:Ryr2,Human:10484|Mouse:MGI:99685|Rat:620314,,,,,,
Target,747,RyR1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=747,VGIC,Ryanodine receptors (RyR),Human:P21817|Mouse:E9PZQ0|Rat:F1LMY4,Human:RYR1|Mouse:Ryr1|Rat:Ryr1,Human:10483|Mouse:MGI:99659|Rat:1586637,,,,,,
Target,1866,RTP Type S,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1866,CatalyticReceptor,Receptor tyrosine phosphatase (RTP) family,Human:Q13332|Mouse:B0V2N1|Rat:Q64605,Human:PTPRS|Mouse:Ptprs|Rat:Ptprs,Human:9681|Mouse:MGI:97815|Rat:3452,,,,,,
Target,1854,RTP Type E,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1854,CatalyticReceptor,Receptor tyrosine phosphatase (RTP) family,Human:P23469|Mouse:P49446|Rat:B2GV87,Human:PTPRE|Mouse:Ptpre|Rat:Ptpre,Human:9669|Mouse:MGI:97813|Rat:620771,,,,,,
Target,1851,RTP Type B,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1851,CatalyticReceptor,Receptor tyrosine phosphatase (RTP) family,Human:P23467|Mouse:B2RU80,Human:PTPRB|Mouse:Ptprb|Rat:Ptprb,Human:9665|Mouse:MGI:97809|Rat:1305922,,,,,,
Target,2188,RIO kinase 3,RIOK3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2188,Enzyme,RIO3 subfamily,Human:O14730|Mouse:Q9DBU3,Human:RIOK3|Mouse:Riok3|Rat:Riok3,Human:11451|Mouse:MGI:1914128|Rat:1310833,,,,,,
Target,2187,RIO kinase 2,RIOK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2187,Enzyme,RIO2 subfamily,Human:Q9BVS4|Mouse:Q9CQS5|Rat:Q5I0I1,Human:RIOK2|Mouse:Riok2|Rat:Riok2,Human:18999|Mouse:MGI:1914295|Rat:1311588,,,,,,
Target,2186,RIO kinase 1,RIOK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2186,Enzyme,RIO1 subfamily,Human:Q9BRS2|Mouse:Q922Q2,Human:RIOK1|Mouse:Riok1|Rat:Riok1,Human:18656|Mouse:MGI:1918590|Rat:1306086,,,,,,
Target,1530,ribosomal protein S6 kinase A6,RSK4,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1530,Enzyme,RSK subfamily,Human:Q9UK32|Mouse:Q7TPS0,Human:RPS6KA6|Mouse:Rps6ka6|Rat:Rps6ka6,Human:10435|Mouse:MGI:1914321|Rat:1560817,,,,,,
Target,1524,ribosomal protein S6 kinase A4,MSK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1524,Enzyme,MSK subfamily,Human:O75676|Mouse:Q9Z2B9,Human:RPS6KA4|Mouse:Rps6ka4|Rat:Rps6ka4,Human:10433|Mouse:MGI:1930076|Rat:1307277,,,,,,
Target,1528,ribosomal protein S6 kinase A3,RSK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1528,Enzyme,RSK subfamily,Human:P51812|Mouse:P18654,Human:RPS6KA3|Mouse:Rps6ka3|Rat:Rps6ka3,Human:10432|Mouse:MGI:104557|Rat:1563860,,,,,,
Target,1527,ribosomal protein S6 kinase A1,p90RSK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1527,Enzyme,RSK subfamily,Human:Q15418|Mouse:P18653|Rat:Q63531,Human:RPS6KA1|Mouse:Rps6ka1|Rat:Rps6ka1,Human:10430|Mouse:MGI:104558|Rat:620675,,,,,,
Target,2754,ribonucleotide reductase regulatory TP53 inducible subunit M2B,ribonucleotide reductase M2B (TP53 inducible),,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2754,Enzyme,1.17.4.1 Ribonucleoside-diphosphate reductases|Nucleoside synthesis and metabolism,Human:Q7LG56|Mouse:Q6PEE3,Human:RRM2B|Mouse:Rrm2b|Rat:Rrm2b,Human:17296|Mouse:MGI:2155865|Rat:1306045,,,,,,
Target,2631,ribonucleotide reductase regulatory subunit M2,ribonucleotide reductase M2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2631,Enzyme,Nucleoside synthesis and metabolism|1.17.4.1 Ribonucleoside-diphosphate reductases,Human:P31350|Mouse:P11157|Rat:Q4KLN6,Human:RRM2|Mouse:Rrm2|Rat:Rrm2,Human:10452|Mouse:MGI:98181|Rat:1598310,,,,,,
Target,2630,ribonucleotide reductase catalytic subunit M1,ribonucleotide reductase M1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2630,Enzyme,1.17.4.1 Ribonucleoside-diphosphate reductases|Nucleoside synthesis and metabolism,Human:P23921|Mouse:P07742,Human:RRM1|Mouse:Rrm1|Rat:Rrm1,Human:10451|Mouse:MGI:98180|Rat:1592569,,,,,,
Target,2963,Rhodopsin,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2963,GPCR,Opsin receptors,Human:P08100|Mouse:P15409|Rat:P51489,Human:RHO|Mouse:Rho|Rat:Rho,Human:10012|Mouse:MGI:97914|Rat:3573,,,,,,
Target,1504,Rho associated coiled-coil containing protein kinase 2,Rho kinase 2,ROCK2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1504,Enzyme,Rho kinase,Human:O75116|Mouse:P70336|Rat:Q62868,Human:ROCK2|Mouse:Rock2|Rat:Rock2,Human:10252|Mouse:MGI:107926|Rat:3590,,,,,,
Target,1503,Rho associated coiled-coil containing protein kinase 1,Rho kinase 1,ROCK1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1503,Enzyme,Rho kinase,Human:Q13464|Mouse:P70335|Rat:Q63644,Human:ROCK1|Mouse:Rock1|Rat:Rock1,Human:10251|Mouse:MGI:107927|Rat:620424,,,,,,
Target,597,Rev-Erb-&beta;,,NR1D2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=597,NHR,1D. Rev-Erb receptors,Human:Q14995|Mouse:Q60674|Rat:Q63504,Human:NR1D2|Mouse:Nr1d2|Rat:Nr1d2,Human:7963|Mouse:MGI:2449205|Rat:628828,,,,,,
Target,596,Rev-Erb-&alpha;,,NR1D1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=596,NHR,1D. Rev-Erb receptors,Human:P20393|Mouse:Q3UV55|Rat:Q63503,Human:NR1D1|Mouse:Nr1d1|Rat:Nr1d1,Human:7962|Mouse:MGI:2444210|Rat:628827,,,,,,
Target,2185,ret proto-oncogene,Ret,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2185,CatalyticReceptor,Type XIV RTKs: RET,Human:P07949|Mouse:P35546,Human:RET|Mouse:Ret|Rat:Ret,Human:9967|Mouse:MGI:97902|Rat:3556,,,,,,
Target,2549,retinol binding protein 4,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2549,OtherProtein,Fatty acid-binding proteins,Human:P02753|Mouse:Q00724|Rat:P04916,Human:RBP4|Mouse:Rbp4|Rat:Rbp4,Human:9922|Mouse:MGI:97879|Rat:3546,,,,,,
Target,2548,retinol binding protein 3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2548,OtherProtein,Fatty acid-binding proteins,Human:P10745|Mouse:P49194,Human:RBP3|Mouse:Rbp3|Rat:Rbp3,Human:9921|Mouse:MGI:97878|Rat:3545,,,,,,
Target,2546,retinol binding protein 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2546,OtherProtein,Fatty acid-binding proteins,Human:P09455|Mouse:Q00915|Rat:P02696,Human:RBP1|Mouse:Rbp1|Rat:Rbp1,Human:9919|Mouse:MGI:97876|Rat:3543,,,,,,
Target,612,Retinoid X receptor-&gamma;,,NR2B3,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=612,NHR,2B. Retinoid X receptors,Human:P48443|Mouse:P28705|Rat:Q5BJR8,Human:RXRG|Mouse:Rxrg|Rat:Rxrg,Human:10479|Mouse:MGI:98216|Rat:620046,,,,,,
Target,611,Retinoid X receptor-&beta;,,NR2B2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=611,NHR,2B. Retinoid X receptors,Human:P28702|Mouse:P28704|Rat:P49743,Human:RXRB|Mouse:Rxrb|Rat:Rxrb,Human:10478|Mouse:MGI:98215|Rat:3611,,,,,,
Target,610,Retinoid X receptor-&alpha;,,NR2B1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=610,NHR,2B. Retinoid X receptors,Human:P19793|Mouse:P28700|Rat:Q05343,Human:RXRA|Mouse:Rxra|Rat:Rxra,Human:10477|Mouse:MGI:98214|Rat:3610,,,,,,
Target,592,Retinoic acid receptor-&gamma;,,NR1B3,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=592,NHR,1B. Retinoic acid receptors,Human:P13631|Mouse:P18911,Human:RARG|Mouse:Rarg|Rat:Rarg,Human:9866|Mouse:MGI:97858|Rat:1583230,,,,,,
Target,591,Retinoic acid receptor-&beta;,,NR1B2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=591,NHR,1B. Retinoic acid receptors,Human:P10826|Mouse:P22605|Rat:D3ZFD9,Human:RARB|Mouse:Rarb|Rat:Rarb,Human:9865|Mouse:MGI:97857|Rat:3535,,,,,,
Target,590,Retinoic acid receptor-&alpha;,,NR1B1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=590,NHR,1B. Retinoic acid receptors,Human:P10276|Mouse:P11416,Human:RARA|Mouse:Rara|Rat:Rara,Human:9864|Mouse:MGI:97856|Rat:3534,,,,,,
Target,2413,renin,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2413,Enzyme,A1: Pepsin,Human:P00797|Mouse:P06281|Rat:P08424,Human:REN|Mouse:Ren1|Rat:Ren,Human:9958|Mouse:MGI:97898|Rat:3554,,,,,,
Target,2192,receptor interacting serine/threonine kinase 4,ANKRD3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2192,Enzyme,Receptor interacting protein kinase (RIPK) family,Human:P57078|Mouse:Q9ERK0,Human:RIPK4|Mouse:Ripk4|Rat:Ripk4,Human:496|Mouse:MGI:1919638|Rat:1311691,,,,,,
Target,2190,receptor interacting serine/threonine kinase 2,RIPK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2190,Enzyme,Receptor interacting protein kinase (RIPK) family,Human:O43353|Mouse:P58801,Human:RIPK2|Mouse:Ripk2|Rat:Ripk2,Human:10020|Mouse:MGI:1891456|Rat:1309167,,,,,,
Target,2189,receptor interacting serine/threonine kinase 1,RIPK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2189,Enzyme,Receptor interacting protein kinase (RIPK) family,Human:Q13546|Mouse:Q60855,Human:RIPK1|Mouse:Ripk1|Rat:Ripk1,Human:10019|Mouse:MGI:108212|Rat:1310158,,,,,,
Target,1881,receptor activator of NF-kappa B,RANK,TNFRSF11A,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1881,CatalyticReceptor,Tumour necrosis factor (TNF) receptor family,Human:Q9Y6Q6|Mouse:O35305,Human:TNFRSF11A|Mouse:Tnfrsf11a|Rat:Tnfrsf11a,Human:11908|Mouse:MGI:1314891|Rat:1563614,,,,,,
Target,599,RAR-related orphan receptor-&beta;,,NR1F2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=599,NHR,1F. Retinoic acid-related orphans,Human:Q92753|Mouse:Q8R1B8|Rat:P45446,Human:RORB|Mouse:Rorb|Rat:Rorb,Human:10259|Mouse:MGI:1343464|Rat:1306778,,,,,,
Target,598,RAR-related orphan receptor-&alpha;,,NR1F1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=598,NHR,1F. Retinoic acid-related orphans,Human:P35398|Mouse:P51448,Human:RORA|Mouse:Rora|Rat:Rora,Human:10258|Mouse:MGI:104661|Rat:1308419,,,,,,
Target,53,RAMP3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=53,AccessoryProtein,,Human:O60896|Mouse:Q9WUP1|Rat:Q9JJ73,Human:RAMP3|Mouse:Ramp3|Rat:Ramp3,Human:9845|Mouse:MGI:1860292|Rat:61873,,,,,,
Target,52,RAMP2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=52,AccessoryProtein,,Human:O60895|Mouse:Q9WUP0|Rat:Q9JHJ1,Human:RAMP2|Mouse:Ramp2|Rat:Ramp2,Human:9844|Mouse:MGI:1859650|Rat:61872,,,,,,
Target,51,RAMP1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=51,AccessoryProtein,,Human:O60894|Mouse:Q9WTJ5|Rat:Q9JJ74,Human:RAMP1|Mouse:Ramp1|Rat:Ramp1,Human:9843|Mouse:MGI:1858418|Rat:61870,,,,,,
Target,2184,"Raf-1 proto-oncogene, serine/threonine kinase",c-Raf,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2184,Enzyme,RAF family,Human:P04049|Mouse:Q99N57|Rat:P11345,Human:RAF1|Mouse:Raf1|Rat:Raf1,Human:9829|Mouse:MGI:97847|Rat:3531,,,,,,
Target,3006,pyruvate kinase M1/2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3006,Enzyme,2.7.1.40 Pyruvate kinases,Human:P14618|Mouse:P52480|Rat:P11980,Human:PKM|Mouse:Pkm|Rat:Pkm,Human:9021|Mouse:MGI:97591|Rat:3337,,,,,,
Target,3007,pyruvate kinase L/R,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3007,Enzyme,2.7.1.40 Pyruvate kinases,Human:P30613|Rat:P12928,Human:PKLR|Mouse:Pklr|Rat:Pklr,Human:9020|Mouse:MGI:97604|Rat:3336,,,,,,
Target,2144,pyruvate dehydrogenase kinase 4,LOC389533,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2144,Enzyme,PDHK family,Human:Q16654|Mouse:O70571|Rat:O54937,Human:PDK4|Mouse:Pdk4|Rat:Pdk4,Human:8812|Mouse:MGI:1351481|Rat:69061,,,,,,
Target,2143,pyruvate dehydrogenase kinase 3,PDHK3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2143,Enzyme,PDHK family,Human:Q15120|Mouse:Q922H2,Human:PDK3|Mouse:Pdk3|Rat:Pdk3,Human:8811|Mouse:MGI:2384308|Rat:1593276,,,,,,
Target,2142,pyruvate dehydrogenase kinase 2,PDHK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2142,Enzyme,PDHK family,Human:Q15119|Mouse:Q9JK42|Rat:Q64536,Human:PDK2|Mouse:Pdk2|Rat:Pdk2,Human:8810|Mouse:MGI:1343087|Rat:69428,,,,,,
Target,2915,pyruvate dehydrogenase kinase 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2915,Enzyme,PDHK family,Human:Q15118|Mouse:Q8BFP9,Human:PDK1|Mouse:Pdk1|Rat:Pdk1,Human:8809|Mouse:MGI:1926119|Rat:69427,,,,,,
Target,1262,Pyruvate carboxylase,PC,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1262,Enzyme,Carboxylases,Human:P11498|Mouse:Q05920|Rat:P52873,Human:PC|Mouse:Pcx|Rat:Pc,Human:8636|Mouse:MGI:97520|Rat:3262,,,,,,
Target,735,Px1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=735,OtherIC,Connexins and Pannexins,Human:Q96RD7|Mouse:Q9JIP4|Rat:P60570,Human:PANX1|Mouse:Panx1|Rat:Panx1,Human:8599|Mouse:MGI:1860055|Rat:735204,,,,,,
Target,3095,PVR cell adhesion molecule,CD155,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3095,OtherProtein,Immunoglobulin like domain containing proteins,Human:P15151,Human:PVR,Human:9705,,,,,,
Target,1575,Puromycin-sensitive aminopeptidase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1575,Enzyme,M1: Aminopeptidase N,Human:P55786|Mouse:Q11011,Human:NPEPPS|Mouse:Npepps|Rat:Npepps,Human:7900|Mouse:MGI:1101358|Rat:619962,,,,,,
Target,2841,purine nucleoside phosphorylase,PNP,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2841,Enzyme,Nucleoside synthesis and metabolism|2.4.2.1 Purine-nucleoside phosphorylase,Human:P00491|Mouse:P23492|Rat:P85973,Human:PNP|Mouse:Pnp|Rat:Pnp,Human:7892|Mouse:MGI:97365|Rat:1597189,,,,,,
Target,3103,P-selectin (CD62),,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3103,OtherProtein,CD molecules,Human:P16109,Human:SELP,Human:10721,,,,,,
Target,1161,Proton-coupled Amino acid Transporter 1,PAT1,SLC36A1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1161,Transporter,SLC36 family of proton-coupled amino acid transporters,Human:Q7Z2H8|Mouse:Q8K4D3|Rat:Q924A5,Human:SLC36A1|Mouse:Slc36a1|Rat:Slc36a1,Human:18761|Mouse:MGI:2445299|Rat:619801,,,,,,
Target,2976,protein tyrosine phosphatase non-receptor type 1,PTP1B,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2976,Enzyme,Protein tyrosine phosphatases non-receptor type (PTPN),Human:P18031|Mouse:P35821|Rat:P20417,Human:PTPN1|Mouse:Ptpn1|Rat:Ptpn1,Human:9642|Mouse:MGI:97805|Rat:61965,,,,,,
Target,2182,protein tyrosine kinase 6,Brk,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2182,Enzyme,Src family,Human:Q13882|Mouse:Q64434,Human:PTK6|Mouse:Ptk6|Rat:Ptk6,Human:9617|Mouse:MGI:99683|Rat:1309098,,,,,,
Target,2181,protein tyrosine kinase 2 beta,Pyk2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2181,Enzyme,Fak family,Human:Q14289|Mouse:Q9QVP9|Rat:P70600,Human:PTK2B|Mouse:Ptk2b|Rat:Ptk2b,Human:9612|Mouse:MGI:104908|Rat:628758,,,,,,
Target,2180,protein tyrosine kinase 2,FAK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2180,Enzyme,Fak family,Human:Q05397|Mouse:P34152|Rat:O35346,Human:PTK2|Mouse:Ptk2|Rat:Ptk2,Human:9611|Mouse:MGI:95481|Rat:3443,,,,,,
Target,1521,protein kinase N2,PKN2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1521,Enzyme,Protein kinase N (PKN) family,Human:Q16513|Mouse:Q8BWW9|Rat:O08874,Human:PKN2|Mouse:Pkn2|Rat:Pkn2,Human:9406|Mouse:MGI:109211|Rat:620146,,,,,,
Target,1520,protein kinase N1,PKN1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1520,Enzyme,Protein kinase N (PKN) family,Human:Q16512|Mouse:P70268|Rat:Q63433,Human:PKN1|Mouse:Pkn1|Rat:Pkn1,Human:9405|Mouse:MGI:108022|Rat:69308,,,,,,
Target,2167,"protein kinase, membrane associated tyrosine/threonine 1",Myt1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2167,Enzyme,WEE family,Human:Q99640|Mouse:Q9ESG9,Human:PKMYT1|Mouse:Pkmyt1|Rat:Pkmyt1,Human:29650|Mouse:MGI:2137630|Rat:1305434,,,,,,
Target,1493,Protein kinase G (PKG) 2,PKG2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1493,Enzyme,Protein kinase G (PKG) family,Human:Q13237|Mouse:Q61410|Rat:Q64595,Human:PRKG2|Mouse:Prkg2|Rat:Prkg2,Human:9416|Mouse:MGI:108173|Rat:3401,,,,,,
Target,2800,"protein kinase, DNA-activated, catalytic subunit",,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2800,Enzyme,Other PIKK family kinases,Human:P78527|Mouse:P97313,Human:PRKDC|Mouse:Prkdc|Rat:Prkdc,Human:9413|Mouse:MGI:104779|Rat:1308982,,,,,,
Target,1489,protein kinase D1,PKD1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1489,Enzyme,Protein kinase D (PKD) family,Human:Q15139|Mouse:Q62101|Rat:Q9WTQ1,Human:PRKD1|Mouse:Prkd1|Rat:Prkd1,Human:9407|Mouse:MGI:99879|Rat:620964,,,,,,
Target,1491,protein kinase C zeta,PKC&zeta;,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1491,Enzyme,Iota subfamily,Human:Q05513|Mouse:Q02956|Rat:P09217,Human:PRKCZ|Mouse:Prkcz|Rat:Prkcz,Human:9412|Mouse:MGI:97602|Rat:3399,,,,,,
Target,1488,protein kinase C theta,PKC&theta;,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1488,Enzyme,Delta subfamily,Human:Q04759|Mouse:Q02111|Rat:Q9WTQ0,Human:PRKCQ|Mouse:Prkcq|Rat:Prkcq,Human:9410|Mouse:MGI:97601|Rat:620968,,,,,,
Target,1490,protein kinase C iota,PKC&iota;,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1490,Enzyme,Iota subfamily,Human:P41743|Mouse:Q62074|Rat:F1M7Y5,Human:PRKCI|Mouse:Prkci|Rat:Prkci,Human:9404|Mouse:MGI:99260|Rat:620961,,,,,,
Target,1484,protein kinase C gamma,PKC&gamma;,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1484,Enzyme,Alpha subfamily,Human:P05129|Mouse:P63318|Rat:P63319,Human:PRKCG|Mouse:Prkcg|Rat:Prkcg,Human:9402|Mouse:MGI:97597|Rat:3397,,,,,,
Target,1486,protein kinase C epsilon,PKC&epsilon;,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1486,Enzyme,Eta subfamily,Human:Q02156|Mouse:P16054|Rat:P09216,Human:PRKCE|Mouse:Prkce|Rat:Prkce,Human:9401|Mouse:MGI:97599|Rat:61925,,,,,,
Target,1485,protein kinase C delta,PKC&delta;,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1485,Enzyme,Delta subfamily,Human:Q05655|Mouse:P28867|Rat:P09215,Human:PRKCD|Mouse:Prkcd|Rat:Prkcd,Human:9399|Mouse:MGI:97598|Rat:67383,,,,,,
Target,1483,protein kinase C beta,PKC&beta;,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1483,Enzyme,Alpha subfamily,Human:P05771|Mouse:P68404|Rat:P68403,Human:PRKCB|Mouse:Prkcb|Rat:Prkcb,Human:9395|Mouse:MGI:97596|Rat:3396,,,,,,
Target,1475,"protein kinase, cAMP-dependent, regulatory, type II, beta subunit",PKAR2B,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1475,Enzyme,Protein kinase A (PKA) family,Human:P31323|Mouse:P31324|Rat:P12369,Human:PRKAR2B|Mouse:Prkar2b|Rat:Prkar2b,Human:9392|Mouse:MGI:97760|Rat:3394,,,,,,
Target,1472,"protein kinase, cAMP-dependent, regulatory, type I, alpha subunit",PKAR1A,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1472,Enzyme,Protein kinase A (PKA) family,Human:P10644|Mouse:Q9DBC7|Rat:P09456,Human:PRKAR1A|Mouse:Prkar1a|Rat:Prkar1a,Human:9388|Mouse:MGI:104878|Rat:3391,,,,,,
Target,1477,"protein kinase, cAMP-dependent, catalytic, beta subunit",PKACb,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1477,Enzyme,Protein kinase A (PKA) family,Human:P22694|Mouse:P68181|Rat:P68182,Human:PRKACB|Mouse:Prkacb|Rat:Prkacb,Human:9381|Mouse:MGI:97594|Rat:1310574,,,,,,
Target,1476,"protein kinase, cAMP-dependent, catalytic, alpha subunit",PKACa,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1476,Enzyme,Protein kinase A (PKA) family,Human:P17612|Mouse:P05132|Rat:P27791,Human:PRKACA|Mouse:Prkaca|Rat:Prkaca,Human:9380|Mouse:MGI:97592|Rat:3389,,,,,,
Target,1482,protein kinase C alpha,PKC&alpha;,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1482,Enzyme,Delta subfamily,Human:P17252|Mouse:P20444|Rat:P05696,Human:PRKCA|Mouse:Prkca|Rat:Prkca,Human:9393|Mouse:MGI:97595|Rat:3395,,,,,,
Target,1547,protein kinase AMP-activated non-catalytic subunit gamma 3,AMPKG3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1547,Enzyme,AMPK subfamily,Human:Q9UGI9|Mouse:Q8BGM7,Human:PRKAG3|Mouse:Prkag3|Rat:Prkag3,Human:9387|Mouse:MGI:1891343|Rat:1308698,,,,,,
Target,1546,protein kinase AMP-activated non-catalytic subunit gamma 2,AMPKG2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1546,Enzyme,AMPK subfamily,Human:Q9UGJ0|Mouse:Q91WG5,Human:PRKAG2|Mouse:Prkag2|Rat:Prkag2,Human:9386|Mouse:MGI:1336153|Rat:727782,,,,,,
Target,1545,protein kinase AMP-activated non-catalytic subunit gamma 1,AMPKG1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1545,Enzyme,AMPK subfamily,Human:P54619|Mouse:O54950|Rat:P80385,Human:PRKAG1|Mouse:Prkag1|Rat:Prkag1,Human:9385|Mouse:MGI:108411|Rat:3388,,,,,,
Target,1544,protein kinase AMP-activated non-catalytic subunit beta 2,AMPKB2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1544,Enzyme,AMPK subfamily,Human:O43741|Mouse:Q7TQI6|Rat:Q6AYZ8,Human:PRKAB2|Mouse:Prkab2|Rat:Prkab2,Human:9379|Mouse:MGI:1336185|Rat:620905,,,,,,
Target,1543,protein kinase AMP-activated non-catalytic subunit beta 1,AMPKB1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1543,Enzyme,AMPK subfamily,Human:Q9Y478|Mouse:Q9R078|Rat:P80386,Human:PRKAB1|Mouse:Prkab1|Rat:Prkab1,Human:9378|Mouse:MGI:1336167|Rat:71057,,,,,,
Target,1542,protein kinase AMP-activated catalytic subunit alpha 2,AMPKA2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1542,Enzyme,AMPK subfamily,Human:P54646|Mouse:Q8BRK8|Rat:Q09137,Human:PRKAA2|Mouse:Prkaa2|Rat:Prkaa2,Human:9377|Mouse:MGI:1336173|Rat:620893,,,,,,
Target,1541,protein kinase AMP-activated catalytic subunit alpha 1,AMPKA1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1541,Enzyme,AMPK subfamily,Human:Q13131|Mouse:Q5EG47|Rat:P54645,Human:PRKAA1|Mouse:Prkaa1|Rat:Prkaa1,Human:9376|Mouse:MGI:2145955|Rat:3387,,,,,,
Target,2396,"protein C, inactivator of coagulation factors Va and VIIIa",,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2396,Enzyme,S1: Chymotrypsin,Human:P04070|Mouse:P33587|Rat:P31394,Human:PROC|Mouse:Proc|Rat:Proc,Human:9451|Mouse:MGI:97771|Rat:3411,,,,,,
Target,1254,protein arginine methyltransferase 3,PRMT3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1254,Enzyme,2.1.1.- Protein arginine N-methyltransferases,Human:O60678|Mouse:Q922H1|Rat:O70467,Human:PRMT3|Mouse:Prmt3|Rat:Prmt3,Human:30163|Mouse:MGI:1919224|Rat:620413,,,,,,
Target,1252,protein arginine methyltransferase 1 ,PRMT1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1252,Enzyme,2.1.1.- Protein arginine N-methyltransferases,Human:Q99873|Mouse:Q9JIF0|Rat:Q63009,Human:PRMT1|Mouse:Prmt1|Rat:Prmt1,Human:5187|Mouse:MGI:107846|Rat:62020,,,,,,
Target,2409,proteasome 20S subunit beta 9,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2409,Enzyme,T1: Proteasome,Human:P28065|Mouse:P28076|Rat:P28077,Human:PSMB9|Mouse:Psmb9|Rat:Psmb9,Human:9546|Mouse:MGI:1346526|Rat:3427,,,,,,
Target,2408,proteasome 20S subunit beta 8,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2408,Enzyme,T1: Proteasome,Human:P28062|Mouse:P28063|Rat:P28064,Human:PSMB8|Mouse:Psmb8|Rat:Psmb8,Human:9545|Mouse:MGI:1346527|Rat:3426,,,,,,
Target,2407,proteasome 20S subunit beta 6,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2407,Enzyme,T1: Proteasome,Human:P28072|Mouse:Q60692|Rat:P28073,Human:PSMB6|Mouse:Psmb6|Rat:Psmb6,Human:9543|Mouse:MGI:104880|Rat:61881,,,,,,
Target,2406,proteasome 20S subunit beta 5,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2406,Enzyme,T1: Proteasome,Human:P28074|Mouse:O55234|Rat:P28075,Human:PSMB5|Mouse:Psmb5|Rat:Psmb5,Human:9542|Mouse:MGI:1194513|Rat:61879,,,,,,
Target,2405,proteasome 20S subunit beta 2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2405,Enzyme,T1: Proteasome,Human:P49721|Mouse:Q9R1P3|Rat:P40307,Human:PSMB2|Mouse:Psmb2|Rat:Psmb2,Human:9539|Mouse:MGI:1347045|Rat:61874,,,,,,
Target,2404,proteasome 20S subunit beta 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2404,Enzyme,T1: Proteasome,Human:P20618|Mouse:O09061|Rat:P18421,Human:PSMB1|Mouse:Psmb1|Rat:Psmb1,Human:9537|Mouse:MGI:104884|Rat:621092,,,,,,
Target,938,PROT,,SLC6A7,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=938,Transporter,Glycine transporter subfamily,Human:Q99884|Mouse:Q6PGE7|Rat:P28573,Human:SLC6A7|Mouse:Slc6a7|Rat:Slc6a7,Human:11054|Mouse:MGI:2147363|Rat:620928,,,,,,
Target,1267,Propionyl-CoA carboxylase &beta; subunit,PCCB,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1267,Enzyme,Carboxylases,Human:P05166|Mouse:Q99MN9|Rat:P07633,Human:PCCB|Mouse:Pccb|Rat:Pccb,Human:8654|Mouse:MGI:1914154|Rat:3265,,,,,,
Target,1266,Propionyl-CoA carboxylase &alpha; subunit,PCCA,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1266,Enzyme,Carboxylases,Human:P05165|Mouse:Q91ZA3|Rat:P14882,Human:PCCA|Mouse:Pcca|Rat:Pcca,Human:8653|Mouse:MGI:97499|Rat:3264,,,,,,
Target,2395,prolyl endopeptidase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2395,Enzyme,S9: Prolyl oligopeptidase,Human:P48147|Mouse:Q9QUR6|Rat:O70196,Human:PREP|Mouse:Prep|Rat:Prep,Human:9358|Mouse:MGI:1270863|Rat:620841,,,,,,
Target,627,Progesterone receptor,,NR3C3,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=627,NHR,3C. 3-Ketosteroid receptors,Human:P06401|Mouse:Q00175|Rat:Q63449,Human:PGR|Mouse:Pgr|Rat:Pgr,Human:8910|Mouse:MGI:97567|Rat:3317,,,,,,
Target,2177,pre-mRNA processing factor 4B,PRP4,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2177,Enzyme,PRP4 subfamily,Human:Q13523|Mouse:Q61136|Rat:Q5RKH1,Human:PRPF4B|Mouse:Prpf4b|Rat:Prpf4b,Human:17346|Mouse:MGI:109584|Rat:1307784,,,,,,
Target,606,Pregnane X receptor,,NR1I2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=606,NHR,1I. Vitamin D receptor-like receptors,Human:O75469|Mouse:O54915|Rat:Q9R1A7,Human:NR1I2|Mouse:Nr1i2|Rat:Nr1i2,Human:7968|Mouse:MGI:1337040|Rat:69057,,,,,,
Target,2864,poly (ADP-ribose) polymerase 3,PARP3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2864,Enzyme,Poly ADP-ribose polymerases,Human:Q9Y6F1,Human:PARP3|Mouse:Parp3|Rat:Parp3,Human:273|Mouse:MGI:1891258|Rat:1305189,,,,,,
Target,2772,poly(ADP-ribose) polymerase 2,PARP2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2772,Enzyme,Poly ADP-ribose polymerases,Human:Q9UGN5|Mouse:O88554,Human:PARP2|Mouse:Parp2|Rat:Parp2,Human:272|Mouse:MGI:1341112|Rat:1310568,,,,,,
Target,2771,poly(ADP-ribose) polymerase 1,PARP1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771,Enzyme,Poly ADP-ribose polymerases,Human:P09874|Mouse:P11103|Rat:P27008,Human:PARP1|Mouse:Parp1|Rat:Parp1,Human:270|Mouse:MGI:1340806|Rat:2053,,,,,,
Target,2171,polo like kinase 4,PLK4,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2171,Enzyme,Polo-like kinase (PLK) family,Human:O00444|Mouse:Q64702|Rat:B2GUY1,Human:PLK4|Mouse:Plk4|Rat:Plk4,Human:11397|Mouse:MGI:101783|Rat:1305390,,,,,,
Target,2170,polo like kinase 3,PLK3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2170,Enzyme,Polo-like kinase (PLK) family,Human:Q9H4B4|Mouse:Q60806|Rat:Q9R011,Human:PLK3|Mouse:Plk3|Rat:Plk3,Human:2154|Mouse:MGI:109604|Rat:62039,,,,,,
Target,2169,polo like kinase 2,PLK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2169,Enzyme,Polo-like kinase (PLK) family,Human:Q9NYY3|Mouse:P53351|Rat:Q9R012,Human:PLK2|Mouse:Plk2|Rat:Plk2,Human:19699|Mouse:MGI:1099790|Rat:620760,,,,,,
Target,2168,polo like kinase 1,PLK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2168,Enzyme,Polo-like kinase (PLK) family,Human:P53350|Mouse:Q07832|Rat:Q62673,Human:PLK1|Mouse:Plk1|Rat:Plk1,Human:9077|Mouse:MGI:97621|Rat:3352,,,,,,
Target,846,PMCA4,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=846,Transporter,P2B P-type ATPases: Ca<sup>2+</sup>-ATPases,Human:P23634|Rat:Q64542,Human:ATP2B4|Mouse:Atp2b4|Rat:Atp2b4,Human:817|Mouse:MGI:88111|Rat:621305,,,,,,
Target,845,PMCA3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=845,Transporter,P2B P-type ATPases: Ca<sup>2+</sup>-ATPases,Human:Q16720|Rat:Q64568,Human:ATP2B3|Mouse:Atp2b3|Rat:Atp2b3,Human:816|Mouse:MGI:1347353|Rat:621304,,,,,,
Target,844,PMCA2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=844,Transporter,P2B P-type ATPases: Ca<sup>2+</sup>-ATPases,Human:Q01814|Mouse:Q9R0K7|Rat:P11506,Human:ATP2B2|Mouse:Atp2b2|Rat:Atp2b2,Human:815|Mouse:MGI:105368|Rat:2176,,,,,,
Target,843,PMCA1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=843,Transporter,P2B P-type ATPases: Ca<sup>2+</sup>-ATPases,Human:P20020|Rat:P11505,Human:ATP2B1|Mouse:Atp2b1|Rat:Atp2b1,Human:814|Mouse:MGI:104653|Rat:621303,,,,,,
Target,1434,PLD2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1434,Enzyme,Phosphatidylcholine-specific phospholipase D|Hydrolases,Human:O14939|Mouse:P97813|Rat:P70498,Human:PLD2|Mouse:Pld2|Rat:Pld2,Human:9068|Mouse:MGI:892877|Rat:3350,,,,,,
Target,1433,PLD1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1433,Enzyme,Phosphatidylcholine-specific phospholipase D,Human:Q13393|Mouse:Q9Z280|Rat:P70496,Human:PLD1|Mouse:Pld1|Rat:Pld1,Human:9067|Mouse:MGI:109585|Rat:3349,,,,,,
Target,1409,PLC&delta;1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1409,Enzyme,Phosphoinositide-specific phospholipase C,Human:P51178|Mouse:Q8R3B1|Rat:P10688,Human:PLCD1|Mouse:Plcd1|Rat:Plcd1,Human:9060|Mouse:MGI:97614|Rat:3346,,,,,,
Target,1804,platelet derived growth factor receptor beta,PDGFR&beta;,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804,CatalyticReceptor,"Type III RTKs: PDGFR, CSFR, Kit, FLT3 receptor family",Human:P09619|Mouse:P05622|Rat:Q05030,Human:PDGFRB|Mouse:Pdgfrb|Rat:Pdgfrb,Human:8804|Mouse:MGI:97531|Rat:3285,,,,,,
Target,1803,platelet derived growth factor receptor alpha,PDGFR&alpha;,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1803,CatalyticReceptor,"Type III RTKs: PDGFR, CSFR, Kit, FLT3 receptor family",Human:P16234|Mouse:P26618|Rat:P20786,Human:PDGFRA|Mouse:Pdgfra|Rat:Pdgfra,Human:8803|Mouse:MGI:97530|Rat:3284,,,,,,
Target,1432,PLA<sub>2</sub>-G7,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1432,Enzyme,Phospholipase A<sub>2</sub>|Hydrolases,Human:Q13093|Mouse:Q60963,Human:PLA2G7|Mouse:Pla2g7|Rat:Pla2g7,Human:9040|Mouse:MGI:1351327|Rat:1310734,,,,,,
Target,3058,Plasmodium falciparum threonine--tRNA ligase,PfThrRS,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3058,OtherProtein,Aminoacyl-tRNA synthetases,Plasmodium falciparum 3D7:Q8IIA4,Plasmodium falciparum 3D7:ThrRS,Plasmodium falciparum 3D7:PF3D7_1126000,,,,,,
Target,3077,Plasmodium falciparum purine nucleoside phosphorylase,PfPNP,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3077,OtherProtein,Nucleoside synthesis and metabolism (<i>Plasmodium</i> spp.),Plasmodium falciparum 3D7:Q8I3X4,Plasmodium falciparum 3D7:PNP,Plasmodium falciparum 3D7:PF3D7_0513300,,,,,,
Target,2971,Plasmodium falciparum non-SERCA-type Ca2+ -transporting P-ATPase,PfATP4,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2971,OtherProtein,Transporters (<i>Plasmodium</i> spp.),Plasmodium falciparum 3D7:A0A143ZZK9,Plasmodium falciparum 3D7:ATP4,Plasmodium falciparum 3D7:PF3D7_1211900,,,,,,
Target,3168,Plasmodium falciparum isoleucine--tRNA ligase,Pfapi-IRS,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3168,OtherProtein,Aminoacyl-tRNA synthetases,Plasmodium falciparum 3D7:Q8I5G6,Plasmodium falciparum 3D7:api-IRS,Plasmodium falciparum 3D7:PF3D7_1225100,,,,,,
Target,2975,Plasmodium falciparum elongation factor 2,PfeEF2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2975,OtherProtein,Ribosomal factors (<i>Plasmodium</i> spp.),Plasmodium falciparum 3D7:Q8IKW5,Plasmodium falciparum 3D7:eEF2,Plasmodium falciparum 3D7:PF3D7_1451100,,,,,,
Target,2949,Plasmodium falciparum dihydroorotate dehydrogenase,PfDHODH,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2949,OtherProtein,Nucleoside synthesis and metabolism (<i>Plasmodium</i> spp.),Plasmodium falciparum 3D7:Q08210,Plasmodium falciparum 3D7:DHODH,Plasmodium falciparum 3D7:PF3D7_0603300,,,,,,
Target,3087,Plasmodium falciparum cytochrome b,PfCYTB,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3087,OtherProtein,Mitochondrial function/Mitochondrial electron flow,Plasmodium falciparum:Q02768,Plasmodium falciparum 3D7:CYTB,Plasmodium falciparum 3D7:mal_mito_3,,,,,,
Target,2393,"plasminogen activator, urokinase",,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2393,Enzyme,S1: Chymotrypsin,Human:P00749|Mouse:P06869|Rat:P29598,Human:PLAU|Mouse:Plau|Rat:Plau,Human:9052|Mouse:MGI:97611|Rat:3343,,,,,,
Target,2392,"plasminogen activator, tissue type",,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2392,Enzyme,S1: Chymotrypsin,Human:P00750|Mouse:P11214|Rat:P19637,Human:PLAT|Mouse:Plat|Rat:Plat,Human:9051|Mouse:MGI:97610|Rat:3342,,,,,,
Target,2394,plasminogen,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2394,Enzyme,S1: Chymotrypsin,Human:P00747|Mouse:P20918|Rat:Q01177,Human:PLG|Mouse:Plg|Rat:Plg,Human:9071|Mouse:MGI:97620|Rat:619893,,,,,,
Target,1120,Plasma membrane monoamine transporter,PMAT,SLC29A4,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1120,Transporter,SLC29 family,Human:Q7RTT9|Mouse:Q8R139,Human:SLC29A4|Mouse:Slc29a4|Rat:Slc29a4,Human:23097|Mouse:MGI:2385330|Rat:1310545,,,,,,
Target,2160,"Pim-3 proto-oncogene, serine/threonine kinase",Pim3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2160,Enzyme,PIM family,Human:Q86V86|Mouse:P58750|Rat:O70444,Human:PIM3|Mouse:Pim3|Rat:Pim3,Human:19310|Mouse:MGI:1355297|Rat:620462,,,,,,
Target,2158,"Pim-1 proto-oncogene, serine/threonine kinase",Pim1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2158,Enzyme,PIM family,Human:P11309|Mouse:P06803|Rat:P26794,Human:PIM1|Mouse:Pim1|Rat:Pim1,Human:8986|Mouse:MGI:97584|Rat:3330,,,,,,
Target,2145,phosphorylase kinase catalytic subunit gamma 1,PHKG1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2145,Enzyme,Phosphorylase kinase (PHK) family,Human:Q16816|Mouse:P07934|Rat:P13286,Human:PHKG1|Mouse:Phkg1|Rat:Phkg1,Human:8930|Mouse:MGI:97579|Rat:3325,,,,,,
Target,2761,phosphoribosyl pyrophosphate amidotransferase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2761,Enzyme,C44: Phosphoribosyl pyrophosphate amidotransferase,Human:Q06203|Rat:P35433,Human:PPAT|Mouse:Ppat|Rat:Ppat,Human:9238|Mouse:MGI:2387203|Rat:620237,,,,,,
Target,2612,"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase",GART,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2612,Enzyme,"2.1.2.- Hydroxymethyl-, formyl- and related transferases|6.3.3.- Cyclo-ligases|Nucleoside synthesis and metabolism",Human:P22102|Mouse:Q64737,Human:GART|Mouse:Gart|Rat:Gart,Human:4163|Mouse:MGI:95654|Rat:1308717,,,,,,
Target,854,Phospholipid-transporting ATPase IA,ATP8A1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=854,Transporter,P4 P-type ATPases: Phospholipid-transporting ATPases,Human:Q9Y2Q0|Mouse:P70704,Human:ATP8A1|Mouse:Atp8a1|Rat:Atp8a1,Human:13531|Mouse:MGI:1330848|Rat:1309619,,,,,,
Target,2505,phosphoinositide-3-kinase regulatory subunit 3,p55&gamma;/PIK3R3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2505,Enzyme,Phosphatidylinositol kinases,Human:Q92569|Mouse:Q64143|Rat:Q63789,Human:PIK3R3|Mouse:Pik3r3|Rat:Pik3r3,Human:8981|Mouse:MGI:109277|Rat:621042,,,,,,
Target,2504,phosphoinositide-3-kinase regulatory subunit 2,p85&beta;/PIK3R2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2504,Enzyme,Phosphatidylinositol kinases,Human:O00459|Mouse:O08908|Rat:Q5FVS6,Human:PIK3R2|Mouse:Pik3r2|Rat:Pik3r2,Human:8980|Mouse:MGI:1098772|Rat:68341,,,,,,
Target,2503,phosphoinositide-3-kinase regulatory subunit 1,p85&alpha;/PIK3R1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2503,Enzyme,Phosphatidylinositol kinases,Human:P27986|Mouse:P26450|Rat:Q63787,Human:PIK3R1|Mouse:Pik3r1|Rat:Pik3r1,Human:8979|Mouse:MGI:97583|Rat:3329,,,,,,
Target,1309,phosphodiesterase 9A,PDE9A,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1309,Enzyme,"Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)",Human:O76083|Mouse:O70628,Human:PDE9A|Mouse:Pde9a|Rat:Pde9a,Human:8795|Mouse:MGI:1277179|Rat:621035,,,,,,
Target,1308,phosphodiesterase 8B,PDE8B,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1308,Enzyme,"Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)",Human:O95263|Mouse:E9Q4S1,Human:PDE8B|Mouse:Pde8b|Rat:Pde8b,Human:8794|Mouse:MGI:2443999|Rat:735041,,,,,,
Target,1307,phosphodiesterase 8A,PDE8A,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1307,Enzyme,"Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)",Human:O60658|Mouse:O88502,Human:PDE8A|Mouse:Pde8a|Rat:Pde8a,Human:8793|Mouse:MGI:1277116|Rat:735125,,,,,,
Target,1306,phosphodiesterase 7B,PDE7B,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1306,Enzyme,"Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)",Human:Q9NP56|Mouse:Q9QXQ1,Human:PDE7B|Mouse:Pde7b|Rat:Pde7b,Human:8792|Mouse:MGI:1352752|Rat:621016,,,,,,
Target,1305,phosphodiesterase 7A,PDE7A,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1305,Enzyme,"Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)",Human:Q13946|Mouse:P70453|Rat:O08593,Human:PDE7A|Mouse:Pde7a|Rat:Pde7a,Human:8791|Mouse:MGI:1202402|Rat:68391,,,,,,
Target,1317,phosphodiesterase 6H,PDE6H,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1317,Enzyme,"Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)",Human:Q13956|Mouse:P61249|Rat:P61250,Human:PDE6H|Mouse:Pde6h|Rat:Pde6h,Human:8790|Mouse:MGI:1925850|Rat:70933,,,,,,
Target,1316,phosphodiesterase 6G,PDE6G,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1316,Enzyme,"Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)",Human:P18545|Mouse:P09174,Human:PDE6G|Mouse:Pde6g|Rat:Pde6h,Human:8789|Mouse:MGI:97526|Rat:70933,,,,,,
Target,1314,phosphodiesterase 6C,PDE6C,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1314,Enzyme,"Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)",Human:P51160|Mouse:Q91ZQ1,Human:PDE6C|Mouse:Pde6c|Rat:Pde6c,Human:8787|Mouse:MGI:105956|Rat:1309844,,,,,,
Target,1313,phosphodiesterase 6B,PDE6B,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1313,Enzyme,"Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)",Human:P35913|Mouse:P23440,Human:PDE6B|Mouse:Pde6b|Rat:Pde6b,Human:8786|Mouse:MGI:97525|Rat:1311039,,,,,,
Target,1312,phosphodiesterase 6A,PDE6A,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1312,Enzyme,"Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)",Human:P16499|Mouse:P27664,Human:PDE6A|Mouse:Pde6a|Rat:Pde6a,Human:8785|Mouse:MGI:97524|Rat:1306835,,,,,,
Target,1304,phosphodiesterase 5A,PDE5A,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1304,Enzyme,"Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)",Human:O76074|Mouse:Q8CG03|Rat:O54735,Human:PDE5A|Mouse:Pde5a|Rat:Pde5a,Human:8784|Mouse:MGI:2651499|Rat:620995,,,,,,
Target,1303,phosphodiesterase 4D,PDE4D,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1303,Enzyme,"Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)",Human:Q08499|Mouse:Q01063|Rat:P14270,Human:PDE4D|Mouse:Pde4d|Rat:Pde4d,Human:8783|Mouse:MGI:99555|Rat:3281,,,,,,
Target,1302,phosphodiesterase 4C,PDE4C,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1302,Enzyme,"Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)",Human:Q08493|Mouse:Q3UEI1|Rat:P14644,Human:PDE4C|Mouse:Pde4c|Rat:Pde4c,Human:8782|Mouse:MGI:99556|Rat:727918,,,,,,
Target,1301,phosphodiesterase 4B,PDE4B,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1301,Enzyme,"Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)",Human:Q07343|Rat:P14646,Human:PDE4B|Mouse:Pde4b|Rat:Pde4b,Human:8781|Mouse:MGI:99557|Rat:3280,,,,,,
Target,1300,phosphodiesterase 4A,PDE4A,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1300,Enzyme,"Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)",Human:P27815|Mouse:O89084|Rat:P54748,Human:PDE4A|Mouse:Pde4a|Rat:Pde4a,Human:8780|Mouse:MGI:99558|Rat:3279,,,,,,
Target,1299,phosphodiesterase 3B,PDE3B,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1299,Enzyme,"Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)",Human:Q13370|Mouse:Q61409|Rat:Q63085,Human:PDE3B|Mouse:Pde3b|Rat:Pde3b,Human:8779|Mouse:MGI:1333863|Rat:61943,,,,,,
Target,1298,phosphodiesterase 3A,PDE3A,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1298,Enzyme,"Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)",Human:Q14432|Mouse:Q9Z0X4|Rat:Q62865,Human:PDE3A|Mouse:Pde3a|Rat:Pde3a,Human:8778|Mouse:MGI:1860764|Rat:61942,,,,,,
Target,1297,phosphodiesterase 2A,PDE2A,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1297,Enzyme,"Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)",Human:O00408|Mouse:Q922S4|Rat:Q01062,Human:PDE2A|Mouse:Pde2a|Rat:Pde2a,Human:8777|Mouse:MGI:2446107|Rat:620965,,,,,,
Target,1296,phosphodiesterase 1C,PDE1C,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1296,Enzyme,"Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)",Human:Q14123|Mouse:Q64338|Rat:Q63421,Human:PDE1C|Mouse:Pde1c|Rat:Pde1c,Human:8776|Mouse:MGI:108413|Rat:68332,,,,,,
Target,1295,phosphodiesterase 1B,PDE1B,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1295,Enzyme,"Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)",Human:Q01064|Mouse:Q01065|Rat:Q01066,Human:PDE1B|Mouse:Pde1b|Rat:Pde1b,Human:8775|Mouse:MGI:97523|Rat:3278,,,,,,
Target,1294,phosphodiesterase 1A,PDE1A,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1294,Enzyme,"Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)",Human:P54750|Mouse:Q61481,Human:PDE1A|Mouse:Pde1a|Rat:Pde1a,Human:8774|Mouse:MGI:1201792|Rat:68329,,,,,,
Target,1311,phosphodiesterase 11A,PDE11A,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1311,Enzyme,"Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)",Human:Q9HCR9|Mouse:P0C1Q2|Rat:Q8VID6,Human:PDE11A|Mouse:Pde11a|Rat:Pde11a,Human:8773|Mouse:MGI:3036251|Rat:621793,,,,,,
Target,1310,phosphodiesterase 10A,PDE10A,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1310,Enzyme,"Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs)",Human:Q9Y233|Mouse:Q8CA95|Rat:Q9QYJ6,Human:PDE10A|Mouse:Pde10a|Rat:Pde10a,Human:8772|Mouse:MGI:1345143|Rat:68434,,,,,,
Target,1277,Phosphatidylserine decarboxylase ,PSDC,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1277,Enzyme,Decarboxylases,Human:Q9UG56|Mouse:Q8BSF4,Human:PISD|Mouse:Pisd|Rat:Pisd,Human:8999|Mouse:MGI:2445114|Rat:1596729,,,,,,
Target,2163,phosphatidylinositol-5-phosphate 4-kinase type 2 gamma,PIP4K2C,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2163,Enzyme,Phosphatidylinositol phosphate kinases|Type II PIP kinases (1-phosphatidylinositol-5-phosphate 4-kinase family),Human:Q8TBX8|Mouse:Q91XU3|Rat:O88370,Human:PIP4K2C|Mouse:Pip4k2c|Rat:Pip4k2c,Human:23786|Mouse:MGI:2152214|Rat:621711,,,,,,
Target,2162,phosphatidylinositol-5-phosphate 4-kinase type 2 beta,PIP4K2B,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2162,Enzyme,Type II PIP kinases (1-phosphatidylinositol-5-phosphate 4-kinase family)|Phosphatidylinositol phosphate kinases,Human:P78356|Mouse:Q80XI4|Rat:O88377,Human:PIP4K2B|Mouse:Pip4k2b|Rat:Pip4k2b,Human:8998|Mouse:MGI:1934234|Rat:621710,,,,,,
Target,2288,phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma,C2&gamma;/PIK3C2G,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2288,Enzyme,Phosphatidylinositol-4-phosphate 3-kinase family|Phosphatidylinositol kinases,Human:O75747|Mouse:O70167|Rat:O70173,Human:PIK3C2G|Mouse:Pik3c2g|Rat:Pik3c2g,Human:8973|Mouse:MGI:1203730|Rat:620231,,,,,,
Target,2151,phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta,C2&beta;/PIK3C2B,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2151,Enzyme,Phosphatidylinositol-4-phosphate 3-kinase family|Phosphatidylinositol kinases,Human:O00750,Human:PIK3C2B|Mouse:Pik3c2b|Rat:Pik3c2b,Human:8972|Mouse:MGI:2685045|Rat:1306541,,,,,,
Target,2499,phosphatidylinositol 4-kinase type 2 beta,PI4KII&beta;/PI4K2B,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2499,Enzyme,Phosphatidylinositol kinases,Human:Q8TCG2|Mouse:Q8CBQ5|Rat:Q5XIL2,Human:PI4K2B|Mouse:Pi4k2b|Rat:Pi4k2b,Human:18215|Mouse:MGI:1914323|Rat:1359515,,,,,,
Target,2149,phosphatidylinositol 4-kinase beta,PI4KIII&beta;/PIK4CB,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2149,Enzyme,1-phosphatidylinositol 4-kinase family|Phosphatidylinositol kinases,Human:Q9UBF8|Mouse:Q8BKC8|Rat:O08561,Human:PI4KB|Mouse:Pi4kb|Rat:Pi4kb,Human:8984|Mouse:MGI:1334433|Rat:621214,,,,,,
Target,2156,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",PI3K&gamma;,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2156,Enzyme,"Phosphatidylinositol-4,5-bisphosphate 3-kinase family|Phosphatidylinositol kinases",Human:P48736|Mouse:Q9JHG7,Human:PIK3CG|Mouse:Pik3cg|Rat:Pik3cg,Human:8978|Mouse:MGI:1353576|Rat:1306468,,,,,,
Target,2155,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",PI3K&delta;,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2155,Enzyme,"Phosphatidylinositol-4,5-bisphosphate 3-kinase family|Phosphatidylinositol kinases",Human:O00329|Mouse:O35904,Human:PIK3CD|Mouse:Pik3cd|Rat:Pik3cd,Human:8977|Mouse:MGI:1098211|Rat:1310990,,,,,,
Target,2154,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",PI3K&beta;,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2154,Enzyme,"Phosphatidylinositol-4,5-bisphosphate 3-kinase family|Phosphatidylinositol kinases",Human:P42338|Mouse:Q8BTI9|Rat:Q9Z1L0,Human:PIK3CB|Mouse:Pik3cb|Rat:Pik3cb,Human:8976|Mouse:MGI:1922019|Rat:620917,,,,,,
Target,2153,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",PI3K&alpha;,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2153,Enzyme,"Phosphatidylinositol-4,5-bisphosphate 3-kinase family|Phosphatidylinositol kinases",Human:P42336|Mouse:P42337,Human:PIK3CA|Mouse:Pik3ca|Rat:Pik3ca,Human:8975|Mouse:MGI:1206581|Rat:620916,,,,,,
Target,2152,phosphatidylinositol 3-kinase catalytic subunit type 3,VPS34,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2152,Enzyme,Phosphatidylinositol 3-kinase family|Phosphatidylinositol kinases,Human:Q8NEB9|Mouse:Q6PF93|Rat:O88763,Human:PIK3C3|Mouse:Pik3c3|Rat:Pik3c3,Human:8974|Mouse:MGI:2445019|Rat:620899,,,,,,
Target,2497,phosphatase and tensin homolog,PTEN,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2497,Enzyme,Lipid phosphate phosphatases,Human:P60484|Mouse:O08586,Human:PTEN|Mouse:Pten|Rat:Pten,Human:9588|Mouse:MGI:109583|Rat:61995,,,,,,
Target,2496,Phenylethanolamine N-methyltransferase,PNMT,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2496,Enzyme,Catecholamine turnover,Human:P11086|Mouse:P40935|Rat:P10937,Human:PNMT|Mouse:Pnmt|Rat:Pnmt,Human:9160|Mouse:MGI:97724|Rat:3361,,,,,,
Target,595,Peroxisome proliferator-activated receptor-&gamma;,,NR1C3,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=595,NHR,1C. Peroxisome proliferator-activated receptors,Human:P37231|Mouse:P37238|Rat:O88275,Human:PPARG|Mouse:Pparg|Rat:Pparg,Human:9236|Mouse:MGI:97747|Rat:3371,,,,,,
Target,594,Peroxisome proliferator-activated receptor-&beta;/&delta;,,NR1C2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=594,NHR,1C. Peroxisome proliferator-activated receptors,Human:Q03181|Mouse:P35396,Human:PPARD|Mouse:Ppard|Rat:Ppard,Human:9235|Mouse:MGI:101884|Rat:3370,,,,,,
Target,593,Peroxisome proliferator-activated receptor-&alpha;,,NR1C1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=593,NHR,1C. Peroxisome proliferator-activated receptors,Human:Q07869|Mouse:P23204|Rat:P37230,Human:PPARA|Mouse:Ppara|Rat:Ppara,Human:9232|Mouse:MGI:104740|Rat:3369,,,,,,
Target,2544,peripheral myelin protein 2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2544,OtherProtein,Fatty acid-binding proteins,Human:P02689|Mouse:P24526,Human:PMP2|Mouse:Pmp2|Rat:Pmp2,Human:9117|Mouse:MGI:102667|Rat:1585218,,,,,,
Target,2751,peptidylprolyl isomerase A,Cyclophilin A,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2751,Enzyme,Peptidyl-prolyl cis/trans isomerases,Human:P62937|Mouse:P17742|Rat:P10111,Human:PPIA|Mouse:Ppia|Rat:Ppia,Human:9253|Mouse:MGI:97749|Rat:3372,,,,,,
Target,3171,"peptidylprolyl cis/trans isomerase, NIMA-interacting 1",,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3171,Enzyme,Peptidyl-prolyl cis/trans isomerases,Human:Q13526|Mouse:Q9QUR7,Human:PIN1|Mouse:Pin1|Rat:Pin1,Human:8988|Mouse:MGI:1346036|Rat:1310299,,,,,,
Target,2877,peptidyl arginine deiminase 4,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2877,Enzyme,3.5.3.15 Peptidyl arginine deiminases (PADI),Human:Q9UM07|Mouse:Q9Z183|Rat:O88807,Human:PADI4|Mouse:Padi4|Rat:Padi4,Human:18368|Mouse:MGI:1338898|Rat:3290,,,,,,
Target,2878,peptidyl arginine deiminase 3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2878,Enzyme,3.5.3.15 Peptidyl arginine deiminases (PADI),Human:Q9ULW8|Mouse:Q9Z184|Rat:P70708,Human:PADI3|Mouse:Padi3|Rat:Padi3,Human:18337|Mouse:MGI:1338891|Rat:3289,,,,,,
Target,2894,peptidyl arginine deiminase 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2894,Enzyme,3.5.3.15 Peptidyl arginine deiminases (PADI),Human:Q9ULC6|Mouse:Q9Z185|Rat:O88806,Human:PADI1|Mouse:Padi1|Rat:Padi1,Human:18367|Mouse:MGI:1338893|Rat:3287,,,,,,
Target,985,Peptide transporter 2,PEPT2,SLC15A2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=985,Transporter,SLC15 family of peptide transporters,Human:Q16348|Mouse:Q9ES07|Rat:Q63424,Human:SLC15A2|Mouse:Slc15a2|Rat:Slc15a2,Human:10921|Mouse:MGI:1890457|Rat:61972,,,,,,
Target,984,Peptide transporter 1,PEPT1,SLC15A1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=984,Transporter,SLC15 family of peptide transporters,Human:P46059|Mouse:Q9JIP7|Rat:P51574,Human:SLC15A1|Mouse:Slc15a1|Rat:Slc15a1,Human:10920|Mouse:MGI:1861376|Rat:621736,,,,,,
Target,3052,paraoxonase 1,PON1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3052,Enzyme,Paraoxonase (PON) family,Human:P27169|Mouse:P52430|Rat:P55159,Human:PON1|Mouse:Pon1|Rat:Pon1,Human:9204|Mouse:MGI:103295|Rat:620062,,,,,,
Target,347,PAR1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=347,GPCR,Proteinase-activated receptors,Human:P25116|Mouse:P30558|Rat:P26824,Human:F2R|Mouse:F2r|Rat:F2r,Human:3537|Mouse:MGI:101802|Rat:2586,,,,,,
Target,2590,pancreatic lipase,PNLIP,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2590,Enzyme,Hydrolases,Human:P16233|Mouse:Q6P8U6|Rat:P27657,Human:PNLIP|Mouse:Pnlip|Rat:Pnlip,Human:9155|Mouse:MGI:97722|Rat:3360,,,,,,
Target,334,PAF receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=334,GPCR,Platelet-activating factor receptor,Human:P25105|Mouse:Q62035|Rat:P46002,Human:PTAFR|Mouse:Ptafr|Rat:Ptafr,Human:9582|Mouse:MGI:106066|Rat:61897,,,,,,
Target,325,P2Y<sub>4</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=325,GPCR,P2Y receptors,Human:P51582|Mouse:Q9JJS7|Rat:O35811,Human:P2RY4|Mouse:P2ry4|Rat:P2ry4,Human:8542|Mouse:MGI:1926594|Rat:61798,,,,,,
Target,324,P2Y<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=324,GPCR,P2Y receptors,Human:P41231|Mouse:P35383|Rat:P41232,Human:P2RY2|Mouse:P2ry2|Rat:P2ry2,Human:8541|Mouse:MGI:105107|Rat:62088,,,,,,
Target,323,P2Y<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=323,GPCR,P2Y receptors,Human:P47900|Mouse:P49650|Rat:P49651,Human:P2RY1|Mouse:P2ry1|Rat:P2ry1,Human:8539|Mouse:MGI:105049|Rat:3242,,,,,,
Target,330,P2Y<sub>14</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=330,GPCR,P2Y receptors,Human:Q15391|Mouse:Q9ESG6|Rat:O35881,Human:P2RY14|Mouse:P2ry14|Rat:P2ry14,Human:16442|Mouse:MGI:2155705|Rat:70912,,,,,,
Target,329,P2Y<sub>13</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=329,GPCR,P2Y receptors,Human:Q9BPV8|Mouse:Q9D8I2|Rat:Q6GUG4,Human:P2RY13|Mouse:P2ry13|Rat:P2ry13,Human:4537|Mouse:MGI:1921441|Rat:1302941,,,,,,
Target,328,P2Y<sub>12</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=328,GPCR,P2Y receptors,Human:Q9H244|Mouse:Q9CPV9|Rat:Q9EPX4,Human:P2RY12|Mouse:P2ry12|Rat:P2ry12,Human:18124|Mouse:MGI:1918089|Rat:621681,,,,,,
Target,327,P2Y<sub>11</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=327,GPCR,P2Y receptors,Human:Q96G91,Human:P2RY11,Human:8540,,,,,,
Target,484,P2X7,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=484,LGIC,P2X receptors,Human:Q99572|Mouse:Q9Z1M0|Rat:Q64663,Human:P2RX7|Mouse:P2rx7|Rat:P2rx7,Human:8537|Mouse:MGI:1339957|Rat:3241,,,,,,
Target,483,P2X6,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=483,LGIC,P2X receptors,Human:O15547|Mouse:O54803|Rat:P51579,Human:P2RX6|Mouse:P2rx6|Rat:P2rx6,Human:8538|Mouse:MGI:1337113|Rat:3243,,,,,,
Target,482,P2X5,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=482,LGIC,P2X receptors,Human:Q93086|Mouse:Q3UYI1|Rat:P51578,Human:P2RX5|Mouse:P2rx5|Rat:P2rx5,Human:8536|Mouse:MGI:2137026|Rat:620256,,,,,,
Target,481,P2X4,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=481,LGIC,P2X receptors,Human:Q99571|Mouse:Q9JJX6|Rat:P51577,Human:P2RX4|Mouse:P2rx4|Rat:P2rx4,Human:8535|Mouse:MGI:1338859|Rat:62073,,,,,,
Target,480,P2X3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=480,LGIC,P2X receptors,Human:P56373|Mouse:Q3UR32|Rat:P49654,Human:P2RX3|Mouse:P2rx3|Rat:P2rx3,Human:8534|Mouse:MGI:1097160|Rat:620253,,,,,,
Target,479,P2X2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=479,LGIC,P2X receptors,Human:Q9UBL9|Rat:P49653,Human:P2RX2|Mouse:P2rx2|Rat:P2rx2,Human:15459|Mouse:MGI:2665170|Rat:620251,,,,,,
Target,478,P2X1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=478,LGIC,P2X receptors,Human:P51575|Mouse:P51576|Rat:P47824,Human:P2RX1|Mouse:P2rx1|Rat:P2rx1,Human:8533|Mouse:MGI:1098235|Rat:3240,,,,,,
Target,2137,p21 (RAC1) activated kinase 6,PAK6,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2137,Enzyme,PAKB subfamily,Human:Q9NQU5|Mouse:Q3ULB5,Human:PAK6|Mouse:Pak6|Rat:Pak6,Human:16061|Mouse:MGI:2679420|Rat:1306213,,,,,,
Target,2138,p21 (RAC1) activated kinase 5,PAK5,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2138,Enzyme,PAKB subfamily,Human:Q9P286|Mouse:Q8C015|Rat:D4A280,Human:PAK5|Mouse:Pak5|Rat:Pak5,Human:15916|Mouse:MGI:1920334|Rat:1312009,,,,,,
Target,2136,p21 (RAC1) activated kinase 4,PAK4,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2136,Enzyme,PAKB subfamily,Human:O96013|Mouse:Q8BTW9,Human:PAK4|Mouse:Pak4|Rat:Pak4,Human:16059|Mouse:MGI:1917834|Rat:1307705,,,,,,
Target,2135,p21 (RAC1) activated kinase 3,PAK3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2135,Enzyme,PAKA subfamily,Human:O75914|Mouse:Q61036|Rat:Q62829,Human:PAK3|Mouse:Pak3|Rat:Pak3,Human:8592|Mouse:MGI:1339656|Rat:3251,,,,,,
Target,2134,p21 (RAC1) activated kinase 2,PAK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2134,Enzyme,PAKA subfamily,Human:Q13177|Mouse:Q8CIN4|Rat:Q64303,Human:PAK2|Mouse:Pak2|Rat:Pak2,Human:8591|Mouse:MGI:1339984|Rat:61953,,,,,,
Target,2133,p21 (RAC1) activated kinase 1,PAK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2133,Enzyme,PAKA subfamily,Human:Q13153|Mouse:O88643|Rat:P35465,Human:PAK1|Mouse:Pak1|Rat:Pak1,Human:8590|Mouse:MGI:1339975|Rat:3250,,,,,,
Target,322,OX<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=322,GPCR,Orexin receptors,Human:O43614|Mouse:P58308|Mouse:P58308-2|Rat:P56719,Human:HCRTR2|Mouse:Hcrtr2|Rat:Hcrtr2,Human:4849|Mouse:MGI:2680765|Rat:2788,,,,,,
Target,321,OX<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=321,GPCR,Orexin receptors,Human:O43613|Mouse:P58307|Rat:P56718,Human:HCRTR1|Mouse:Hcrtr1|Rat:Hcrtr1,Human:4848|Mouse:MGI:2385650|Rat:2787,,,,,,
Target,2132,oxidative stress responsive kinase 1,OSR1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2132,Enzyme,FRAY subfamily,Human:O95747|Mouse:Q6P9R2,Human:OXSR1|Mouse:Oxsr1|Rat:Oxsr1,Human:8508|Mouse:MGI:1917378|Rat:1310466,,,,,,
Target,369,OT receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=369,GPCR,Vasopressin and oxytocin receptors,Human:P30559|Mouse:P97926|Rat:P70536,Human:OXTR|Mouse:Oxtr|Rat:Oxtr,Human:8529|Mouse:MGI:109147|Rat:3239,,,,,,
Target,1081,ORNT3,,SLC25A29,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1081,Transporter,Mitochondrial amino acid transporter subfamily,Human:Q8N8R3|Mouse:Q8BL03|Rat:Q5HZE0,Human:SLC25A29|Mouse:Slc25a29|Rat:Slc25a29,Human:20116|Mouse:MGI:2444911|Rat:1308104,,,,,,
Target,1276,Ornithine decarboxylase,ODC,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1276,Enzyme,Decarboxylases,Human:P11926|Mouse:P00860|Rat:P09057,Human:ODC1|Mouse:Odc1|Rat:Odc1,Human:8109|Mouse:MGI:97402|Rat:3227,,,,,,
Target,1023,Organic cation/carnitine transporter 2,OCTN2,SLC22A5,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1023,Transporter,Organic zwitterions/cation transporters (OCTN),Human:O76082|Mouse:Q9Z0E8|Rat:O70594,Human:SLC22A5|Mouse:Slc22a5|Rat:Slc22a5,Human:10969|Mouse:MGI:1329012|Rat:3702,,,,,,
Target,1022,Organic cation/carnitine transporter 1,OCTN1,SLC22A4,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1022,Transporter,Organic zwitterions/cation transporters (OCTN),Human:Q9H015|Mouse:Q9Z306|Rat:Q9R141,Human:SLC22A4|Mouse:Slc22a4|Rat:Slc22a4,Human:10968|Mouse:MGI:1353479|Rat:621149,,,,,,
Target,1030,Organic anion transporter 4,,SLC22A11,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1030,Transporter,Organic anion transporters (OATs),Human:Q9NSA0,Human:SLC22A11,Human:18120,,,,,,
Target,1027,Organic anion transporter 3,OAT3,SLC22A8,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1027,Transporter,Organic anion transporters (OATs),Human:Q8TCC7|Mouse:O88909|Rat:Q9R1U7,Human:SLC22A8|Mouse:Slc22a8|Rat:Slc22a8,Human:10972|Mouse:MGI:1336187|Rat:632286,,,,,,
Target,1026,Organic anion transporter 2,OAT2,SLC22A7,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1026,Transporter,Organic anion transporters (OATs),Human:Q9Y694|Mouse:Q91WU2|Rat:Q5RLM2,Human:SLC22A7|Mouse:Slc22a7|Rat:Slc22a7,Human:10971|Mouse:MGI:1859559|Rat:621699,,,,,,
Target,1025,Organic anion transporter 1,OAT1,SLC22A6,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1025,Transporter,Organic anion transporters (OATs),Human:Q4U2R8|Mouse:Q8VC69|Rat:O35956,Human:SLC22A6|Mouse:Slc22a6|Rat:Slc22a6,Human:10970|Mouse:MGI:892001|Rat:69338,,,,,,
Target,3101,O-GlcNAcase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3101,Enzyme,Hydrolases,Human:O60502|Mouse:Q9EQQ9|Rat:Q8VIJ5,Human:OGA|Mouse:Oga|Rat:Oga,Human:7056|Mouse:MGI:1932139|Rat:621077,,,,,,
Target,1224,OATP2B1,,SLCO2B1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1224,Transporter,SLCO family of organic anion transporting polypeptides,Human:O94956|Mouse:Q8BXB6|Rat:Q9JHI3,Human:SLCO2B1|Mouse:Slco2b1|Rat:Slco2b1,Human:10962|Mouse:MGI:1351872|Rat:621391,,,,,,
Target,1221,OATP1B3,,SLCO1B3,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1221,Transporter,SLCO family of organic anion transporting polypeptides,Human:Q9NPD5,Human:SLCO1B3,Human:10961,,,,,,
Target,1220,OATP1B1,,SLCO1B1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1220,Transporter,SLCO family of organic anion transporting polypeptides,Human:Q9Y6L6,Human:SLCO1B1,Human:10959,,,,,,
Target,2694,nuclear receptor coactivator 2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2694,Enzyme,2.3.1.48 Histone acetyltransferases (HATs),Human:Q15596|Mouse:Q61026|Rat:Q9WUI9,Human:NCOA2|Mouse:Ncoa2|Rat:Ncoa2,Human:7669|Mouse:MGI:1276533|Rat:620108,,,,,,
Target,2693,nuclear receptor coactivator 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2693,Enzyme,2.3.1.48 Histone acetyltransferases (HATs),Human:Q15788|Mouse:P70365,Human:NCOA1|Mouse:Ncoa1|Rat:Ncoa1,Human:7668|Mouse:MGI:1276523|Rat:1309046,,,,,,
Target,2130,"NUAK family, SNF1-like kinase, 2",NuaK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2130,Enzyme,NuaK subfamily,Human:Q9H093|Mouse:Q8BZN4|Rat:Q66HE5,Human:NUAK2|Mouse:Nuak2|Rat:Nuak2,Human:29558|Mouse:MGI:1921387|Rat:1359167,,,,,,
Target,2129,NUAK family kinase 1,NuaK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2129,Enzyme,NuaK subfamily,Human:O60285|Mouse:Q641K5,Human:NUAK1|Mouse:Nuak1|Rat:Nuak1,Human:14311|Mouse:MGI:1925226|Rat:1309956,,,,,,
Target,310,NTS<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=310,GPCR,Neurotensin receptors,Human:O95665|Mouse:P70310|Rat:Q63384,Human:NTSR2|Mouse:Ntsr2|Rat:Ntsr2,Human:8040|Mouse:MGI:108018|Rat:70962,,,,,,
Target,302,NPS receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=302,GPCR,Neuropeptide S receptor,Human:Q6W5P4|Mouse:Q8BZP8|Rat:P0C0L6,Human:NPSR1|Mouse:Npsr1|Rat:Npsr1,Human:23631|Mouse:MGI:2441738|Rat:1564154,,,,,,
Target,2629,NPC1 like intracellular cholesterol transporter 1,,SLC65A2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2629,Transporter,SLC65 NPC-type cholesterol transporters,Human:Q9UHC9|Mouse:Q6T3U4|Rat:Q6T3U3,Human:NPC1L1|Mouse:Npc1l1|Rat:Npc1l1,Human:7898|Mouse:MGI:2685089|Rat:1303135,,,,,,
Target,320,NOP receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=320,GPCR,Opioid receptors,Human:P41146|Mouse:P35377|Rat:P35370,Human:OPRL1|Mouse:Oprl1|Rat:Oprl1,Human:8155|Mouse:MGI:97440|Rat:68438,,,,,,
Target,362,NK<sub>3</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=362,GPCR,Tachykinin receptors,Human:P29371|Mouse:P47937|Rat:P16177,Human:TACR3|Mouse:Tacr3|Rat:Tacr3,Human:11528|Mouse:MGI:892968|Rat:3810,,,,,,
Target,361,NK<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=361,GPCR,Tachykinin receptors,Human:P21452|Mouse:P30549|Rat:P16610,Human:TACR2|Mouse:Tacr2|Rat:Tacr2,Human:11527|Mouse:MGI:98477|Rat:3812,,,,,,
Target,360,NK<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=360,GPCR,Tachykinin receptors,Human:P25103|Mouse:P30548|Rat:P14600,Human:TACR1|Mouse:Tacr1|Rat:Tacr1,Human:11526|Mouse:MGI:98475|Rat:3811,,,,,,
Target,2124,NIMA related kinase 9,NEK9,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2124,Enzyme,NIMA (never in mitosis gene a)- related kinase (NEK) family,Human:Q8TD19|Mouse:Q8K1R7,Human:NEK9|Mouse:Nek9|Rat:Nek9,Human:18591|Mouse:MGI:2387995|Rat:1307187,,,,,,
Target,2120,NIMA related kinase 5,NEK5,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2120,Enzyme,NIMA (never in mitosis gene a)- related kinase (NEK) family,Human:Q6P3R8|Mouse:Q7TSC3,Human:NEK5|Mouse:Nek5|Rat:Nek5,Human:7748|Mouse:MGI:2142824|Rat:1593817,,,,,,
Target,2119,NIMA related kinase 4,NEK4,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2119,Enzyme,NIMA (never in mitosis gene a)- related kinase (NEK) family,Human:P51957|Mouse:Q9Z1J2,Human:NEK4|Mouse:Nek4|Rat:Nek4,Human:11399|Mouse:MGI:1344404|Rat:1304995,,,,,,
Target,2118,NIMA related kinase 3,NEK3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2118,Enzyme,NIMA (never in mitosis gene a)- related kinase (NEK) family,Human:P51956|Mouse:Q9R0A5,Human:NEK3|Mouse:Nek3|Rat:Nek3,Human:7746|Mouse:MGI:1344371|Rat:1307419,,,,,,
Target,2117,NIMA related kinase 2,NEK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2117,Enzyme,NIMA (never in mitosis gene a)- related kinase (NEK) family,Human:P51955|Mouse:O35942,Human:NEK2|Mouse:Nek2|Rat:Nek2,Human:7745|Mouse:MGI:109359|Rat:619792,,,,,,
Target,2116,NIMA related kinase 11,NEK11,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2116,Enzyme,NIMA (never in mitosis gene a)- related kinase (NEK) family,Human:Q8NG66|Mouse:Q8C0Q4,Human:NEK11|Mouse:Nek11|Rat:Nek11,Human:18593|Mouse:MGI:2442276|Rat:1308801,,,,,,
Target,2114,NIMA related kinase 1,NEK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2114,Enzyme,NIMA (never in mitosis gene a)- related kinase (NEK) family,Human:Q96PY6|Mouse:P51954,Human:NEK1|Mouse:Nek1|Rat:Nek1,Human:7744|Mouse:MGI:97303|Rat:1309375,,,,,,
Target,474,nicotinic acetylcholine receptor &beta;4 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=474,LGIC,Nicotinic acetylcholine receptors  (nACh),Human:P30926|Mouse:Q8R493|Rat:P12392,Human:CHRNB4|Mouse:Chrnb4|Rat:Chrnb4,Human:1964|Mouse:MGI:87892|Rat:2351,,,,,,
Target,473,nicotinic acetylcholine receptor &beta;3 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=473,LGIC,Nicotinic acetylcholine receptors  (nACh),Human:Q05901|Mouse:Q8BMN3|Rat:P12391,Human:CHRNB3|Mouse:Chrnb3|Rat:Chrnb3,Human:1963|Mouse:MGI:106212|Rat:621544,,,,,,
Target,472,nicotinic acetylcholine receptor &beta;2 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=472,LGIC,Nicotinic acetylcholine receptors  (nACh),Human:P17787|Mouse:Q9ERK7|Rat:P12390,Human:CHRNB2|Mouse:Chrnb2|Rat:Chrnb2,Human:1962|Mouse:MGI:87891|Rat:2350,,,,,,
Target,469,nicotinic acetylcholine receptor &alpha;9 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=469,LGIC,Nicotinic acetylcholine receptors  (nACh),Human:Q9UGM1|Rat:P43144,Human:CHRNA9|Mouse:Chrna9|Rat:Chrna9,Human:14079|Mouse:MGI:1202403|Rat:621534,,,,,,
Target,468,nicotinic acetylcholine receptor &alpha;7 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=468,LGIC,Nicotinic acetylcholine receptors  (nACh),Human:P36544|Mouse:P49582|Rat:Q05941,Human:CHRNA7|Mouse:Chrna7|Rat:Chrna7,Human:1960|Mouse:MGI:99779|Rat:2348,,,,,,
Target,467,nicotinic acetylcholine receptor &alpha;6 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=467,LGIC,Nicotinic acetylcholine receptors  (nACh),Human:Q15825|Mouse:Q9R0W9|Rat:P43143,Human:CHRNA6|Mouse:Chrna6|Rat:Chrna6,Human:15963|Mouse:MGI:106213|Rat:69281,,,,,,
Target,466,nicotinic acetylcholine receptor &alpha;5 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=466,LGIC,Nicotinic acetylcholine receptors  (nACh),Human:P30532|Mouse:Q2MKA5|Rat:P20420,Human:CHRNA5|Mouse:Chrna5|Rat:Chrna5,Human:1959|Mouse:MGI:87889|Rat:2347,,,,,,
Target,465,nicotinic acetylcholine receptor &alpha;4 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=465,LGIC,Nicotinic acetylcholine receptors  (nACh),Human:P43681|Mouse:O70174|Rat:P09483,Human:CHRNA4|Mouse:Chrna4|Rat:Chrna4,Human:1958|Mouse:MGI:87888|Rat:2346,,,,,,
Target,464,nicotinic acetylcholine receptor &alpha;3 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=464,LGIC,Nicotinic acetylcholine receptors  (nACh),Human:P32297|Mouse:Q8R4G9|Rat:P04757,Human:CHRNA3|Mouse:Chrna3|Rat:Chrna3,Human:1957|Mouse:MGI:87887|Rat:2345,,,,,,
Target,463,nicotinic acetylcholine receptor &alpha;2 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=463,LGIC,Nicotinic acetylcholine receptors  (nACh),Human:Q15822|Mouse:Q91X60|Rat:P12389,Human:CHRNA2|Mouse:Chrna2|Rat:Chrna2,Human:1956|Mouse:MGI:87886|Rat:621533,,,,,,
Target,462,nicotinic acetylcholine receptor &alpha;1 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=462,LGIC,Nicotinic acetylcholine receptors  (nACh),Human:P02708|Mouse:P04756|Rat:P25108,Human:CHRNA1|Mouse:Chrna1|Rat:Chrna1,Human:1955|Mouse:MGI:87885|Rat:69277,,,,,,
Target,470,nicotinic acetylcholine receptor &alpha;10 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=470,LGIC,Nicotinic acetylcholine receptors  (nACh),Human:Q9GZZ6|Rat:Q9JLB5,Human:CHRNA10|Mouse:Chrna10|Rat:Chrna10,Human:13800|Mouse:MGI:3609260|Rat:620142,,,,,,
Target,1611,Neutral endopeptidase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1611,Enzyme,M13: Neprilysin,Human:P08473|Mouse:Q61391|Rat:P07861,Human:MME|Mouse:Mme|Rat:Mme,Human:7154|Mouse:MGI:97004|Rat:3098,,,,,,
Target,1819,neurotrophic receptor tyrosine kinase 3,trkC,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1819,CatalyticReceptor,Type VII RTKs: Neurotrophin receptor/Trk family,Human:Q16288|Mouse:Q6VNS1|Rat:Q03351,Human:NTRK3|Mouse:Ntrk3|Rat:Ntrk3,Human:8033|Mouse:MGI:97385|Rat:3214,,,,,,
Target,1818,neurotrophic receptor tyrosine kinase 2,trkB,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1818,CatalyticReceptor,Type VII RTKs: Neurotrophin receptor/Trk family,Human:Q16620|Mouse:P15209|Rat:Q63604,Human:NTRK2|Mouse:Ntrk2|Rat:Ntrk2,Human:8032|Mouse:MGI:97384|Rat:3213,,,,,,
Target,1817,neurotrophic receptor tyrosine kinase 1,trkA,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1817,CatalyticReceptor,Type VII RTKs: Neurotrophin receptor/Trk family,Human:P04629|Mouse:Q3UFB7|Rat:P35739,Human:NTRK1|Mouse:Ntrk1|Rat:Ntrk1,Human:8031|Mouse:MGI:97383|Rat:620144,,,,,,
Target,631,Neuron-derived orphan receptor 1,,NR4A3,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=631,NHR,4A. Nerve growth factor IB-like receptors,Human:Q92570|Mouse:Q9QZB6|Rat:P51179,Human:NR4A3|Mouse:Nr4a3|Rat:Nr4a3,Human:7982|Mouse:MGI:1352457|Rat:61882,,,,,,
Target,1251,Neuronal NOS,nNOS,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1251,Enzyme,Nitric oxide synthases,Human:P29475|Mouse:Q9Z0J4|Rat:P29476,Human:NOS1|Mouse:Nos1|Rat:Nos1,Human:7872|Mouse:MGI:97360|Rat:3184,,,,,,
Target,926,NET,,SLC6A2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=926,Transporter,Monoamine transporter subfamily,Human:P23975|Mouse:O55192,Human:SLC6A2|Mouse:Slc6a2|Rat:Slc6a2,Human:11048|Mouse:MGI:1270850|Rat:621822,,,,,,
Target,586,Na<sub>v</sub>1.9,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=586,VGIC,Voltage-gated sodium channels (Na<sub>V</sub>),Human:Q9UI33|Mouse:Q9R053|Rat:O88457,Human:SCN11A|Mouse:Scn11a|Rat:Scn11a,Human:10583|Mouse:MGI:1345149|Rat:3630,,,,,,
Target,585,Na<sub>v</sub>1.8,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=585,VGIC,Voltage-gated sodium channels (Na<sub>V</sub>),Human:Q9Y5Y9|Mouse:Q6QIY3|Rat:Q62968,Human:SCN10A|Mouse:Scn10a|Rat:Scn10a,Human:10582|Mouse:MGI:108029|Rat:3629,,,,,,
Target,584,Na<sub>v</sub>1.7,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=584,VGIC,Voltage-gated sodium channels (Na<sub>V</sub>),Human:Q15858|Mouse:Q62205|Rat:O08562,Human:SCN9A|Mouse:Scn9a|Rat:Scn9a,Human:10597|Mouse:MGI:107636|Rat:69368,,,,,,
Target,583,Na<sub>v</sub>1.6,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=583,VGIC,Voltage-gated sodium channels (Na<sub>V</sub>),Human:Q9UQD0|Mouse:Q9WTU3|Rat:O88420,Human:SCN8A|Mouse:Scn8a|Rat:Scn8a,Human:10596|Mouse:MGI:103169|Rat:3638,,,,,,
Target,582,Na<sub>v</sub>1.5,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=582,VGIC,Voltage-gated sodium channels (Na<sub>V</sub>),Human:Q14524|Mouse:Q9JJV9|Rat:P15389,Human:SCN5A|Mouse:Scn5a|Rat:Scn5a,Human:10593|Mouse:MGI:98251|Rat:3637,,,,,,
Target,581,Na<sub>v</sub>1.4,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=581,VGIC,Voltage-gated sodium channels (Na<sub>V</sub>),Human:P35499|Mouse:Q9ER60|Rat:P15390,Human:SCN4A|Mouse:Scn4a|Rat:Scn4a,Human:10591|Mouse:MGI:98250|Rat:3636,,,,,,
Target,580,Na<sub>v</sub>1.3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=580,VGIC,Voltage-gated sodium channels (Na<sub>V</sub>),Human:Q9NY46|Rat:P08104,Human:SCN3A|Mouse:Scn3a|Rat:Scn3a,Human:10590|Mouse:MGI:98249|Rat:3635,,,,,,
Target,579,Na<sub>v</sub>1.2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=579,VGIC,Voltage-gated sodium channels (Na<sub>V</sub>),Human:Q99250|Rat:P04775,Human:SCN2A|Mouse:Scn2a|Rat:Scn2a,Human:10588|Mouse:MGI:98248|Rat:3632,,,,,,
Target,578,Na<sub>v</sub>1.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=578,VGIC,Voltage-gated sodium channels (Na<sub>V</sub>),Human:P35498|Rat:P04774,Human:SCN1A|Mouse:Scn1a|Rat:Scn1a,Human:10585|Mouse:MGI:98246|Rat:69364,,,,,,
Target,970,Na-Cl symporter,NCC,SLC12A3,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=970,Transporter,SLC12 family of cation-coupled chloride transporters,Human:P55017|Mouse:P59158|Rat:P55018,Human:SLC12A3|Mouse:Slc12a3|Rat:Slc12a3,Human:10912|Mouse:MGI:108114|Rat:3686,,,,,,
Target,2111,myosin light chain kinase family member 4,Sgk085,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2111,Enzyme,Myosin Light Chain Kinase (MLCK) family,Human:Q86YV6|Mouse:Q5SUV5,Human:MYLK4|Mouse:Mylk4,Human:27972|Mouse:MGI:3643758,,,,,,
Target,2110,myosin light chain kinase 3,caMLCK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2110,Enzyme,Myosin Light Chain Kinase (MLCK) family,Human:Q32MK0|Mouse:Q3UIZ8|Rat:E9PT87,Human:MYLK3|Mouse:Mylk3|Rat:Mylk3,Human:29826|Mouse:MGI:2443063|Rat:1305801,,,,,,
Target,1553,myosin light chain kinase 2,skMLCK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1553,Enzyme,Myosin Light Chain Kinase (MLCK) family,Human:Q9H1R3|Mouse:Q8VCR8|Rat:P20689,Human:MYLK2|Mouse:Mylk2|Rat:Mylk2,Human:16243|Mouse:MGI:2139434|Rat:620934,,,,,,
Target,1552,myosin light chain kinase,smMLCK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1552,Enzyme,Myosin Light Chain Kinase (MLCK) family,Human:Q15746|Mouse:Q6PDN3,Human:MYLK|Mouse:Mylk|Rat:Mylk,Human:7590|Mouse:MGI:894806|Rat:1310915,,,,,,
Target,2112,myosin IIIA,MYO3A,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2112,Enzyme,NinaC subfamily,Human:Q8NEV4|Mouse:Q8K3H5,Human:MYO3A|Mouse:Myo3a|Rat:Myo3a,Human:7601|Mouse:MGI:2183924|Rat:1560083,,,,,,
Target,2789,myeloperoxidase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2789,Enzyme,1.-.-.- Oxidoreductases,Human:P05164|Mouse:P11247,Human:MPO|Mouse:Mpo|Rat:Mpo,Human:7218|Mouse:MGI:97137|Rat:1592081,,,,,,
Target,1847,muscle associated receptor tyrosine kinase,MuSK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1847,CatalyticReceptor,Type IX RTKs: MuSK,Human:O15146|Mouse:Q61006|Rat:Q62838,Human:MUSK|Mouse:Musk|Rat:Musk,Human:7525|Mouse:MGI:103581|Rat:3211,,,,,,
Target,319,&mu; receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=319,GPCR,Opioid receptors,Human:P35372|Mouse:P42866|Rat:P33535,Human:OPRM1|Mouse:Oprm1|Rat:Oprm1,Human:8156|Mouse:MGI:97441|Rat:3234,,,,,,
Target,288,MT<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=288,GPCR,Melatonin receptors,Human:P49286|Mouse:Q8CIQ6|Rat:P49287,Human:MTNR1B|Mouse:Mtnr1b|Rat:Mtnr1b,Human:7464|Mouse:MGI:2181726|Rat:620798,,,,,,
Target,287,MT<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=287,GPCR,Melatonin receptors,Human:P48039|Mouse:Q61184|Rat:P49218,Human:MTNR1A|Mouse:Mtnr1a|Rat:Mtnr1a,Human:7463|Mouse:MGI:102967|Rat:620797,,,,,,
Target,17,M<sub>5</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=17,GPCR,Acetylcholine receptors (muscarinic),Human:P08912|Mouse:Q920H4|Rat:P08911,Human:CHRM5|Mouse:Chrm5|Rat:Chrm5,Human:1954|Mouse:MGI:109248|Rat:620027,,,,,,
Target,16,M<sub>4</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=16,GPCR,Acetylcholine receptors (muscarinic),Human:P08173|Mouse:P32211|Rat:P08485,Human:CHRM4|Mouse:Chrm4|Rat:Chrm4,Human:1953|Mouse:MGI:88399|Rat:2344,,,,,,
Target,15,M<sub>3</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=15,GPCR,Acetylcholine receptors (muscarinic),Human:P20309|Mouse:Q9ERZ3|Rat:P08483,Human:CHRM3|Mouse:Chrm3|Rat:Chrm3,Human:1952|Mouse:MGI:88398|Rat:2343,,,,,,
Target,14,M<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=14,GPCR,Acetylcholine receptors (muscarinic),Human:P08172|Mouse:Q9ERZ4|Rat:P10980,Human:CHRM2|Mouse:Chrm2|Rat:Chrm2,Human:1951|Mouse:MGI:88397|Rat:620023,,,,,,
Target,13,M<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=13,GPCR,Acetylcholine receptors (muscarinic),Human:P11229|Mouse:P12657|Rat:P08482,Human:CHRM1|Mouse:Chrm1|Rat:Chrm1,Human:1950|Mouse:MGI:88396|Rat:2342,,,,,,
Target,297,motilin receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=297,GPCR,Motilin receptor,Human:O43193,Human:MLNR,Human:4495,,,,,,
Target,992,Monocarboxylate transporter 8,MCT8,SLC16A2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=992,Transporter,SLC16 family of monocarboxylate transporters,Human:P36021|Mouse:O70324|Rat:Q8K1P8,Human:SLC16A2|Mouse:Slc16a2|Rat:Slc16a2,Human:10923|Mouse:MGI:1203732|Rat:628608,,,,,,
Target,996,Monocarboxylate transporter 7,MCT7,SLC16A6,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=996,Transporter,SLC16 family of monocarboxylate transporters,Human:O15403|Mouse:B1AT66,Human:SLC16A6|Mouse:Slc16a6|Rat:Slc16a6,Human:10927|Mouse:MGI:2144585|Rat:735117,,,,,,
Target,995,Monocarboxylate transporter 6,MCT6,SLC16A5,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=995,Transporter,SLC16 family of monocarboxylate transporters,Human:O15375|Mouse:G5E8K6,Human:SLC16A5|Mouse:Slc16a5|Rat:Slc16a5,Human:10926|Mouse:MGI:2443515|Rat:1582896,,,,,,
Target,994,Monocarboxylate transporter 5,MCT5,SLC16A4,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=994,Transporter,SLC16 family of monocarboxylate transporters,Human:O15374|Mouse:Q8R0M8,Human:SLC16A4|Mouse:Slc16a4|Rat:Slc16a4,Human:10925|Mouse:MGI:2385183|Rat:1359655,,,,,,
Target,989,Monocarboxylate transporter 4,MCT4,SLC16A3,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=989,Transporter,SLC16 family of monocarboxylate transporters,Human:O15427|Mouse:P57787|Rat:O35910,Human:SLC16A3|Mouse:Slc16a3|Rat:Slc16a3,Human:10924|Mouse:MGI:1933438|Rat:620603,,,,,,
Target,991,Monocarboxylate transporter 3,MCT3,SLC16A8,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=991,Transporter,SLC16 family of monocarboxylate transporters,Human:O95907|Mouse:O35308|Rat:O70461,Human:SLC16A8|Mouse:Slc16a8|Rat:Slc16a8,Human:16270|Mouse:MGI:1929519|Rat:69282,,,,,,
Target,990,Monocarboxylate transporter 2,MCT2,SLC16A7,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=990,Transporter,SLC16 family of monocarboxylate transporters,Human:O60669|Mouse:O70451|Rat:Q63344,Human:SLC16A7|Mouse:Slc16a7|Rat:Slc16a7,Human:10928|Mouse:MGI:1330284|Rat:3691,,,,,,
Target,988,Monocarboxylate transporter 1,MCT1,SLC16A1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=988,Transporter,SLC16 family of monocarboxylate transporters,Human:P53985|Mouse:P53986|Rat:P53987,Human:SLC16A1|Mouse:Slc16a1|Rat:Slc16a1,Human:10922|Mouse:MGI:106013|Rat:3690,,,,,,
Target,2490,Monoamine oxidase B,MAO-B,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2490,Enzyme,Catecholamine turnover,Human:P27338|Mouse:Q8BW75|Rat:P19643,Human:MAOB|Mouse:Maob|Rat:Maob,Human:6834|Mouse:MGI:96916|Rat:3041,,,,,,
Target,2489,Monoamine oxidase A,MAO-A,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2489,Enzyme,Catecholamine turnover,Human:P21397|Mouse:Q64133|Rat:G3V9Z3,Human:MAOA|Mouse:Maoa|Rat:Maoa,Human:6833|Mouse:MGI:96915|Rat:61898,,,,,,
Target,1633,MMP9,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1633,Enzyme,M10: Matrix metallopeptidase,Human:P14780|Mouse:P41245|Rat:P50282,Human:MMP9|Mouse:Mmp9|Rat:Mmp9,Human:7176|Mouse:MGI:97011|Rat:621320,,,,,,
Target,1632,MMP8,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1632,Enzyme,M10: Matrix metallopeptidase,Human:P22894|Mouse:O70138|Rat:O88766,Human:MMP8|Mouse:Mmp8|Rat:Mmp8,Human:7175|Mouse:MGI:1202395|Rat:631408,,,,,,
Target,1631,MMP7,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1631,Enzyme,M10: Matrix metallopeptidase,Human:P09237|Mouse:Q10738|Rat:P50280,Human:MMP7|Mouse:Mmp7|Rat:Mmp7,Human:7174|Mouse:MGI:103189|Rat:3100,,,,,,
Target,1630,MMP3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1630,Enzyme,M10: Matrix metallopeptidase,Human:P08254|Mouse:P28862|Rat:P03957,Human:MMP3|Mouse:Mmp3|Rat:Mmp3,Human:7173|Mouse:MGI:97010|Rat:621317,,,,,,
Target,1650,MMP28,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1650,Enzyme,M10: Matrix metallopeptidase,Human:Q9H239,Human:MMP28|Mouse:Mmp28|Rat:Mmp28,Human:14366|Mouse:MGI:2153062|Rat:1311573,,,,,,
Target,1649,MMP27,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1649,Enzyme,M10: Matrix metallopeptidase,Human:Q9H306,Human:MMP27|Mouse:Mmp27|Rat:Mmp27,Human:14250|Mouse:MGI:3039232|Rat:1306642,,,,,,
Target,1648,MMP26,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1648,Enzyme,M10: Matrix metallopeptidase,Human:Q9NRE1,Human:MMP26,Human:14249,,,,,,
Target,1647,MMP25,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1647,Enzyme,M10: Matrix metallopeptidase,Human:Q9NPA2|Mouse:Q3U435,Human:MMP25|Mouse:Mmp25|Rat:Mmp25,Human:14246|Mouse:MGI:2443938|Rat:1308298,,,,,,
Target,1646,MMP24,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1646,Enzyme,M10: Matrix metallopeptidase,Human:Q9Y5R2|Mouse:Q9R0S2|Rat:Q99PW6,Human:MMP24|Mouse:Mmp24|Rat:Mmp24,Human:7172|Mouse:MGI:1341867|Rat:620202,,,,,,
Target,1645,MMP23,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1645,Enzyme,M10: Matrix metallopeptidase,Human:O75900|Mouse:O88676|Rat:O88272,Human:MMP23B|Mouse:Mmp23|Rat:Mmp23,Human:7171|Mouse:MGI:1347361|Rat:620201,,,,,,
Target,1644,MMP21,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1644,Enzyme,M10: Matrix metallopeptidase,Human:Q8N119|Mouse:Q8K3F2,Human:MMP21|Mouse:Mmp21|Rat:Mmp21,Human:14357|Mouse:MGI:2664387|Rat:1309332,,,,,,
Target,1643,MMP20,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1643,Enzyme,M10: Matrix metallopeptidase,Human:O60882|Mouse:P57748,Human:MMP20|Mouse:Mmp20|Rat:Mmp20,Human:7167|Mouse:MGI:1353466|Rat:1308730,,,,,,
Target,1629,MMP2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1629,Enzyme,M10: Matrix metallopeptidase,Human:P08253|Mouse:P33434|Rat:P33436,Human:MMP2|Mouse:Mmp2|Rat:Mmp2,Human:7166|Mouse:MGI:97009|Rat:621316,,,,,,
Target,1642,MMP19,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1642,Enzyme,M10: Matrix metallopeptidase,Human:Q99542|Mouse:Q9JHI0,Human:MMP19|Mouse:Mmp19|Rat:Mmp19,Human:7165|Mouse:MGI:1927899|Rat:1311376,,,,,,
Target,1641,MMP17,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1641,Enzyme,M10: Matrix metallopeptidase,Human:Q9ULZ9|Mouse:Q9R0S3|Rat:D3ZXJ0,Human:MMP17|Mouse:Mmp17|Rat:Mmp17,Human:7163|Mouse:MGI:1346076|Rat:1311541,,,,,,
Target,1640,MMP16,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1640,Enzyme,M10: Matrix metallopeptidase,Human:P51512|Mouse:Q9WTR0|Rat:O35548,Human:MMP16|Mouse:Mmp16|Rat:Mmp16,Human:7162|Mouse:MGI:1276107|Rat:620199,,,,,,
Target,1639,MMP15,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1639,Enzyme,M10: Matrix metallopeptidase,Human:P51511|Mouse:O54732|Rat:D3ZCG5,Human:MMP15|Mouse:Mmp15|Rat:Mmp15,Human:7161|Mouse:MGI:109320|Rat:1308937,,,,,,
Target,1638,MMP14,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1638,Enzyme,M10: Matrix metallopeptidase,Human:P50281|Mouse:P53690|Rat:Q10739,Human:MMP14|Mouse:Mmp14|Rat:Mmp14,Human:7160|Mouse:MGI:101900|Rat:620198,,,,,,
Target,1637,MMP13,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1637,Enzyme,M10: Matrix metallopeptidase,Human:P45452|Mouse:P33435|Rat:P23097,Human:MMP13|Mouse:Mmp13|Rat:Mmp13,Human:7159|Mouse:MGI:1340026|Rat:620196,,,,,,
Target,1636,MMP12,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1636,Enzyme,M10: Matrix metallopeptidase,Human:P39900|Mouse:P34960|Rat:Q63341,Human:MMP12|Mouse:Mmp12|Rat:Mmp12,Human:7158|Mouse:MGI:97005|Rat:620195,,,,,,
Target,1635,MMP11,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1635,Enzyme,M10: Matrix metallopeptidase,Human:P24347|Mouse:Q02853|Rat:Q499S5,Human:MMP11|Mouse:Mmp11|Rat:Mmp11,Human:7157|Mouse:MGI:97008|Rat:3099,,,,,,
Target,1634,MMP10,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1634,Enzyme,M10: Matrix metallopeptidase,Human:P09238|Mouse:O55123|Rat:P07152,Human:MMP10|Mouse:Mmp10|Rat:Mmp10,Human:7156|Mouse:MGI:97007|Rat:620192,,,,,,
Target,1628,MMP1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1628,Enzyme,M10: Matrix metallopeptidase,Human:P03956|Mouse:Q9EPL5|Rat:P81563,Human:MMP1|Mouse:Mmp1a|Rat:Mmp1,Human:7155|Mouse:MGI:1933846|Rat:1307917,,,,,,
Target,2089,mitogen-activated protein kinase kinase kinase kinase 5,KHS1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2089,Enzyme,KHS subfamily,Human:Q9Y4K4|Mouse:Q8BPM2,Human:MAP4K5|Mouse:Map4k5|Rat:Map4k5,Human:6867|Mouse:MGI:1925503|Rat:1562028,,,,,,
Target,2088,mitogen-activated protein kinase kinase kinase kinase 4,HGK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2088,Enzyme,MSN subfamily,Human:O95819|Mouse:P97820,Human:MAP4K4|Mouse:Map4k4|Rat:Map4k4,Human:6866|Mouse:MGI:1349394|Rat:1305322,,,,,,
Target,2087,mitogen-activated protein kinase kinase kinase kinase 3,KHS2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2087,Enzyme,KHS subfamily,Human:Q8IVH8|Mouse:Q99JP0|Rat:Q924I2,Human:MAP4K3|Mouse:Map4k3|Rat:Map4k3,Human:6865|Mouse:MGI:2154405|Rat:621280,,,,,,
Target,2086,mitogen-activated protein kinase kinase kinase kinase 2,GCK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2086,Enzyme,KHS subfamily,Human:Q12851|Mouse:Q61161,Human:MAP4K2|Mouse:Map4k2|Rat:Map4k2,Human:6864|Mouse:MGI:1346883|Rat:1308199,,,,,,
Target,2085,mitogen-activated protein kinase kinase kinase kinase 1,HPK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2085,Enzyme,KHS subfamily,Human:Q92918|Mouse:P70218,Human:MAP4K1|Mouse:Map4k1|Rat:Map4k1,Human:6863|Mouse:MGI:1346882|Rat:1305463,,,,,,
Target,2084,mitogen-activated protein kinase kinase kinase 9,MLK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2084,Enzyme,MLK subfamily,Human:P80192|Mouse:Q3U1V8,Human:MAP3K9|Mouse:Map3k9|Rat:Map3k9,Human:6861|Mouse:MGI:2449952|Rat:1562149,,,,,,
Target,2081,mitogen-activated protein kinase kinase kinase 6,MEKK6,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2081,Enzyme,STE11 family,Human:O95382|Mouse:Q9WTR2,Human:MAP3K6|Mouse:Map3k6|Rat:Map3k6,Human:6858|Mouse:MGI:1855691|Rat:1304625,,,,,,
Target,2079,mitogen-activated protein kinase kinase kinase 4,MEKK4,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2079,Enzyme,STE11 family,Human:Q9Y6R4|Mouse:O08648,Human:MAP3K4|Mouse:Map3k4|Rat:Map3k4,Human:6856|Mouse:MGI:1346875|Rat:1311192,,,,,,
Target,2078,mitogen-activated protein kinase kinase kinase 3,MEKK3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2078,Enzyme,STE11 family,Human:Q99759|Mouse:Q61084,Human:MAP3K3|Mouse:Map3k3|Rat:Map3k3,Human:6855|Mouse:MGI:1346874|Rat:1304575,,,,,,
Target,2077,mitogen-activated protein kinase kinase kinase 2,MEKK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2077,Enzyme,STE11 family,Human:Q9Y2U5|Mouse:Q61083,Human:MAP3K2|Mouse:Map3k2|Rat:Map3k2,Human:6854|Mouse:MGI:1346873|Rat:620967,,,,,,
Target,2076,mitogen-activated protein kinase kinase kinase 19,YSK4,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2076,Enzyme,STE20 subfamily,Human:Q56UN5|Mouse:E9Q3S4,Human:MAP3K19|Mouse:Map3k19|Rat:Map3k19,Human:26249|Mouse:MGI:1203481|Rat:1566400,,,,,,
Target,2075,mitogen-activated protein kinase kinase kinase 15,MAP3K15,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2075,Enzyme,STE11 family,Human:Q6ZN16|Mouse:A2AQW0,Human:MAP3K15|Mouse:Map3k15|Rat:Map3k15,Human:31689|Mouse:MGI:2448588|Rat:1560603,,,,,,
Target,2073,mitogen-activated protein kinase kinase kinase 13,LZK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2073,Enzyme,LZK subfamily,Human:O43283|Mouse:Q1HKZ5,Human:MAP3K13|Mouse:Map3k13|Rat:Map3k13,Human:6852|Mouse:MGI:2444243|Rat:1561227,,,,,,
Target,2072,mitogen-activated protein kinase kinase kinase 12,DLK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2072,Enzyme,LZK subfamily,Human:Q12852|Mouse:Q60700|Rat:Q63796,Human:MAP3K12|Mouse:Map3k12|Rat:Map3k12,Human:6851|Mouse:MGI:1346881|Rat:3988,,,,,,
Target,2071,mitogen-activated protein kinase kinase kinase 11,MLK3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2071,Enzyme,MLK subfamily,Human:Q16584|Mouse:Q80XI6|Rat:Q66HA1,Human:MAP3K11|Mouse:Map3k11|Rat:Map3k11,Human:6850|Mouse:MGI:1346880|Rat:1359261,,,,,,
Target,2070,mitogen-activated protein kinase kinase kinase 10,MLK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2070,Enzyme,MLK subfamily,Human:Q02779|Mouse:Q66L42,Human:MAP3K10|Mouse:Map3k10|Rat:Map3k10,Human:6849|Mouse:MGI:1346879|Rat:1308381,,,,,,
Target,2069,mitogen-activated protein kinase kinase kinase 1,MEKK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2069,Enzyme,STE11 family,Human:Q13233|Mouse:P53349|Rat:Q62925,Human:MAP3K1|Mouse:Map3k1|Rat:Map3k1,Human:6848|Mouse:MGI:1346872|Rat:620966,,,,,,
Target,2067,mitogen-activated protein kinase kinase 6,MKK6,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2067,Enzyme,STE7 family,Human:P52564|Mouse:P70236|Rat:Q925D6,Human:MAP2K6|Mouse:Map2k6|Rat:Map2k6,Human:6846|Mouse:MGI:1346870|Rat:620666,,,,,,
Target,2066,mitogen-activated protein kinase kinase 5,MEK5,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2066,Enzyme,STE7 family,Human:Q13163|Mouse:Q9WVS7|Rat:Q62862,Human:MAP2K5|Mouse:Map2k5|Rat:Map2k5,Human:6845|Mouse:MGI:1346345|Rat:61890,,,,,,
Target,2064,mitogen-activated protein kinase kinase 3,MKK3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2064,Enzyme,STE7 family,Human:P46734|Mouse:O09110,Human:MAP2K3|Mouse:Map2k3|Rat:Map2k3,Human:6843|Mouse:MGI:1346868|Rat:1306620,,,,,,
Target,2063,mitogen-activated protein kinase kinase 2,MEK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2063,Enzyme,STE7 family,Human:P36507|Mouse:Q63932|Rat:P36506,Human:MAP2K2|Mouse:Map2k2|Rat:Map2k2,Human:6842|Mouse:MGI:1346867|Rat:61888,,,,,,
Target,2062,mitogen-activated protein kinase kinase 1,MEK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2062,Enzyme,STE7 family,Human:Q02750|Mouse:P31938|Rat:Q01986,Human:MAP2K1|Mouse:Map2k1|Rat:Map2k1,Human:6840|Mouse:MGI:1346866|Rat:70495,,,,,,
Target,1497,mitogen-activated protein kinase 9,JNK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1497,Enzyme,JNK subfamily,Human:P45984|Mouse:Q9WTU6|Rat:P49186,Human:MAPK9|Mouse:Mapk9|Rat:Mapk9,Human:6886|Mouse:MGI:1346862|Rat:628847,,,,,,
Target,1496,mitogen-activated protein kinase 8,JNK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1496,Enzyme,JNK subfamily,Human:P45983|Mouse:Q91Y86|Rat:P49185,Human:MAPK8|Mouse:Mapk8|Rat:Mapk8,Human:6881|Mouse:MGI:1346861|Rat:621506,,,,,,
Target,2093,mitogen-activated protein kinase 7,ERK5,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2093,Enzyme,ERK subfamily,Human:Q13164|Mouse:Q9WVS8|Rat:P0C865,Human:MAPK7|Mouse:Mapk7|Rat:Mapk7,Human:6880|Mouse:MGI:1346347|Rat:621505,,,,,,
Target,2092,mitogen-activated protein kinase 6,ERK3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2092,Enzyme,ERK subfamily,Human:Q16659|Mouse:Q61532|Rat:P27704,Human:MAPK6|Mouse:Mapk6|Rat:Mapk6,Human:6879|Mouse:MGI:1354946|Rat:62087,,,,,,
Target,2091,mitogen-activated protein kinase 4,ERK4,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2091,Enzyme,ERK subfamily,Human:P31152|Mouse:Q6P5G0|Rat:Q63454,Human:MAPK4|Mouse:Mapk4|Rat:Mapk4,Human:6878|Mouse:MGI:2444559|Rat:3047,,,,,,
Target,1494,mitogen-activated protein kinase 3,ERK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1494,Enzyme,ERK subfamily,Human:P27361|Mouse:Q63844|Rat:P21708,Human:MAPK3|Mouse:Mapk3|Rat:Mapk3,Human:6877|Mouse:MGI:1346859|Rat:3046,,,,,,
Target,2090,mitogen-activated protein kinase 15,ERK7,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2090,Enzyme,Erk7 subfamily,Human:Q8TD08|Mouse:Q80Y86|Rat:Q9Z2A6,Human:MAPK15|Mouse:Mapk15|Rat:Mapk15,Human:24667|Mouse:MGI:2652894|Rat:628675,,,,,,
Target,1499,mitogen-activated protein kinase 14,p38&alpha;,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1499,Enzyme,p38 subfamily,Human:Q16539|Mouse:P47811|Rat:P70618,Human:MAPK14|Mouse:Mapk14|Rat:Mapk14,Human:6876|Mouse:MGI:1346865|Rat:70496,,,,,,
Target,1502,mitogen-activated protein kinase 13,p38&delta;,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1502,Enzyme,p38 subfamily,Human:O15264|Mouse:Q9Z1B7|Rat:Q9WTY9,Human:MAPK13|Mouse:Mapk13|Rat:Mapk13,Human:6875|Mouse:MGI:1346864|Rat:3045,,,,,,
Target,1501,mitogen-activated protein kinase 12,p38&gamma;,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1501,Enzyme,p38 subfamily,Human:P53778|Mouse:O08911|Rat:Q63538,Human:MAPK12|Mouse:Mapk12|Rat:Mapk12,Human:6874|Mouse:MGI:1353438|Rat:70975,,,,,,
Target,1500,mitogen-activated protein kinase 11,p38&beta;,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1500,Enzyme,p38 subfamily,Human:Q15759|Mouse:Q9WUI1,Human:MAPK11|Mouse:Mapk11|Rat:Mapk11,Human:6873|Mouse:MGI:1338024|Rat:1309340,,,,,,
Target,1498,mitogen-activated protein kinase 10,JNK3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1498,Enzyme,JNK subfamily,Human:P53779|Mouse:E9QN59|Rat:P49187,Human:MAPK10|Mouse:Mapk10|Rat:Mapk10,Human:6872|Mouse:MGI:1346863|Rat:3663,,,,,,
Target,1495,mitogen-activated protein kinase 1,ERK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1495,Enzyme,ERK subfamily,Human:P28482|Mouse:P63085|Rat:P63086,Human:MAPK1|Mouse:Mapk1|Rat:Mapk1,Human:6871|Mouse:MGI:1346858|Rat:70500,,,,,,
Target,1059,Mitochondrial ornithine transporter 2,ORC2,SLC25A2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1059,Transporter,Mitochondrial amino acid transporter subfamily,Human:Q9BXI2,Human:SLC25A2|Mouse:Slc25a2|Rat:Slc25a2,Human:22921|Mouse:MGI:2137907|Rat:1310667,,,,,,
Target,1060,Mitochondrial ornithine transporter 1 ,ORC1,SLC25A15,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1060,Transporter,Mitochondrial amino acid transporter subfamily,Human:Q9Y619|Mouse:Q9WVD5,Human:SLC25A15|Mouse:Slc25a15|Rat:Slc25a15,Human:10985|Mouse:MGI:1342274|Rat:1311488,,,,,,
Target,1064,Mitochondrial adenine nucleotide translocator 3,ANT3,SLC25A6,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1064,Transporter,Mitochondrial nucleotide transporter subfamily,Human:P12236,Human:SLC25A6|Rat:Slc25a6,Human:10992|Rat:1560896,,,,,,
Target,1063,Mitochondrial adenine nucleotide translocator 2,ANT2,SLC25A5,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1063,Transporter,Mitochondrial nucleotide transporter subfamily,Human:P05141|Mouse:P51881|Rat:Q09073,Human:SLC25A5|Mouse:Slc25a5|Rat:Slc25a5,Human:10991|Mouse:MGI:1353496|Rat:620353,,,,,,
Target,1062,Mitochondrial adenine nucleotide translocator 1,ANT1,SLC25A4,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1062,Transporter,Mitochondrial nucleotide transporter subfamily,Human:P12235|Mouse:P48962|Rat:Q05962,Human:SLC25A4|Mouse:Slc25a4|Rat:Slc25a4,Human:10990|Mouse:MGI:1353495|Rat:620352,,,,,,
Target,1239,Mitochondrial 5'-nucleotidase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1239,Enzyme,Adenosine turnover,Human:Q9NPB1|Mouse:Q8VCE6,Human:NT5M|Mouse:Nt5m|Rat:Nt5m,Human:15769|Mouse:MGI:1917127|Rat:1309622,,,,,,
Target,2103,misshapen like kinase 1,MINK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2103,Enzyme,MSN subfamily,Human:Q8N4C8|Mouse:Q9JM52|Rat:F1LP90,Human:MINK1|Mouse:Mink1|Rat:Mink1,Human:17565|Mouse:MGI:1355329|Rat:1359135,,,,,,
Target,626,Mineralocorticoid receptor,,NR3C2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=626,NHR,3C. 3-Ketosteroid receptors,Human:P08235|Mouse:Q8VII8|Rat:P22199,Human:NR3C2|Mouse:Nr3c2|Rat:Nr3c2,Human:7979|Mouse:MGI:99459|Rat:3094,,,,,,
Target,1510,Microtubule associated serine/threonine kinase 1,MAST1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1510,Enzyme,MAST family,Human:Q9Y2H9|Mouse:Q9R1L5|Rat:Q810W7,Human:MAST1|Mouse:Mast1|Rat:MAST1,Human:19034|Mouse:MGI:1861901|Rat:631372,,,,,,
Target,2100,microtubule affinity regulating kinase 4,MARK4,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2100,Enzyme,MARK subfamily,Human:Q96L34|Mouse:Q8CIP4,Human:MARK4|Mouse:Mark4|Rat:Mark4,Human:13538|Mouse:MGI:1920955|Rat:1591792,,,,,,
Target,2099,microtubule affinity regulating kinase 3,MARK3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2099,Enzyme,MARK subfamily,Human:P27448|Mouse:Q03141|Rat:Q8VHF0,Human:MARK3|Mouse:Mark3|Rat:Mark3,Human:6897|Mouse:MGI:1341865|Rat:619883,,,,,,
Target,2098,microtubule affinity regulating kinase 2,MARK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2098,Enzyme,MARK subfamily,Human:Q7KZI7|Mouse:Q05512|Rat:O08679,Human:MARK2|Mouse:Mark2|Rat:Mark2,Human:3332|Mouse:MGI:99638|Rat:708483,,,,,,
Target,2097,microtubule affinity regulating kinase 1,MARK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2097,Enzyme,MARK subfamily,Human:Q9P0L2|Mouse:Q8VHJ5|Rat:O08678,Human:MARK1|Mouse:Mark1|Rat:Mark1,Human:6896|Mouse:MGI:2664902|Rat:619882,,,,,,
Target,296,mGlu<sub>8</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=296,GPCR,Metabotropic glutamate receptors,Human:O00222|Mouse:P47743|Rat:P70579,Human:GRM8|Mouse:Grm8|Rat:Grm8,Human:4600|Mouse:MGI:1351345|Rat:619858,,,,,,
Target,295,mGlu<sub>7</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=295,GPCR,Metabotropic glutamate receptors,Human:Q14831|Mouse:Q68ED2|Rat:P35400,Human:GRM7|Mouse:Grm7|Rat:Grm7,Human:4599|Mouse:MGI:1351344|Rat:619857,,,,,,
Target,293,mGlu<sub>5</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=293,GPCR,Metabotropic glutamate receptors,Human:P41594|Mouse:Q3UVX5|Rat:P31424,Human:GRM5|Mouse:Grm5|Rat:Grm5,Human:4597|Mouse:MGI:1351342|Rat:2746,,,,,,
Target,292,mGlu<sub>4</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=292,GPCR,Metabotropic glutamate receptors,Human:Q14833|Mouse:Q68EF4|Rat:P31423,Human:GRM4|Mouse:Grm4|Rat:Grm4,Human:4596|Mouse:MGI:1351341|Rat:2745,,,,,,
Target,289,mGlu<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=289,GPCR,Metabotropic glutamate receptors,Human:Q13255|Mouse:P97772|Rat:P23385,Human:GRM1|Mouse:Grm1|Rat:Grm1,Human:4593|Mouse:MGI:1351338|Rat:2742,,,,,,
Target,640,mevalonate kinase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=640,Enzyme,Lanosterol biosynthesis pathway,Human:Q03426|Mouse:Q9R008|Rat:P17256,Human:MVK|Mouse:Mvk|Rat:Mvk,Human:7530|Mouse:MGI:107624|Rat:621295,,,,,,
Target,1815,"MET proto-oncogene, receptor tyrosine kinase",MET,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1815,CatalyticReceptor,Type X RTKs: HGF (hepatocyte growth factor) receptor family,Human:P08581|Mouse:P16056|Rat:P97523,Human:MET|Mouse:Met|Rat:Met,Human:7029|Mouse:MGI:96969|Rat:3082,,,,,,
Target,1573,Methionyl aminopeptidase 2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1573,Enzyme,M24: Methionyl aminopeptidase,Human:P50579|Mouse:O08663|Rat:P38062,Human:METAP2|Mouse:Metap2|Rat:Metap2,Human:16672|Mouse:MGI:1929701|Rat:70995,,,,,,
Target,1572,Methionyl aminopeptidase 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1572,Enzyme,M24: Methionyl aminopeptidase,Human:P53582|Mouse:Q8BP48|Rat:D3ZE72,Human:METAP1|Mouse:Metap1|Rat:Metap1,Human:15789|Mouse:MGI:1922874|Rat:1305545,,,,,,
Target,1837,"MER proto-oncogene, tyrosine kinase",Mer,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1837,CatalyticReceptor,"Type XI RTKs: TAM (TYRO3-, AXL- and MER-TK) receptor family",Human:Q12866|Mouse:Q60805|Rat:P57097,Human:MERTK|Mouse:Mertk|Rat:Mertk,Human:7027|Mouse:MGI:96965|Rat:69283,,,,,,
Target,2101,megakaryocyte-associated tyrosine kinase,CTK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2101,Enzyme,Csk family,Human:P42679|Mouse:P41242|Rat:P41243,Human:MATK|Mouse:Matk|Rat:Matk,Human:6906|Mouse:MGI:99259|Rat:69058,,,,,,
Target,2109,mechanistic target of rapamycin kinase,mTOR,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2109,Enzyme,FRAP subfamily,Human:P42345|Mouse:Q9JLN9|Rat:P42346,Human:MTOR|Mouse:Mtor|Rat:Mtor,Human:3942|Mouse:MGI:1928394|Rat:68371,,,,,,
Target,3136,MDM2 proto-oncogene,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3136,Enzyme,E3 ubiquitin ligase components,Human:Q00987|Mouse:P23804,Human:MDM2|Mouse:Mdm2|Rat:Mdm2,Human:6973|Mouse:MGI:96952|Rat:1305332,,,,,,
Target,286,MC<sub>5</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=286,GPCR,Melanocortin receptors,Human:P33032|Mouse:P41149|Rat:P35345,Human:MC5R|Mouse:Mc5r|Rat:Mc5r,Human:6933|Mouse:MGI:99420|Rat:3058,,,,,,
Target,285,MC<sub>4</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=285,GPCR,Melanocortin receptors,Human:P32245|Mouse:P56450|Rat:P70596,Human:MC4R|Mouse:Mc4r|Rat:Mc4r,Human:6932|Mouse:MGI:99457|Rat:3057,,,,,,
Target,284,MC<sub>3</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=284,GPCR,Melanocortin receptors,Human:P41968|Mouse:P33033|Rat:P32244,Human:MC3R|Mouse:Mc3r|Rat:Mc3r,Human:6931|Mouse:MGI:96929|Rat:3056,,,,,,
Target,283,MC<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=283,GPCR,Melanocortin receptors,Human:Q01718|Mouse:Q64326,Human:MC2R|Mouse:Mc2r|Rat:Mc2r,Human:6930|Mouse:MGI:96928|Rat:628649,,,,,,
Target,282,MC<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=282,GPCR,Melanocortin receptors,Human:Q01726|Mouse:Q01727,Human:MC1R|Mouse:Mc1r|Rat:Mc1r,Human:6929|Mouse:MGI:99456|Rat:1312046,,,,,,
Target,2847,"MCL1 apoptosis regulator, BCL2 family member",Mcl-1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2847,OtherProtein,B-cell lymphoma 2 (Bcl-2) protein family,Human:Q07820|Mouse:P97287|Rat:Q9Z1P3,Human:MCL1|Mouse:Mcl1|Rat:Mcl1,Human:6943|Mouse:MGI:101769|Rat:620525,,,,,,
Target,280,MCH<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=280,GPCR,Melanin-concentrating hormone receptors,Human:Q99705|Mouse:Q8JZL2|Rat:P97639,Human:MCHR1|Mouse:Mchr1|Rat:Mchr1,Human:4479|Mouse:MGI:2180756|Rat:619841,,,,,,
Target,2102,maternal embryonic leucine zipper kinase,MELK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2102,Enzyme,MELK subfamily,Human:Q14680|Mouse:Q61846,Human:MELK|Mouse:Melk|Rat:Melk,Human:16870|Mouse:MGI:106924|Rat:1308974,,,,,,
Target,2105,MAPK interacting serine/threonine kinase 2,Mnk2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2105,Enzyme,MKN subfamily,Human:Q9HBH9|Mouse:Q8CDB0|Rat:Q5U2N4,Human:MKNK2|Mouse:Mknk2|Rat:Mknk2,Human:7111|Mouse:MGI:894279|Rat:1305728,,,,,,
Target,2104,MAPK interacting serine/threonine kinase 1,Mnk1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2104,Enzyme,MKN subfamily,Human:Q9BUB5|Mouse:O08605|Rat:Q4G050,Human:MKNK1|Mouse:Mknk1|Rat:Mknk1,Human:7110|Mouse:MGI:894316|Rat:1559603,,,,,,
Target,2096,MAPK activated protein kinase 5,MAPKAPK5,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2096,Enzyme,MAPKAPK subfamily,Human:Q8IW41|Mouse:O54992,Human:MAPKAPK5|Mouse:Mapkapk5|Rat:Mapkapk5,Human:6889|Mouse:MGI:1333110|Rat:1564113,,,,,,
Target,2095,MAPK activated protein kinase 3,MAPKAPK3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2095,Enzyme,MAPKAPK subfamily,Human:Q16644|Mouse:Q3UMW7|Rat:Q66H84,Human:MAPKAPK3|Mouse:Mapkapk3|Rat:Mapkapk3,Human:6888|Mouse:MGI:2143163|Rat:1304980,,,,,,
Target,2094,MAPK activated protein kinase 2,MAPKAPK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2094,Enzyme,MAPKAPK subfamily,Human:P49137|Mouse:P49138,Human:MAPKAPK2|Mouse:Mapkapk2|Rat:Mapkapk2,Human:6887|Mouse:MGI:109298|Rat:631362,,,,,,
Target,2627,maltase-glucoamylase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2627,Enzyme,3.2.1.- Glycosidases,Human:O43451,Human:MGAM|Mouse:Mgam|Rat:Mgam,Human:7043|Mouse:MGI:1203495,,,,,,
Target,1816,macrophage stimulating 1 receptor,Ron,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1816,CatalyticReceptor,Type X RTKs: HGF (hepatocyte growth factor) receptor family,Human:Q04912|Mouse:Q62190,Human:MST1R|Mouse:Mst1r|Rat:Mst1r,Human:7381|Mouse:MGI:99614|Rat:1306465,,,,,,
Target,2683,lysine demethylase 5D,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2683,Enzyme,1.14.11.- Histone demethylases,Human:Q9BY66|Mouse:Q62240,Human:KDM5D|Mouse:Kdm5d,Human:11115|Mouse:MGI:99780,,,,,,
Target,2664,lysine acetyltransferase 5,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2664,Enzyme,2.3.1.48 Histone acetyltransferases (HATs),Human:Q92993|Mouse:Q8CHK4|Rat:Q99MK2,Human:KAT5|Mouse:Kat5|Rat:Kat5,Human:5275|Mouse:MGI:1932051|Rat:621061,,,,,,
Target,2737,lysine acetyltransferase 2B,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2737,Enzyme,2.3.1.48 Histone acetyltransferases (HATs),Human:Q92831|Mouse:Q9JHD1,Human:KAT2B|Mouse:Kat2b|Rat:Kat2b,Human:8638|Mouse:MGI:1343094|Rat:1305902,,,,,,
Target,2736,lysine acetyltransferase 2A,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2736,Enzyme,2.3.1.48 Histone acetyltransferases (HATs),Human:Q92830|Mouse:Q9JHD2,Human:KAT2A|Mouse:Kat2a|Rat:Kat2a,Human:4201|Mouse:MGI:1343101|Rat:1307242,,,,,,
Target,2060,"LYN proto-oncogene, Src family tyrosine kinase",Lyn,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2060,Enzyme,Src family,Human:P07948|Mouse:P25911|Rat:Q07014,Human:LYN|Mouse:Lyn|Rat:Lyn,Human:6735|Mouse:MGI:96892|Rat:621017,,,,,,
Target,2890,lymphocyte antigen 96,MD-2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2890,OtherProtein,Lymphocyte antigens,Human:Q9Y6Y9|Mouse:Q9JHF9,Human:LY96|Mouse:Ly96|Rat:Ly96,Human:17156|Mouse:MGI:1341909|Rat:1302993,,,,,,
Target,1243,L-Tyrosine hydroxylase ,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1243,Enzyme,Amino acid hydroxylases|Catecholamine turnover,Human:P07101|Mouse:P24529|Rat:P04177,Human:TH|Mouse:Th|Rat:Th,Human:11782|Mouse:MGI:98735|Rat:3853,,,,,,
Target,897,L-type amino acid transporter 2,LAT2,SLC7A8,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=897,Transporter,SLC7 family,Human:Q9UHI5|Mouse:Q9QXW9|Rat:Q9WVR6,Human:SLC7A8|Mouse:Slc7a8|Rat:Slc7a8,Human:11066|Mouse:MGI:1355323|Rat:619904,,,,,,
Target,1242,L-Tryptophan hydroxylase 2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1242,Enzyme,Amino acid hydroxylases,Human:Q8IWU9|Mouse:Q8CGV2|Rat:Q8CGU9,Human:TPH2|Mouse:Tph2|Rat:Tph2,Human:20692|Mouse:MGI:2651811|Rat:631332,,,,,,
Target,1241,L-Tryptophan hydroxylase 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1241,Enzyme,Amino acid hydroxylases,Human:P17752|Mouse:P17532|Rat:P09810,Human:TPH1|Mouse:Tph1|Rat:Tph1,Human:12008|Mouse:MGI:98796|Rat:3895,,,,,,
Target,1240,L-Phenylalanine hydroxylase ,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1240,Enzyme,Amino acid hydroxylases|Catecholamine turnover,Human:P00439|Mouse:P16331|Rat:P04176,Human:PAH|Mouse:Pah|Rat:Pah,Human:8582|Mouse:MGI:97473|Rat:3248,,,,,,
Target,1380,L-PGDS,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1380,Enzyme,Prostaglandin synthases,Human:P41222|Mouse:O09114|Rat:P22057,Human:PTGDS|Mouse:Ptgds|Rat:Ptgds,Human:9592|Mouse:MGI:99261|Rat:3433,,,,,,
Target,163,LPA<sub>6</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=163,GPCR,Lysophospholipid (LPA) receptors,Human:P43657|Mouse:Q8BMC0|Rat:Q4G072,Human:LPAR6|Mouse:Lpar6|Rat:Lpar6,Human:15520|Mouse:MGI:1914418|Rat:1595950,,,,,,
Target,94,LPA<sub>4</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=94,GPCR,Lysophospholipid (LPA) receptors,Human:Q99677|Mouse:Q8BLG2,Human:LPAR4|Mouse:Lpar4|Rat:Lpar4,Human:4478|Mouse:MGI:1925384|Rat:1563686,,,,,,
Target,892,Low affinity cationic amino acid transporter 2,CAT2,SLC7A2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=892,Transporter,SLC7 family,Human:P52569|Mouse:P18581|Rat:B5D5N9,Human:SLC7A2|Mouse:Slc7a2|Rat:Slc7a2,Human:11060|Mouse:MGI:99828|Rat:68387,,,,,,
Target,601,Liver X receptor-&beta;,,NR1H2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=601,NHR,1H. Liver X receptor-like receptors,Human:P55055|Mouse:Q60644|Rat:Q62755,Human:NR1H2|Mouse:Nr1h2|Rat:Nr1h2,Human:7965|Mouse:MGI:1352463|Rat:61906,,,,,,
Target,602,Liver X receptor-&alpha;,,NR1H3,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=602,NHR,1H. Liver X receptor-like receptors,Human:Q13133|Mouse:Q9Z0Y9|Rat:Q62685,Human:NR1H3|Mouse:Nr1h3|Rat:Nr1h3,Human:7966|Mouse:MGI:1352462|Rat:61909,,,,,,
Target,2626,"lipase, gastric",,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2626,Enzyme,3.1.1.- Carboxylic Ester Hydrolases|S33: Prolyl aminopeptidase,Human:P07098|Mouse:Q9CPP7|Rat:P04634,Human:LIPF|Mouse:Lipf|Rat:Lipf,Human:6622|Mouse:MGI:1914967|Rat:708441,,,,,,
Target,2055,LIM domain kinase 2,LIMK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2055,Enzyme,LIMK subfamily,Human:P53671|Mouse:O54785|Rat:P53670,Human:LIMK2|Mouse:Limk2|Rat:Limk2,Human:6614|Mouse:MGI:1197517|Rat:62056,,,,,,
Target,2054,LIM domain kinase 1,LIMK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2054,Enzyme,LIMK subfamily,Human:P53667|Mouse:P53668|Rat:P53669,Human:LIMK1|Mouse:Limk1|Rat:Limk1,Human:6613|Mouse:MGI:104572|Rat:62055,,,,,,
Target,254,LH receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=254,GPCR,Glycoprotein hormone receptors,Human:P22888|Mouse:P30730|Rat:P16235,Human:LHCGR|Mouse:Lhcgr|Rat:Lhcgr,Human:6585|Mouse:MGI:96783|Rat:3007,,,,,,
Target,1391,Leukotriene C4 synthase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1391,Enzyme,Leukotriene and lipoxin metabolism,Human:Q16873|Mouse:Q60860|Rat:Q925U2,Human:LTC4S|Mouse:Ltc4s|Rat:Ltc4s,Human:6719|Mouse:MGI:107498|Rat:620677,,,,,,
Target,1395,Leukotriene A<sub>4</sub> hydrolase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1395,Enzyme,Leukotriene and lipoxin metabolism|M1: Aminopeptidase N|Hydrolases,Human:P09960|Mouse:P24527|Rat:P30349,Human:LTA4H|Mouse:Lta4h|Rat:Lta4h,Human:6710|Mouse:MGI:96836|Rat:1311333,,,,,,
Target,1838,leukocyte receptor tyrosine kinase,LTK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1838,CatalyticReceptor,Type XIX RTKs: Leukocyte tyrosine kinase (LTK) receptor family,Human:P29376|Mouse:P08923,Human:LTK|Mouse:Ltk|Rat:Ltk,Human:6721|Mouse:MGI:96840|Rat:1309323,,,,,,
Target,2059,leucine rich repeat kinase 2,LRRK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2059,Enzyme,Leucine-rich repeat kinase (LRRK) family,Human:Q5S007|Mouse:Q5S006,Human:LRRK2|Mouse:Lrrk2|Rat:Lrrk2,Human:18618|Mouse:MGI:1913975|Rat:1561168,,,,,,
Target,1569,Leucine aminopeptidase 3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1569,Enzyme,M17: Leucyl aminopeptidase,Human:P28838|Mouse:Q9CPY7|Rat:Q68FS4,Human:LAP3|Mouse:Lap3|Rat:Lap3,Human:18449|Mouse:MGI:1914238|Rat:1307985,,,,,,
Target,1445,L-Cysteine:2-oxoglutarate aminotransferase,CAT,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1445,Enzyme,Hydrogen sulphide synthesis,Human:Q16773|Mouse:Q8BTY1|Rat:Q08415,Human:KYAT1|Mouse:Kyat1|Rat:Kyat1,Human:1564|Mouse:MGI:1917516|Rat:1306912,,,,,,
Target,2053,"LCK proto-oncogene, Src family tyrosine kinase",Lck,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2053,Enzyme,Src family,Human:P06239|Mouse:P06240|Rat:Q01621,Human:LCK|Mouse:Lck|Rat:Lck,Human:6524|Mouse:MGI:96756|Rat:2994,,,,,,
Target,1271,L-Aromatic amino-acid decarboxylase ,AADC,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1271,Enzyme,Decarboxylases|Catecholamine turnover,Human:P20711|Mouse:O88533|Rat:P14173,Human:DDC|Mouse:Ddc|Rat:Ddc,Human:2719|Mouse:MGI:94876|Rat:2494,,,,,,
Target,1270,L-Arginine decarboxylase ,ADC,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1270,Enzyme,Decarboxylases,Human:Q96A70|Mouse:Q8BVM4,Human:AZIN2|Mouse:Azin2|Rat:Azin2,Human:29957|Mouse:MGI:2442093|Rat:1564776,,,,,,
Target,1515,large tumor suppressor kinase 1,LATS1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1515,Enzyme,NDR family,Human:O95835|Mouse:Q8BYR2,Human:LATS1|Mouse:Lats1|Rat:Lats1,Human:6514|Mouse:MGI:1333883|Rat:1564085,,,,,,
Target,2434,lanosterol synthase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2434,Enzyme,Lanosterol biosynthesis pathway,Human:P48449|Mouse:Q8BLN5|Rat:P48450,Human:LSS|Mouse:Lss|Rat:Lss,Human:6708|Mouse:MGI:1336155|Rat:620955,,,,,,
Target,569,K<SUB>v</SUB>9.3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=569,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q9BQ31|Mouse:Q8BQZ8|Rat:O88759,Human:KCNS3|Mouse:Kcns3|Rat:Kcns3,Human:6302|Mouse:MGI:1098804|Rat:621527,,,,,,
Target,567,K<SUB>v</SUB>9.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=567,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q96KK3|Mouse:O35173|Rat:O88758,Human:KCNS1|Mouse:Kcns1|Rat:Kcns1,Human:6300|Mouse:MGI:1197019|Rat:621524,,,,,,
Target,566,K<SUB>v</SUB>8.2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=566,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q8TDN2|Mouse:Q8CFS6,Human:KCNV2|Mouse:Kcnv2|Rat:Kcnv2,Human:19698|Mouse:MGI:2670981|Rat:1309271,,,,,,
Target,565,K<SUB>v</SUB>8.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=565,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q6PIU1|Mouse:Q8BZN2|Rat:P97557,Human:KCNV1|Mouse:Kcnv1|Rat:Kcnv1,Human:18861|Mouse:MGI:1914748|Rat:621264,,,,,,
Target,564,K<SUB>v</SUB>7.5,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=564,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q9NR82|Mouse:Q9JK45,Human:KCNQ5|Mouse:Kcnq5|Rat:Kcnq5,Human:6299|Mouse:MGI:1924937|Rat:628848,,,,,,
Target,563,K<SUB>v</SUB>7.4,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=563,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:P56696|Mouse:Q9JK97|Rat:Q9JK96,Human:KCNQ4|Mouse:Kcnq4|Rat:Kcnq4,Human:6298|Mouse:MGI:1926803|Rat:61799,,,,,,
Target,562,K<SUB>v</SUB>7.3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=562,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:O43525|Mouse:Q8K3F6|Rat:O88944,Human:KCNQ3|Mouse:Kcnq3|Rat:Kcnq3,Human:6297|Mouse:MGI:1336181|Rat:69222,,,,,,
Target,561,K<SUB>v</SUB>7.2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=561,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:O43526|Mouse:Q9Z351|Rat:O88943,Human:KCNQ2|Mouse:Kcnq2|Rat:Kcnq2,Human:6296|Mouse:MGI:1309503|Rat:621504,,,,,,
Target,560,K<SUB>v</SUB>7.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=560,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:P51787|Mouse:P97414|Rat:Q9Z0N7,Human:KCNQ1|Mouse:Kcnq1|Rat:Kcnq1,Human:6294|Mouse:MGI:108083|Rat:621503,,,,,,
Target,559,K<SUB>v</SUB>6.4,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=559,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q8TDN1|Mouse:Q80XM3,Human:KCNG4|Mouse:Kcng4|Rat:Kcng4,Human:19697|Mouse:MGI:1913983|Rat:1308553,,,,,,
Target,558,K<SUB>v</SUB>6.3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=558,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q8TAE7|Mouse:P59053|Rat:Q8R523,Human:KCNG3|Mouse:Kcng3|Rat:Kcng3,Human:18306|Mouse:MGI:2663923|Rat:628832,,,,,,
Target,557,K<SUB>v</SUB>6.2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=557,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q9UJ96|Rat:Q9QYU3,Human:KCNG2|Mouse:Kcng2|Rat:Kcng2,Human:6249|Mouse:MGI:3694646|Rat:1309521,,,,,,
Target,556,K<SUB>v</SUB>6.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=556,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q9UIX4|Mouse:A2BDX4,Human:KCNG1|Mouse:Kcng1|Rat:Kcng1,Human:6248|Mouse:MGI:3616086|Rat:631416,,,,,,
Target,555,K<SUB>v</SUB>5.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=555,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q9H3M0|Mouse:Q7TSH7,Human:KCNF1|Mouse:Kcnf1|Rat:Kcnf1,Human:6246|Mouse:MGI:2687399|Rat:631414,,,,,,
Target,554,K<SUB>v</SUB>4.3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=554,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q9UK17|Mouse:Q9Z0V1|Rat:Q62897,Human:KCND3|Mouse:Kcnd3|Rat:Kcnd3,Human:6239|Mouse:MGI:1928743|Rat:68394,,,,,,
Target,553,K<SUB>v</SUB>4.2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=553,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q9NZV8|Mouse:Q9Z0V2|Rat:Q63881,Human:KCND2|Mouse:Kcnd2|Rat:Kcnd2,Human:6238|Mouse:MGI:102663|Rat:68393,,,,,,
Target,552,K<SUB>v</SUB>4.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=552,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q9NSA2|Mouse:Q03719,Human:KCND1|Mouse:Kcnd1|Rat:Kcnd1,Human:6237|Mouse:MGI:96671|Rat:621364,,,,,,
Target,551,K<SUB>v</SUB>3.4,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=551,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q03721|Mouse:Q8R1C0|Rat:Q63734,Human:KCNC4|Mouse:Kcnc4|Rat:Kcnc4,Human:6236|Mouse:MGI:96670|Rat:1589169,,,,,,
Target,550,K<SUB>v</SUB>3.3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=550,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q14003|Mouse:Q63959|Rat:Q01956,Human:KCNC3|Mouse:Kcnc3|Rat:Kcnc3,Human:6235|Mouse:MGI:96669|Rat:621358,,,,,,
Target,549,K<SUB>v</SUB>3.2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=549,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q96PR1|Mouse:Q14B80|Rat:P22462,Human:KCNC2|Mouse:Kcnc2|Rat:Kcnc2,Human:6234|Mouse:MGI:96668|Rat:628829,,,,,,
Target,548,K<SUB>v</SUB>3.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=548,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:P48547|Mouse:P15388|Rat:P25122,Human:KCNC1|Mouse:Kcnc1|Rat:Kcnc1,Human:6233|Mouse:MGI:96667|Rat:2955,,,,,,
Target,547,K<SUB>v</SUB>2.2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=547,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q92953|Mouse:A6H8H5|Rat:Q63099,Human:KCNB2|Mouse:Kcnb2|Rat:Kcnb2,Human:6232|Mouse:MGI:99632|Rat:621349,,,,,,
Target,546,K<SUB>v</SUB>2.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=546,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q14721|Mouse:Q03717|Rat:P15387,Human:KCNB1|Mouse:Kcnb1|Rat:Kcnb1,Human:6231|Mouse:MGI:96666|Rat:2954,,,,,,
Target,545,K<SUB>v</SUB>1.8,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=545,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q16322,Human:KCNA10|Mouse:Kcna10|Rat:Kcna10,Human:6219|Mouse:MGI:3037820|Rat:1304667,,,,,,
Target,544,K<SUB>v</SUB>1.7,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=544,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q96RP8|Mouse:Q17ST2,Human:KCNA7|Mouse:Kcna7|Rat:Kcna7,Human:6226|Mouse:MGI:96664|Rat:1309632,,,,,,
Target,543,K<SUB>v</SUB>1.6,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=543,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:P17658|Mouse:Q61923|Rat:P17659,Human:KCNA6|Mouse:Kcna6|Rat:Kcna6,Human:6225|Mouse:MGI:96663|Rat:62083,,,,,,
Target,542,K<SUB>v</SUB>1.5,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=542,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:P22460|Mouse:Q61762|Rat:P19024,Human:KCNA5|Mouse:Kcna5|Rat:Kcna5,Human:6224|Mouse:MGI:96662|Rat:2953,,,,,,
Target,541,K<SUB>v</SUB>1.4,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=541,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:P22459|Mouse:Q61423|Rat:P15385,Human:KCNA4|Mouse:Kcna4|Rat:Kcna4,Human:6222|Mouse:MGI:96661|Rat:2952,,,,,,
Target,540,K<SUB>v</SUB>1.3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=540,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:P22001|Mouse:P16390|Rat:P15384,Human:KCNA3|Mouse:Kcna3|Rat:Kcna3,Human:6221|Mouse:MGI:96660|Rat:2951,,,,,,
Target,577,K<SUB>v</SUB>12.3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=577,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q9UQ05|Rat:Q9R1T9,Human:KCNH4|Mouse:Kcnh4|Rat:Kcnh4,Human:6253|Mouse:MGI:2156184|Rat:621415,,,,,,
Target,576,K<SUB>v</SUB>12.2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=576,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q9ULD8|Mouse:Q9WVJ0|Rat:O89047,Human:KCNH3|Mouse:Kcnh3|Rat:Kcnh3,Human:6252|Mouse:MGI:1341723|Rat:71070,,,,,,
Target,575,K<SUB>v</SUB>12.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=575,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q96L42|Mouse:P59111|Rat:Q9QWS8,Human:KCNH8|Mouse:Kcnh8|Rat:Kcnh8,Human:18864|Mouse:MGI:2445160|Rat:2549,,,,,,
Target,539,K<SUB>v</SUB>1.2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=539,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:P16389|Mouse:P63141|Rat:P63142,Human:KCNA2|Mouse:Kcna2|Rat:Kcna2,Human:6220|Mouse:MGI:96659|Rat:2950,,,,,,
Target,574,K<SUB>v</SUB>11.3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=574,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q9NS40|Mouse:Q9ER47|Rat:O54852,Human:KCNH7|Mouse:Kcnh7|Rat:Kcnh7,Human:18863|Mouse:MGI:2159566|Rat:621112,,,,,,
Target,573,K<SUB>v</SUB>11.2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=573,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q9H252|Rat:O54853,Human:KCNH6|Mouse:Kcnh6|Rat:Kcnh6,Human:18862|Mouse:MGI:2684139|Rat:620304,,,,,,
Target,572,K<SUB>v</SUB>11.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=572,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q12809|Mouse:O35219|Rat:O08962,Human:KCNH2|Mouse:Kcnh2|Rat:Kcnh2,Human:6251|Mouse:MGI:1341722|Rat:621414,,,,,,
Target,538,K<SUB>v</SUB>1.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=538,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q09470|Mouse:P16388|Rat:P10499,Human:KCNA1|Mouse:Kcna1|Rat:Kcna1,Human:6218|Mouse:MGI:96654|Rat:2949,,,,,,
Target,571,K<SUB>v</SUB>10.2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=571,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:Q8NCM2|Mouse:Q920E3|Rat:Q9EPI9,Human:KCNH5|Mouse:Kcnh5|Rat:Kcnh5,Human:6254|Mouse:MGI:3584508|Rat:621417,,,,,,
Target,570,K<SUB>v</SUB>10.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=570,VGIC,Voltage-gated potassium channels (K<sub>v</sub>),Human:O95259|Mouse:Q60603|Rat:Q63472,Human:KCNH1|Mouse:Kcnh1|Rat:Kcnh1,Human:6250|Mouse:MGI:1341721|Rat:68398,,,,,,
Target,442,K<sub>ir</sub>6.2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=442,VGIC,Inwardly rectifying potassium channels (K<sub>IR</sub>),Human:Q14654|Mouse:Q61743|Rat:P70673,Human:KCNJ11|Mouse:Kcnj11|Rat:Kcnj11,Human:6257|Mouse:MGI:107501|Rat:69247,,,,,,
Target,441,K<sub>ir</sub>6.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=441,VGIC,Inwardly rectifying potassium channels (K<sub>IR</sub>),Human:Q15842|Mouse:P97794|Rat:Q63664,Human:KCNJ8|Mouse:Kcnj8|Rat:Kcnj8,Human:6269|Mouse:MGI:1100508|Rat:2960,,,,,,
Target,439,K<sub>ir</sub>4.2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=439,VGIC,Inwardly rectifying potassium channels (K<sub>IR</sub>),Human:Q99712|Mouse:O88932|Rat:Q91ZF1,Human:KCNJ15|Mouse:Kcnj15|Rat:Kcnj15,Human:6261|Mouse:MGI:1310000|Rat:621662,,,,,,
Target,438,K<sub>ir</sub>4.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=438,VGIC,Inwardly rectifying potassium channels (K<sub>IR</sub>),Human:P78508|Mouse:Q9JM63|Rat:P49655,Human:KCNJ10|Mouse:Kcnj10|Rat:Kcnj10,Human:6256|Mouse:MGI:1194504|Rat:61822,,,,,,
Target,437,K<sub>ir</sub>3.4,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=437,VGIC,Inwardly rectifying potassium channels (K<sub>IR</sub>),Human:P48544|Mouse:P48545|Rat:P48548,Human:KCNJ5|Mouse:Kcnj5|Rat:Kcnj5,Human:6266|Mouse:MGI:104755|Rat:61971,,,,,,
Target,436,K<sub>ir</sub>3.3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=436,VGIC,Inwardly rectifying potassium channels (K<sub>IR</sub>),Human:Q92806|Mouse:P48543|Rat:Q63511,Human:KCNJ9|Mouse:Kcnj9|Rat:Kcnj9,Human:6270|Mouse:MGI:108007|Rat:621440,,,,,,
Target,435,K<sub>ir</sub>3.2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=435,VGIC,Inwardly rectifying potassium channels (K<sub>IR</sub>),Human:P48051|Mouse:P48542|Rat:P48550,Human:KCNJ6|Mouse:Kcnj6|Rat:Kcnj6,Human:6267|Mouse:MGI:104781|Rat:2959,,,,,,
Target,434,K<sub>ir</sub>3.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=434,VGIC,Inwardly rectifying potassium channels (K<sub>IR</sub>),Human:P48549|Mouse:P63250|Rat:P63251,Human:KCNJ3|Mouse:Kcnj3|Rat:Kcnj3,Human:6264|Mouse:MGI:104742|Rat:2958,,,,,,
Target,433,K<sub>ir</sub>2.4,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=433,VGIC,Inwardly rectifying potassium channels (K<sub>IR</sub>),Human:Q9UNX9|Mouse:Q8JZN3|Rat:O70596,Human:KCNJ14|Mouse:Kcnj14|Rat:Kcnj14,Human:6260|Mouse:MGI:2384820|Rat:628872,,,,,,
Target,432,K<sub>ir</sub>2.3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=432,VGIC,Inwardly rectifying potassium channels (K<sub>IR</sub>),Human:P48050|Mouse:P52189|Rat:P52190,Human:KCNJ4|Mouse:Kcnj4|Rat:Kcnj4,Human:6265|Mouse:MGI:104743|Rat:621436,,,,,,
Target,431,K<sub>ir</sub>2.2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=431,VGIC,Inwardly rectifying potassium channels (K<sub>IR</sub>),Human:Q14500|Mouse:P52187|Rat:P52188,Human:KCNJ12|Mouse:Kcnj12|Rat:Kcnj12,Human:6258|Mouse:MGI:108495|Rat:621660,,,,,,
Target,430,K<sub>ir</sub>2.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=430,VGIC,Inwardly rectifying potassium channels (K<sub>IR</sub>),Human:P63252|Mouse:P35561|Rat:Q64273,Human:KCNJ2|Mouse:Kcnj2|Rat:Kcnj2,Human:6263|Mouse:MGI:104744|Rat:61968,,,,,,
Target,429,K<sub>ir</sub>1.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=429,VGIC,Inwardly rectifying potassium channels (K<sub>IR</sub>),Human:P48048|Mouse:O88335|Rat:P35560,Human:KCNJ1|Mouse:Kcnj1|Rat:Kcnj1,Human:6255|Mouse:MGI:1927248|Rat:2957,,,,,,
Target,384,K<sub>Ca</sub>3.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=384,VGIC,"Calcium- and sodium-activated potassium channels (K<sub>Ca</sub>, K<sub>Na</sub>)",Human:O15554|Mouse:O89109|Rat:Q9QYW1,Human:KCNN4|Mouse:Kcnn4|Rat:Kcnn4,Human:6293|Mouse:MGI:1277957|Rat:621476,,,,,,
Target,383,K<sub>Ca</sub>2.3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=383,VGIC,"Calcium- and sodium-activated potassium channels (K<sub>Ca</sub>, K<sub>Na</sub>)",Human:Q9UGI6|Mouse:P58391|Rat:P70605,Human:KCNN3|Mouse:Kcnn3|Rat:Kcnn3,Human:6292|Mouse:MGI:2153183|Rat:2964,,,,,,
Target,382,K<sub>Ca</sub>2.2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=382,VGIC,"Calcium- and sodium-activated potassium channels (K<sub>Ca</sub>, K<sub>Na</sub>)",Human:Q9H2S1|Mouse:P58390|Rat:P70604,Human:KCNN2|Mouse:Kcnn2|Rat:Kcnn2,Human:6291|Mouse:MGI:2153182|Rat:2963,,,,,,
Target,381,K<sub>Ca</sub>2.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=381,VGIC,"Calcium- and sodium-activated potassium channels (K<sub>Ca</sub>, K<sub>Na</sub>)",Human:Q92952|Mouse:Q9EQR3|Rat:P70606,Human:KCNN1|Mouse:Kcnn1|Rat:Kcnn1,Human:6290|Mouse:MGI:1933993|Rat:2962,,,,,,
Target,520,K<sub>2P</sub>9.1,TASK3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=520,VGIC,Two-pore domain potassium channels  (K<sub>2P</sub>),Human:Q9NPC2|Mouse:Q3LS21|Rat:Q9ES08,Human:KCNK9|Mouse:Kcnk9|Rat:Kcnk9,Human:6283|Mouse:MGI:3521816|Rat:621451,,,,,,
Target,518,K<sub>2P</sub>6.1,TWIK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=518,VGIC,Two-pore domain potassium channels  (K<sub>2P</sub>),Human:Q9Y257,Human:KCNK6|Mouse:Kcnk6|Rat:Kcnk6,Human:6281|Mouse:MGI:1891291|Rat:621450,,,,,,
Target,515,K<sub>2P</sub>3.1,TASK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=515,VGIC,Two-pore domain potassium channels  (K<sub>2P</sub>),Human:O14649|Mouse:O35111|Rat:O54912,Human:KCNK3|Mouse:Kcnk3|Rat:Kcnk3,Human:6278|Mouse:MGI:1100509|Rat:61997,,,,,,
Target,514,K<sub>2P</sub>2.1,TREK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=514,VGIC,Two-pore domain potassium channels  (K<sub>2P</sub>),Human:O95069|Mouse:P97438,Human:KCNK2|Mouse:Kcnk2|Rat:Kcnk2,Human:6277|Mouse:MGI:109366|Rat:621448,,,,,,
Target,513,K<sub>2P</sub>1.1,TWIK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=513,VGIC,Two-pore domain potassium channels  (K<sub>2P</sub>),Human:O00180|Mouse:O08581|Rat:Q9Z2T2,Human:KCNK1|Mouse:Kcnk1|Rat:Kcnk1,Human:6272|Mouse:MGI:109322|Rat:621447,,,,,,
Target,2824,KRAS,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2824,Enzyme,RAS subfamily,Human:P01116|Mouse:P32883|Rat:P08644,Human:KRAS|Mouse:Kras|Rat:Kras,Human:6407|Mouse:MGI:96680|Rat:2981,,,,,,
Target,1805,"KIT proto-oncogene, receptor tyrosine kinase",Kit,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1805,CatalyticReceptor,"Type III RTKs: PDGFR, CSFR, Kit, FLT3 receptor family",Human:P10721|Mouse:P05532,Human:KIT|Mouse:Kit|Rat:Kit,Human:6342|Mouse:MGI:96677|Rat:620568,,,,,,
Target,2788,kinesin-5,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2788,OtherProtein,Kinesins,Human:P52732|Mouse:Q6P9P6,Human:KIF11|Mouse:Kif11|Rat:Kif11,Human:6388|Mouse:MGI:1098231|Rat:621258,,,,,,
Target,1813,kinase insert domain receptor,VEGFR-2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1813,CatalyticReceptor,Type IV RTKs: VEGF (vascular endothelial growth factor) receptor family,Human:P35968|Mouse:P35918|Rat:O08775,Human:KDR|Mouse:Kdr|Rat:Kdr,Human:6307|Mouse:MGI:96683|Rat:2965,,,,,,
Target,968,Kidney-specific Na-K-Cl symporter,NKCC2,SLC12A1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=968,Transporter,SLC12 family of cation-coupled chloride transporters,Human:Q13621|Mouse:P55014|Rat:P55016,Human:SLC12A1|Mouse:Slc12a1|Rat:Slc12a1,Human:10910|Mouse:MGI:103150|Rat:3685,,,,,,
Target,2757,kelch like ECH-associated protein 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2757,OtherProtein,Kelch-like proteins,Human:Q14145|Mouse:Q9Z2X8|Rat:P57790,Human:KEAP1|Mouse:Keap1|Rat:Keap1,Human:23177|Mouse:MGI:1858732|Rat:621619,,,,,,
Target,972,K-Cl cotransporter 2,KCC2,SLC12A5,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=972,Transporter,SLC12 family of cation-coupled chloride transporters,Human:Q9H2X9|Mouse:Q91V14|Rat:Q63633,Human:SLC12A5|Mouse:Slc12a5|Rat:Slc12a5,Human:13818|Mouse:MGI:1862037|Rat:620811,,,,,,
Target,971,K-Cl cotransporter 1,KCC1,SLC12A4,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=971,Transporter,SLC12 family of cation-coupled chloride transporters,Human:Q9UP95|Mouse:Q9JIS8|Rat:Q63632,Human:SLC12A4|Mouse:Slc12a4|Rat:Slc12a4,Human:10913|Mouse:MGI:1309465|Rat:3687,,,,,,
Target,318,&kappa; receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=318,GPCR,Opioid receptors,Human:P41145|Mouse:P33534|Rat:P34975,Human:OPRK1|Mouse:Oprk1|Rat:Oprk1,Human:8154|Mouse:MGI:97439|Rat:69426,,,,,,
Target,2377,kallikrein related peptidase 7,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2377,Enzyme,S1: Chymotrypsin,Human:P49862|Mouse:Q91VE3|Rat:P36373,Human:KLK7|Mouse:Klk7|Rat:Klk7,Human:6368|Mouse:MGI:1346336|Rat:1306420,,,,,,
Target,2376,kallikrein related peptidase 6,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2376,Enzyme,S1: Chymotrypsin,Human:Q92876,Human:KLK6|Mouse:Klk6|Rat:Klk6,Human:6367|Mouse:MGI:1343166|Rat:3419,,,,,,
Target,2373,kallikrein related peptidase 3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2373,Enzyme,S1: Chymotrypsin,Human:P07288|Mouse:Q9JM71,Human:KLK3|Mouse:Klk1b27,Human:6364|Mouse:MGI:891980,,,,,,
Target,2379,kallikrein B1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2379,Enzyme,S1: Chymotrypsin,Human:P03952|Mouse:P26262|Rat:P14272,Human:KLKB1|Mouse:Klkb1|Rat:Klkb1,Human:6371|Mouse:MGI:102849|Rat:67382,,,,,,
Target,2865,kallikrein 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2865,Enzyme,S1: Chymotrypsin,Human:P06870|Mouse:P15947|Rat:P00758,Human:KLK1|Mouse:Klk1|Rat:Klk1,Human:6357|Mouse:MGI:102850|Rat:2969,,,,,,
Target,2049,Janus kinase 3,JAK3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2049,Enzyme,Janus kinase (JakA) family,Human:P52333|Mouse:Q62137|Rat:Q63272,Human:JAK3|Mouse:Jak3|Rat:Jak3,Human:6193|Mouse:MGI:99928|Rat:2940,,,,,,
Target,2048,Janus kinase 2,JAK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2048,Enzyme,Janus kinase (JakA) family,Human:O60674|Mouse:Q62120|Rat:Q62689,Human:JAK2|Mouse:Jak2|Rat:Jak2,Human:6192|Mouse:MGI:96629|Rat:2939,,,,,,
Target,2047,Janus kinase 1,JAK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2047,Enzyme,Janus kinase (JakA) family,Human:P23458|Mouse:P52332,Human:JAK1|Mouse:Jak1|Rat:Jak1,Human:6190|Mouse:MGI:96628|Rat:69056,,,,,,
Target,669,<i>TAS2R16</i>,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=669,GPCR,Taste 2 receptors,Human:Q9NYV7,Human:TAS2R16,Human:14921,,,,,,
Target,658,<i>TAS1R3</i>,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=658,GPCR,Taste 1 receptors,Human:Q7RTX0|Mouse:Q925D8|Rat:Q923K1,Human:TAS1R3|Mouse:Tas1r3|Rat:Tas1r3,Human:15661|Mouse:MGI:1933547|Rat:620539,,,,,,
Target,657,<i>TAS1R2</i>,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=657,GPCR,Taste 1 receptors,Human:Q8TE23|Mouse:Q925I4,Human:TAS1R2|Mouse:Tas1r2,Human:14905|Mouse:MGI:1933546,,,,,,
Target,646,isopentenyl-diphosphate &Delta;-isomerase 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=646,Enzyme,Lanosterol biosynthesis pathway,Human:Q13907|Mouse:P58044|Rat:O35760,Human:IDI1|Mouse:Idi1|Rat:Idi1,Human:5387|Mouse:MGI:2442264|Rat:621835,,,,,,
Target,2885,isocitrate dehydrogenase (NADP(+)) 2,,IDH2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2885,Enzyme,1.1.1.42 Isocitrate dehydrogenases,Human:P48735|Mouse:P54071|Rat:P56574,Human:IDH2|Mouse:Idh2|Rat:Idh2,Human:5383|Mouse:MGI:96414|Rat:1597139,,,,,,
Target,2884,isocitrate dehydrogenase (NADP(+)) 1,,IDH1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2884,Enzyme,1.1.1.42 Isocitrate dehydrogenases,Human:O75874|Mouse:O88844|Rat:P41562,Human:IDH1|Mouse:Idh1|Rat:Idh1,Human:5382|Mouse:MGI:96413|Rat:2862,,,,,,
Target,745,IP<sub>3</sub>R3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=745,LGIC,IP<sub>3</sub> receptors,Human:Q14573|Mouse:P70227|Rat:Q63269,Human:ITPR3|Mouse:Itpr3|Rat:Itpr3,Human:6182|Mouse:MGI:96624|Rat:2934,,,,,,
Target,744,IP<sub>3</sub>R2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=744,LGIC,IP<sub>3</sub> receptors,Human:Q14571|Mouse:Q9Z329|Rat:P29995,Human:ITPR2|Mouse:Itpr2|Rat:Itpr2,Human:6181|Mouse:MGI:99418|Rat:69649,,,,,,
Target,743,IP<sub>3</sub>R1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=743,LGIC,IP<sub>3</sub> receptors,Human:Q14643|Mouse:P11881|Rat:P29994,Human:ITPR1|Mouse:Itpr1|Rat:Itpr1,Human:6180|Mouse:MGI:96623|Rat:2933,,,,,,
Target,1447,IP<sub>3</sub> kinase A,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1447,Enzyme,"Inositol 1,4,5-trisphosphate 3-kinases",Human:P23677|Mouse:Q8R071|Rat:P17105,Human:ITPKA|Mouse:Itpka|Rat:Itpka,Human:6178|Mouse:MGI:1333822|Rat:619950,,,,,,
Target,345,IP receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=345,GPCR,Prostanoid receptors,Human:P43119|Mouse:P43252|Rat:P43253,Human:PTGIR|Mouse:Ptgir|Rat:Ptgir,Human:9602|Mouse:MGI:99535|Rat:1310890,,,,,,
Target,1431,iPLA<sub>2</sub>-G6,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1431,Enzyme,Phospholipase A<sub>2</sub>,Human:O60733|Mouse:P97819|Rat:P97570,Human:PLA2G6|Mouse:Pla2g6|Rat:Pla2g6,Human:9039|Mouse:MGI:1859152|Rat:628867,,,,,,
Target,164,<i>P2RY8</i>,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=164,GPCR,Class A Orphans,Human:Q86VZ1,Human:P2RY8,Human:15524,,,,,,
Target,165,<i>P2RY10</i>,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=165,GPCR,Class A Orphans,Human:O00398|Mouse:Q8BFU7,Human:P2RY10|Mouse:P2ry10|Rat:P2ry10,Human:19906|Mouse:MGI:1926076|Rat:1561912,,,,,,
Target,2488,iodotyrosine deiodinase,IYD,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2488,Enzyme,Thyroid hormone turnover,Human:Q6PHW0|Mouse:Q9DCX8|Rat:Q5BK17,Human:IYD|Mouse:Iyd|Rat:Iyd,Human:21071|Mouse:MGI:1917587|Rat:1309288,,,,,,
Target,2483,iodothyronine deiodinase 3,DIO3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2483,Enzyme,Thyroid hormone turnover,Human:P55073|Mouse:Q91ZI8|Rat:P49897,Human:DIO3|Mouse:Dio3|Rat:Dio3,Human:2885|Mouse:MGI:1306782|Rat:68420,,,,,,
Target,2303,Interleukin-2 receptor subunit &gamma;,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2303,CatalyticReceptor,IL-2 receptor family,Human:P31785|Mouse:P34902,Human:IL2RG|Mouse:Il2rg|Rat:Il2rg,Human:6010|Mouse:MGI:96551|Rat:621466,,,,,,
Target,2045,interleukin 1 receptor associated kinase 4,IRAK4,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2045,Enzyme,Interleukin-1 receptor-associated kinase (IRAK) family,Human:Q9NWZ3|Mouse:Q8R4K2|Rat:D4A7K4,Human:IRAK4|Mouse:Irak4|Rat:Irak4,Human:17967|Mouse:MGI:2182474|Rat:1305303,,,,,,
Target,2044,interleukin 1 receptor associated kinase 3,IRAK3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2044,Enzyme,Interleukin-1 receptor-associated kinase (IRAK) family,Human:Q9Y616|Mouse:Q8K4B2,Human:IRAK3|Mouse:Irak3|Rat:Irak3,Human:17020|Mouse:MGI:1921164|Rat:1308846,,,,,,
Target,2042,interleukin 1 receptor associated kinase 1,IRAK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2042,Enzyme,Interleukin-1 receptor-associated kinase (IRAK) family,Human:P51617|Mouse:Q62406,Human:IRAK1|Mouse:Irak1|Rat:Irak1,Human:6112|Mouse:MGI:107420|Rat:1563841,,,,,,
Target,1724,Interferon &alpha;/&beta; receptor 2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1724,CatalyticReceptor,Interferon receptor family,Human:P48551|Mouse:O35664,Human:IFNAR2|Mouse:Ifnar2,Human:5433|Mouse:MGI:1098243,,,,,,
Target,2457,"integrin, beta 3 subunit (platelet glycoprotein IIIa, antigen CD61)",,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2457,CatalyticReceptor,Integrins,Human:P05106|Mouse:O54890,Human:ITGB3|Mouse:Itgb3,Human:6156|Mouse:MGI:96612,,,,,,
Target,2455,"integrin, beta 1 subunit (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)",,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2455,CatalyticReceptor,Integrins,Human:P05556|Mouse:P09055|Rat:P49134,Human:ITGB1|Mouse:Itgb1|Rat:Itgb1,Human:6153|Mouse:MGI:96610|Rat:2927,,,,,,
Target,2453,"integrin, alpha V subunit",,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2453,CatalyticReceptor,Integrins,Human:P06756|Mouse:P43406,Human:ITGAV|Mouse:Itgav|Rat:Itgav,Human:6150|Mouse:MGI:96608|Rat:1310613,,,,,,
Target,2451,"integrin, alpha L subunit (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)",,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2451,CatalyticReceptor,Integrins,Human:P20701|Mouse:P24063,Human:ITGAL|Mouse:Itgal|Rat:Itgal,Human:6148|Mouse:MGI:96606|Rat:631424,,,,,,
Target,2441,"integrin, alpha IIb subunit (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)",,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2441,CatalyticReceptor,Integrins,Human:P08514|Mouse:Q9QUM0,Human:ITGA2B|Mouse:Itga2b|Rat:Itga2b,Human:6138|Mouse:MGI:96601|Rat:1596428,,,,,,
Target,2444,"integrin, alpha 5 subunit (fibronectin receptor, alpha polypeptide)",,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2444,CatalyticReceptor,Integrins,Human:P08648|Mouse:P11688,Human:ITGA5|Mouse:Itga5|Rat:Itga5,Human:6141|Mouse:MGI:96604|Rat:2925,,,,,,
Target,2443,"integrin, alpha 4 subunit (antigen CD49D, alpha 4 subunit of VLA-4 receptor)",,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2443,CatalyticReceptor,Integrins,Human:P13612|Mouse:Q00651,Human:ITGA4|Mouse:Itga4|Rat:Itga4,Human:6140|Mouse:MGI:96603|Rat:1593249,,,,,,
Target,1802,Insulin receptor-related receptor,IRR,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1802,CatalyticReceptor,Type II RTKs: Insulin receptor family,Human:P14616|Mouse:Q9WTL4|Rat:Q64716,Human:INSRR|Mouse:Insrr|Rat:Insrr,Human:6093|Mouse:MGI:1346037|Rat:67399,,,,,,
Target,1800,Insulin receptor,InsR,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1800,CatalyticReceptor,Type II RTKs: Insulin receptor family,Human:P06213|Mouse:P15208|Rat:P15127,Human:INSR|Mouse:Insr|Rat:Insr,Human:6091|Mouse:MGI:96575|Rat:2917,,,,,,
Target,1801,Insulin-like growth factor I receptor,IGF1R,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1801,CatalyticReceptor,Type II RTKs: Insulin receptor family,Human:P08069|Mouse:Q60751|Rat:P24062,Human:IGF1R|Mouse:Igf1r|Rat:Igf1r,Human:5465|Mouse:MGI:96433|Rat:2869,,,,,,
Target,2371,insulin degrading enzyme,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2371,Enzyme,M16: Pitrilysin,Human:P14735|Mouse:Q9JHR7|Rat:P35559,Human:IDE|Mouse:Ide|Rat:Ide,Human:5381|Mouse:MGI:96412|Rat:2861,,,,,,
Target,1454,INPP5B,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1454,Enzyme,Inositol polyphosphate phosphatases,Human:P32019|Mouse:Q8K337,Human:INPP5B|Mouse:Inpp5b|Rat:Inpp5b,Human:6077|Mouse:MGI:103257|Rat:1311511,,,,,,
Target,2625,inosine monophosphate dehydrogenase 2,IMPDH2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2625,Enzyme,Nucleoside synthesis and metabolism|1.-.-.- Oxidoreductases,Human:P12268|Mouse:P24547|Rat:E9PU28,Human:IMPDH2|Mouse:Impdh2|Rat:Impdh2,Human:6053|Mouse:MGI:109367|Rat:735092,,,,,,
Target,2624,inosine monophosphate dehydrogenase 1,IMPDH1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2624,Enzyme,Nucleoside synthesis and metabolism|1.-.-.- Oxidoreductases,Human:P20839|Mouse:P50096|Rat:D3ZLZ7,Human:IMPDH1|Mouse:Impdh1|Rat:Impdh1,Human:6052|Mouse:MGI:96567|Rat:1311108,,,,,,
Target,1248,"<i>N</i><sup>G</sup>,<i>N</i><sup>G</sup>-Dimethylarginine dimethylaminohydrolase 2",DDAH2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1248,Enzyme,Dimethylarginine dimethylaminohydrolases,Human:O95865|Mouse:Q99LD8|Rat:Q6MG60,Human:DDAH2|Mouse:Ddah2|Rat:Ddah2,Human:2716|Mouse:MGI:1859016|Rat:1302955,,,,,,
Target,1247,"<i>N</i><sup>G</sup>,<i>N</i><sup>G</sup>-Dimethylarginine dimethylaminohydrolase 1",DDAH1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1247,Enzyme,Dimethylarginine dimethylaminohydrolases,Human:O94760|Mouse:Q9CWS0|Rat:O08557,Human:DDAH1|Mouse:Ddah1|Rat:Ddah1,Human:2715|Mouse:MGI:1916469|Rat:70968,,,,,,
Target,1402,<i>N</i>-Acylethanolamine acid amidase,NAAA,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1402,Enzyme,<i>N</i>-Acylethanolamine turnover,Human:Q02083|Mouse:Q9D7V9|Rat:Q5KTC7,Human:NAAA|Mouse:Naaa|Rat:Naaa,Human:736|Mouse:MGI:1914361|Rat:1307267,,,,,,
Target,2040,inhibitor of nuclear factor kappa B kinase subunit epsilon,IKK-epsilon,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2040,Enzyme,IKK family,Human:Q14164|Mouse:Q9R0T8,Human:IKBKE|Mouse:Ikbke|Rat:Ikbke,Human:14552|Mouse:MGI:1929612|Rat:1308352,,,,,,
Target,2039,inhibitor of nuclear factor kappa B kinase subunit beta,IKK-beta,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2039,Enzyme,IKK family,Human:O14920|Mouse:O88351|Rat:Q9QY78,Human:IKBKB|Mouse:Ikbkb|Rat:Ikbkb,Human:5960|Mouse:MGI:1338071|Rat:621375,,,,,,
Target,1250,Inducible NOS,iNOS,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1250,Enzyme,Nitric oxide synthases,Human:P35228|Mouse:P29477|Rat:Q06518,Human:NOS2|Mouse:Nos2|Rat:Nos2,Human:7873|Mouse:MGI:97361|Rat:3185,,,,,,
Target,2829,"indoleamine 2,3-dioxygenase 1",IDO1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2829,Enzyme,1.13.11.- Dioxygenases,Human:P14902|Mouse:P28776|Rat:Q9ERD9,Human:IDO1|Mouse:Ido1|Rat:Ido1,Human:6059|Mouse:MGI:96416|Rat:619989,,,,,,
Target,1463,IMPase 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1463,Enzyme,Inositol monophosphatase,Human:P29218|Mouse:O55023|Rat:P97697,Human:IMPA1|Mouse:Impa1|Rat:Impa1,Human:6050|Mouse:MGI:1933158|Rat:69254,,,,,,
Target,2046,IL2 inducible T cell kinase,ITK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2046,Enzyme,Tec family,Human:Q08881|Mouse:Q03526,Human:ITK|Mouse:Itk|Rat:Itk,Human:6171|Mouse:MGI:96621|Rat:1311618,,,,,,
Target,258,<i>GPRC5A</i>,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=258,GPCR,Class C Orphans,Human:Q8NFJ5|Mouse:Q8BHL4,Human:GPRC5A|Mouse:Gprc5a|Rat:Gprc5a,Human:9836|Mouse:MGI:1891250|Rat:1310804,,,,,,
Target,109,<i>GPR55</i>,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=109,GPCR,"GPR18, GPR55 and GPR119",Human:Q9Y2T6|Mouse:Q3UJF0|Rat:Q9WU09,Human:GPR55|Mouse:Gpr55|Rat:Gpr55,Human:4511|Mouse:MGI:2685064|Rat:1559828,,,,,,
Target,102,<i>GPR35</i>,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=102,GPCR,Class A Orphans,Human:Q9HC97|Mouse:Q9ES90|Rat:Q33BM1,Human:GPR35|Mouse:Gpr35|Rat:Gpr35,Human:4492|Mouse:MGI:1929509|Rat:1309404,,,,,,
Target,89,<i>GPR18</i>,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=89,GPCR,"GPR18, GPR55 and GPR119",Human:Q14330|Mouse:Q8K1Z6|Rat:A1A5S3,Human:GPR18|Mouse:Gpr18|Rat:Gpr18,Human:4472|Mouse:MGI:107859|Rat:1304889,,,,,,
Target,86,<i>GPR12</i>,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=86,GPCR,Class A Orphans,Human:P47775|Mouse:P35412|Rat:P30951,Human:GPR12|Mouse:Gpr12|Rat:Gpr12,Human:4466|Mouse:MGI:101909|Rat:68333,,,,,,
Target,3094,hydroxysteroid 17-beta dehydrogenase 2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3094,Enzyme,1.-.-.- Oxidoreductases,Human:P37059|Mouse:P51658,Human:HSD17B2|Mouse:Hsd17b2|Rat:Hsd17b2,Human:5211|Mouse:MGI:1096386|Rat:621803,,,,,,
Target,3143,hydroxysteroid 11-beta dehydrogenase 2,11-&beta;HSD2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3143,Enzyme,1.-.-.- Oxidoreductases,Human:P80365|Mouse:P51661,Human:HSD11B2|Mouse:Hsd11b2,Human:5209|Mouse:MGI:104720,,,,,,
Target,2763,hydroxysteroid 11-beta dehydrogenase 1,11-&beta;HSD1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2763,Enzyme,1.-.-.- Oxidoreductases,Human:P28845|Mouse:P50172|Rat:P16232,Human:HSD11B1|Mouse:Hsd11b1|Rat:Hsd11b1,Human:5208|Mouse:MGI:103562|Rat:2834,,,,,,
Target,638,hydroxymethylglutaryl-CoA synthase 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=638,Enzyme,Lanosterol biosynthesis pathway,Human:Q01581|Mouse:Q8JZK9|Rat:P17425,Human:HMGCS1|Mouse:Hmgcs1|Rat:Hmgcs1,Human:5007|Mouse:MGI:107592|Rat:70970,,,,,,
Target,639,hydroxymethylglutaryl-CoA reductase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=639,Enzyme,Lanosterol biosynthesis pathway,Human:P04035|Mouse:Q01237|Rat:P51639,Human:HMGCR|Mouse:Hmgcr|Rat:Hmgcr,Human:5006|Mouse:MGI:96159|Rat:2803,,,,,,
Target,2622,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2",,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2622,Enzyme,1.-.-.- Oxidoreductases|5.-.-.- Isomerases,Human:P26439|Mouse:P24815,Human:HSD3B2|Mouse:Hsd3b1|Rat:Hsd3b1,Human:5218|Mouse:MGI:96233|Rat:1308676,,,,,,
Target,265,H<sub>4</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=265,GPCR,Histamine receptors,Human:Q9H3N8|Mouse:Q91ZY2|Rat:Q91ZY1,Human:HRH4|Mouse:Hrh4|Rat:Hrh4,Human:17383|Mouse:MGI:2429635|Rat:620631,,,,,,
Target,264,H<sub>3</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=264,GPCR,Histamine receptors,Human:Q9Y5N1|Mouse:P58406|Rat:Q9QYN8,Human:HRH3|Mouse:Hrh3|Rat:Hrh3,Human:5184|Mouse:MGI:2139279|Rat:620630,,,,,,
Target,263,H<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=263,GPCR,Histamine receptors,Human:P25021|Mouse:P97292|Rat:P25102,Human:HRH2|Mouse:Hrh2|Rat:Hrh2,Human:5183|Mouse:MGI:108482|Rat:2831,,,,,,
Target,2822,HRAS,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2822,Enzyme,RAS subfamily,Human:P01112|Mouse:Q61411|Rat:P20171,Human:HRAS|Mouse:Hras|Rat:Hras,Human:5173|Mouse:MGI:96224|Rat:2827,,,,,,
Target,1381,H-PGDS,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1381,Enzyme,Prostaglandin synthases,Human:O60760|Mouse:Q9JHF7|Rat:O35543,Human:HPGDS|Mouse:Hpgds|Rat:Hpgds,Human:17890|Mouse:MGI:1859384|Rat:69251,,,,,,
Target,1384,HPGD,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1384,Enzyme,Prostaglandin synthases,Human:P15428|Mouse:Q8VCC1|Rat:O08699,Human:HPGD|Mouse:Hpgd|Rat:Hpgd,Human:5154|Mouse:MGI:108085|Rat:620087,,,,,,
Target,2035,homeodomain interacting protein kinase 3,HIPK3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2035,Enzyme,HIPK subfamily,Human:Q9H422|Mouse:Q9ERH7|Rat:O88850,Human:HIPK3|Mouse:Hipk3|Rat:Hipk3,Human:4915|Mouse:MGI:1314882|Rat:619884,,,,,,
Target,2034,homeodomain interacting protein kinase 2,HIPK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2034,Enzyme,HIPK subfamily,Human:Q9H2X6|Mouse:Q9QZR5,Human:HIPK2|Mouse:Hipk2|Rat:Hipk2,Human:14402|Mouse:MGI:1314872|Rat:1309349,,,,,,
Target,2028,histone H3 associated protein kinase,Haspin,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2028,Enzyme,Haspin family,Human:Q8TF76|Mouse:Q9Z0R0,Human:HASPIN|Mouse:Haspin,Human:19682|Mouse:MGI:1194498,,,,,,
Target,2620,histone deacetylase 9,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2620,Enzyme,3.5.1.- Histone deacetylases (HDACs),Human:Q9UKV0|Mouse:Q99N13,Human:HDAC9|Mouse:Hdac9|Rat:Hdac9,Human:14065|Mouse:MGI:1931221|Rat:1310748,,,,,,
Target,2619,histone deacetylase 8,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2619,Enzyme,3.5.1.- Histone deacetylases (HDACs),Human:Q9BY41|Mouse:Q8VH37|Rat:B1WC68,Human:HDAC8|Mouse:Hdac8|Rat:Hdac8,Human:13315|Mouse:MGI:1917565|Rat:1562895,,,,,,
Target,2661,histone deacetylase 7,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2661,Enzyme,3.5.1.- Histone deacetylases (HDACs),Human:Q8WUI4|Mouse:Q8C2B3|Rat:Q99P96,Human:HDAC7|Mouse:Hdac7|Rat:Hdac7,Human:14067|Mouse:MGI:1891835|Rat:619982,,,,,,
Target,2618,histone deacetylase 6,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2618,Enzyme,3.5.1.- Histone deacetylases (HDACs),Human:Q9UBN7|Mouse:Q9Z2V5,Human:HDAC6|Mouse:Hdac6|Rat:Hdac6,Human:14064|Mouse:MGI:1333752|Rat:619981,,,,,,
Target,2660,histone deacetylase 5,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2660,Enzyme,3.5.1.- Histone deacetylases (HDACs),Human:Q9UQL6|Mouse:Q9Z2V6,Human:HDAC5|Mouse:Hdac5|Rat:Hdac5,Human:14068|Mouse:MGI:1333784|Rat:619980,,,,,,
Target,2659,histone deacetylase 4,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2659,Enzyme,3.5.1.- Histone deacetylases (HDACs),Human:P56524|Mouse:Q6NZM9,Human:HDAC4|Mouse:Hdac4|Rat:Hdac4,Human:14063|Mouse:MGI:3036234|Rat:619979,,,,,,
Target,2617,histone deacetylase 3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2617,Enzyme,3.5.1.- Histone deacetylases (HDACs),Human:O15379|Mouse:O88895|Rat:Q6P6W3,Human:HDAC3|Mouse:Hdac3|Rat:Hdac3,Human:4854|Mouse:MGI:1343091|Rat:619977,,,,,,
Target,2616,histone deacetylase 2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2616,Enzyme,3.5.1.- Histone deacetylases (HDACs),Human:Q92769|Mouse:P70288,Human:HDAC2|Mouse:Hdac2|Rat:Hdac2,Human:4853|Mouse:MGI:1097691|Rat:619976,,,,,,
Target,2615,histone deacetylase 11,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2615,Enzyme,3.5.1.- Histone deacetylases (HDACs),Human:Q96DB2|Mouse:Q91WA3,Human:HDAC11|Mouse:Hdac11|Rat:Hdac11,Human:19086|Mouse:MGI:2385252|Rat:1311706,,,,,,
Target,2614,histone deacetylase 10,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2614,Enzyme,3.5.1.- Histone deacetylases (HDACs),Human:Q969S8|Mouse:Q6P3E7|Rat:Q569C4,Human:HDAC10|Mouse:Hdac10|Rat:Hdac10,Human:18128|Mouse:MGI:2158340|Rat:1305874,,,,,,
Target,2658,histone deacetylase 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2658,Enzyme,3.5.1.- Histone deacetylases (HDACs),Human:Q13547|Mouse:O09106,Human:HDAC1|Mouse:Hdac1|Rat:Hdac1,Human:4852|Mouse:MGI:108086|Rat:1309799,,,,,,
Target,1274,Histidine decarboxylase,HDC,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1274,Enzyme,Decarboxylases,Human:P19113|Mouse:P23738|Rat:P16453,Human:HDC|Mouse:Hdc|Rat:Hdc,Human:4855|Mouse:MGI:96062|Rat:2790,,,,,,
Target,891,High affinity cationic amino acid transporter 1,CAT1,SLC7A1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=891,Transporter,SLC7 family,Human:P30825|Mouse:Q09143|Rat:P30823,Human:SLC7A1|Mouse:Slc7a1|Rat:Slc7a1,Human:11057|Mouse:MGI:88117|Rat:3716,,,,,,
Target,609,Hepatocyte nuclear factor-4-&gamma;,,NR2A2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=609,NHR,2A. Hepatocyte nuclear factor-4 receptors,Human:Q14541|Mouse:Q9WUU6,Human:HNF4G|Mouse:Hnf4g|Rat:Hnf4g,Human:5026|Mouse:MGI:1353604|Rat:1310102,,,,,,
Target,608,Hepatocyte nuclear factor-4-&alpha;,,NR2A1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=608,NHR,2A. Hepatocyte nuclear factor-4 receptors,Human:P41235|Mouse:P49698|Rat:P22449,Human:HNF4A|Mouse:Hnf4a|Rat:Hnf4a,Human:5024|Mouse:MGI:109128|Rat:2810,,,,,,
Target,2543,heat shock protein family A (Hsp70) member 8,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2543,OtherProtein,Heat shock proteins,Human:P11142|Mouse:P63017|Rat:P63018,Human:HSPA8|Mouse:Hspa8|Rat:Hspa8,Human:5241|Mouse:MGI:105384|Rat:621725,,,,,,
Target,2541,heat shock protein family A (Hsp70) member 2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2541,OtherProtein,Heat shock proteins,Human:P54652|Mouse:P17156|Rat:P14659,Human:HSPA2|Mouse:Hspa2|Rat:Hspa2,Human:5235|Mouse:MGI:96243|Rat:620664,,,,,,
Target,2904,heat shock protein 90 beta family member 1,HSP90B1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2904,OtherProtein,Heat shock proteins,Human:P14625|Mouse:P08113|Rat:Q66HD0,Human:HSP90B1|Mouse:Hsp90b1|Rat:Hsp90b1,Human:12028|Mouse:MGI:98817|Rat:1310482,,,,,,
Target,2907,heat shock protein 90 alpha family class B member 1,HSP90AB1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2907,OtherProtein,Heat shock proteins,Human:P08238|Mouse:P11499|Rat:P34058,Human:HSP90AB1|Mouse:Hsp90ab1|Rat:Hsp90ab1,Human:5258|Mouse:MGI:96247|Rat:1303075,,,,,,
Target,2905,heat shock protein 90 alpha family class A member 1,HSP90AA1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2905,OtherProtein,Heat shock proteins,Human:P07900|Mouse:P07901|Rat:P82996,Human:HSP90AA1|Mouse:Hsp90aa1|Rat:Hsp90aa1,Human:5253|Mouse:MGI:96250|Rat:631409,,,,,,
Target,401,HCN2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=401,VGIC,Cyclic nucleotide-regulated channels (CNG),Human:Q9UL51|Mouse:O88703|Rat:Q9JKA9,Human:HCN2|Mouse:Hcn2|Rat:Hcn2,Human:4846|Mouse:MGI:1298210|Rat:620689,,,,,,
Target,2032,"HCK proto-oncogene, Src family tyrosine kinase",Hck,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2032,Enzyme,Src family,Human:P08631|Mouse:P08103|Rat:P50545,Human:HCK|Mouse:Hck|Rat:Hck,Human:4840|Mouse:MGI:96052|Rat:2785,,,,,,
Target,313,HCA<sub>3</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=313,GPCR,Hydroxycarboxylic acid receptors,Human:P49019,Human:HCAR3,Human:16824,,,,,,
Target,312,HCA<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=312,GPCR,Hydroxycarboxylic acid receptors,Human:Q8TDS4|Mouse:Q9EP66|Rat:Q80Z39,Human:HCAR2|Mouse:Hcar2|Rat:Hcar2,Human:24827|Mouse:MGI:1933383|Rat:727952,,,,,,
Target,1442,Haem oxygenase 2,HO2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1442,Enzyme,Haem oxygenase,Human:P30519|Mouse:O70252|Rat:P23711,Human:HMOX2|Mouse:Hmox2|Rat:Hmox2,Human:5014|Mouse:MGI:109373|Rat:67402,,,,,,
Target,1441,Haem oxygenase 1,HO1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1441,Enzyme,Haem oxygenase,Human:P09601|Mouse:P14901|Rat:P06762,Human:HMOX1|Mouse:Hmox1|Rat:Hmox1,Human:5013|Mouse:MGI:96163|Rat:2806,,,,,,
Target,1750,Guanylyl cyclase-C,GC-C,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1750,CatalyticReceptor,Transmembrane guanylyl cyclases,Human:P25092|Mouse:Q3UWA6|Rat:P23897,Human:GUCY2C|Mouse:Gucy2c|Rat:Gucy2c,Human:4688|Mouse:MGI:106903|Rat:2771,,,,,,
Target,1748,Guanylyl cyclase-B,GC-B,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1748,CatalyticReceptor,Transmembrane guanylyl cyclases,Human:P20594|Mouse:Q6VVW5|Rat:P16067,Human:NPR2|Mouse:Npr2|Rat:Npr2,Human:7944|Mouse:MGI:97372|Rat:620851,,,,,,
Target,1289,Guanylyl cyclase &alpha;<sub>2</sub> subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1289,CatalyticReceptor,Nitric oxide (NO)-sensitive (soluble) guanylyl cyclase,Human:P33402|Rat:Q9WVI4,Human:GUCY1A2|Mouse:Gucy1a2|Rat:Gucy1a2,Human:4684|Mouse:MGI:2660877|Rat:621655,,,,,,
Target,1747,Guanylyl cyclase-A,GC-A,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1747,CatalyticReceptor,Transmembrane guanylyl cyclases,Human:P16066|Mouse:P18293|Rat:P18910,Human:NPR1|Mouse:Npr1|Rat:Npr1,Human:7943|Mouse:MGI:97371|Rat:3195,,,,,,
Target,221,GPER,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=221,GPCR,G protein-coupled estrogen receptor,Human:Q99527|Mouse:Q8BMP4|Rat:O08878,Human:GPER1|Mouse:Gper1|Rat:Gper1,Human:4485|Mouse:MGI:1924104|Rat:619845,,,,,,
Target,37,GPBA receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=37,GPCR,Bile acid receptor,Human:Q8TDU6|Mouse:Q80SS6|Rat:Q80T02,Human:GPBAR1|Mouse:Gpbar1|Rat:Gpbar1,Human:19680|Mouse:MGI:2653863|Rat:631400,,,,,,
Target,257,GnRH<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=257,GPCR,Gonadotrophin-releasing hormone receptors,Human:Q96P88,Human:GNRHR2,Human:16341,,,,,,
Target,256,GnRH<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=256,GPCR,Gonadotrophin-releasing hormone receptors,Human:P30968|Mouse:Q01776|Rat:P30969,Human:GNRHR|Mouse:Gnrhr|Rat:Gnrhr,Human:4421|Mouse:MGI:95790|Rat:70513,,,,,,
Target,2030,glycogen synthase kinase 3 beta,GSK3B,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2030,Enzyme,GSK subfamily,Human:P49841|Mouse:Q9WV60|Rat:P18266,Human:GSK3B|Mouse:Gsk3b|Rat:Gsk3b,Human:4617|Mouse:MGI:1861437|Rat:70982,,,,,,
Target,2029,glycogen synthase kinase 3 alpha,GSK3A,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2029,Enzyme,GSK subfamily,Human:P49840|Mouse:Q2NL51|Rat:P18265,Human:GSK3A|Mouse:Gsk3a|Rat:Gsk3a,Human:4616|Mouse:MGI:2152453|Rat:620351,,,,,,
Target,427,glycine receptor &beta; subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=427,LGIC,Glycine receptors,Human:P48167|Mouse:P48168|Rat:P20781,Human:GLRB|Mouse:Glrb|Rat:Glrb,Human:4329|Mouse:MGI:95751|Rat:2706,,,,,,
Target,426,glycine receptor &alpha;4 subunit <i>(pseudogene in humans)</i>,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=426,LGIC,Glycine receptors,Human:Q5JXX5|Mouse:Q61603,Human:GLRA4|Mouse:Glra4|Rat:Glra4,Human:31715|Mouse:MGI:95750|Rat:1564103,,,,,,
Target,425,glycine receptor &alpha;3 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=425,LGIC,Glycine receptors,Human:O75311|Mouse:Q91XP5|Rat:P24524,Human:GLRA3|Mouse:Glra3|Rat:Glra3,Human:4328|Mouse:MGI:95749|Rat:621229,,,,,,
Target,424,glycine receptor &alpha;2 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=424,LGIC,Glycine receptors,Human:P23416|Mouse:Q7TNC8|Rat:P22771,Human:GLRA2|Mouse:Glra2|Rat:Glra2,Human:4327|Mouse:MGI:95748|Rat:2705,,,,,,
Target,423,glycine receptor &alpha;1 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=423,LGIC,Glycine receptors,Human:P23415|Mouse:Q64018|Rat:P07727,Human:GLRA1|Mouse:Glra1|Rat:Glra1,Human:4326|Mouse:MGI:95747|Rat:2704,,,,,,
Target,3098,glycine cleavage system protein H,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3098,Enzyme,Glycine recycling,Human:P23434|Mouse:Q91WK5|Rat:Q5I0P2,Human:GCSH|Mouse:Gcsh|Rat:Gcsh,Human:4208|Mouse:MGI:1915383|Rat:619946,,,,,,
Target,3110,glutathione S-transferase omega 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3110,Enzyme,2.5.1.18 Glutathione transferases,Human:P78417|Mouse:O09131,Human:GSTO1|Mouse:Gsto1|Rat:Gsto1,Human:13312|Mouse:MGI:1342273|Rat:70952,,,,,,
Target,2613,glutathione-disulfide reductase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2613,Enzyme,1.-.-.- Oxidoreductases,Human:P00390|Mouse:P47791|Rat:P70619,Human:GSR|Mouse:Gsr|Rat:Gsr,Human:4623|Mouse:MGI:95804|Rat:621747,,,,,,
Target,1568,Glutamyl aminopeptidase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1568,Enzyme,M1: Aminopeptidase N,Human:Q07075|Mouse:P16406|Rat:P50123,Human:ENPEP|Mouse:Enpep|Rat:Enpep,Human:3355|Mouse:MGI:106645|Rat:621228,,,,,,
Target,2411,glutaminyl-peptide cyclotransferase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2411,Enzyme,M28: Aminopeptidase Y,Human:Q16769|Mouse:Q9CYK2,Human:QPCT|Mouse:Qpct|Rat:Qpct,Human:9753|Mouse:MGI:1917786|Rat:1562284,,,,,,
Target,2891,glutaminase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2891,Enzyme,3.5.1.2 Glutaminases,Human:O94925|Mouse:D3Z7P3|Rat:P13264,Human:GLS|Mouse:Gls|Rat:Gls,Human:4331|Mouse:MGI:95752|Rat:2707,,,,,,
Target,1273,Glutamic acid decarboxylase 2,GAD2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1273,Enzyme,Decarboxylases|GABA turnover,Human:Q05329|Mouse:P48320|Rat:Q05683,Human:GAD2|Mouse:Gad2|Rat:Gad2,Human:4093|Mouse:MGI:95634|Rat:2653,,,,,,
Target,1272,Glutamic acid decarboxylase 1,GAD1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1272,Enzyme,Decarboxylases|GABA turnover,Human:Q99259|Mouse:P48318|Rat:P18088,Human:GAD1|Mouse:Gad1|Rat:Gad1,Human:4092|Mouse:MGI:95632|Rat:2652,,,,,,
Target,461,GluN3B,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=461,LGIC,Ionotropic glutamate receptors,Human:O60391|Mouse:Q91ZU9|Rat:Q8VHN2,Human:GRIN3B|Mouse:Grin3b|Rat:Grin3b,Human:16768|Mouse:MGI:2150393|Rat:621705,,,,,,
Target,460,GluN3A,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=460,LGIC,Ionotropic glutamate receptors,Human:Q8TCU5|Rat:Q9R1M7,Human:GRIN3A|Mouse:Grin3a|Rat:Grin3a,Human:16767|Mouse:MGI:1933206|Rat:621704,,,,,,
Target,459,GluN2D,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=459,LGIC,Ionotropic glutamate receptors,Human:O15399|Mouse:Q03391|Rat:Q62645,Human:GRIN2D|Mouse:Grin2d|Rat:Grin2d,Human:4588|Mouse:MGI:95823|Rat:2740,,,,,,
Target,458,GluN2C,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=458,LGIC,Ionotropic glutamate receptors,Human:Q14957|Mouse:Q01098|Rat:Q00961,Human:GRIN2C|Mouse:Grin2c|Rat:Grin2c,Human:4587|Mouse:MGI:95822|Rat:2739,,,,,,
Target,457,GluN2B,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=457,LGIC,Ionotropic glutamate receptors,Human:Q13224|Mouse:Q01097|Rat:Q00960,Human:GRIN2B|Mouse:Grin2b|Rat:Grin2b,Human:4586|Mouse:MGI:95821|Rat:2738,,,,,,
Target,456,GluN2A,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=456,LGIC,Ionotropic glutamate receptors,Human:Q12879|Mouse:P35436|Rat:Q00959,Human:GRIN2A|Mouse:Grin2a|Rat:Grin2a,Human:4585|Mouse:MGI:95820|Rat:2737,,,,,,
Target,455,GluN1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=455,LGIC,Ionotropic glutamate receptors,Human:Q05586|Mouse:P35438|Rat:P35439,Human:GRIN1|Mouse:Grin1|Rat:Grin1,Human:4584|Mouse:MGI:95819|Rat:2736,,,,,,
Target,454,GluK5,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=454,LGIC,Ionotropic glutamate receptors,Human:Q16478|Mouse:Q61626|Rat:Q63273,Human:GRIK5|Mouse:Grik5|Rat:Grik5,Human:4583|Mouse:MGI:95818|Rat:2735,,,,,,
Target,453,GluK4,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=453,LGIC,Ionotropic glutamate receptors,Human:Q16099|Mouse:Q8BMF5|Rat:Q01812,Human:GRIK4|Mouse:Grik4|Rat:Grik4,Human:4582|Mouse:MGI:95817|Rat:2734,,,,,,
Target,452,GluK3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=452,LGIC,Ionotropic glutamate receptors,Human:Q13003|Mouse:B1AS29|Rat:P42264,Human:GRIK3|Mouse:Grik3|Rat:Grik3,Human:4581|Mouse:MGI:95816|Rat:71027,,,,,,
Target,451,GluK2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=451,LGIC,Ionotropic glutamate receptors,Human:Q13002|Mouse:P39087|Rat:P42260,Human:GRIK2|Mouse:Grik2|Rat:Grik2,Human:4580|Mouse:MGI:95815|Rat:2733,,,,,,
Target,450,GluK1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=450,LGIC,Ionotropic glutamate receptors,Human:P39086|Mouse:Q60934|Rat:P22756,Human:GRIK1|Mouse:Grik1|Rat:Grik1,Human:4579|Mouse:MGI:95814|Rat:2732,,,,,,
Target,2978,glucosylceramidase beta,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2978,Enzyme,3.2.1.- Glycosidases,Human:P04062|Mouse:P17439,Human:GBA|Mouse:Gba|Rat:Gba,Human:4177|Mouse:MGI:95665|Rat:1589149,,,,,,
Target,876,Glucose transporter  2,GLUT2,SLC2A2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=876,Transporter,Class I transporters,Human:P11168|Mouse:P14246|Rat:P12336,Human:SLC2A2|Mouse:Slc2a2|Rat:Slc2a2,Human:11006|Mouse:MGI:1095438|Rat:3705,,,,,,
Target,875,Glucose transporter  1,GLUT1,SLC2A1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=875,Transporter,Class I transporters,Human:P11166|Mouse:P17809|Rat:P11167,Human:SLC2A1|Mouse:Slc2a1|Rat:Slc2a1,Human:11005|Mouse:MGI:95755|Rat:3704,,,,,,
Target,2798,Glucokinase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2798,Enzyme,Hexokinases,Human:P35557|Mouse:P52792|Rat:P17712,Human:GCK|Mouse:Gck|Rat:Gck,Human:4195|Mouse:MGI:1270854|Rat:2670,,,,,,
Target,625,Glucocorticoid receptor,,NR3C1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=625,NHR,3C. 3-Ketosteroid receptors,Human:P04150|Mouse:P06537|Rat:P06536,Human:NR3C1|Mouse:Nr3c1|Rat:Nr3c1,Human:7978|Mouse:MGI:95824|Rat:2741,,,,,,
Target,447,GluA4,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=447,LGIC,Ionotropic glutamate receptors,Human:P48058|Mouse:Q9Z2W8|Rat:P19493,Human:GRIA4|Mouse:Gria4|Rat:Gria4,Human:4574|Mouse:MGI:95811|Rat:61863,,,,,,
Target,446,GluA3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=446,LGIC,Ionotropic glutamate receptors,Human:P42263|Mouse:Q9Z2W9|Rat:P19492,Human:GRIA3|Mouse:Gria3|Rat:Gria3,Human:4573|Mouse:MGI:95810|Rat:70958,,,,,,
Target,445,GluA2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=445,LGIC,Ionotropic glutamate receptors,Human:P42262|Mouse:P23819|Rat:P19491,Human:GRIA2|Mouse:Gria2|Rat:Gria2,Human:4572|Mouse:MGI:95809|Rat:61862,,,,,,
Target,444,GluA1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=444,LGIC,Ionotropic glutamate receptors,Human:P42261|Mouse:P23818|Rat:P19490,Human:GRIA1|Mouse:Gria1|Rat:Gria1,Human:4571|Mouse:MGI:95808|Rat:621531,,,,,,
Target,249,GLP-1 receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=249,GPCR,Glucagon receptor family,Human:P43220|Mouse:O35659|Rat:P32301,Human:GLP1R|Mouse:Glp1r|Rat:Glp1r,Human:4324|Mouse:MGI:99571|Rat:2703,,,,,,
Target,247,GHRH receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=247,GPCR,Glucagon receptor family,Human:Q02643|Mouse:P32082|Rat:Q02644,Human:GHRHR|Mouse:Ghrhr|Rat:Ghrhr,Human:4266|Mouse:MGI:95710|Rat:2688,,,,,,
Target,246,ghrelin receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=246,GPCR,Ghrelin receptor,Human:Q92847|Mouse:Q99P50|Rat:O08725,Human:GHSR|Mouse:Ghsr|Rat:Ghsr,Human:4267|Mouse:MGI:2441906|Rat:621397,,,,,,
Target,643,geranylgeranyl diphosphate synthase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=643,Enzyme,Lanosterol biosynthesis pathway,Human:O95749|Mouse:Q9WTN0|Rat:Q6F596,Human:GGPS1|Mouse:Ggps1|Rat:Ggps1,Human:4249|Mouse:MGI:1341724|Rat:1359680,,,,,,
Target,931,GAT3,,SLC6A11,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=931,Transporter,GABA transporter subfamily,Human:P48066|Mouse:P31650|Rat:P31647,Human:SLC6A11|Mouse:Slc6a11|Rat:Slc6a11,Human:11044|Mouse:MGI:95630|Rat:628737,,,,,,
Target,930,GAT2,,SLC6A13,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=930,Transporter,GABA transporter subfamily,Human:Q9NSD5|Mouse:P31649|Rat:P31646,Human:SLC6A13|Mouse:Slc6a13|Rat:Slc6a13,Human:11046|Mouse:MGI:95629|Rat:620788,,,,,,
Target,929,GAT1,,SLC6A1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=929,Transporter,GABA transporter subfamily,Human:P30531|Mouse:P31648|Rat:P23978,Human:SLC6A1|Mouse:Slc6a1|Rat:Slc6a1,Human:11042|Mouse:MGI:95627|Rat:620533,,,,,,
Target,1268,&gamma;-Glutamyl carboxylase,GGCX,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1268,Enzyme,Carboxylases,Human:P38435|Mouse:Q9QYC7|Rat:O88496,Human:GGCX|Mouse:Ggcx|Rat:Ggcx,Human:4247|Mouse:MGI:1927655|Rat:68383,,,,,,
Target,241,GABA<sub>B2</sub>,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=241,GPCR,GABA<sub>B</sub> receptors,Human:O75899|Mouse:Q80T41|Rat:O88871,Human:GABBR2|Mouse:Gabbr2|Rat:Gabbr2,Human:4507|Mouse:MGI:2386030|Rat:619864,,,,,,
Target,240,GABA<sub>B1</sub>,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=240,GPCR,GABA<sub>B</sub> receptors,Human:Q9UBS5|Mouse:Q9WV18|Rat:Q9Z0U4,Human:GABBR1|Mouse:Gabbr1|Rat:Gabbr1,Human:4070|Mouse:MGI:1860139|Rat:621537,,,,,,
Target,418,GABA<sub>A</sub> receptor &theta; subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=418,LGIC,GABA<sub>A</sub> receptors,Human:Q9UN88|Mouse:Q9JLF1,Human:GABRQ|Mouse:Gabrq|Rat:Gabrq,Human:14454|Mouse:MGI:1888498|Rat:68331,,,,,,
Target,422,GABA<sub>A</sub> receptor &rho;3 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=422,LGIC,GABA<sub>A</sub> receptors,Human:A8MPY1|Rat:P50573,Human:GABRR3|Mouse:Gabrr3|Rat:Gabrr3,Human:17969|Mouse:MGI:3588203|Rat:621564,,,,,,
Target,421,GABA<sub>A</sub> receptor &rho;2 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=421,LGIC,GABA<sub>A</sub> receptors,Human:P28476|Mouse:P56476|Rat:P47742,Human:GABRR2|Mouse:Gabrr2|Rat:Gabrr2,Human:4091|Mouse:MGI:95626|Rat:61902,,,,,,
Target,420,GABA<sub>A</sub> receptor &rho;1 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=420,LGIC,GABA<sub>A</sub> receptors,Human:P24046|Mouse:P56475|Rat:P50572,Human:GABRR1|Mouse:Gabrr1|Rat:Gabrr1,Human:4090|Mouse:MGI:95625|Rat:61900,,,,,,
Target,419,GABA<sub>A</sub> receptor &pi; subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=419,LGIC,GABA<sub>A</sub> receptors,Human:O00591|Mouse:Q8QZW7|Rat:O09028,Human:GABRP|Mouse:Gabrp|Rat:Gabrp,Human:4089|Mouse:MGI:2387597|Rat:620532,,,,,,
Target,415,GABA<sub>A</sub> receptor &gamma;3 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=415,LGIC,GABA<sub>A</sub> receptors,Human:Q99928|Mouse:P27681|Rat:P28473,Human:GABRG3|Mouse:Gabrg3|Rat:Gabrg3,Human:4088|Mouse:MGI:95624|Rat:621735,,,,,,
Target,414,GABA<sub>A</sub> receptor &gamma;2 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=414,LGIC,GABA<sub>A</sub> receptors,Human:P18507|Mouse:P22723|Rat:P18508,Human:GABRG2|Mouse:Gabrg2|Rat:Gabrg2,Human:4087|Mouse:MGI:95623|Rat:61966,,,,,,
Target,413,GABA<sub>A</sub> receptor &gamma;1 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=413,LGIC,GABA<sub>A</sub> receptors,Human:Q8N1C3|Mouse:Q9R0Y8|Rat:P23574,Human:GABRG1|Mouse:Gabrg1|Rat:Gabrg1,Human:4086|Mouse:MGI:103156|Rat:621732,,,,,,
Target,417,GABA<sub>A</sub> receptor &epsilon; subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=417,LGIC,GABA<sub>A</sub> receptors,Human:P78334|Rat:Q9ES14,Human:GABRE|Mouse:Gabre|Rat:Gabre,Human:4085|Mouse:MGI:1330235|Rat:68320,,,,,,
Target,416,GABA<sub>A</sub> receptor &delta; subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=416,LGIC,GABA<sub>A</sub> receptors,Human:O14764|Mouse:P22933|Rat:P18506,Human:GABRD|Mouse:Gabrd|Rat:Gabrd,Human:4084|Mouse:MGI:95622|Rat:61901,,,,,,
Target,412,GABA<sub>A</sub> receptor &beta;3 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=412,LGIC,GABA<sub>A</sub> receptors,Human:P28472|Mouse:P63080|Rat:P63079,Human:GABRB3|Mouse:Gabrb3|Rat:Gabrb3,Human:4083|Mouse:MGI:95621|Rat:2651,,,,,,
Target,411,GABA<sub>A</sub> receptor &beta;2 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=411,LGIC,GABA<sub>A</sub> receptors,Human:P47870|Mouse:P63137|Rat:P63138,Human:GABRB2|Mouse:Gabrb2|Rat:Gabrb2,Human:4082|Mouse:MGI:95620|Rat:2650,,,,,,
Target,410,GABA<sub>A</sub> receptor &beta;1 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=410,LGIC,GABA<sub>A</sub> receptors,Human:P18505|Mouse:P50571|Rat:P15431,Human:GABRB1|Mouse:Gabrb1|Rat:Gabrb1,Human:4081|Mouse:MGI:95619|Rat:2649,,,,,,
Target,409,GABA<sub>A</sub> receptor &alpha;6 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=409,LGIC,GABA<sub>A</sub> receptors,Human:Q16445|Mouse:P16305|Rat:P30191,Human:GABRA6|Mouse:Gabra6|Rat:Gabra6,Human:4080|Mouse:MGI:95618|Rat:61861,,,,,,
Target,408,GABA<sub>A</sub> receptor &alpha;5 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=408,LGIC,GABA<sub>A</sub> receptors,Human:P31644|Mouse:Q8BHJ7|Rat:P19969,Human:GABRA5|Mouse:Gabra5|Rat:Gabra5,Human:4079|Mouse:MGI:95617|Rat:61859,,,,,,
Target,407,GABA<sub>A</sub> receptor &alpha;4 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=407,LGIC,GABA<sub>A</sub> receptors,Human:P48169|Mouse:Q9D6F4|Rat:P28471,Human:GABRA4|Mouse:Gabra4|Rat:Gabra4,Human:4078|Mouse:MGI:95616|Rat:621670,,,,,,
Target,406,GABA<sub>A</sub> receptor &alpha;3 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=406,LGIC,GABA<sub>A</sub> receptors,Human:P34903|Mouse:P26049|Rat:P20236,Human:GABRA3|Mouse:Gabra3|Rat:Gabra3,Human:4077|Mouse:MGI:95615|Rat:2648,,,,,,
Target,405,GABA<sub>A</sub> receptor &alpha;2 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=405,LGIC,GABA<sub>A</sub> receptors,Human:P47869|Mouse:P26048|Rat:P23576,Human:GABRA2|Mouse:Gabra2|Rat:Gabra2,Human:4076|Mouse:MGI:95614|Rat:61856,,,,,,
Target,404,GABA<sub>A</sub> receptor &alpha;1 subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=404,LGIC,GABA<sub>A</sub> receptors,Human:P14867|Mouse:P62812|Rat:P62813,Human:GABRA1|Mouse:Gabra1|Rat:Gabra1,Human:4075|Mouse:MGI:95613|Rat:61855,,,,,,
Target,2025,fyn related Src family tyrosine kinase,FRK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2025,Enzyme,Src family,Human:P42685|Mouse:Q922K9|Rat:Q62662,Human:FRK|Mouse:Frk|Rat:Frk,Human:3955|Mouse:MGI:103265|Rat:621423,,,,,,
Target,2026,"FYN proto-oncogene, Src family tyrosine kinase",Fyn,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2026,Enzyme,Src family,Human:P06241|Mouse:P39688|Rat:Q62844,Human:FYN|Mouse:Fyn|Rat:Fyn,Human:4037|Mouse:MGI:95602|Rat:2641,,,,,,
Target,2366,"furin, paired basic amino acid cleaving enzyme",,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2366,Enzyme,S8: Subtilisin,Human:P09958|Mouse:P23188|Rat:P23377,Human:FURIN|Mouse:Furin|Rat:Furin,Human:8568|Mouse:MGI:97513|Rat:3274,,,,,,
Target,798,F-type ATPase &gamma; subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=798,Transporter,F-type ATPase,Human:P36542|Mouse:Q91VR2|Rat:P35435,Human:ATP5F1C|Mouse:Atp5c1|Rat:Atp5f1c,Human:833|Mouse:MGI:1261437|Rat:620011,,,,,,
Target,805,F-type ATPase E subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=805,Transporter,F-type ATPase,Human:P56385|Mouse:Q06185|Rat:P29419,Human:ATP5ME|Mouse:Atp5k|Rat:Atp5me,Human:846|Mouse:MGI:106636|Rat:621377,,,,,,
Target,799,F-type ATPase &delta; subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=799,Transporter,F-type ATPase,Human:P30049|Mouse:Q9D3D9|Rat:P35434,Human:ATP5F1D|Mouse:Atp5d|Rat:Atp5f1d,Human:837|Mouse:MGI:1913293|Rat:621372,,,,,,
Target,797,F-type ATPase &beta; subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=797,Transporter,F-type ATPase,Human:P06576|Mouse:P56480|Rat:P10719,Human:ATP5F1B|Mouse:Atp5b|Rat:Atp5f1b,Human:830|Mouse:MGI:107801|Rat:621368,,,,,,
Target,801,F-type ATPase A subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=801,Transporter,F-type ATPase,Human:P00846|Mouse:P00848|Rat:P05504,Human:MT-ATP6|Mouse:mt-Atp6|Rat:Mt-atp6,Human:7414|Mouse:MGI:99927|Rat:621239,,,,,,
Target,796,F-type ATPase &alpha; subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=796,Transporter,F-type ATPase,Human:P25705|Mouse:Q03265|Rat:P15999,Human:ATP5F1A|Mouse:Atp5a1|Rat:Atp5f1a,Human:823|Mouse:MGI:88115|Rat:619993,,,,,,
Target,253,FSH receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=253,GPCR,Glycoprotein hormone receptors,Human:P23945|Mouse:P35378|Rat:P20395,Human:FSHR|Mouse:Fshr|Rat:Fshr,Human:3969|Mouse:MGI:95583|Rat:2632,,,,,,
Target,344,FP receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=344,GPCR,Prostanoid receptors,Human:P43088|Mouse:P43117|Rat:P43118,Human:PTGFR|Mouse:Ptgfr|Rat:Ptgfr,Human:9600|Mouse:MGI:97796|Rat:3436,,,,,,
Target,222,FPR1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=222,GPCR,Formylpeptide receptors,Human:P21462|Mouse:P33766,Human:FPR1|Mouse:Fpr1|Rat:Fpr1,Human:3826|Mouse:MGI:107443|Rat:1310883,,,,,,
Target,1606,Folate hydrolase (prostate-specific membrane antigen) 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1606,Enzyme,M28: Aminopeptidase Y,Human:Q04609|Mouse:O35409|Rat:P70627,Human:FOLH1|Mouse:Folh1|Rat:Folh1,Human:3788|Mouse:MGI:1858193|Rat:70963,,,,,,
Target,1814,fms related receptor tyrosine kinase 4,VEGFR-3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1814,CatalyticReceptor,Type IV RTKs: VEGF (vascular endothelial growth factor) receptor family,Human:P35916|Mouse:P35917|Rat:Q91ZT1,Human:FLT4|Mouse:Flt4|Rat:Flt4,Human:3767|Mouse:MGI:95561|Rat:621737,,,,,,
Target,1807,fms related receptor tyrosine kinase 3,FLT3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1807,CatalyticReceptor,"Type III RTKs: PDGFR, CSFR, Kit, FLT3 receptor family",Human:P36888|Mouse:Q00342,Human:FLT3|Mouse:Flt3|Rat:Flt3,Human:3765|Mouse:MGI:95559|Rat:61308,,,,,,
Target,1812,fms related receptor tyrosine kinase 1,VEGFR-1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1812,CatalyticReceptor,Type IV RTKs: VEGF (vascular endothelial growth factor) receptor family,Human:P17948|Mouse:P35969|Rat:P53767,Human:FLT1|Mouse:Flt1|Rat:Flt1,Human:3763|Mouse:MGI:95558|Rat:2621,,,,,,
Target,2609,FKBP prolyl isomerase 1A,FKBP12,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2609,Enzyme,Peptidyl-prolyl cis/trans isomerases,Human:P62942|Mouse:P26883|Rat:Q62658,Human:FKBP1A|Mouse:Fkbp1a|Rat:Fkbp1a,Human:3711|Mouse:MGI:95541|Rat:2617,,,,,,
Target,1811,fibroblast growth factor receptor 4,FGFR4,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1811,CatalyticReceptor,Type V RTKs: FGF (fibroblast growth factor) receptor family,Human:P22455|Mouse:Q03142|Rat:Q498D6,Human:FGFR4|Mouse:Fgfr4|Rat:Fgfr4,Human:3691|Mouse:MGI:95525|Rat:2612,,,,,,
Target,1810,fibroblast growth factor receptor 3,FGFR3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1810,CatalyticReceptor,Type V RTKs: FGF (fibroblast growth factor) receptor family,Human:P22607|Mouse:Q61851,Human:FGFR3|Mouse:Fgfr3|Rat:Fgfr3,Human:3690|Mouse:MGI:95524|Rat:620714,,,,,,
Target,1809,fibroblast growth factor receptor 2,FGFR2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1809,CatalyticReceptor,Type V RTKs: FGF (fibroblast growth factor) receptor family,Human:P21802|Mouse:P21803,Human:FGFR2|Mouse:Fgfr2|Rat:Fgfr2,Human:3689|Mouse:MGI:95523|Rat:2611,,,,,,
Target,1808,fibroblast growth factor receptor 1,FGFR1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1808,CatalyticReceptor,Type V RTKs: FGF (fibroblast growth factor) receptor family,Human:P11362|Mouse:P16092|Rat:Q04589,Human:FGFR1|Mouse:Fgfr1|Rat:Fgfr1,Human:3688|Mouse:MGI:95522|Rat:620713,,,,,,
Target,2024,"FGR proto-oncogene, Src family tyrosine kinase",Fgr,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2024,Enzyme,Src family,Human:P09769|Mouse:P14234|Rat:Q6P6U0,Human:FGR|Mouse:Fgr|Rat:Fgr,Human:3697|Mouse:MGI:95527|Rat:621319,,,,,,
Target,127,FFA4 receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=127,GPCR,Free fatty acid receptors,Human:Q5NUL3|Mouse:Q7TMA4|Rat:Q2AC31,Human:FFAR4|Mouse:Ffar4|Rat:Ffar4,Human:19061|Mouse:MGI:2147577|Rat:1308252,,,,,,
Target,225,FFA1 receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=225,GPCR,Free fatty acid receptors,Human:O14842|Mouse:Q76JU9|Rat:Q8K3T4,Human:FFAR1|Mouse:Ffar1|Rat:Ffar1,Human:4498|Mouse:MGI:2684079|Rat:628613,,,,,,
Target,2023,"FES proto-oncogene, tyrosine kinase",Fes,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2023,Enzyme,Fer family,Human:P07332|Mouse:P16879,Human:FES|Mouse:Fes|Rat:Fes,Human:3657|Mouse:MGI:95514|Rat:1564385,,,,,,
Target,2022,FER tyrosine kinase,Fer,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2022,Enzyme,Fer family,Human:P16591|Mouse:P70451|Rat:P09760,Human:FER|Mouse:Fer|Rat:Fer,Human:3655|Mouse:MGI:105917|Rat:1306273,,,,,,
Target,2608,fatty acid synthase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2608,Enzyme,2.3.1.-  Acyltransferases,Human:P49327|Mouse:P19096|Rat:P12785,Human:FASN|Mouse:Fasn|Rat:Fasn,Human:3594|Mouse:MGI:95485|Rat:620665,,,,,,
Target,2536,fatty acid binding protein 6,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2536,OtherProtein,Fatty acid-binding proteins,Human:P51161|Mouse:P51162|Rat:P80020,Human:FABP6|Mouse:Fabp6|Rat:Fabp6,Human:3561|Mouse:MGI:96565|Rat:2592,,,,,,
Target,2532,fatty acid binding protein 2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2532,OtherProtein,Fatty acid-binding proteins,Human:P12104|Mouse:P55050|Rat:P02693,Human:FABP2|Mouse:Fabp2|Rat:Fabp2,Human:3556|Mouse:MGI:95478|Rat:2591,,,,,,
Target,1400,Fatty acid amide hydrolase,FAAH,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1400,Enzyme,Hydrolases|<i>N</i>-Acylethanolamine turnover,Human:O00519|Mouse:O08914|Rat:P97612,Human:FAAH|Mouse:Faah|Rat:Faah,Human:3553|Mouse:MGI:109609|Rat:61808,,,,,,
Target,2826,"farnesyltransferase, CAAX box, beta",FNTB,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2826,Enzyme,2.5.1.58 Protein farnesyltransferase,Human:P49356|Mouse:Q8K2I1|Rat:Q02293,Human:FNTB|Mouse:Fntb|Rat:Fntb,Human:3785|Mouse:MGI:1861305|Rat:620119,,,,,,
Target,2825,"farnesyltransferase, CAAX box, alpha",FNTA,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2825,Enzyme,2.5.1.58 Protein farnesyltransferase,Human:P49354|Mouse:Q61239|Rat:Q04631,Human:FNTA|Mouse:Fnta|Rat:Fnta,Human:3782|Mouse:MGI:104683|Rat:2625,,,,,,
Target,644,farnesyl diphosphate synthase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=644,Enzyme,Lanosterol biosynthesis pathway,Human:P14324|Mouse:Q920E5|Rat:P05369,Human:FDPS|Mouse:Fdps|Rat:Fdps,Human:3631|Mouse:MGI:104888|Rat:68953,,,,,,
Target,603,Farnesoid X receptor,,NR1H4,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=603,NHR,1H. Liver X receptor-like receptors,Human:Q96RI1|Mouse:Q3V1T8|Rat:Q62735,Human:NR1H4|Mouse:Nr1h4|Rat:Nr1h4,Human:7967|Mouse:MGI:1352464|Rat:628831,,,,,,
Target,1718,Eythropoietin receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1718,CatalyticReceptor,Prolactin receptor family,Human:P19235|Mouse:P14753|Rat:Q07303,Human:EPOR|Mouse:Epor|Rat:Epor,Human:3416|Mouse:MGI:95408|Rat:2560,,,,,,
Target,3014,exportin 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3014,OtherProtein,Nuclear export proteins,Human:O14980|Mouse:Q6P5F9|Rat:Q80U96,Human:XPO1|Mouse:Xpo1|Rat:Xpo1,Human:12825|Mouse:MGI:2144013|Rat:620517,,,,,,
Target,872,Excitatory amino acid transporter 5,EAAT5,SLC1A7,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=872,Transporter,Glutamate transporter subfamily,Human:O00341|Mouse:Q8JZR4,Human:SLC1A7|Mouse:Slc1a7|Rat:Slc1a7,Human:10945|Mouse:MGI:2444087|Rat:1311928,,,,,,
Target,871,Excitatory amino acid transporter 4,EAAT4,SLC1A6,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=871,Transporter,Glutamate transporter subfamily,Human:P48664|Mouse:O35544|Rat:O35921,Human:SLC1A6|Mouse:Slc1a6|Rat:Slc1a6,Human:10944|Mouse:MGI:1096331|Rat:620340,,,,,,
Target,870,Excitatory amino acid transporter 3,EAAT3,SLC1A1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=870,Transporter,Glutamate transporter subfamily,Human:P43005|Mouse:P51906|Rat:P51907,Human:SLC1A1|Mouse:Slc1a1|Rat:Slc1a1,Human:10939|Mouse:MGI:105083|Rat:3696,,,,,,
Target,869,Excitatory amino acid transporter 2,EAAT2,SLC1A2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=869,Transporter,Glutamate transporter subfamily,Human:P43004|Mouse:P43006|Rat:P31596,Human:SLC1A2|Mouse:Slc1a2|Rat:Slc1a2,Human:10940|Mouse:MGI:101931|Rat:3697,,,,,,
Target,868,Excitatory amino acid transporter 1,EAAT1,SLC1A3,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=868,Transporter,Glutamate transporter subfamily,Human:P43003|Mouse:P56564|Rat:P24942,Human:SLC1A3|Mouse:Slc1a3|Rat:Slc1a3,Human:10941|Mouse:MGI:99917|Rat:3698,,,,,,
Target,2018,eukaryotic translation initiation factor 2 alpha kinase 4,GCN2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2018,Enzyme,GCN2 subfamily,Human:Q9P2K8|Mouse:Q9QZ05,Human:EIF2AK4|Mouse:Eif2ak4|Rat:Eif2ak4,Human:19687|Mouse:MGI:1353427|Rat:1311439,,,,,,
Target,2016,eukaryotic translation initiation factor 2 alpha kinase 2,PKR,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2016,Enzyme,Other PEK family kinases,Human:P19525|Mouse:Q03963|Rat:Q63184,Human:EIF2AK2|Mouse:Eif2ak2|Rat:Eif2ak2,Human:9437|Mouse:MGI:1353449|Rat:3402,,,,,,
Target,2015,eukaryotic translation initiation factor 2 alpha kinase 1,HRI,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2015,Enzyme,Other PEK family kinases,Human:Q9BQI3|Mouse:Q9Z2R9|Rat:Q63185,Human:EIF2AK1|Mouse:Eif2ak1|Rat:Eif2ak1,Human:24921|Mouse:MGI:1353448|Rat:70883,,,,,,
Target,2756,eukaryotic translation elongation factor 2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2756,OtherProtein,Ribosomal factors,Human:P13639|Mouse:P58252|Rat:P05197,Human:EEF2|Mouse:Eef2|Rat:Eef2,Human:3214|Mouse:MGI:95288|Rat:61979,,,,,,
Target,220,ET<sub>B</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=220,GPCR,Endothelin receptors,Human:P24530|Mouse:P48302|Rat:P21451,Human:EDNRB|Mouse:Ednrb|Rat:Ednrb,Human:3180|Mouse:MGI:102720|Rat:2536,,,,,,
Target,219,ET<sub>A</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=219,GPCR,Endothelin receptors,Human:P25101|Mouse:Q61614|Rat:P26684,Human:EDNRA|Mouse:Ednra|Rat:Ednra,Human:3179|Mouse:MGI:105923|Rat:2535,,,,,,
Target,624,Estrogen-related receptor-&gamma;,,NR3B3,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=624,NHR,3B. Estrogen-related receptors,Human:P62508|Mouse:P62509|Rat:P62510,Human:ESRRG|Mouse:Esrrg|Rat:Esrrg,Human:3474|Mouse:MGI:1347056|Rat:1303236,,,,,,
Target,623,Estrogen-related receptor-&beta;,,NR3B2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=623,NHR,3B. Estrogen-related receptors,Human:O95718|Mouse:Q61539|Rat:P11475,Human:ESRRB|Mouse:Esrrb|Rat:Esrrb,Human:3473|Mouse:MGI:1346832|Rat:1359557,,,,,,
Target,622,Estrogen-related receptor-&alpha;,,NR3B1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=622,NHR,3B. Estrogen-related receptors,Human:P11474|Mouse:O08580|Rat:Q5QJV7,Human:ESRRA|Mouse:Esrra|Rat:Esrra,Human:3471|Mouse:MGI:1346831|Rat:1583866,,,,,,
Target,621,Estrogen receptor-&beta;,,NR3A2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=621,NHR,3A. Estrogen receptors,Human:Q92731|Mouse:O08537|Rat:Q62986,Human:ESR2|Mouse:Esr2|Rat:Esr2,Human:3468|Mouse:MGI:109392|Rat:2582,,,,,,
Target,620,Estrogen receptor-&alpha;,,NR3A1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=620,NHR,3A. Estrogen receptors,Human:P03372|Mouse:P19785|Rat:P06211,Human:ESR1|Mouse:Esr1|Rat:Esr1,Human:3467|Mouse:MGI:1352467|Rat:2581,,,,,,
Target,1799,erb-b2 receptor tyrosine kinase 4,HER4,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1799,CatalyticReceptor,Type I RTKs: ErbB (epidermal growth factor) receptor family,Human:Q15303|Mouse:Q61527|Rat:Q62956,Human:ERBB4|Mouse:Erbb4|Rat:Erbb4,Human:3432|Mouse:MGI:104771|Rat:620486,,,,,,
Target,1798,erb-b2 receptor tyrosine kinase 3,HER3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1798,CatalyticReceptor,Type I RTKs: ErbB (epidermal growth factor) receptor family,Human:P21860|Mouse:Q61526|Rat:Q62799,Human:ERBB3|Mouse:Erbb3|Rat:Erbb3,Human:3431|Mouse:MGI:95411|Rat:69323,,,,,,
Target,2019,erb-b2 receptor tyrosine kinase 2,HER2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2019,CatalyticReceptor,Type I RTKs: ErbB (epidermal growth factor) receptor family,Human:P04626|Mouse:P70424|Rat:P06494,Human:ERBB2|Mouse:Erbb2|Rat:Erbb2,Human:3430|Mouse:MGI:95410|Rat:2561,,,,,,
Target,1117,Equilibrative nucleoside transporter 1,ENT1,SLC29A1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1117,Transporter,SLC29 family,Human:Q99808|Mouse:Q9JIM1|Rat:O54698,Human:SLC29A1|Mouse:Slc29a1|Rat:Slc29a1,Human:11003|Mouse:MGI:1927073|Rat:61899,,,,,,
Target,343,EP<sub>4</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=343,GPCR,Prostanoid receptors,Human:P35408|Mouse:P32240|Rat:P43114,Human:PTGER4|Mouse:Ptger4|Rat:Ptger4,Human:9596|Mouse:MGI:104311|Rat:628641,,,,,,
Target,342,EP<sub>3</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=342,GPCR,Prostanoid receptors,Human:P43115|Mouse:P30557|Rat:P34980,Human:PTGER3|Mouse:Ptger3|Rat:Ptger3,Human:9595|Mouse:MGI:97795|Rat:3435,,,,,,
Target,341,EP<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=341,GPCR,Prostanoid receptors,Human:P43116|Mouse:Q62053|Rat:Q62928,Human:PTGER2|Mouse:Ptger2|Rat:Ptger2,Human:9594|Mouse:MGI:97794|Rat:620020,,,,,,
Target,340,EP<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=340,GPCR,Prostanoid receptors,Human:P34995|Mouse:P35375|Rat:P70597,Human:PTGER1|Mouse:Ptger1|Rat:Ptger1,Human:9593|Mouse:MGI:97793|Rat:3434,,,,,,
Target,2970,epoxide hydrolase 2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2970,Enzyme,Hydrolases,Human:P34913|Mouse:P34914|Rat:P80299,Human:EPHX2|Mouse:Ephx2|Rat:Ephx2,Human:3402|Mouse:MGI:99500|Rat:620732,,,,,,
Target,1797,epidermal growth factor receptor,EGFR,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1797,CatalyticReceptor,Type I RTKs: ErbB (epidermal growth factor) receptor family,Human:P00533|Mouse:Q01279,Human:EGFR|Mouse:Egfr|Rat:Egfr,Human:3236|Mouse:MGI:95294|Rat:2543,,,,,,
Target,1834,EPH receptor B6,EphB6,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1834,CatalyticReceptor,Type XIII RTKs: Ephrin receptor family,Human:O15197|Mouse:O08644|Rat:P0C0K7,Human:EPHB6|Mouse:Ephb6|Rat:Ephb6,Human:3396|Mouse:MGI:1096338|Rat:1306163,,,,,,
Target,1833,EPH receptor B4,EphB4,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1833,CatalyticReceptor,Type XIII RTKs: Ephrin receptor family,Human:P54760|Mouse:P54761,Human:EPHB4|Mouse:Ephb4,Human:3395|Mouse:MGI:104757,,,,,,
Target,1831,EPH receptor B2,EphB2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1831,CatalyticReceptor,Type XIII RTKs: Ephrin receptor family,Human:P29323|Mouse:P54763,Human:EPHB2|Mouse:Ephb2|Rat:Ephb2,Human:3393|Mouse:MGI:99611|Rat:1564232,,,,,,
Target,1830,EPH receptor B1,EphB1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1830,CatalyticReceptor,Type XIII RTKs: Ephrin receptor family,Human:P54762|Mouse:Q8CBF3|Rat:P09759,Human:EPHB1|Mouse:Ephb1|Rat:Ephb1,Human:3392|Mouse:MGI:1096337|Rat:2556,,,,,,
Target,1828,EPH receptor A8,EphA8,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1828,CatalyticReceptor,Type XIII RTKs: Ephrin receptor family,Human:P29322|Mouse:O09127|Rat:P29321,Human:EPHA8|Mouse:Epha8|Rat:Epha8,Human:3391|Mouse:MGI:109378|Rat:708543,,,,,,
Target,1827,EPH receptor A7,EphA7,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1827,CatalyticReceptor,Type XIII RTKs: Ephrin receptor family,Human:Q15375|Mouse:Q61772|Rat:P54759,Human:EPHA7|Mouse:Epha7|Rat:Epha7,Human:3390|Mouse:MGI:95276|Rat:70957,,,,,,
Target,1826,EPH receptor A6,EphA6,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1826,CatalyticReceptor,Type XIII RTKs: Ephrin receptor family,Human:Q9UF33|Mouse:Q62413|Rat:P54758,Human:EPHA6|Mouse:Epha6|Rat:Epha6,Human:19296|Mouse:MGI:108034|Rat:1304614,,,,,,
Target,1825,EPH receptor A5,EphA5,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1825,CatalyticReceptor,Type XIII RTKs: Ephrin receptor family,Human:P54756|Mouse:Q60629|Rat:P54757,Human:EPHA5|Mouse:Epha5|Rat:Epha5,Human:3389|Mouse:MGI:99654|Rat:620831,,,,,,
Target,1824,EPH receptor A4,EphA4,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1824,CatalyticReceptor,Type XIII RTKs: Ephrin receptor family,Human:P54764|Mouse:Q03137,Human:EPHA4|Mouse:Epha4|Rat:Epha4,Human:3388|Mouse:MGI:98277|Rat:1560587,,,,,,
Target,1823,EPH receptor A3,EphA3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1823,CatalyticReceptor,Type XIII RTKs: Ephrin receptor family,Human:P29320|Mouse:P29319|Rat:O08680,Human:EPHA3|Mouse:Epha3|Rat:Epha3,Human:3387|Mouse:MGI:99612|Rat:68389,,,,,,
Target,1822,EPH receptor A2,EphA2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1822,CatalyticReceptor,Type XIII RTKs: Ephrin receptor family,Human:P29317|Mouse:Q03145,Human:EPHA2|Mouse:Epha2|Rat:Epha2,Human:3386|Mouse:MGI:95278|Rat:1307204,,,,,,
Target,1821,EPH receptor A1,EphA1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1821,CatalyticReceptor,Type XIII RTKs: Ephrin receptor family,Human:P21709|Mouse:Q60750,Human:EPHA1|Mouse:Epha1|Rat:Epha1,Human:3385|Mouse:MGI:107381|Rat:1304680,,,,,,
Target,2654,enhancer of zeste 2 polycomb repressive complex 2 subunit,EZH2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2654,Enzyme,2.1.1.43 Histone methyltransferases (HMTs),Human:Q15910|Mouse:Q61188,Human:EZH2|Mouse:Ezh2|Rat:Ezh2,Human:3527|Mouse:MGI:107940|Rat:1595860,,,,,,
Target,2835,enhancer of zeste 1 polycomb repressive complex 2 subunit,EZH1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2835,Enzyme,2.1.1.43 Histone methyltransferases (HMTs),Human:Q92800|Mouse:P70351,Human:EZH1|Mouse:Ezh1|Rat:Ezh1,Human:3526|Mouse:MGI:1097695|Rat:1305028,,,,,,
Target,1615,Endothelin-converting enzyme 1,ECE1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1615,Enzyme,M13: Neprilysin,Human:P42892|Mouse:Q4PZA2|Rat:P42893,Human:ECE1|Mouse:Ece1|Rat:Ece1,Human:3146|Mouse:MGI:1101357|Rat:620293,,,,,,
Target,1249,Endothelial NOS,eNOS,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1249,Enzyme,Nitric oxide synthases,Human:P29474|Mouse:P70313|Rat:Q62600,Human:NOS3|Mouse:Nos3|Rat:Nos3,Human:7876|Mouse:MGI:97362|Rat:3186,,,,,,
Target,2020,endoplasmic reticulum to nucleus signaling 1,IRE1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2020,Enzyme,IRE family,Human:O75460|Mouse:Q9EQY0,Human:ERN1|Mouse:Ern1|Rat:Ern1,Human:3449|Mouse:MGI:1930134|Rat:1559716,,,,,,
Target,741,ENaC &gamma;,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=741,LGIC,Epithelial sodium channel (ENaC),Human:P51170|Mouse:Q9WU39|Rat:P37091,Human:SCNN1G|Mouse:Scnn1g|Rat:Scnn1g,Human:10602|Mouse:MGI:104695|Rat:3641,,,,,,
Target,740,ENaC &delta;,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=740,LGIC,Epithelial sodium channel (ENaC),Human:P51172,Human:SCNN1D,Human:10601,,,,,,
Target,739,ENaC &beta;,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=739,LGIC,Epithelial sodium channel (ENaC),Human:P51168|Mouse:Q9WU38|Rat:P37090,Human:SCNN1B|Mouse:Scnn1b|Rat:Scnn1b,Human:10600|Mouse:MGI:104696|Rat:3640,,,,,,
Target,738,ENaC &alpha;,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=738,LGIC,Epithelial sodium channel (ENaC),Human:P37088|Mouse:Q61180|Rat:Q9Z2W4,Human:SCNN1A|Mouse:Scnn1a|Rat:Scnn1a,Human:10599|Mouse:MGI:101782|Rat:3639,,,,,,
Target,2358,"elastase, neutrophil expressed",,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2358,Enzyme,S1: Chymotrypsin,Human:P08246|Mouse:Q3UP87,Human:ELANE|Mouse:Elane|Rat:Elane,Human:3309|Mouse:MGI:2679229|Rat:1307968,,,,,,
Target,2834,egl-9 family hypoxia inducible factor 3,PHD3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2834,Enzyme,Prolyl hydroxylases,Human:Q9H6Z9|Mouse:Q91UZ4|Rat:Q62630,Human:EGLN3|Mouse:Egln3|Rat:Egln3,Human:14661|Mouse:MGI:1932288|Rat:71019,,,,,,
Target,2832,egl-9 family hypoxia inducible factor 2,PHD1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2832,Enzyme,Prolyl hydroxylases,Human:Q96KS0|Mouse:Q91YE2|Rat:Q6AYU4,Human:EGLN2|Mouse:Egln2|Rat:Egln2,Human:14660|Mouse:MGI:1932287|Rat:631376,,,,,,
Target,2833,egl-9 family hypoxia inducible factor 1,PHD2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2833,Enzyme,Prolyl hydroxylases,Human:Q9GZT9|Mouse:Q91YE3|Rat:P59722,Human:EGLN1|Mouse:Egln1|Rat:Egln1,Human:1232|Mouse:MGI:1932286|Rat:631375,,,,,,
Target,1232,Ecto-5'-Nucleotidase,NT5E,CD73,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1232,Enzyme,Adenosine turnover,Human:P21589|Mouse:Q61503|Rat:P21588,Human:NT5E|Mouse:Nt5e|Rat:Nt5e,Human:8021|Mouse:MGI:99782|Rat:61956,,,,,,
Target,2010,dual specificity tyrosine phosphorylation regulated kinase 1B,DYRK1B,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2010,Enzyme,Dyrk1 subfamily,Human:Q9Y463|Mouse:Q9Z188,Human:DYRK1B|Mouse:Dyrk1b|Rat:Dyrk1b,Human:3092|Mouse:MGI:1330302|Rat:1307223,,,,,,
Target,2009,dual specificity tyrosine phosphorylation regulated kinase 1A,DYRK1A,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2009,Enzyme,Dyrk1 subfamily,Human:Q13627|Mouse:Q61214|Rat:Q63470,Human:DYRK1A|Mouse:Dyrk1a|Rat:Dyrk1a,Human:3091|Mouse:MGI:1330299|Rat:2528,,,,,,
Target,218,D<sub>5</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=218,GPCR,Dopamine receptors,Human:P21918|Mouse:Q8BLD9|Rat:P25115,Human:DRD5|Mouse:Drd5|Rat:Drd5,Human:3026|Mouse:MGI:94927|Rat:2523,,,,,,
Target,217,D<sub>4</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=217,GPCR,Dopamine receptors,Human:P21917|Mouse:P51436|Rat:P30729,Human:DRD4|Mouse:Drd4|Rat:Drd4,Human:3025|Mouse:MGI:94926|Rat:2522,,,,,,
Target,216,D<sub>3</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=216,GPCR,Dopamine receptors,Human:P35462|Mouse:P30728|Rat:P19020,Human:DRD3|Mouse:Drd3|Rat:Drd3,Human:3024|Mouse:MGI:94925|Rat:2521,,,,,,
Target,215,D<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=215,GPCR,Dopamine receptors,Human:P14416|Mouse:P61168|Rat:P61169,Human:DRD2|Mouse:Drd2|Rat:Drd2,Human:3023|Mouse:MGI:94924|Rat:2520,,,,,,
Target,214,D<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=214,GPCR,Dopamine receptors,Human:P21728|Mouse:Q61616|Rat:P18901,Human:DRD1|Mouse:Drd1|Rat:Drd1,Human:3020|Mouse:MGI:99578|Rat:2518,,,,,,
Target,339,DP<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=339,GPCR,Prostanoid receptors,Human:Q9Y5Y4|Mouse:Q9Z2J6|Rat:Q6XKD3,Human:PTGDR2|Mouse:Ptgdr2|Rat:Ptgdr2,Human:4502|Mouse:MGI:1330275|Rat:1311986,,,,,,
Target,338,DP<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=338,GPCR,Prostanoid receptors,Human:Q13258|Mouse:P70263|Rat:Q9R261,Human:PTGDR|Mouse:Ptgdr|Rat:Ptgdr,Human:9591|Mouse:MGI:102966|Rat:619707,,,,,,
Target,2007,doublecortin like kinase 3,DCAMKL3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2007,Enzyme,DCAMKL family,Human:Q9C098|Mouse:Q8BWQ5,Human:DCLK3|Mouse:Dclk3|Rat:Dclk3,Human:19005|Mouse:MGI:3039580|Rat:1309232,,,,,,
Target,2006,doublecortin like kinase 2,DCAMKL2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2006,Enzyme,DCAMKL family,Human:Q8N568|Mouse:Q6PGN3|Rat:Q5MPA9,Human:DCLK2|Mouse:Dclk2|Rat:Dclk2,Human:19002|Mouse:MGI:1918012|Rat:1308384,,,,,,
Target,2005,doublecortin like kinase 1,DCAMKL1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2005,Enzyme,DCAMKL family,Human:O15075|Mouse:Q9JLM8|Rat:O08875,Human:DCLK1|Mouse:Dclk1|Rat:Dclk1,Human:2700|Mouse:MGI:1330861|Rat:68437,,,,,,
Target,2486,Dopamine beta-hydroxylase (dopamine beta-monooxygenase),DBH,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2486,Enzyme,Catecholamine turnover,Human:P09172|Mouse:Q64237|Rat:Q05754,Human:DBH|Mouse:Dbh|Rat:Dbh,Human:2689|Mouse:MGI:94864|Rat:2489,,,,,,
Target,2637,DNA topoisomerase II alpha,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2637,Enzyme,DNA topoisomerases,Human:P11388|Mouse:Q01320|Rat:P41516,Human:TOP2A|Mouse:Top2a|Rat:Top2a,Human:11989|Mouse:MGI:98790|Rat:62048,,,,,,
Target,2636,DNA topoisomerase I,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2636,Enzyme,DNA topoisomerases,Human:P11387|Mouse:Q04750|Rat:Q9WUL0,Human:TOP1|Mouse:Top1|Rat:Top1,Human:11986|Mouse:MGI:98788|Rat:621246,,,,,,
Target,2605,DNA methyltransferase 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2605,Enzyme,2.1.1.- Methyltransferases,Human:P26358|Mouse:P13864|Rat:Q9Z330,Human:DNMT1|Mouse:Dnmt1|Rat:Dnmt1,Human:2976|Mouse:MGI:94912|Rat:620979,,,,,,
Target,2750,DNA (cytosine-5-)-methyltransferase 3&alpha;,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2750,Enzyme,2.1.1.- Methyltransferases,Human:Q9Y6K1|Mouse:O88508|Rat:Q1LZ53,Human:DNMT3A|Mouse:Dnmt3a|Rat:Dnmt3a,Human:2978|Mouse:MGI:1261827|Rat:1303336,,,,,,
Target,1505,DM1 protein kinase,DMPK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1505,Enzyme,GEK subfamily,Human:Q09013|Mouse:P54265,Human:DMPK|Mouse:Dmpk|Rat:Dmpk,Human:2933|Mouse:MGI:94906|Rat:1309825,,,,,,
Target,1844,discoidin domain receptor tyrosine kinase 2,DDR2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1844,CatalyticReceptor,Type XVI RTKs: DDR (collagen receptor) family,Human:Q16832|Mouse:Q62371,Human:DDR2|Mouse:Ddr2|Rat:Ddr2,Human:2731|Mouse:MGI:1345277|Rat:619855,,,,,,
Target,1843,discoidin domain receptor tyrosine kinase 1,DDR1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1843,CatalyticReceptor,Type XVI RTKs: DDR (collagen receptor) family,Human:Q08345|Mouse:Q03146|Rat:Q63474,Human:DDR1|Mouse:Ddr1|Rat:Ddr1,Human:2730|Mouse:MGI:99216|Rat:2252,,,,,,
Target,1612,dipeptidyl peptidase 4,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1612,Enzyme,S9: Prolyl oligopeptidase,Human:P27487|Mouse:P28843|Rat:P14740,Human:DPP4|Mouse:Dpp4|Rat:Dpp4,Human:3009|Mouse:MGI:94919|Rat:2515,,,,,,
Target,1393,Dipeptidase 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1393,Enzyme,M19: Membrane dipeptidase|Leukotriene and lipoxin metabolism,Human:P16444|Mouse:P31428|Rat:P31430,Human:DPEP1|Mouse:Dpep1|Rat:Dpep1,Human:3002|Mouse:MGI:94917|Rat:620324,,,,,,
Target,3102,dihydropyrimidine dehydrogenase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3102,Enzyme,Nucleotide turnover,Human:Q12882|Mouse:Q8CHR6|Rat:O89000,Human:DPYD|Mouse:Dpyd|Rat:Dpyd,Human:3012|Mouse:MGI:2139667|Rat:621218,,,,,,
Target,2604,dihydroorotate dehydrogenase (quinone),DHODH,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2604,Enzyme,Nucleoside synthesis and metabolism|1.-.-.- Oxidoreductases,Human:Q02127|Mouse:O35435|Rat:Q63707,Human:DHODH|Mouse:Dhodh|Rat:Dhodh,Human:2867|Mouse:MGI:1928378|Rat:68352,,,,,,
Target,2603,dihydrofolate reductase,DHFR,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2603,Enzyme,1.-.-.- Oxidoreductases|Nucleoside synthesis and metabolism,Human:P00374|Mouse:P00375|Rat:Q920D2,Human:DHFR|Mouse:Dhfr|Rat:Dhfr,Human:2861|Mouse:MGI:94890|Rat:2500,,,,,,
Target,317,&delta; receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=317,GPCR,Opioid receptors,Human:P41143|Mouse:P32300|Rat:P33533,Human:OPRD1|Mouse:Oprd1|Rat:Oprd1,Human:8153|Mouse:MGI:97438|Rat:3233,,,,,,
Target,2004,death associated protein kinase 3,DAPK3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2004,Enzyme,Death-associated kinase (DAPK) family,Human:O43293|Mouse:O54784|Rat:O88764,Human:DAPK3|Mouse:Dapk3|Rat:Dapk3,Human:2676|Mouse:MGI:1203520|Rat:621766,,,,,,
Target,2003,death associated protein kinase 2,DAPK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2003,Enzyme,Death-associated kinase (DAPK) family,Human:Q9UIK4|Mouse:Q8VDF3,Human:DAPK2|Mouse:Dapk2|Rat:Dapk2,Human:2675|Mouse:MGI:1341297|Rat:1304708,,,,,,
Target,2002,death associated protein kinase 1,DAPK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2002,Enzyme,Death-associated kinase (DAPK) family,Human:P53355|Mouse:Q80YE7,Human:DAPK1|Mouse:Dapk1|Rat:Dapk1,Human:2674|Mouse:MGI:1916885|Rat:1311629,,,,,,
Target,635,DAX1,,NR0B1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=635,NHR,0B. DAX-like receptors,Human:P51843|Mouse:Q61066|Rat:P70503,Human:NR0B1|Mouse:Nr0b1|Rat:Nr0b1,Human:7960|Mouse:MGI:1352460|Rat:62028,,,,,,
Target,927,DAT,,SLC6A3,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=927,Transporter,Monoamine transporter subfamily,Human:Q01959|Mouse:Q61327|Rat:P23977,Human:SLC6A3|Mouse:Slc6a3|Rat:Slc6a3,Human:11049|Mouse:MGI:94862|Rat:3715,,,,,,
Target,2306,Cytokine receptor common &beta; subunit,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2306,CatalyticReceptor,IL-3 receptor family,Human:P32927|Mouse:P26955,Human:CSF2RB|Mouse:Csf2rb|Rat:Csf2rb,Human:2436|Mouse:MGI:1339759|Rat:620189,,,,,,
Target,3002,cytochrome b-245 beta chain,NOX2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3002,Enzyme,NADPH oxidases,Human:P04839|Mouse:Q61093,Human:CYBB|Mouse:Cybb|Rat:Cybb,Human:2578|Mouse:MGI:88574|Rat:620574,,,,,,
Target,3133,cytidine deaminase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3133,Enzyme,Pyrimidine salvage,Human:P32320,Human:CDA,Human:1712,,,,,,
Target,3163,"cystinosin, lysosomal cystine transporter",,SLC66A4,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3163,Transporter,SLC66 Lysosomal amino acid transporters,Human:O60931|Mouse:P57757,Human:CTNS|Mouse:Ctns|Rat:Ctns,Human:2518|Mouse:MGI:1932872|Rat:1308466,,,,,,
Target,902,Cystine/glutamate transporter,xCT,SLC7A11,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=902,Transporter,SLC7 family,Human:Q9UPY5|Mouse:Q9WTR6,Human:SLC7A11|Mouse:Slc7a11|Rat:Slc7a11,Human:11059|Mouse:MGI:1347355|Rat:1309275,,,,,,
Target,1444,Cystathionine &gamma;-lyase,CSE,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1444,Enzyme,Hydrogen sulphide synthesis,Human:P32929|Mouse:Q8VCN5|Rat:P18757,Human:CTH|Mouse:Cth|Rat:Cth,Human:2501|Mouse:MGI:1339968|Rat:2443,,,,,,
Target,1443,Cystathionine &beta;-synthase,CBS,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1443,Enzyme,Hydrogen sulphide synthesis,Human:P35520|Mouse:Q91WT9|Rat:P32232,Human:CBS|Mouse:Cbs|Rat:Cbs,Human:1550|Mouse:MGI:88285|Rat:2287,,,,,,
Target,270,CysLT<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=270,GPCR,Leukotriene receptors,Human:Q9NS75|Mouse:Q920A1|Rat:Q924T9,Human:CYSLTR2|Mouse:Cysltr2|Rat:Cysltr2,Human:18274|Mouse:MGI:1917336|Rat:619797,,,,,,
Target,269,CysLT<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=269,GPCR,Leukotriene receptors,Human:Q9Y271|Mouse:Q99JA4|Rat:Q924T8,Human:CYSLTR1|Mouse:Cysltr1|Rat:Cysltr1,Human:17451|Mouse:MGI:1926218|Rat:619796,,,,,,
Target,1356,CYP8A1,Prostacyclin synthase,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1356,Enzyme,"CYP5, CYP7 and CYP8 families|Prostaglandin synthases",Human:Q16647|Mouse:O35074|Rat:Q62969,Human:PTGIS|Mouse:Ptgis|Rat:Ptgis,Human:9603|Mouse:MGI:1097156|Rat:3438,,,,,,
Target,1353,CYP5A1,Thromboxane-A synthase,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1353,Enzyme,"CYP5, CYP7 and CYP8 families|Prostaglandin synthases",Human:P24557|Mouse:P36423|Rat:P49430,Human:TBXAS1|Mouse:Tbxas1|Rat:Tbxas1,Human:11609|Mouse:MGI:98497|Rat:3826,,,,,,
Target,1374,CYP51A1,Lanosterol 14-&alpha;-demethylase,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1374,Enzyme,"CYP39, CYP46 and CYP51 families",Human:Q16850|Mouse:Q8K0C4|Rat:Q64654,Human:CYP51A1|Mouse:Cyp51|Rat:Cyp51,Human:2649|Mouse:MGI:106040|Rat:2481,,,,,,
Target,1341,CYP4A11,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1341,Enzyme,CYP4 family,Human:Q02928,Human:CYP4A11,Human:2642,,,,,,
Target,1339,CYP3A7,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1339,Enzyme,CYP3 family,Human:P24462,Human:CYP3A7,Human:2640,,,,,,
Target,1338,CYP3A5,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1338,Enzyme,CYP3 family,Human:P20815,Human:CYP3A5,Human:2638,,,,,,
Target,1340,CYP3A43,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1340,Enzyme,CYP3 family,Human:Q9HB55,Human:CYP3A43,Human:17450,,,,,,
Target,1337,CYP3A4,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1337,Enzyme,CYP3 family,Human:P08684,Human:CYP3A4,Human:2637,,,,,,
Target,1330,CYP2E1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1330,Enzyme,CYP2 family: drug metabolising subset,Human:P05181|Mouse:Q05421|Rat:P05182,Human:CYP2E1|Mouse:Cyp2e1|Rat:Cyp2e1,Human:2631|Mouse:MGI:88607|Rat:2475,,,,,,
Target,1329,CYP2D6,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1329,Enzyme,CYP2 family: drug metabolising subset,Human:P10635,Human:CYP2D6,Human:2625,,,,,,
Target,1326,CYP2C9,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1326,Enzyme,CYP2 family: drug metabolising subset,Human:P11712,Human:CYP2C9,Human:2623,,,,,,
Target,1325,CYP2C8,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1325,Enzyme,CYP2 family: drug metabolising subset,Human:P10632,Human:CYP2C8,Human:2622,,,,,,
Target,1328,CYP2C19,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1328,Enzyme,CYP2 family: drug metabolising subset,Human:P33261,Human:CYP2C19,Human:2621,,,,,,
Target,1327,CYP2C18,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1327,Enzyme,CYP2 family: drug metabolising subset,Human:P33260,Human:CYP2C18,Human:2620,,,,,,
Target,1324,CYP2B6,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1324,Enzyme,CYP2 family: drug metabolising subset,Human:P20813,Human:CYP2B6,Human:2615,,,,,,
Target,1321,CYP2A6,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1321,Enzyme,CYP2 family: drug metabolising subset,Human:P11509,Human:CYP2A6,Human:2610,,,,,,
Target,1370,CYP27B1,25-Hydroxyvitamin D 1-alpha-hydroxylase,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1370,Enzyme,"CYP24, CYP26 and CYP27 families",Human:O15528|Mouse:O35084|Rat:O35132,Human:CYP27B1|Mouse:Cyp27b1|Rat:Cyp27b1,Human:2606|Mouse:MGI:1098274|Rat:69192,,,,,,
Target,1368,CYP26C1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1368,Enzyme,"CYP24, CYP26 and CYP27 families",Human:Q6V0L0,Human:CYP26C1|Mouse:Cyp26c1|Rat:Cyp26c1,Human:20577|Mouse:MGI:2679699|Rat:1308843,,,,,,
Target,1367,CYP26B1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1367,Enzyme,"CYP24, CYP26 and CYP27 families",Human:Q9NR63|Mouse:Q811W2|Rat:G3V7X8,Human:CYP26B1|Mouse:Cyp26b1|Rat:Cyp26b1,Human:20581|Mouse:MGI:2176159|Rat:631379,,,,,,
Target,1366,CYP26A1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1366,Enzyme,"CYP24, CYP26 and CYP27 families",Human:O43174|Mouse:O55127,Human:CYP26A1|Mouse:Cyp26a1|Rat:Cyp26a1,Human:2603|Mouse:MGI:1096359|Rat:620161,,,,,,
Target,1364,CYP21A2,Steroid 21-hydroxylase,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1364,Enzyme,"CYP11, CYP17, CYP19, CYP20 and CYP21 families",Human:P08686,Human:CYP21A2|Mouse:Cyp21a2-ps,Human:2600|Mouse:MGI:3645529,,,,,,
Target,1320,CYP1B1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1320,Enzyme,CYP1 family,Human:Q16678|Mouse:Q64429|Rat:Q64678,Human:CYP1B1|Mouse:Cyp1b1|Rat:Cyp1b1,Human:2597|Mouse:MGI:88590|Rat:2460,,,,,,
Target,1319,CYP1A2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1319,Enzyme,CYP1 family,Human:P05177|Mouse:P00186|Rat:P04799,Human:CYP1A2|Mouse:Cyp1a2|Rat:Cyp1a2,Human:2596|Mouse:MGI:88589|Rat:2459,,,,,,
Target,1318,CYP1A1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1318,Enzyme,CYP1 family,Human:P04798|Mouse:P00184|Rat:P00185,Human:CYP1A1|Mouse:Cyp1a1|Rat:Cyp1a1,Human:2595|Mouse:MGI:88588|Rat:2458,,,,,,
Target,1362,CYP19A1,Aromatase,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1362,Enzyme,"CYP11, CYP17, CYP19, CYP20 and CYP21 families",Human:P11511|Mouse:P28649|Rat:P22443,Human:CYP19A1|Mouse:Cyp19a1|Rat:Cyp19a1,Human:2594|Mouse:MGI:88587|Rat:2457,,,,,,
Target,1361,CYP17A1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1361,Enzyme,"CYP11, CYP17, CYP19, CYP20 and CYP21 families",Human:P05093|Mouse:P27786|Rat:P11715,Human:CYP17A1|Mouse:Cyp17a1|Rat:Cyp17a1,Human:2593|Mouse:MGI:88586|Rat:2456,,,,,,
Target,1360,CYP11B2,Aldosterone synthase,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1360,Enzyme,"CYP11, CYP17, CYP19, CYP20 and CYP21 families",Human:P19099|Mouse:P15539|Rat:P30099|Rat:P30100,Human:CYP11B2|Mouse:Cyp11b2|Rat:Cyp11b2,Human:2592|Mouse:MGI:88584|Rat:2454,,,,,,
Target,1359,CYP11B1,Steroid 11&beta;-hydroxylase,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1359,Enzyme,"CYP11, CYP17, CYP19, CYP20 and CYP21 families",Human:P15538|Rat:P15393,Human:CYP11B1|Mouse:Cyp11b1|Rat:Cyp11b1,Human:2591|Mouse:MGI:88583|Rat:2453,,,,,,
Target,1358,CYP11A1,Cholesterol side-chain cleavage enzyme,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1358,Enzyme,"CYP11, CYP17, CYP19, CYP20 and CYP21 families",Human:P05108|Mouse:Q9QZ82|Rat:P14137,Human:CYP11A1|Mouse:Cyp11a1|Rat:Cyp11a1,Human:2590|Mouse:MGI:88582|Rat:69325,,,,,,
Target,2027,cyclin G associated kinase,GAK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2027,Enzyme,Numb-associated kinase (NAK) family,Human:O14976|Mouse:Q99KY4|Rat:P97874,Human:GAK|Mouse:Gak|Rat:Gak,Human:4113|Mouse:MGI:2442153|Rat:621589,,,,,,
Target,1983,cyclin dependent kinase like 2,CdkL2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1983,Enzyme,Cyclin-dependent kinase-like (CDKL) family,Human:Q92772|Mouse:Q9QUK0|Rat:Q5XIT0,Human:CDKL2|Mouse:Cdkl2|Rat:Cdkl2,Human:1782|Mouse:MGI:1858227|Rat:1309625,,,,,,
Target,1982,cyclin dependent kinase like 1,CdkL1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1982,Enzyme,Cyclin-dependent kinase-like (CDKL) family,Human:Q00532|Mouse:Q8CEQ0|Rat:Q66HE7,Human:CDKL1|Mouse:Cdkl1|Rat:Cdkl1,Human:1781|Mouse:MGI:1918341|Rat:1305080,,,,,,
Target,1981,cyclin dependent kinase 9,CDK9,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1981,Enzyme,CDK9 subfamily,Human:P50750|Mouse:Q99J95|Rat:Q641Z4,Human:CDK9|Mouse:Cdk9|Rat:Cdk9,Human:1780|Mouse:MGI:1328368|Rat:1359638,,,,,,
Target,1980,cyclin dependent kinase 8,CDK8,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1980,Enzyme,CDK8 subfamily,Human:P49336|Mouse:Q8R3L8,Human:CDK8|Mouse:Cdk8,Human:1779|Mouse:MGI:1196224,,,,,,
Target,1979,cyclin dependent kinase 7,CDK7,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1979,Enzyme,CDK7 subfamily,Human:P50613|Mouse:Q03147|Rat:P51952,Human:CDK7|Mouse:Cdk7|Rat:Cdk7,Human:1778|Mouse:MGI:102956|Rat:621124,,,,,,
Target,1978,cyclin dependent kinase 6,CDK6,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1978,Enzyme,CDK4 subfamily,Human:Q00534|Mouse:Q64261,Human:CDK6|Mouse:Cdk6|Rat:Cdk6,Human:1777|Mouse:MGI:1277162|Rat:621121,,,,,,
Target,1977,cyclin dependent kinase 5,CDK5,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1977,Enzyme,CDK5 subfamily,Human:Q00535|Mouse:P49615|Rat:Q03114,Human:CDK5|Mouse:Cdk5|Rat:Cdk5,Human:1774|Mouse:MGI:101765|Rat:70514,,,,,,
Target,1976,cyclin dependent kinase 4,CDK4,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1976,Enzyme,CDK4 subfamily,Human:P11802|Mouse:P30285|Rat:P35426,Human:CDK4|Mouse:Cdk4|Rat:Cdk4,Human:1773|Mouse:MGI:88357|Rat:621120,,,,,,
Target,1973,cyclin dependent kinase 2,CDK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1973,Enzyme,CDK1 subfamily,Human:P24941|Mouse:P97377|Rat:Q63699,Human:CDK2|Mouse:Cdk2|Rat:Cdk2,Human:1771|Mouse:MGI:104772|Rat:70486,,,,,,
Target,1970,cyclin dependent kinase 17,CDK17,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1970,Enzyme,TAIRE subfamily,Human:Q00537|Mouse:Q8K0D0|Rat:O35831,Human:CDK17|Mouse:Cdk17|Rat:Cdk17,Human:8750|Mouse:MGI:97517|Rat:1565593,,,,,,
Target,1969,cyclin dependent kinase 16,CDK16,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1969,Enzyme,TAIRE subfamily,Human:Q00536|Mouse:Q04735|Rat:Q63686,Human:CDK16|Mouse:Cdk16|Rat:Cdk16,Human:8749|Mouse:MGI:97516|Rat:620584,,,,,,
Target,1968,cyclin dependent kinase 15,CDK15,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1968,Enzyme,TAIRE subfamily,Human:Q96Q40|Mouse:Q3V3A1,Human:CDK15|Mouse:Cdk15|Rat:Cdk15,Human:14434|Mouse:MGI:3583944|Rat:1306205,,,,,,
Target,1961,cyclin dependent kinase 1,CDK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1961,Enzyme,CDK1 subfamily,Human:P06493|Mouse:P11440|Rat:P39951,Human:CDK1|Mouse:Cdk1|Rat:Cdk1,Human:1722|Mouse:MGI:88351|Rat:2319,,,,,,
Target,71,CXCR4,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=71,GPCR,Chemokine receptors,Human:P61073|Mouse:P70658|Rat:O08565,Human:CXCR4|Mouse:Cxcr4|Rat:Cxcr4,Human:2561|Mouse:MGI:109563|Rat:620465,,,,,,
Target,68,CXCR1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=68,GPCR,Chemokine receptors,Human:P25024|Mouse:Q810W6|Rat:P70612,Human:CXCR1|Mouse:Cxcr1|Rat:Cxcr1,Human:6026|Mouse:MGI:2448715|Rat:2905,,,,,,
Target,728,Cx43,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=728,OtherIC,Connexins and Pannexins,Human:P17302|Mouse:P23242|Rat:P08050,Human:GJA1|Mouse:Gja1|Rat:Gja1,Human:4274|Mouse:MGI:95713|Rat:2690,,,,,,
Target,2929,C-type lectin domain family 4 member E,Mincle,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2929,OtherProtein,C-type lectin-like receptors (CLRs),Human:Q9ULY5|Mouse:Q9R0Q8|Rat:Q67EQ1,Human:CLEC4E|Mouse:Clec4e|Rat:Clec4e,Human:14555|Mouse:MGI:1861232|Rat:1359298,,,,,,
Target,43,CT receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=43,GPCR,Calcitonin receptors,Human:P30988|Mouse:Q60755|Rat:P32214,Human:CALCR|Mouse:Calcr|Rat:Calcr,Human:1440|Mouse:MGI:101950|Rat:621001,,,,,,
Target,1994,C-terminal Src kinase,CSK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1994,Enzyme,Csk family,Human:P41240|Mouse:P41241|Rat:P32577,Human:CSK|Mouse:Csk|Rat:Csk,Human:2444|Mouse:MGI:88537|Rat:1308800,,,,,,
Target,934,CT1,,SLC6A8,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=934,Transporter,GABA transporter subfamily,Human:P48029|Mouse:Q8VBW1|Rat:P28570,Human:SLC6A8|Mouse:Slc6a8|Rat:Slc6a8,Human:11055|Mouse:MGI:2147834|Rat:619711,,,,,,
Target,1840,"c-ros oncogene 1, receptor tyrosine kinase",ROS,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1840,CatalyticReceptor,Type XVII RTKs: ROS receptors,Human:P08922|Mouse:Q78DX7|Rat:Q63132,Human:ROS1|Mouse:Ros1|Rat:Ros1,Human:10261|Mouse:MGI:97999|Rat:3591,,,,,,
Target,212,CRF<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=212,GPCR,Corticotropin-releasing factor receptors,Human:P34998|Mouse:P35347|Rat:P35353,Human:CRHR1|Mouse:Crhr1|Rat:Crhr1,Human:2357|Mouse:MGI:88498|Rat:61276,,,,,,
Target,2734,CREB binding protein,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2734,OtherProtein,Non-enzymatic BRD containing proteins,Human:Q92793,Human:CREBBP|Mouse:Crebbp|Rat:Crebbp,Human:2348|Mouse:MGI:1098280|Rat:2401,,,,,,
Target,1424,cPLA<sub>2</sub>-4A,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1424,Enzyme,Phospholipase A<sub>2</sub>,Human:P47712|Mouse:P47713|Rat:P50393,Human:PLA2G4A|Mouse:Pla2g4a|Rat:Pla2g4a,Human:9035|Mouse:MGI:1195256|Rat:67366,,,,,,
Target,1379,cPGES,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1379,Enzyme,Prostaglandin synthases,Human:Q15185|Mouse:Q9R0Q7|Rat:P83868,Human:PTGES3|Mouse:Ptges3|Rat:Ptges3,Human:16049|Mouse:MGI:1929282|Rat:1561913,,,,,,
Target,1376,COX-2 ,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1376,Enzyme,Cyclooxygenase,Human:P35354|Mouse:Q05769|Rat:P35355,Human:PTGS2|Mouse:Ptgs2|Rat:Ptgs2,Human:9605|Mouse:MGI:97798|Rat:620349,,,,,,
Target,1375,COX-1 ,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1375,Enzyme,Cyclooxygenase,Human:P23219|Mouse:P22437|Rat:Q63921,Human:PTGS1|Mouse:Ptgs1|Rat:Ptgs1,Human:9604|Mouse:MGI:97797|Rat:3439,,,,,,
Target,3132,CoV Papain-like protease,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3132,OtherProtein,Coronavirus (CoV) proteins,SARS-CoV-2:P0DTC1,,,,,,,,
Target,3111,CoV 3C-like (main) protease,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3111,OtherProtein,Coronavirus (CoV) proteins,SARS-CoV:P0C6U8,,,,,,,,
Target,617,COUP-TF1,,NR2F1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=617,NHR,2F. COUP-TF-like receptors,Human:P10589|Mouse:Q60632,Human:NR2F1|Mouse:Nr2f1|Rat:Nr2f1,Human:7975|Mouse:MGI:1352451|Rat:621682,,,,,,
Target,607,Constitutive androstane receptor,,NR1I3,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=607,NHR,1I. Vitamin D receptor-like receptors,Human:Q14994|Mouse:Q3V008|Rat:Q9QUS1,Human:NR1I3|Mouse:Nr1i3|Rat:Nr1i3,Human:7969|Mouse:MGI:1346307|Rat:621400,,,,,,
Target,1989,component of inhibitor of nuclear factor kappa B kinase complex,IKK-alpha,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1989,Enzyme,IKK family,Human:O15111|Mouse:Q60680,Human:CHUK|Mouse:Chuk|Rat:Chuk,Human:1974|Mouse:MGI:99484|Rat:1306661,,,,,,
Target,2842,complement factor D,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2842,Enzyme,3.4.21.46 Complement factor D,Human:P00746|Mouse:P03953|Rat:P32038,Human:CFD|Mouse:Cfd|Rat:Cfd,Human:2771|Mouse:MGI:87931|Rat:2498,,,,,,
Target,2339,complement factor B,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2339,Enzyme,S1: Chymotrypsin,Human:P00751|Mouse:P04186,Human:CFB|Mouse:Cfb|Rat:Cfb,Human:1037|Mouse:MGI:105975|Rat:2204,,,,,,
Target,2335,complement C1s,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2335,Enzyme,S1: Chymotrypsin,Human:P09871|Mouse:Q8CFG8|Rat:Q6P6T1,Human:C1S|Mouse:C1s2|Rat:C1s,Human:1247|Mouse:MGI:3644269|Rat:619983,,,,,,
Target,1806,colony stimulating factor 1 receptor,CSFR,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1806,CatalyticReceptor,"Type III RTKs: PDGFR, CSFR, Kit, FLT3 receptor family",Human:P07333|Mouse:P09581|Rat:Q00495,Human:CSF1R|Mouse:Csf1r|Rat:Csf1r,Human:2433|Mouse:MGI:1339758|Rat:2425,,,,,,
Target,1928,coenzyme Q8B,ADCK4,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1928,Enzyme,ABC1-B subfamily,Human:Q96D53|Mouse:Q566J8|Rat:Q6AY19,Human:COQ8B|Mouse:Coq8b|Rat:Coq8b,Human:19041|Mouse:MGI:1924139|Rat:1311356,,,,,,
Target,1927,coenzyme Q8A,ADCK3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1927,Enzyme,ABC1-B subfamily,Human:Q8NI60|Mouse:Q60936|Rat:Q5BJQ0,Human:COQ8A|Mouse:Coq8a|Rat:Coq8a,Human:16812|Mouse:MGI:1914676|Rat:1308245,,,,,,
Target,2361,coagulation factor XII,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2361,Enzyme,S1: Chymotrypsin,Human:P00748|Mouse:Q80YC5|Rat:D3ZTE0,Human:F12|Mouse:F12|Rat:F12,Human:3530|Mouse:MGI:1891012|Rat:1359175,,,,,,
Target,2360,coagulation factor XI,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2360,Enzyme,S1: Chymotrypsin|Blood coagulation components,Human:P03951|Mouse:Q91Y47,Human:F11|Mouse:F11|Rat:F11,Human:3529|Mouse:MGI:99481|Rat:1309364,,,,,,
Target,2359,coagulation factor X,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2359,Enzyme,S1: Chymotrypsin|Blood coagulation components,Human:P00742|Mouse:O88947|Rat:Q63207,Human:F10|Mouse:F10|Rat:F10,Human:3528|Mouse:MGI:103107|Rat:61850,,,,,,
Target,2363,coagulation factor VII,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2363,Enzyme,S1: Chymotrypsin,Human:P08709|Mouse:P70375|Rat:Q8K3U6,Human:F7|Mouse:F7|Rat:F7,Human:3544|Mouse:MGI:109325|Rat:628678,,,,,,
Target,2364,coagulation factor IX,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2364,Enzyme,S1: Chymotrypsin,Human:P00740|Mouse:P16294|Rat:P16296,Human:F9|Mouse:F9|Rat:F9,Human:3551|Mouse:MGI:88384|Rat:2589,,,,,,
Target,2362,"coagulation factor II, thrombin",,prothrombin,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2362,Enzyme,S1: Chymotrypsin|Blood coagulation components,Human:P00734|Mouse:P19221|Rat:P18292,Human:F2|Mouse:F2|Rat:F2,Human:3535|Mouse:MGI:88380|Rat:61996,,,,,,
Target,394,CNGA1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=394,VGIC,Cyclic nucleotide-regulated channels (CNG),Human:P29973|Mouse:P29974|Rat:Q62927,Human:CNGA1|Mouse:Cnga1|Rat:Cnga1,Human:2148|Mouse:MGI:88436|Rat:621815,,,,,,
Target,700,ClC-Ka,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=700,OtherIC,ClC family,Human:P51800|Mouse:Q9WUB7|Rat:Q06393,Human:CLCNKA|Mouse:Clcnka|Rat:Clcnka,Human:2026|Mouse:MGI:1329026|Rat:68435,,,,,,
Target,699,ClC-2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=699,OtherIC,ClC family,Human:P51788|Mouse:Q9R0A1|Rat:P35525,Human:CLCN2|Mouse:Clcn2|Rat:Clcn2,Human:2020|Mouse:MGI:105061|Rat:2361,,,,,,
Target,1509,citron rho-interacting serine/threonine kinase,CRIK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1509,Enzyme,Other DMPK family kinases,Human:O14578|Mouse:P49025,Human:CIT|Mouse:Cit|Rat:Cit,Human:1985|Mouse:MGI:105313|Rat:70878,,,,,,
Target,2038,ciliogenesis associated kinase 1,ICK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2038,Enzyme,RCK family,Human:Q9UPZ9|Mouse:Q9JKV2|Rat:Q62726,Human:CILK1|Mouse:Cilk1|Rat:Cilk1,Human:21219|Mouse:MGI:1934157|Rat:71050,,,,,,
Target,2338,chymotrypsin like elastase 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2338,Enzyme,S1: Chymotrypsin,Human:Q9UNI1|Mouse:Q91X79|Rat:P00773,Human:CELA1|Mouse:Cela1|Rat:Cela1,Human:3308|Mouse:MGI:95314|Rat:2547,,,,,,
Target,2340,chymase 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2340,Enzyme,S1: Chymotrypsin,Human:P23946|Mouse:P21844|Rat:P50339,Human:CMA1|Mouse:Cma1|Rat:Cma1,Human:2097|Mouse:MGI:96941|Rat:2365,,,,,,
Target,2480,choline O-acetyltransferase,ChAT,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2480,Enzyme,Acetylcholine turnover,Human:P28329|Mouse:Q03059|Rat:P32738,Human:CHAT|Mouse:Chat|Rat:Chat,Human:1912|Mouse:MGI:88392|Rat:1304627,,,,,,
Target,3187,chitinase 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3187,Enzyme,Chitinases,Human:Q13231|Mouse:Q9D7Q1,Human:CHIT1|Mouse:Chit1|Rat:Chit1,Human:1936|Mouse:MGI:1919134|Rat:1305646,,,,,,
Target,1988,checkpoint kinase 2,Chk2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1988,Enzyme,RAD53 family|CHK1 subfamily,Human:O96017|Mouse:Q9Z265,Human:CHEK2|Mouse:Chek2|Rat:Chek2,Human:16627|Mouse:MGI:1355321|Rat:621543,,,,,,
Target,1987,checkpoint kinase 1,Chk1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1987,Enzyme,CHK1 subfamily,Human:O14757|Mouse:O35280|Rat:Q91ZN7,Human:CHEK1|Mouse:Chek1|Rat:Chek1,Human:1925|Mouse:MGI:1202065|Rat:620545,,,,,,
Target,707,CFTR,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=707,OtherIC,CFTR,Human:P13569|Mouse:P26361|Rat:P34158,Human:CFTR|Mouse:Cftr|Rat:Cftr,Human:1884|Mouse:MGI:88388|Rat:2332,,,,,,
Target,3086,cereblon,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3086,Enzyme,E3 ubiquitin ligase components,Human:Q96SW2|Mouse:Q8C7D2|Rat:Q56AP7,Human:CRBN|Mouse:Crbn|Rat:Crbn,Human:30185|Mouse:MGI:1913277|Rat:1310533,,,,,,
Target,1993,CDC like kinase 4,CLK4,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1993,Enzyme,CLK family,Human:Q9HAZ1|Mouse:O35493,Human:CLK4|Mouse:Clk4|Rat:Clk4,Human:13659|Mouse:MGI:1098551|Rat:1310274,,,,,,
Target,1992,CDC like kinase 3,CLK3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1992,Enzyme,CLK family,Human:P49761|Mouse:O35492|Rat:Q63117,Human:CLK3|Mouse:Clk3|Rat:Clk3,Human:2071|Mouse:MGI:1098670|Rat:621259,,,,,,
Target,1991,CDC like kinase 2,CLK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1991,Enzyme,CLK family,Human:P49760|Mouse:O35491,Human:CLK2|Mouse:Clk2|Rat:Clk2,Human:2069|Mouse:MGI:1098669|Rat:1359711,,,,,,
Target,1990,CDC like kinase 1,CLK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1990,Enzyme,CLK family,Human:P49759|Mouse:P22518,Human:CLK1|Mouse:Clk1|Rat:Clk1,Human:2068|Mouse:MGI:107403|Rat:1311469,,,,,,
Target,1506,CDC42 binding protein kinase gamma,DMPK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1506,Enzyme,GEK subfamily,Human:Q6DT37|Mouse:Q80UW5,Human:CDC42BPG|Mouse:Cdc42bpg|Rat:Cdc42bpg,Human:29829|Mouse:MGI:2652845|Rat:1307260,,,,,,
Target,2836,CD66e (CEACAM5),,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2836,OtherProtein,CD molecules,Human:P06731,Human:CEACAM5,Human:1817,,,,,,
Target,2997,CD1d molecule,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2997,OtherProtein,CD molecules,Human:P15813|Mouse:P11610|Mouse:P11609|Rat:Q63493,Human:CD1D|Mouse:Cd1d1|Mouse:Cd1d2|Rat:Cd1d1,Human:1637|Mouse:MGI:107674|Mouse:MGI:107675|Rat:2296,,,,,,
Target,66,CCR9,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=66,GPCR,Chemokine receptors,Human:P51686|Mouse:Q9WUT7|Rat:Q8CH33,Human:CCR9|Mouse:Ccr9|Rat:Ccr9,Human:1610|Mouse:MGI:1341902|Rat:628750,,,,,,
Target,62,CCR5,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=62,GPCR,Chemokine receptors,Human:P51681|Mouse:P51682|Rat:O08556,Human:CCR5|Mouse:Ccr5|Rat:Ccr5,Human:1606|Mouse:MGI:107182|Rat:620596,,,,,,
Target,77,CCK<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=77,GPCR,Cholecystokinin receptors,Human:P32239|Mouse:P56481|Rat:P30553,Human:CCKBR|Mouse:Cckbr|Rat:Cckbr,Human:1571|Mouse:MGI:99479|Rat:2290,,,,,,
Target,76,CCK<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=76,GPCR,Cholecystokinin receptors,Human:P32238|Mouse:O08786|Rat:P30551,Human:CCKAR|Mouse:Cckar|Rat:Cckar,Human:1570|Mouse:MGI:99478|Rat:2289,,,,,,
Target,57,CB<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=57,GPCR,Cannabinoid receptors,Human:P34972|Mouse:P47936|Rat:Q9QZN9,Human:CNR2|Mouse:Cnr2|Rat:Cnr2,Human:2160|Mouse:MGI:104650|Rat:619713,,,,,,
Target,56,CB<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=56,GPCR,Cannabinoid receptors,Human:P21554|Mouse:P47746|Rat:P20272,Human:CNR1|Mouse:Cnr1|Rat:Cnr1,Human:2159|Mouse:MGI:104615|Rat:2369,,,,,,
Target,1383,CBR1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1383,Enzyme,Prostaglandin synthases,Human:P16152|Mouse:P48758|Rat:P47727,Human:CBR1|Mouse:Cbr1|Rat:Cbr1,Human:1548|Mouse:MGI:88284|Rat:2286,,,,,,
Target,894,Cationic amino acid transporter 4,CAT4,SLC7A4,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=894,Transporter,SLC7 family,Human:O43246|Mouse:Q8BLQ7,Human:SLC7A4|Mouse:Slc7a4|Rat:Slc7a4,Human:11062|Mouse:MGI:2146512|Rat:1305905,,,,,,
Target,893,Cationic amino acid transporter 3,CAT3,SLC7A3,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=893,Transporter,SLC7 family,Human:Q8WY07|Mouse:P70423|Rat:O08812,Human:SLC7A3|Mouse:Slc7a3|Rat:Slc7a3,Human:11061|Mouse:MGI:1100521|Rat:68342,,,,,,
Target,2352,cathepsin V,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2352,Enzyme,C1: Papain,Human:O60911|Rat:P07154,Human:CTSV|Rat:Ctsl,Human:2538|Rat:2448,,,,,,
Target,2353,cathepsin S,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2353,Enzyme,C1: Papain,Human:P25774|Mouse:O70370|Rat:Q02765,Human:CTSS|Mouse:Ctss|Rat:Ctss,Human:2545|Mouse:MGI:107341|Rat:621513,,,,,,
Target,2351,cathepsin L,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2351,Enzyme,C1: Papain,Human:P07711|Mouse:P06797,Human:CTSL|Mouse:Ctsl,Human:2537|Mouse:MGI:88564,,,,,,
Target,2350,cathepsin K,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2350,Enzyme,C1: Papain,Human:P43235|Mouse:P55097|Rat:O35186,Human:CTSK|Mouse:Ctsk|Rat:Ctsk,Human:2536|Mouse:MGI:107823|Rat:61810,,,,,,
Target,2349,cathepsin H,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2349,Enzyme,C1: Papain,Human:P09668|Mouse:P49935|Rat:P00786,Human:CTSH|Mouse:Ctsh|Rat:Ctsh,Human:2535|Mouse:MGI:107285|Rat:2447,,,,,,
Target,2348,cathepsin G,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2348,Enzyme,S1: Chymotrypsin,Human:P08311|Mouse:P28293|Rat:P17977,Human:CTSG|Mouse:Ctsg|Rat:Ctsg,Human:2532|Mouse:MGI:88563|Rat:1307681,,,,,,
Target,2347,cathepsin F,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2347,Enzyme,C1: Papain,Human:Q9UBX1|Mouse:Q9R013,Human:CTSF|Mouse:Ctsf|Rat:Ctsf,Human:2531|Mouse:MGI:1861434|Rat:1308181,,,,,,
Target,2345,cathepsin D,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2345,Enzyme,A1: Pepsin,Human:P07339|Mouse:P18242|Rat:P24268,Human:CTSD|Mouse:Ctsd|Rat:Ctsd,Human:2529|Mouse:MGI:88562|Rat:621511,,,,,,
Target,2343,cathepsin B,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2343,Enzyme,C1: Papain,Human:P07858|Mouse:P10605|Rat:P00787,Human:CTSB|Mouse:Ctsb|Rat:Ctsb,Human:2527|Mouse:MGI:88561|Rat:621509,,,,,,
Target,2472,Catechol-O-methyltransferase,COMT,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2472,Enzyme,Catecholamine turnover,Human:P21964|Mouse:O88587|Rat:P22734,Human:COMT|Mouse:Comt|Rat:Comt,Human:2228|Mouse:MGI:88470|Rat:2379,,,,,,
Target,2979,catalase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2979,Enzyme,1.-.-.- Oxidoreductases,Human:P04040|Mouse:P24270|Rat:P04762,Human:CAT|Mouse:Cat|Rat:Cat,Human:1516|Mouse:MGI:88271|Rat:2279,,,,,,
Target,537,Ca<sub>v</sub>3.3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=537,VGIC,Voltage-gated calcium channels  (Ca<sub>V</sub>),Human:Q9P0X4|Rat:Q9Z0Y8,Human:CACNA1I|Mouse:Cacna1i|Rat:Cacna1i,Human:1396|Mouse:MGI:2178051|Rat:68944,,,,,,
Target,536,Ca<sub>v</sub>3.2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=536,VGIC,Voltage-gated calcium channels  (Ca<sub>V</sub>),Human:O95180|Mouse:O88427|Rat:Q9EQ60,Human:CACNA1H|Mouse:Cacna1h|Rat:Cacna1h,Human:1395|Mouse:MGI:1928842|Rat:68943,,,,,,
Target,535,Ca<sub>v</sub>3.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=535,VGIC,Voltage-gated calcium channels  (Ca<sub>V</sub>),Human:O43497|Rat:O54898,Human:CACNA1G|Mouse:Cacna1g|Rat:Cacna1g,Human:1394|Mouse:MGI:1201678|Rat:68942,,,,,,
Target,534,Ca<sub>v</sub>2.3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=534,VGIC,Voltage-gated calcium channels  (Ca<sub>V</sub>),Human:Q15878|Mouse:Q61290|Rat:Q07652,Human:CACNA1E|Mouse:Cacna1e|Rat:Cacna1e,Human:1392|Mouse:MGI:106217|Rat:2246,,,,,,
Target,533,Ca<sub>v</sub>2.2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=533,VGIC,Voltage-gated calcium channels  (Ca<sub>V</sub>),Human:Q00975|Mouse:O55017|Rat:Q02294,Human:CACNA1B|Mouse:Cacna1b|Rat:Cacna1b,Human:1389|Mouse:MGI:88296|Rat:628852,,,,,,
Target,532,Ca<sub>v</sub>2.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=532,VGIC,Voltage-gated calcium channels  (Ca<sub>V</sub>),Human:O00555|Mouse:P97445|Rat:P54282,Human:CACNA1A|Mouse:Cacna1a|Rat:Cacna1a,Human:1388|Mouse:MGI:109482|Rat:2244,,,,,,
Target,531,Ca<sub>v</sub>1.4,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=531,VGIC,Voltage-gated calcium channels  (Ca<sub>V</sub>),Human:O60840|Mouse:Q9JIS7,Human:CACNA1F|Mouse:Cacna1f|Rat:Cacna1f,Human:1393|Mouse:MGI:1859639|Rat:621535,,,,,,
Target,530,Ca<sub>v</sub>1.3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=530,VGIC,Voltage-gated calcium channels  (Ca<sub>V</sub>),Human:Q01668|Mouse:Q99246|Rat:P27732,Human:CACNA1D|Mouse:Cacna1d|Rat:Cacna1d,Human:1391|Mouse:MGI:88293|Rat:70973,,,,,,
Target,529,Ca<sub>v</sub>1.2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=529,VGIC,Voltage-gated calcium channels  (Ca<sub>V</sub>),Human:Q13936|Mouse:Q01815|Rat:P22002,Human:CACNA1C|Mouse:Cacna1c|Rat:Cacna1c,Human:1390|Mouse:MGI:103013|Rat:2245,,,,,,
Target,528,Ca<sub>v</sub>1.1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=528,VGIC,Voltage-gated calcium channels  (Ca<sub>V</sub>),Human:Q13698|Mouse:Q02789|Rat:Q02485,Human:CACNA1S|Mouse:Cacna1s|Rat:Cacna1s,Human:1397|Mouse:MGI:88294|Rat:70983,,,,,,
Target,54,CaS receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=54,GPCR,Calcium-sensing receptor,Human:P41180|Mouse:Q9QY96|Rat:P48442,Human:CASR|Mouse:Casr|Rat:Casr,Human:1514|Mouse:MGI:1351351|Rat:2277,,,,,,
Target,1625,Caspase 9,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1625,Enzyme,C14: Caspase,Human:P55211|Mouse:Q8C3Q9|Rat:Q9JHK1,Human:CASP9|Mouse:Casp9|Rat:Casp9,Human:1511|Mouse:MGI:1277950|Rat:61867,,,,,,
Target,1624,Caspase 8,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1624,Enzyme,C14: Caspase,Human:Q14790|Mouse:O89110|Rat:Q9JHX4,Human:CASP8|Mouse:Casp8|Rat:Casp8,Human:1509|Mouse:MGI:1261423|Rat:620945,,,,,,
Target,1623,Caspase 7,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1623,Enzyme,C14: Caspase,Human:P55210|Mouse:P97864,Human:CASP7|Mouse:Casp7|Rat:Casp7,Human:1508|Mouse:MGI:109383|Rat:620944,,,,,,
Target,1620,Caspase 4,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1620,Enzyme,C14: Caspase,Human:P49662|Mouse:P70343,Human:CASP4|Mouse:Casp4|Rat:Casp4,Human:1505|Mouse:MGI:107700|Rat:621757,,,,,,
Target,1619,Caspase 3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1619,Enzyme,C14: Caspase,Human:P42574|Mouse:P70677|Rat:P55213,Human:CASP3|Mouse:Casp3|Rat:Casp3,Human:1504|Mouse:MGI:107739|Rat:2275,,,,,,
Target,1617,Caspase 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1617,Enzyme,C14: Caspase,Human:P29466|Mouse:P29452|Rat:P43527,Human:CASP1|Mouse:Casp1|Rat:Casp1,Human:1499|Mouse:MGI:96544|Rat:2274,,,,,,
Target,1551,"casein kinase 2, beta polypeptide subunit",CK2-B,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1551,Enzyme,Casein kinase 2 (CK2) family,Human:P67870|Mouse:P67871|Rat:P67874,Human:CSNK2B|Mouse:Csnk2b|Rat:Csnk2b,Human:2460|Mouse:MGI:88548|Rat:619978,,,,,,
Target,1550,"casein kinase 2, alpha prime polypeptide subunit",CK2-A2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1550,Enzyme,Casein kinase 2 (CK2) family,Human:P19784|Mouse:O54833,Human:CSNK2A2|Mouse:Csnk2a2|Rat:Csnk2a2,Human:2459|Mouse:MGI:88547|Rat:1306882,,,,,,
Target,1549,"casein kinase 2, alpha 1 polypeptide subunit",CK2-A1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1549,Enzyme,Casein kinase 2 (CK2) family,Human:P68400|Mouse:Q60737|Rat:P19139,Human:CSNK2A1|Mouse:Csnk2a1|Rat:Csnk2a1,Human:2457|Mouse:MGI:88543|Rat:621663,,,,,,
Target,2001,casein kinase 1 gamma 3,CK1-G3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2001,Enzyme,Casein kinase 1 (CK1) family,Human:Q9Y6M4|Mouse:Q8C4X2|Rat:Q62763,Human:CSNK1G3|Mouse:Csnk1g3|Rat:Csnk1g3,Human:2456|Mouse:MGI:1917675|Rat:621408,,,,,,
Target,2000,casein kinase 1 gamma 2,CK1-G2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2000,Enzyme,Casein kinase 1 (CK1) family,Human:P78368|Mouse:Q8BVP5|Rat:Q62762,Human:CSNK1G2|Mouse:Csnk1g2|Rat:Csnk1g2,Human:2455|Mouse:MGI:1920014|Rat:621407,,,,,,
Target,1999,casein kinase 1 gamma 1,CK1-G1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1999,Enzyme,Casein kinase 1 (CK1) family,Human:Q9HCP0|Mouse:Q8BTH8|Rat:Q62761,Human:CSNK1G1|Mouse:Csnk1g1|Rat:Csnk1g1,Human:2454|Mouse:MGI:2660884|Rat:621404,,,,,,
Target,1998,casein kinase 1 epsilon,CK1-E,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1998,Enzyme,Casein kinase 1 (CK1) family,Human:P49674|Mouse:Q9JMK2,Human:CSNK1E|Mouse:Csnk1e|Rat:Csnk1e,Human:2453|Mouse:MGI:1351660|Rat:62045,,,,,,
Target,1995,casein kinase 1 alpha 1,CK1-A,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1995,Enzyme,Casein kinase 1 (CK1) family,Human:P48729|Mouse:Q8BK63|Rat:P97633,Human:CSNK1A1|Mouse:Csnk1a1|Rat:Csnk1a1,Human:2451|Mouse:MGI:1934950|Rat:71098,,,,,,
Target,1076,Carnitine/acylcarnitine carrier,CAC,SLC25A20,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1076,Transporter,Mitochondrial amino acid transporter subfamily,Human:O43772|Mouse:Q9Z2Z6|Rat:P97521,Human:SLC25A20|Mouse:Slc25a20|Rat:Slc25a20,Human:1421|Mouse:MGI:1928738|Rat:621443,,,,,,
Target,1610,Carboxypeptidase Q,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1610,Enzyme,M14: Carboxypeptidase A,Human:Q9Y646|Mouse:Q9WVJ3|Rat:Q6IRK9,Human:CPQ|Mouse:Cpq|Rat:Cpq,Human:16910|Mouse:MGI:1889205|Rat:628610,,,,,,
Target,1598,"Carboxypeptidase N, polypeptide 2",,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1598,Enzyme,M14: Carboxypeptidase A,Human:P22792|Mouse:Q9DBB9,Human:CPN2|Mouse:Cpn2|Rat:Cpn2,Human:2313|Mouse:MGI:1919006|Rat:1305170,,,,,,
Target,1597,"Carboxypeptidase N, polypeptide 1",,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1597,Enzyme,M14: Carboxypeptidase A,Human:P15169|Mouse:Q9JJN5|Rat:Q9EQV8,Human:CPN1|Mouse:Cpn1|Rat:Cpn1,Human:2312|Mouse:MGI:2135874|Rat:70931,,,,,,
Target,1582,Carboxypeptidase D,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1582,Enzyme,M14: Carboxypeptidase A,Human:O75976|Mouse:O89001|Rat:Q9JHW1,Human:CPD|Mouse:Cpd|Rat:Cpd,Human:2301|Mouse:MGI:107265|Rat:2393,,,,,,
Target,1593,Carboxypeptidase B1 (tissue),,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1593,Enzyme,M14: Carboxypeptidase A,Human:P15086|Rat:P19223,Human:CPB1|Mouse:Cpb1|Rat:Cpb1,Human:2299|Mouse:MGI:1923953|Rat:2391,,,,,,
Target,1587,Carboxypeptidase A1 (pancreatic),,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1587,Enzyme,M14: Carboxypeptidase A,Human:P15085|Mouse:Q7TPZ8|Rat:P00731,Human:CPA1|Mouse:Cpa1|Rat:Cpa1,Human:2296|Mouse:MGI:88478|Rat:2388,,,,,,
Target,2872,carboxyl ester lipase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2872,Enzyme,3.1.1.- Carboxylic Ester Hydrolases,Human:P19835|Mouse:Q64285|Rat:P07882,Human:CEL|Mouse:Cel|Rat:Cel,Human:1848|Mouse:MGI:88374|Rat:2331,,,,,,
Target,2592,carboxylesterase 1,CES1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2592,Enzyme,Hydrolases,Human:P23141|Mouse:Q8VCC2|Rat:P16303,Human:CES1|Mouse:Ces1g|Rat:Ces1d,Human:1863|Mouse:MGI:88378|Rat:70896,,,,,,
Target,3055,carbonic anhydrase 9,CA IX,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3055,Enzyme,Carbonic anhydrases,Human:Q16790|Mouse:Q8VHB5,Human:CA9|Mouse:Car9|Rat:Ca9,Human:1383|Mouse:MGI:2447188|Rat:1306426,,,,,,
Target,2749,carbonic anhydrase 7,CA VII,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2749,Enzyme,Carbonic anhydrases,Human:P43166|Mouse:Q9ERQ8,Human:CA7|Mouse:Car7|Rat:Car7,Human:1381|Mouse:MGI:103100|Rat:1306842,,,,,,
Target,3093,carbonic anhydrase 5A,CA VA,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3093,Enzyme,Carbonic anhydrases,Human:P35218|Mouse:P23589|Rat:P43165,Human:CA5A|Mouse:Car5a|Rat:Ca5a,Human:1377|Mouse:MGI:101946|Rat:2243,,,,,,
Target,2599,carbonic anhydrase 4,CA IV,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2599,Enzyme,Carbonic anhydrases,Human:P22748|Mouse:Q64444|Rat:P48284,Human:CA4|Mouse:Car4|Rat:Ca4,Human:1375|Mouse:MGI:1096574|Rat:2242,,,,,,
Target,3092,carbonic anhydrase 2,CA II,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3092,Enzyme,Carbonic anhydrases,Human:P00918|Mouse:P00920|Rat:P27139,Human:CA2|Mouse:Car2|Rat:Car2,Human:1373|Mouse:MGI:88269|Rat:2240,,,,,,
Target,2598,carbonic anhydrase 14,CA XIV,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2598,Enzyme,Carbonic anhydrases,Human:Q9ULX7|Mouse:Q9WVT6|Rat:A2IBE0,Human:CA14|Mouse:Car14|Rat:Ca14,Human:1372|Mouse:MGI:1344341|Rat:1599277,,,,,,
Target,2748,carbonic anhydrase 13,CA XIII,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2748,Enzyme,Carbonic anhydrases,Human:Q8N1Q1|Mouse:Q9D6N1,Human:CA13|Mouse:Car13|Rat:Car13,Human:14914|Mouse:MGI:1931322|Rat:499566,,,,,,
Target,2747,carbonic anhydrase 12,CA XII,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2747,Enzyme,Carbonic anhydrases,Human:O43570|Mouse:Q8CI85,Human:CA12|Mouse:Car12|Rat:Ca12,Human:1371|Mouse:MGI:1923709|Rat:1306612,,,,,,
Target,2597,carbonic anhydrase 1,CA I,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2597,Enzyme,Carbonic anhydrases,Human:P00915|Mouse:P13634|Rat:B0BNN3,Human:CA1|Mouse:Car1|Rat:Car1,Human:1368|Mouse:MGI:88268|Rat:1309780,,,,,,
Target,2336,calpain 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2336,Enzyme,C2: Calpain,Human:P07384|Mouse:O35350|Rat:P97571,Human:CAPN1|Mouse:Capn1|Rat:Capn1,Human:1476|Mouse:MGI:88263|Rat:2267,,,,,,
Target,1959,calcium/calmodulin dependent serine protein kinase,CASK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1959,Enzyme,CASK family,Human:O14936|Mouse:O70589|Rat:Q62915,Human:CASK|Mouse:Cask|Rat:Cask,Human:1497|Mouse:MGI:1309489|Rat:62004,,,,,,
Target,1957,calcium/calmodulin dependent protein kinase kinase 2,CAMKK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1957,Enzyme,Meta subfamily,Human:Q96RR4|Mouse:Q8C078|Rat:O88831,Human:CAMKK2|Mouse:Camkk2|Rat:Camkk2,Human:1470|Mouse:MGI:2444812|Rat:620092,,,,,,
Target,1956,calcium/calmodulin dependent protein kinase kinase 1,CAMKK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1956,Enzyme,Meta subfamily,Human:Q8N5S9|Mouse:Q8VBY2|Rat:P97756,Human:CAMKK1|Mouse:Camkk1|Rat:Camkk1,Human:1469|Mouse:MGI:1891766|Rat:62023,,,,,,
Target,1955,calcium/calmodulin dependent protein kinase IV,CaMK4,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1955,Enzyme,CAMK1 family,Human:Q16566|Mouse:P08414|Rat:P13234,Human:CAMK4|Mouse:Camk4|Rat:Camk4,Human:1464|Mouse:MGI:88258|Rat:2264,,,,,,
Target,1557,calcium/calmodulin-dependent protein kinase II gamma subunit,CaMK2&gamma;,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1557,Enzyme,CAMK2 family,Human:Q13555|Mouse:Q923T9|Rat:P11730,Human:CAMK2G|Mouse:Camk2g|Rat:Camk2g,Human:1463|Mouse:MGI:88259|Rat:621802,,,,,,
Target,1558,calcium/calmodulin-dependent protein kinase II delta subunit,CaMK2&delta;,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1558,Enzyme,CAMK2 family,Human:Q13557|Mouse:Q6PHZ2|Rat:P15791,Human:CAMK2D|Mouse:Camk2d|Rat:Camk2d,Human:1462|Mouse:MGI:1341265|Rat:2263,,,,,,
Target,1556,calcium/calmodulin-dependent protein kinase II beta subunit,CaMK2&beta;,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1556,Enzyme,CAMK2 family,Human:Q13554|Mouse:P28652|Rat:P08413,Human:CAMK2B|Mouse:Camk2b|Rat:Camk2b,Human:1461|Mouse:MGI:88257|Rat:2262,,,,,,
Target,1555,calcium/calmodulin-dependent protein kinase II alpha subunit,CaMK2&alpha;,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1555,Enzyme,CAMK2 family,Human:Q9UQM7|Mouse:P11798|Rat:P11275,Human:CAMK2A|Mouse:Camk2a|Rat:Camk2a,Human:1460|Mouse:MGI:88256|Rat:2261,,,,,,
Target,1954,calcium/calmodulin dependent protein kinase IG,CaMK1-gamma,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1954,Enzyme,CAMK1 family,Human:Q96NX5|Mouse:Q91VB2|Rat:Q7TNJ7,Human:CAMK1G|Mouse:Camk1g|Rat:Camk1g,Human:14585|Mouse:MGI:2388073|Rat:621800,,,,,,
Target,1953,calcium/calmodulin dependent protein kinase ID,CaMK1-delta,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1953,Enzyme,CAMK1 family,Human:Q8IU85|Mouse:Q8BW96,Human:CAMK1D|Mouse:Camk1d|Rat:Camk1d,Human:19341|Mouse:MGI:2442190|Rat:1560691,,,,,,
Target,1952,calcium/calmodulin dependent protein kinase I,CaMK1-alpha,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1952,Enzyme,CAMK1 family,Human:Q14012|Mouse:Q91YS8|Rat:Q63450,Human:CAMK1|Mouse:Camk1|Rat:Camk1,Human:1459|Mouse:MGI:1098535|Rat:629473,,,,,,
Target,47,calcitonin receptor-like receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=47,GPCR,Calcitonin receptors,Human:Q16602|Mouse:Q9R1W5|Rat:Q63118,Human:CALCRL|Mouse:Calcrl|Rat:Calcrl,Human:16709|Mouse:MGI:1926944|Rat:2255,,,,,,
Target,2471,butyrylcholinesterase,BChE,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2471,Enzyme,Hydrolases|Acetylcholine turnover,Human:P06276|Mouse:Q03311,Human:BCHE|Mouse:Bche|Rat:Bche,Human:983|Mouse:MGI:894278|Rat:619996,,,,,,
Target,42,B<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=42,GPCR,Bradykinin receptors,Human:P30411|Mouse:P32299|Rat:P25023,Human:BDKRB2|Mouse:Bdkrb2|Rat:Bdkrb2,Human:1030|Mouse:MGI:102845|Rat:2201,,,,,,
Target,41,B<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=41,GPCR,Bradykinin receptors,Human:P46663|Mouse:Q61125|Rat:P97583,Human:BDKRB1|Mouse:Bdkrb1|Rat:Bdkrb1,Human:1029|Mouse:MGI:88144|Rat:620401,,,,,,
Target,1948,Bruton tyrosine kinase,Btk,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1948,Enzyme,Tec family,Human:Q06187|Mouse:P35991,Human:BTK|Mouse:Btk|Rat:Btk,Human:1133|Mouse:MGI:88216|Rat:1359683,,,,,,
Target,1939,branched chain keto acid dehydrogenase kinase,BCKDK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1939,Enzyme,Pyruvate dehydrogenase kinase (PDHK) family,Human:O14874|Mouse:O55028|Rat:Q00972,Human:BCKDK|Mouse:Bckdk|Rat:Bckdk,Human:16902|Mouse:MGI:1276121|Rat:2198,,,,,,
Target,2893,Branched chain amino acid transaminase 2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2893,Enzyme,2.6.1.42 Branched-chain-amino-acid transaminase,Human:O15382|Mouse:O35855|Rat:O35854,Human:BCAT2|Mouse:Bcat2|Rat:Bcat2,Human:977|Mouse:MGI:1276534|Rat:68948,,,,,,
Target,1943,"B-Raf proto-oncogene, serine/threonine kinase",B-Raf,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1943,Enzyme,RAF family,Human:P15056|Mouse:P28028,Human:BRAF|Mouse:Braf|Rat:Braf,Human:1097|Mouse:MGI:88190|Rat:619908,,,,,,
Target,1789,bone morphogenetic protein receptor type IB,BMPR1B,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1789,CatalyticReceptor,Type I receptor serine/threonine kinases,Human:O00238|Mouse:P36898,Human:BMPR1B|Mouse:Bmpr1b|Rat:Bmpr1b,Human:1077|Mouse:MGI:107191|Rat:1595863,,,,,,
Target,1794,bone morphogenetic protein receptor type 2,BMPR2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1794,CatalyticReceptor,Type II receptor serine/threonine kinases,Human:Q13873|Mouse:O35607,Human:BMPR2|Mouse:Bmpr2|Rat:Bmpr2,Human:1078|Mouse:MGI:1095407|Rat:71082,,,,,,
Target,1942,BMX non-receptor tyrosine kinase,Etk,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1942,Enzyme,Tec family,Human:P51813|Mouse:P97504,Human:BMX|Mouse:Bmx|Rat:Bmx,Human:1079|Mouse:MGI:1101778|Rat:1565643,,,,,,
Target,1941,BMP2 inducible kinase,BIKE,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1941,Enzyme,Numb-associated kinase (NAK) family,Human:Q9NSY1|Mouse:Q91Z96,Human:BMP2K|Mouse:Bmp2k|Rat:Bmp2k,Human:18041|Mouse:MGI:2155456|Rat:1564828,,,,,,
Target,268,BLT<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=268,GPCR,Leukotriene receptors,Human:Q9NPC1|Mouse:Q9JJL9|Rat:Q924U0,Human:LTB4R2|Mouse:Ltb4r2|Rat:Ltb4r2,Human:19260|Mouse:MGI:1888501|Rat:621029,,,,,,
Target,267,BLT<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=267,GPCR,Leukotriene receptors,Human:Q15722|Mouse:O88855|Rat:Q9R0Q2,Human:LTB4R|Mouse:Ltb4r1|Rat:Ltb4r,Human:6713|Mouse:MGI:1309472|Rat:620410,,,,,,
Target,1940,"BLK proto-oncogene, Src family tyrosine kinase",Blk,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1940,Enzyme,Src family,Human:P51451|Mouse:P16277,Human:BLK|Mouse:Blk|Rat:Blk,Human:1057|Mouse:MGI:88169|Rat:1308859,,,,,,
Target,932,BGT1,,SLC6A12,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=932,Transporter,GABA transporter subfamily,Human:P48065|Mouse:P31651|Rat:P48056,Human:SLC6A12|Mouse:Slc6a12|Rat:Slc6a12,Human:11045|Mouse:MGI:95628|Rat:620255,,,,,,
Target,30,&beta;<sub>3</sub>-adrenoceptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=30,GPCR,Adrenoceptors,Human:P13945|Mouse:P25962|Rat:P26255,Human:ADRB3|Mouse:Adrb3|Rat:Adrb3,Human:288|Mouse:MGI:87939|Rat:2061,,,,,,
Target,29,&beta;<sub>2</sub>-adrenoceptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=29,GPCR,Adrenoceptors,Human:P07550|Mouse:P18762|Rat:P10608,Human:ADRB2|Mouse:Adrb2|Rat:Adrb2,Human:286|Mouse:MGI:87938|Rat:2060,,,,,,
Target,28,&beta;<sub>1</sub>-adrenoceptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=28,GPCR,Adrenoceptors,Human:P08588|Mouse:P34971|Rat:P18090,Human:ADRB1|Mouse:Adrb1|Rat:Adrb1,Human:285|Mouse:MGI:87937|Rat:2059,,,,,,
Target,2330,beta-secretase 1,BACE1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2330,Enzyme,A1: Pepsin,Human:P56817|Mouse:P56818|Rat:P56819,Human:BACE1|Mouse:Bace1|Rat:Bace1,Human:933|Mouse:MGI:1346542|Rat:2191,,,,,,
Target,1467,beta adrenergic receptor kinase 2,GRK3,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1467,Enzyme,Beta-adrenergic receptor kinases (&beta;ARKs),Human:P35626|Mouse:Q3UYH7|Rat:P26819,Human:GRK3|Mouse:Grk3|Rat:Grk3,Human:290|Mouse:MGI:87941|Rat:2063,,,,,,
Target,1466,beta adrenergic receptor kinase 1,GRK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1466,Enzyme,Beta-adrenergic receptor kinases (&beta;ARKs),Human:P25098|Mouse:Q99MK8|Rat:P26817,Human:GRK2|Mouse:Grk2|Rat:Grk2,Human:289|Mouse:MGI:87940|Rat:2062,,,,,,
Target,2755,BCR activator of RhoGEF and GTPase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2755,Enzyme,BCR family,Human:P11274|Mouse:Q6PAJ1,Human:BCR|Mouse:Bcr|Rat:Bcr,Human:1014|Mouse:MGI:88141|Rat:1307993,,,,,,
Target,2846,Bcl-2-like 2,Bcl-w,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2846,OtherProtein,B-cell lymphoma 2 (Bcl-2) protein family,Human:Q92843|Mouse:P70345,Human:BCL2L2|Mouse:Bcl2l2|Rat:Bcl2l2,Human:995|Mouse:MGI:108052|Rat:620717,,,,,,
Target,2845,Bcl-2-like 1,Bcl-xL,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2845,OtherProtein,B-cell lymphoma 2 (Bcl-2) protein family,Human:Q07817|Mouse:Q64373|Rat:P53563,Human:BCL2L1|Mouse:Bcl2l1|Rat:Bcl2l1,Human:992|Mouse:MGI:88139|Rat:2200,,,,,,
Target,2844,BCL2 apoptosis regulator,Bcl-2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2844,OtherProtein,B-cell lymphoma 2 (Bcl-2) protein family,Human:P10415|Mouse:P10417|Rat:P49950,Human:BCL2|Mouse:Bcl2|Rat:Bcl2,Human:990|Mouse:MGI:88138|Rat:2199,,,,,,
Target,969,Basolateral Na-K-Cl symporter,NKCC1,SLC12A2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=969,Transporter,SLC12 family of cation-coupled chloride transporters,Human:P55011|Mouse:P55012,Human:SLC12A2|Mouse:Slc12a2|Rat:Slc12a2,Human:10911|Mouse:MGI:101924|Rat:620809,,,,,,
Target,2795,baculoviral IAP repeat containing 5,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2795,OtherProtein,Inhibitors of apoptosis (IAP) protein family,Human:O15392|Mouse:O70201|Rat:Q9JHY7,Human:BIRC5|Mouse:Birc5|Rat:Birc5,Human:593|Mouse:MGI:1203517|Rat:70499,,,,,,
Target,1835,AXL receptor tyrosine kinase,Axl,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1835,CatalyticReceptor,"Type XI RTKs: TAM (TYRO3-, AXL- and MER-TK) receptor family",Human:P30530|Mouse:Q00993,Human:AXL|Mouse:Axl|Rat:Axl,Human:905|Mouse:MGI:1347244|Rat:620028,,,,,,
Target,1938,aurora kinase C,AurC,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1938,Enzyme,Aurora kinase (Aur) family,Human:Q9UQB9|Mouse:O88445,Human:AURKC|Mouse:Aurkc|Rat:Aurkc,Human:11391|Mouse:MGI:1321119|Rat:1309573,,,,,,
Target,1937,aurora kinase B,AurB,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1937,Enzyme,Aurora kinase (Aur) family,Human:Q96GD4|Mouse:O70126|Rat:O55099,Human:AURKB|Mouse:Aurkb|Rat:Aurkb,Human:11390|Mouse:MGI:107168|Rat:621625,,,,,,
Target,1936,aurora kinase A,AurA,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1936,Enzyme,Aurora kinase (Aur) family,Human:O14965|Mouse:P97477|Rat:P59241,Human:AURKA|Mouse:Aurka|Rat:Aurka,Human:11393|Mouse:MGI:894678|Rat:628895,,,,,,
Target,35,AT<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=35,GPCR,Angiotensin receptors,Human:P50052|Mouse:P35374|Rat:P35351,Human:AGTR2|Mouse:Agtr2|Rat:Agtr2,Human:338|Mouse:MGI:87966|Rat:2072,,,,,,
Target,34,AT<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=34,GPCR,Angiotensin receptors,Human:P30556|Mouse:P29755|Mouse:P29754|Rat:P29089|Rat:P25095,Human:AGTR1|Mouse:Agtr1a|Mouse:Agtr1b|Rat:Agtr1a|Rat:Agtr1b,Human:336|Mouse:MGI:87964|Mouse:MGI:87965|Rat:2070|Rat:2071,,,,,,
Target,2594,"ATP-binding cassette, sub-family C (CFTR/MRP), member 8",SUR1,ABCC8,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2594,Transporter,ABCC subfamily,Human:Q09428|Rat:Q09429,Human:ABCC8|Mouse:Abcc8|Rat:Abcc8,Human:59|Mouse:MGI:1352629|Rat:3786,,,,,,
Target,851,ATP4B,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=851,Transporter,H<sup>+</sup>/K<sup>+</sup>-ATPases,Human:P51164|Mouse:P50992|Rat:P18598,Human:ATP4B|Mouse:Atp4b|Rat:Atp4b,Human:820|Mouse:MGI:88114|Rat:2178,,,,,,
Target,849,ATP4A,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=849,Transporter,H<sup>+</sup>/K<sup>+</sup>-ATPases,Human:P20648|Mouse:Q64436|Rat:P09626,Human:ATP4A|Mouse:Atp4a|Rat:Atp4a,Human:819|Mouse:MGI:88113|Rat:2177,,,,,,
Target,1934,ATM serine/threonine kinase,ATM,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1934,Enzyme,Other PIKK family kinases,Human:Q13315|Mouse:Q62388,Human:ATM|Mouse:Atm|Rat:Atm,Human:795|Mouse:MGI:107202|Rat:1593265,,,,,,
Target,937,"ATB<sup>0,+</sup>",,SLC6A14,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=937,Transporter,Glycine transporter subfamily,Human:Q9UN76|Mouse:Q9JMA9,Human:SLC6A14|Mouse:Slc6a14|Rat:Slc6a14,Human:11047|Mouse:MGI:1890216|Rat:1561810,,,,,,
Target,21,A<sub>3</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=21,GPCR,Adenosine receptors,Human:P0DMS8|Mouse:Q61618|Rat:P28647,Human:ADORA3|Mouse:Adora3|Rat:Adora3,Human:268|Mouse:MGI:104847|Rat:2051,,,,,,
Target,20,A<sub>2B</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=20,GPCR,Adenosine receptors,Human:P29275|Mouse:Q60614|Rat:P29276,Human:ADORA2B|Mouse:Adora2b|Rat:Adora2b,Human:264|Mouse:MGI:99403|Rat:2050,,,,,,
Target,19,A<sub>2A</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=19,GPCR,Adenosine receptors,Human:P29274|Mouse:Q60613|Rat:P30543,Human:ADORA2A|Mouse:Adora2a|Rat:Adora2a,Human:263|Mouse:MGI:99402|Rat:2049,,,,,,
Target,18,A<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=18,GPCR,Adenosine receptors,Human:P30542|Mouse:Q60612|Rat:P25099,Human:ADORA1|Mouse:Adora1|Rat:Adora1,Human:262|Mouse:MGI:99401|Rat:2048,,,,,,
Target,2762,asparaginase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2762,Enzyme,3.1.1.- Carboxylic Ester Hydrolases,Human:Q86U10|Mouse:A0JNU3|Rat:O88202,Human:ASPG|Mouse:Aspg|Rat:Aspg,Human:20123|Mouse:MGI:2144822|Rat:708388,,,,,,
Target,686,ASIC3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=686,LGIC,Acid-sensing (proton-gated) ion channels (ASICs),Human:Q9UHC3|Mouse:Q6X1Y6|Rat:O35240,Human:ASIC3|Mouse:Asic3|Rat:Asic3,Human:101|Mouse:MGI:2159339|Rat:708578,,,,,,
Target,685,ASIC2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=685,LGIC,Acid-sensing (proton-gated) ion channels (ASICs),Human:Q16515|Mouse:Q925H0|Rat:Q62962,Human:ASIC2|Mouse:Asic2|Rat:Asic2,Human:99|Mouse:MGI:1100867|Rat:2017,,,,,,
Target,684,ASIC1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=684,LGIC,Acid-sensing (proton-gated) ion channels (ASICs),Human:P78348|Mouse:Q6NXK8|Rat:P55926,Human:ASIC1|Mouse:Asic1|Rat:Asic1,Human:100|Mouse:MGI:1194915|Rat:71062,,,,,,
Target,2951,Aryl hydrocarbon receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2951,OtherProtein,Aryl hydrocarbon receptor,Human:P35869|Mouse:P30561|Rat:P41738,Human:AHR|Mouse:Ahr|Rat:Ahr,Human:348|Mouse:MGI:105043|Rat:2074,,,,,,
Target,1246,Arginine:glycine amidinotransferase,AGAT,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1246,Enzyme,Arginine:glycine amidinotransferase,Human:P50440|Mouse:Q9D964|Rat:P50442,Human:GATM|Mouse:Gatm|Rat:Gatm,Human:4175|Mouse:MGI:1914342|Rat:71090,,,,,,
Target,1245,Arginase II,ARG2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1245,Enzyme,Arginase,Human:P78540|Mouse:O08691|Rat:O08701,Human:ARG2|Mouse:Arg2|Rat:Arg2,Human:664|Mouse:MGI:1330806|Rat:2151,,,,,,
Target,1244,Arginase I,ARG1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1244,Enzyme,Arginase,Human:P05089|Mouse:Q61176|Rat:P07824,Human:ARG1|Mouse:Arg1|Rat:Arg1,Human:663|Mouse:MGI:88070|Rat:2150,,,,,,
Target,1933,"A-Raf proto-oncogene, serine/threonine kinase",A-Raf,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1933,Enzyme,RAF family,Human:P10398|Mouse:P04627|Rat:P14056,Human:ARAF|Mouse:Araf|Rat:Araf,Human:646|Mouse:MGI:88065|Rat:2148,,,,,,
Target,690,AQP3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=690,OtherIC,Aquaporins,Human:Q92482|Mouse:Q8R2N1|Rat:P47862,Human:AQP3|Mouse:Aqp3|Rat:Aqp3,Human:636|Mouse:MGI:1333777|Rat:68428,,,,,,
Target,688,AQP1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=688,OtherIC,Aquaporins,Human:P29972|Mouse:Q02013|Rat:P29975,Human:AQP1|Mouse:Aqp1|Rat:Aqp1,Human:633|Mouse:MGI:103201|Rat:2141,,,,,,
Target,687,AQP0,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=687,OtherIC,Aquaporins,Human:P30301|Mouse:Q640N8|Rat:P09011,Human:MIP|Mouse:Mip|Rat:Mip,Human:7103|Mouse:MGI:96990|Rat:3090,,,,,,
Target,1921,AP2 associated kinase 1,AAK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1921,Enzyme,NAK family,Human:Q2M2I8|Mouse:Q3UHJ0|Rat:P0C1X8,Human:AAK1|Mouse:Aak1|Rat:Aak1,Human:19679|Mouse:MGI:1098687|Rat:1305520,,,,,,
Target,1793,anti-Mullerian hormone receptor type 2,MISR2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1793,CatalyticReceptor,Type II receptor serine/threonine kinases,Human:Q16671|Mouse:Q8K592|Rat:Q62893,Human:AMHR2|Mouse:Amhr2|Rat:Amhr2,Human:465|Mouse:MGI:105062|Rat:70964,,,,,,
Target,1932,ankyrin repeat and kinase domain containing 1,SgK288,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1932,Enzyme,Receptor interacting protein kinase (RIPK) family,Human:Q8NFD2|Mouse:Q8BZ25,Human:ANKK1|Mouse:Ankk1|Rat:Ankk1,Human:21027|Mouse:MGI:3045301|Rat:1305538,,,,,,
Target,1614,Angiotensin-converting enzyme 2,ACE2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1614,Enzyme,M2: Angiotensin-converting enzymes (ACE and ACE2),Human:Q9BYF1|Mouse:Q8R0I0|Rat:Q5EGZ1,Human:ACE2|Mouse:Ace2|Rat:Ace2,Human:13557|Mouse:MGI:1917258|Rat:728890,,,,,,
Target,1613,Angiotensin-converting enzyme,ACE,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1613,Enzyme,M2: Angiotensin-converting enzymes (ACE and ACE2),Human:P12821|Mouse:P09470|Rat:P47820,Human:ACE|Mouse:Ace|Rat:Ace,Human:2707|Mouse:MGI:87874|Rat:2493,,,,,,
Target,628,Androgen receptor,,NR3C4,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=628,NHR,3C. 3-Ketosteroid receptors,Human:P10275|Mouse:P19091|Rat:P15207,Human:AR|Mouse:Ar|Rat:Ar,Human:644|Mouse:MGI:88064|Rat:2147,,,,,,
Target,2839,"amyloid P component, serum",,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2839,OtherProtein,Serum pentraxins,Human:P02743|Mouse:P12246|Rat:P23680,Human:APCS|Mouse:Apcs|Rat:Apcs,Human:584|Mouse:MGI:98229|Rat:68322,,,,,,
Target,2596,amylase alpha 2A,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2596,Enzyme,3.2.1.- Glycosidases,Human:P04746|Mouse:P00688|Rat:P00689,Human:AMY2A|Mouse:Amy2a5|Rat:Amy2a3,Human:477|Mouse:MGI:88020|Rat:1593187,,,,,,
Target,1560,Aminopeptidase N,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1560,Enzyme,M1: Aminopeptidase N,Human:P15144|Mouse:P97449|Rat:P15684,Human:ANPEP|Mouse:Anpep|Rat:Anpep,Human:500|Mouse:MGI:5000466|Rat:2991,,,,,,
Target,1559,Aminopeptidase A,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1559,Enzyme,M18: Aminopeptidase I,Human:Q9ULA0|Mouse:Q9Z2W0|Rat:Q4V8H5,Human:DNPEP|Mouse:Dnpep|Rat:Dnpep,Human:2981|Mouse:MGI:1278328|Rat:1583848,,,,,,
Target,2767,amine oxidase copper containing 3,VAP-1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2767,Enzyme,1.-.-.- Oxidoreductases,Human:Q16853|Mouse:O70423|Rat:O08590,Human:AOC3|Mouse:Aoc3|Rat:Aoc3,Human:550|Mouse:MGI:1306797|Rat:62058,,,,,,
Target,27,&alpha;<sub>2C</sub>-adrenoceptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=27,GPCR,Adrenoceptors,Human:P18825|Mouse:Q01337|Rat:P22086,Human:ADRA2C|Mouse:Adra2c|Rat:Adra2c,Human:283|Mouse:MGI:87936|Rat:2058,,,,,,
Target,26,&alpha;<sub>2B</sub>-adrenoceptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=26,GPCR,Adrenoceptors,Human:P18089|Mouse:P30545|Rat:P19328,Human:ADRA2B|Mouse:Adra2b|Rat:Adra2b,Human:282|Mouse:MGI:87935|Rat:2057,,,,,,
Target,25,&alpha;<sub>2A</sub>-adrenoceptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=25,GPCR,Adrenoceptors,Human:P08913|Mouse:Q01338|Rat:P22909,Human:ADRA2A|Mouse:Adra2a|Rat:Adra2a,Human:281|Mouse:MGI:87934|Rat:2056,,,,,,
Target,24,&alpha;<sub>1D</sub>-adrenoceptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=24,GPCR,Adrenoceptors,Human:P25100|Mouse:P97714|Rat:P23944,Human:ADRA1D|Mouse:Adra1d|Rat:Adra1d,Human:280|Mouse:MGI:106673|Rat:62064,,,,,,
Target,23,&alpha;<sub>1B</sub>-adrenoceptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=23,GPCR,Adrenoceptors,Human:P35368|Mouse:P97717|Rat:P15823,Human:ADRA1B|Mouse:Adra1b|Rat:Adra1b,Human:278|Mouse:MGI:104774|Rat:2054,,,,,,
Target,22,&alpha;<sub>1A</sub>-adrenoceptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=22,GPCR,Adrenoceptors,Human:P35348|Mouse:P97718|Rat:P43140,Human:ADRA1A|Mouse:Adra1a|Rat:Adra1a,Human:277|Mouse:MGI:104773|Rat:2055,,,,,,
Target,2611,alpha glucosidase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2611,Enzyme,3.2.1.- Glycosidases,Human:P10253|Mouse:P70699|Rat:Q6P7A9,Human:GAA|Mouse:Gaa|Rat:Gaa,Human:4065|Mouse:MGI:95609|Rat:735227,,,,,,
Target,1839,ALK receptor tyrosine kinase,ALK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1839,CatalyticReceptor,Type XIX RTKs: Leukocyte tyrosine kinase (LTK) receptor family,Human:Q9UM73|Mouse:P97793,Human:ALK|Mouse:Alk|Rat:Alk,Human:427|Mouse:MGI:103305|Rat:628622,,,,,,
Target,2768,aldo-keto reductase family 1 member B,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2768,Enzyme,1.-.-.- Oxidoreductases,Human:P15121|Mouse:P45376|Rat:P07943,Human:AKR1B1|Mouse:Akr1b3|Rat:Akr1b1,Human:381|Mouse:MGI:1353494|Rat:2092,,,,,,
Target,3186,aldehyde oxidase 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3186,Enzyme,1.2.3.1 Aldehyde oxidase,Human:Q06278|Mouse:O54754,Human:AOX1|Mouse:Aox1|Rat:Aox1,Human:553|Mouse:MGI:88035|Rat:620528,,,,,,
Target,2467,aldehyde dehydrogenase 9 family member A1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2467,Enzyme,GABA turnover,Human:P49189|Mouse:Q9JLJ2|Rat:Q9JLJ3,Human:ALDH9A1|Mouse:Aldh9a1|Rat:Aldh9a1,Human:412|Mouse:MGI:1861622|Rat:68409,,,,,,
Target,2466,aldehyde dehydrogenase 5 family member A1,SSADH,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2466,Enzyme,GABA turnover,Human:P51649|Mouse:Q8BWF0|Rat:G3V945,Human:ALDH5A1|Mouse:Aldh5a1|Rat:Aldh5a1,Human:408|Mouse:MGI:2441982|Rat:621422,,,,,,
Target,2595,aldehyde dehydrogenase 2 family member,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2595,Enzyme,1.-.-.- Oxidoreductases,Human:P05091|Mouse:P47738|Rat:P11884,Human:ALDH2|Mouse:Aldh2|Rat:Aldh2,Human:404|Mouse:MGI:99600|Rat:69219,,,,,,
Target,874,Alanine/serine/cysteine transporter 2,ASCT2,SLC1A5,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=874,Transporter,Alanine/serine/cysteine transporter subfamily,Human:Q15758|Mouse:P51912,Human:SLC1A5|Mouse:Slc1a5|Rat:Slc1a5,Human:10943|Mouse:MGI:105305|Rat:708512,,,,,,
Target,873,Alanine/serine/cysteine transporter 1,ASCT1,SLC1A4,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=873,Transporter,Alanine/serine/cysteine transporter subfamily,Human:P43007|Mouse:O35874,Human:SLC1A4|Mouse:Slc1a4|Rat:Slc1a4,Human:10942|Mouse:MGI:2135601|Rat:735146,,,,,,
Target,1480,AKT serine/threonine kinase 2,Akt2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1480,Enzyme,"Akt (Protein kinase B, PKB) family",Human:P31751|Mouse:Q60823|Rat:P47197,Human:AKT2|Mouse:Akt2|Rat:Akt2,Human:392|Mouse:MGI:104874|Rat:2082,,,,,,
Target,1479,AKT serine/threonine kinase 1,Akt1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1479,Enzyme,"Akt (Protein kinase B, PKB) family",Human:P31749|Mouse:P31750|Rat:P47196,Human:AKT1|Mouse:Akt1|Rat:Akt1,Human:391|Mouse:MGI:87986|Rat:2081,,,,,,
Target,1382,AKR1C3,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1382,Enzyme,Prostaglandin synthases,Human:P42330|Mouse:Q8K023|Rat:P51652,Human:AKR1C3|Mouse:Akr1c18|Rat:Akr1c3,Human:386|Mouse:MGI:2145420|Rat:708428,,,,,,
Target,1055,AGC2,,SLC25A13,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1055,Transporter,Mitochondrial amino acid transporter subfamily,Human:Q9UJS0|Mouse:Q9QXX4,Human:SLC25A13|Mouse:Slc25a13|Rat:Slc25a13,Human:10983|Mouse:MGI:1354721|Rat:1565889,,,,,,
Target,1054,AGC1,,SLC25A12,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1054,Transporter,Mitochondrial amino acid transporter subfamily,Human:O75746|Mouse:Q8BH59,Human:SLC25A12|Mouse:Slc25a12|Rat:Slc25a12,Human:10982|Mouse:MGI:1926080|Rat:1305181,,,,,,
Target,190,ADGRF1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=190,GPCR,Adhesion Class GPCRs,Human:Q5T601|Mouse:Q8VEC3,Human:ADGRF1|Mouse:Adgrf1|Rat:Adgrf1,Human:18990|Mouse:MGI:1924846|Rat:1310285,,,,,,
Target,202,ADGRD1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=202,GPCR,Adhesion Class GPCRs,Human:Q6QNK2|Mouse:Q80T32,Human:ADGRD1|Mouse:Adgrd1|Rat:Adgrd1,Human:19893|Mouse:MGI:3041203|Rat:1594795,,,,,,
Target,1282,adenylyl cyclase 5,AC5,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1282,Enzyme,Adenylyl cyclases (ACs),Human:O95622|Mouse:P84309|Rat:Q04400,Human:ADCY5|Mouse:Adcy5|Rat:Adcy5,Human:236|Mouse:MGI:99673|Rat:71014,,,,,,
Target,1279,adenylyl cyclase 2,AC2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1279,Enzyme,Adenylyl cyclases (ACs),Human:Q08462|Mouse:Q80TL1|Rat:P26769,Human:ADCY2|Mouse:Adcy2|Rat:Adcy2,Human:233|Mouse:MGI:99676|Rat:619965,,,,,,
Target,1278,adenylyl cyclase 1,AC1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1278,Enzyme,Adenylyl cyclases (ACs),Human:Q08828|Mouse:O88444,Human:ADCY1|Mouse:Adcy1|Rat:Adcy1,Human:232|Mouse:MGI:99677|Rat:1309318,,,,,,
Target,1231,Adenosine kinase,ADK,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1231,Enzyme,Adenosine turnover,Human:P55263|Mouse:P55264|Rat:Q64640,Human:ADK|Mouse:Adk|Rat:Adk,Human:257|Mouse:MGI:87930|Rat:2046,,,,,,
Target,1230,Adenosine deaminase,ADA,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1230,Enzyme,Adenosine turnover,Human:P00813|Mouse:P03958|Rat:Q920P6,Human:ADA|Mouse:Ada|Rat:Ada,Human:186|Mouse:MGI:87916|Rat:2031,,,,,,
Target,1678,ADAMTS5,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1678,Enzyme,M12: Astacin/Adamalysin,Human:Q9UNA0|Mouse:Q9R001,Human:ADAMTS5|Mouse:Adamts5|Rat:Adamts5,Human:221|Mouse:MGI:1346321|Rat:735196,,,,,,
Target,1669,ADAM28,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1669,Enzyme,M12: Astacin/Adamalysin,Human:Q9UKQ2|Mouse:Q9JLN6,Human:ADAM28|Mouse:Adam28|Rat:Adam28,Human:206|Mouse:MGI:105988|Rat:727820,,,,,,
Target,1662,ADAM17,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1662,Enzyme,M12: Astacin/Adamalysin,Human:P78536|Mouse:Q9Z0F8|Rat:Q9Z1K9,Human:ADAM17|Mouse:Adam17|Rat:Adam17,Human:195|Mouse:MGI:1096335|Rat:620404,,,,,,
Target,3128,acyl-CoA synthetase short chain family member 2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3128,Enzyme,Acyl-CoA synthetases,Human:Q9NR19,Human:ACSS2,Human:15814,,,,,,
Target,1784,activin A receptor type IL,ALK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1784,CatalyticReceptor,Type I receptor serine/threonine kinases,Human:P37023|Mouse:Q61288|Rat:P80203,Human:ACVRL1|Mouse:Acvrl1|Rat:Acvrl1,Human:175|Mouse:MGI:1338946|Rat:2029,,,,,,
Target,1787,activin A receptor type 1B,ALK4,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1787,CatalyticReceptor,Type I receptor serine/threonine kinases,Human:P36896|Mouse:Q61271|Rat:P80202,Human:ACVR1B|Mouse:Acvr1b|Rat:Acvr1b,Human:172|Mouse:MGI:1338944|Rat:735207,,,,,,
Target,1785,activin A receptor type 1,ALK2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1785,CatalyticReceptor,Type I receptor serine/threonine kinases,Human:Q04771|Mouse:P37172|Rat:P80201,Human:ACVR1|Mouse:Acvr1|Rat:Acvr1,Human:171|Mouse:MGI:87911|Rat:620200,,,,,,
Target,1264,Acetyl-CoA carboxylase 2,ACC2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1264,Enzyme,Carboxylases,Human:O00763,Human:ACACB|Mouse:Acacb|Rat:Acacb,Human:85|Mouse:MGI:2140940|Rat:620500,,,,,,
Target,1263,Acetyl-CoA carboxylase 1,ACC1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1263,Enzyme,Carboxylases,Human:Q13085|Mouse:Q5SWU9|Rat:P11497,Human:ACACA|Mouse:Acaca|Rat:Acaca,Human:84|Mouse:MGI:108451|Rat:621248,,,,,,
Target,2436,acetyl-CoA acetyltransferase 2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2436,Enzyme,Lanosterol biosynthesis pathway,Human:Q9BWD1|Mouse:Q8CAY6|Rat:Q5XI22,Human:ACAT2|Mouse:Acat2|Rat:Acat2,Human:94|Mouse:MGI:87871|Rat:1359366,,,,,,
Target,2435,acetyl-CoA acetyltransferase 1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2435,Enzyme,Lanosterol biosynthesis pathway,Human:P24752|Mouse:Q8QZT1|Rat:P17764,Human:ACAT1|Mouse:Acat1|Rat:Acat1,Human:93|Mouse:MGI:87870|Rat:2016,,,,,,
Target,2465,acetylcholinesterase (Cartwright blood group),AChE,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2465,Enzyme,Acetylcholine turnover|Hydrolases,Human:P22303|Mouse:P21836|Rat:P37136,Human:ACHE|Mouse:Ache|Rat:Ache,Human:108|Mouse:MGI:87876|Rat:69313,,,,,,
Target,1924,"ABL proto-oncogene 2, non-receptor tyrosine kinase",Arg,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1924,Enzyme,Abl family,Human:P42684|Mouse:Q4JIM5,Human:ABL2|Mouse:Abl2|Rat:Abl2,Human:77|Mouse:MGI:87860|Rat:1590898,,,,,,
Target,1923,"ABL proto-oncogene 1, non-receptor tyrosine kinase",Abl,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1923,Enzyme,Abl family,Human:P00519|Mouse:P00520,Human:ABL1|Mouse:Abl1|Rat:Abl1,Human:76|Mouse:MGI:87859|Rat:1584969,,,,,,
Target,792,ABCG2,ABCP,ABCG2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=792,Transporter,ABCG subfamily,Human:Q9UNQ0|Mouse:Q7TMS5|Rat:Q80W57,Human:ABCG2|Mouse:Abcg2|Rat:Abcg2,Human:74|Mouse:MGI:1347061|Rat:631345,,,,,,
Target,791,ABCG1,ABC8,ABCG1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=791,Transporter,ABCG subfamily,Human:P45844|Mouse:Q64343,Human:ABCG1|Mouse:Abcg1|Rat:Abcg1,Human:73|Mouse:MGI:107704|Rat:620294,,,,,,
Target,2746,ABCC9,SUR2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2746,Transporter,ABCC subfamily,Human:O60706|Mouse:P70170|Rat:Q63563,Human:ABCC9|Mouse:Abcc9|Rat:Abcc9,Human:60|Mouse:MGI:1352630|Rat:3787,,,,,,
Target,784,ABCC6,MRP6,ABCC6,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=784,Transporter,ABCC subfamily,Human:O95255|Mouse:Q9R1S7|Rat:O88269,Human:ABCC6|Mouse:Abcc6|Rat:Abcc6,Human:57|Mouse:MGI:1351634|Rat:620268,,,,,,
Target,783,ABCC5,MRP5,ABCC5,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=783,Transporter,ABCC subfamily,Human:O15440|Mouse:Q9R1X5|Rat:Q9QYM0,Human:ABCC5|Mouse:Abcc5|Rat:Abcc5,Human:56|Mouse:MGI:1351644|Rat:70913,,,,,,
Target,782,ABCC4,MRP4,ABCC4,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=782,Transporter,ABCC subfamily,Human:O15439,Human:ABCC4|Mouse:Abcc4|Rat:Abcc4,Human:55|Mouse:MGI:2443111|Rat:620266,,,,,,
Target,780,ABCC2,"MRP2, cMOAT",ABCC2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=780,Transporter,ABCC subfamily,Human:Q92887|Mouse:Q8VI47|Rat:Q63120,Human:ABCC2|Mouse:Abcc2|Rat:Abcc2,Human:53|Mouse:MGI:1352447|Rat:2366,,,,,,
Target,779,ABCC1,MRP1,ABCC1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=779,Transporter,ABCC subfamily,Human:P33527|Mouse:O35379|Rat:Q8CG09,Human:ABCC1|Mouse:Abcc1|Rat:Abcc1,Human:51|Mouse:MGI:102676|Rat:3112,,,,,,
Target,772,ABCB5,,ABCB5,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=772,Transporter,ABCB subfamily,Human:Q2M3G0,Human:ABCB5|Mouse:Abcb5|Rat:Abcb5,Human:46|Mouse:MGI:1924956|Rat:1566342,,,,,,
Target,778,ABCB11,ABC16,ABCB11,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=778,Transporter,ABCB subfamily,Human:O95342|Mouse:Q9QY30|Rat:O70127,Human:ABCB11|Mouse:Abcb11|Rat:Abcb11,Human:42|Mouse:MGI:1351619|Rat:619930,,,,,,
Target,768,ABCB1,"MDR1, PGP1",ABCB1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=768,Transporter,ABCB subfamily,Human:P08183|Mouse:P21447,Human:ABCB1|Mouse:Abcb1a|Rat:Abcb1a,Human:40|Mouse:MGI:97570|Rat:619951,,,,,,
Target,756,ABCA1,"ABC1, CERP",ABCA1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=756,Transporter,ABCA subfamily,Human:O95477|Mouse:P41233,Human:ABCA1|Mouse:Abca1|Rat:Abca1,Human:29|Mouse:MGI:99607|Rat:631344,,,,,,
Target,1236,5'-nucleotidase II,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1236,Enzyme,Adenosine turnover,Human:P49902|Mouse:Q3V1L4,Human:NT5C2|Mouse:Nt5c2|Rat:Nt5c2,Human:8022|Mouse:MGI:2178563|Rat:1311328,,,,,,
Target,3099,5-methyltetrahydrofolate-homocysteine methyltransferase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3099,Enzyme,Methionine turnover,Human:Q99707|Mouse:A6H5Y3|Rat:Q9Z2Q4,Human:MTR|Mouse:Mtr|Rat:Mtr,Human:7468|Mouse:MGI:894292|Rat:621283,,,,,,
Target,1385,5-LOX,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1385,Enzyme,Lipoxygenases,Human:P09917|Mouse:P48999|Rat:P12527,Human:ALOX5|Mouse:Alox5|Rat:Alox5,Human:435|Mouse:MGI:87999|Rat:2096,,,,,,
Target,12,5-HT<sub>7</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=12,GPCR,5-Hydroxytryptamine receptors,Human:P34969|Mouse:P32304|Rat:P32305,Human:HTR7|Mouse:Htr7|Rat:Htr7,Human:5302|Mouse:MGI:99841|Rat:71034,,,,,,
Target,11,5-HT<sub>6</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=11,GPCR,5-Hydroxytryptamine receptors,Human:P50406|Mouse:Q9R1C8|Rat:P31388,Human:HTR6|Mouse:Htr6|Rat:Htr6,Human:5301|Mouse:MGI:1196627|Rat:62044,,,,,,
Target,10,5-HT<sub>5A</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=10,GPCR,5-Hydroxytryptamine receptors,Human:P47898|Mouse:P30966|Rat:P35364,Human:HTR5A|Mouse:Htr5a|Rat:Htr5a,Human:5300|Mouse:MGI:96283|Rat:2851,,,,,,
Target,9,5-HT<sub>4</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=9,GPCR,5-Hydroxytryptamine receptors,Human:Q13639|Mouse:P97288|Rat:Q62758,Human:HTR4|Mouse:Htr4|Rat:Htr4,Human:5299|Mouse:MGI:109246|Rat:2850,,,,,,
Target,377,5-HT<sub>3</sub>E,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=377,LGIC,5-HT<sub>3</sub> receptors,Human:A5X5Y0,Human:HTR3E,Human:24005,,,,,,
Target,376,5-HT<sub>3</sub>D,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=376,LGIC,5-HT<sub>3</sub> receptors,Human:Q70Z44,Human:HTR3D,Human:24004,,,,,,
Target,375,5-HT<sub>3</sub>C,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=375,LGIC,5-HT<sub>3</sub> receptors,Human:Q8WXA8,Human:HTR3C,Human:24003,,,,,,
Target,374,5-HT<sub>3</sub>B,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=374,LGIC,5-HT<sub>3</sub> receptors,Human:O95264|Mouse:Q9JHJ5|Rat:Q9JJ16,Human:HTR3B|Mouse:Htr3b|Rat:Htr3b,Human:5298|Mouse:MGI:1861899|Rat:61820,,,,,,
Target,373,5-HT<sub>3</sub>A,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=373,LGIC,5-HT<sub>3</sub> receptors,Human:P46098|Mouse:P23979|Rat:P35563,Human:HTR3A|Mouse:Htr3a|Rat:Htr3a,Human:5297|Mouse:MGI:96282|Rat:61818,,,,,,
Target,7,5-HT<sub>2B</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=7,GPCR,5-Hydroxytryptamine receptors,Human:P41595|Mouse:Q02152|Rat:P30994,Human:HTR2B|Mouse:Htr2b|Rat:Htr2b,Human:5294|Mouse:MGI:109323|Rat:61801,,,,,,
Target,6,5-HT<sub>2A</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=6,GPCR,5-Hydroxytryptamine receptors,Human:P28223|Mouse:P35363|Rat:P14842,Human:HTR2A|Mouse:Htr2a|Rat:Htr2a,Human:5293|Mouse:MGI:109521|Rat:61800,,,,,,
Target,5,5-HT<sub>1F</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=5,GPCR,5-Hydroxytryptamine receptors,Human:P30939|Mouse:Q02284|Rat:P30940,Human:HTR1F|Mouse:Htr1f|Rat:Htr1f,Human:5292|Mouse:MGI:99842|Rat:71083,,,,,,
Target,4,5-ht<sub>1e</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=4,GPCR,5-Hydroxytryptamine receptors,Human:P28566,Human:HTR1E,Human:5291,,,,,,
Target,3,5-HT<sub>1D</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3,GPCR,5-Hydroxytryptamine receptors,Human:P28221|Mouse:Q61224|Rat:P28565,Human:HTR1D|Mouse:Htr1d|Rat:Htr1d,Human:5289|Mouse:MGI:96276|Rat:2847,,,,,,
Target,2,5-HT<sub>1B</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2,GPCR,5-Hydroxytryptamine receptors,Human:P28222|Mouse:P28334|Rat:P28564,Human:HTR1B|Mouse:Htr1b|Rat:Htr1b,Human:5287|Mouse:MGI:96274|Rat:2846,,,,,,
Target,1,5-HT<sub>1A</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1,GPCR,5-Hydroxytryptamine receptors,Human:P08908|Mouse:Q64264|Rat:P19327,Human:HTR1A|Mouse:Htr1a|Rat:Htr1a,Human:5286|Mouse:MGI:96273|Rat:2845,,,,,,
Target,2621,4-hydroxyphenylpyruvate dioxygenase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2621,Enzyme,1.-.-.- Oxidoreductases,Human:P32754|Mouse:P49429|Rat:P32755,Human:HPD|Mouse:Hpd|Rat:Hpd,Human:5147|Mouse:MGI:96213|Rat:61974,,,,,,
Target,2464,4-aminobutyrate aminotransferase,GABA-T,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2464,Enzyme,GABA turnover,Human:P80404|Mouse:P61922|Rat:P50554,Human:ABAT|Mouse:Abat|Rat:Abat,Human:23|Mouse:MGI:2443582|Rat:620948,,,,,,
Target,1519,3-phosphoinositide dependent protein kinase 1,PDK1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1519,Enzyme,PDK1 family,Human:O15530|Mouse:Q9Z2A0|Rat:O55173,Human:PDPK1|Mouse:Pdpk1|Rat:Pdpk1,Human:8816|Mouse:MGI:1338068|Rat:620307,,,,,,
Target,1388,15-LOX-1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1388,Enzyme,Lipoxygenases,Human:P16050|Mouse:P39654|Rat:Q02759,Human:ALOX15|Mouse:Alox15|Rat:Alox15,Human:433|Mouse:MGI:87997|Rat:70493,,,,,,
